000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|þpakki||N05AX08|01.04.2000||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|1440|2795|lyfalmen|V1070|1792|00|20|0|2|Vistor hf|Janssen-Cilag AB|||1440||1440|2795 000018|G01AF0501|Pevaryl|krem/sti|0| |15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|A|2|0|0|0|0|JAS|0|0|0|100|SEK|||lyfalmen|||00|15|0|4|Vistor hf|Janssen-Cilag AB||||||0 000020|J07AL0201|Prevenar|stl|0| |0,5|ml|1|hgl||J07AL02|01.10.2002||R|K|2|0|0|0|0|WLV|0|0|0|100|USD|6878|10174|lyfalmen|||02|0|0|0|Icepharma hf|Wyeth Lederle Vaccines SA|||6878||6878|10174 000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|47886|61486|lyfsjukr|||00|2|0|24|Icepharma hf|Roche|||47886||47886|61486 000055|B03XA0103|NeoRecormon|sts|60000|ae/rörly|1|ml|1|rörlyk|+leysir|B03XA01|01.11.2003||R|K|2|0|1|0|1|ROC|0|0|0|100|DKK|129022|162500|lyfsjukr|||00|1|0|60|Icepharma hf|Roche|||129022||129022|162500 000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|71751|91197|lyfsjukr|||00|2|0|36|Icepharma hf|Roche|||71751||71751|91197 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|10901|15634|lyfalmen|||00|28|0|14|Icepharma hf|Eli Lilly Nederland -|||10901||10901|15634 000166|A07FA0201|Precosa|hylki|250|mg|20|stk|1|glas||A07FA02|01.12.1998||R|A|3|0|0|0|0|LAO|0|0|0|100|IKR|104|982|lyfalmen|||00|20|0|5|Vistor hf|Laboratories Biocodex|||104||104|982 000182|A07FA0201|Precosa|hylki|250|mg|50|stk|1|glas||A07FA02|01.12.1998||R|A|3|0|0|0|0|LAO|0|0|0|100|IKR|239|1165|lyfalmen|||00|50|0|12|Vistor hf|Laboratories Biocodex|||239||239|1165 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|32436|42568|lyfalmen|||00|28|0|42|Icepharma hf|Eli Lilly Nederland -|||32436||32436|42568 000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|42183|54703|lyfalmen|||00|28|0|56|Icepharma hf|Eli Lilly Nederland -|||42183||42183|54703 000198|N05AH0302|Zyprexa Velotab|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|21222|28606|lyfalmen|V0813|28078|00|28|0|28|Icepharma hf|Eli Lilly Nederland -|||21222||21222|28606 000211|J07AL0201|Prevenar|stl|0| |0,5|ml|1|spr|áfyllt sprauta|J07AL02|01.04.2006||R|K|2|0|0|0|0|WLV|0|0|0|100|USD|6878|10174|lyfalmen|||02|0|0|0|Icepharma hf|Wyeth Lederle Vaccines SA|||6878||6878|10174 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|6208|8888|lyfsjukr|||00|1|0|0|Vistor hf|Ferring|||6208||6208|8888 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|7977|15366|vetalmen|||00|100|0|0|Vistor hf|Boehringer Ingelheim|||7977||7977|15366 000237|G02CX0101|Tractocile|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|18491|24889|lyfsjukr|||00|5|0|0|Vistor hf|Ferring|||18491||18491|24889 000240|D07AC1301|Elocon|áburður|1|mg/g|50|ml|1|glas||D07AC13|01.04.1994||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|2024|3587|lyfalmen|||20|50|0|50|Vistor hf|Schering-Plough|||2024||2024|3587 000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|21243|28633|lyfalmen|||00|0|0|1|Vistor hf|N.V. Organon|||21243||21243|28633 000315|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|30|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|5642|8078|lyfsjukr|||00|3000|0|3|Icepharma hf|Fresenius Kabi|||5642||5642|8078 000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|42139|54648|lyfalmen|||00|1|0|6|Vistor hf|N.V. Organon|||42139||42139|54648 000373|N02CC0402|Maxalt Smelt|munnltfl|10|mg|6|stk|1|þpakki||N02CC04|01.03.1999||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|5956|8923|lyfalmen|||00|6|0|6|Icepharma hf|M.S.D.|||5956||5956|8923 000390|J01CR0202|Augmentin|sts|600|mg/hgl|10|hgl|1|pakki|500+100 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2534|3628|lyfsjukr|||00|10|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2534||2534|3628 000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2175|3114|lyfsjukr|||00|5|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2175||2175|3114 000530|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|20|spr|án nála|J07BF03|01.06.2005||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|29388|38773|lyfalmen|||02|10|0|0|Icepharma hf|Sanofi Pasteur MSD|||29388||29388|38773 000548|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|2056|3630|lyfalmen|||06|5|0|0|Vistor hf|Novartis Healthcare A/S-|||2056||2056|3630 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|5455|8243|lyfalmen|||23|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5455||5455|8243 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|4277|6644|lyfalmen|||00|60|0|3|Vistor hf|Janssen-Cilag AB|||4277||4277|6644 000565|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.07.2001||L|A|2|0|0|0|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|8|0|0|Vistor hf|Novartis Healthcare A/S-||||||4428 000573|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|5841|8767|lyfalmen|||00|24|0|0|Vistor hf|Novartis Healthcare A/S-|||5841||5841|8767 000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|fl||B05BA02|01.04.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|15701|21415|lyfsjukr|||00|1000|0|1|Icepharma hf|Fresenius Kabi|||15701||15701|21415 000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|4808|7365|lyfalmen|||00|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||||4808|7365 000770|V08BA0104|E-Z paste|pasta|60|%|1|lbs|1|pakki|til inntöku|V08BA01|01.01.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|2590|3708|lyfsjukr|||00|1|1|0|Parlogis hf|Parlogis - óskráð lyf|||2590||2590|3708 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|3977|6237|lyfalmen|||23|2|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3977||3977|6237 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|125|0|2|Vistor hf|McNeil Denmark ApS||||||0 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|125|0|1|Vistor hf|McNeil Denmark ApS||||||0 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|171478|215358|lyfsjukr|||00|6|0|123|Gróco ehf|Serono Nordic|||171478||171478|215358 000891|M05BA0101|Didronate|töflur|200|mg|60|stk|1|þpakki||M05BA01|01.04.1996||R|A|4|0|0|E|0|PGA|0|0|0|100|DKK|14629|20398|lyfalmen|||00|60|0|30|Sofus Consulting AB|Procter & Gamble-|||14629||14629|20398 000957|H01AC0101|Genotropin|sts|0| |5|mg|1|hgl|+ leysir 1 ml|H01AC01|01.05.2001||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|35778|46411|lyfsjukr|||02|5|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||35778||35778|46411 001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|6636|9501|lyfsjukr|||02|0|0|1|Vistor hf|N.V. Organon|||6636||6636|9501 001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|þpakki||M01AH01|01.03.2003||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1800|3283|lyfalmen|||00|10|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1800||1800|3283 001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|þpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|12424|17653|lyfalmen|||00|30|0|240|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||12424||12424|17653 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|þpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|25032|33350|lyfalmen|||00|100|0|800|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||25032||25032|33350 001291|C07AB0206|Seloken ZOC|forðatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2387|4080|lyfalmen|||43|100|0|16|Vistor hf|AstraZeneca A/S DK|||2387||2387|4080 001324|C09CA0201|Teveten|töflur|600|mg|98|stk|1|þpakki||C09CA02|01.08.2001||R|A|3|0|0|B|0|SOP|0|0|0|100|XEU|12356|17568|lyfalmen|||00|98|0|98|Icepharma hf|Solvay Pharmaceuticals|||12356||12356|17568 001337|V08CA0901|Gadovist|stl|1|mmol/ml|30|ml|10|hgl||V08CA09|01.12.2003||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|419497|524141|lyfsjukr|||02|300|0|0|Icepharma hf|Bayer Schering Pharma AG|||419497||419497|524141 001346|C09CA0201|Teveten|töflur|400|mg|56|stk|1|þpakki||C09CA02|01.10.2001||R|A|3|0|0|B|0|SOP|0|0|0|100|XEU|4893|7480|lyfalmen|||00|56|0|37|Icepharma hf|Solvay Pharmaceuticals|||4893||4893|7480 001386|C10AA0102|Sivacor|töflur|10|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1400|2740|lyfalmen|||00|28|0|19|Actavis Group hf|Actavis hf|||1400||1400|2740 001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|34080|44297|lyfsjukr|||02|2|0|5|Vistor hf|N.V. Organon|||34080||34080|44297 001400|C10AA0102|Sivacor|töflur|10|mg|98|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|868|2018|lyfalmen|V0358|2018|00|98|0|65|Actavis Group hf|Actavis hf|||868||868|2018 001409|C10AA0102|Sivacor|töflur|20|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|928|2100|lyfalmen|||00|28|0|37|Actavis Group hf|Actavis hf|||928||928|2100 001422|C10AA0102|Sivacor|töflur|20|mg|98|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1050|2265|lyfalmen|V0365|2265|00|98|0|131|Actavis Group hf|Actavis hf|||1050||1050|2265 001431|C10AA0102|Sivacor|töflur|40|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|2700|4504|lyfalmen|||00|28|0|75|Actavis Group hf|Actavis hf|||2700||2700|4504 001442|C10AA0102|Sivacor|töflur|40|mg|98|stk|1|plglas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1630|3052|lyfalmen|V0367|3035|00|98|0|261|Actavis Group hf|Actavis hf|||1630||1630|3052 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|6996|10334|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|||6996||6996|10334 001512|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|þpakki||C04AD03|01.05.2002||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|4307|6685|lyfalmen|||10|100|0|40|Vistor hf|Sanofi-aventis Norge AS|||4307||4307|6685 001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|þpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|883|2039|lyfalmen|||10|30|0|30|Actavis Group hf|Actavis hf|||883||883|2039 001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|þpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|2456|4173|lyfalmen|||10|100|0|100|Actavis Group hf|Actavis hf|||2456||2456|4173 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|28108|36862|lyfsjukr|||00|4104|0|0|Icepharma hf|Fresenius Kabi|||28108||28108|36862 001599|B03AC0201|Venofer|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.07.2005||R|A|3|0|0|E|0|SKY|0|0|1|100|CHF|15427|21392|lyfalmen|V0011|18085|00|25|0|5|Icepharma hf|SkyPharma PLC|||15427||15427|21392 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|38092|49292|lyfsjukr|||00|6160|0|6|Icepharma hf|Fresenius Kabi|||38092||38092|49292 001622|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|2|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|25848|34048|lyfsjukr|||00|5132|0|5|Icepharma hf|Fresenius Kabi|||25848||25848|34048 001685|B05AA0108|Albuminativ 200 g/l|irl|200|mg/ml|50|ml|1|hgl||B05AA01|01.03.1981||R|A|5|0|0|0|1|OCT|0|0|0|100|DKK|7260|10395|lyfsjukr|||02|50|0|0|Vistor hf|Octapharma AB|||7260||7260|10395 001693|B05AA0108|Albuminativ 200 g/l|irl|200|mg/ml|100|ml|1|hgl||B05AA01|01.03.1981||R|A|5|0|0|0|1|OCT|0|0|0|100|DKK|11593|16301|lyfsjukr|||02|100|0|0|Vistor hf|Octapharma AB|||11593||11593|16301 001792|N02BA0109|Alka-Seltzer|freyðit|324|mg|20|stk|1|pakki||N02BA01|01.08.2004||L|A|3|0|0|0|0|BAS|0|0|1|100|DKK|||lyfalmen|||00|20|0|2|Vistor hf|Bayer A/S||||||0 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|K|3|0|0|0|1|NOH|0|0|0|100|DKK|1360|1947|lyfsjukr|||02|10|0|10|Vistor hf|Novartis Healthcare A/S-|||1360||1360|1947 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|4196|6535|lyfalmen|||06|15|0|75|K.Pétursson hf|Alcon|||4196||4196|6535 001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|1069|2291|lyfalmen|||00|7|0|5|Vistor hf|AstraZeneca A/S DK|||1069||1069|2291 001894|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|glas|300+150+300 mg|J05AR04|01.08.2003||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|77962|98930|lyfsjukr|||00|60|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||77962||77962|98930 001954|N05AX0802|Rison|töflur|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|2358|4040|lyfalmen|V0791|4040|00|60|0|12|Actavis Group hf|Actavis hf|||2358||2358|4040 001957|N05AX0802|Rison|töflur|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|12969|18331|lyfalmen|V0795|18331|00|60|0|48|Actavis Group hf|Actavis hf|||12969||12969|18331 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|A|3|0|0|0|0|BIG|0|0|0|100|SEK|4565|7035|lyfalmen|||00|45|0|45|Icepharma hf|Bioglan AB|||4565||4565|7035 001965|N05AX0802|Rison|töflur|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|5475|8270|lyfalmen|V0793|8270|00|60|0|24|Actavis Group hf|Actavis hf|||5475||5475|8270 001974|J01CA0801|Selexid|töflur|200|mg|100|stk|1|glas||J01CA08|01.10.1990||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|9447|13660|lyfalmen|V0456|13538|43|100|0|33|Vistor hf|LEO Pharma A/S|||9447||9447|13660 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|4007|6278|lyfalmen|V0084|6184|00|28|0|19|Vistor hf|AstraZeneca A/S DK|||4007||4007|6278 001986|N05AX0802|Rison|töflur|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|8009|11709|lyfalmen|V0794|11709|00|60|0|36|Actavis Group hf|Actavis hf|||8009||8009|11709 001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|7921|11590|lyfalmen|V0086|11375|00|56|0|37|Vistor hf|AstraZeneca A/S DK|||7921||7921|11590 002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|1410|2754|lyfalmen|||00|7|0|9|Vistor hf|AstraZeneca A/S DK|||1410||1410|2754 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|5280|8006|lyfalmen|V0085|7892|00|28|0|37|Vistor hf|AstraZeneca A/S DK|||5280||5280|8006 002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.01.2000||R|A|2|0|0|B|0|SCH|0|0|0|100|SEK|4836|7403|lyfalmen|||00|100|0|27|Icepharma hf|Schering Oy|||4836||4836|7403 002169|B05BA1010|Kabiven Peripheral|irþ|0| |2400|ml|2|pokar|3ja hólfa poki |B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|22445|29812|lyfsjukr|||00|4800|0|5|Icepharma hf|Fresenius Kabi|||22445||22445|29812 002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|þpakki|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|6454|9599|lyfalmen|||00|50|0|33|Vistor hf|AstraZeneca A/S DK|||6454||6454|9599 002186|B05BA1010|Kabiven Peripheral|irþ|0| |1920|ml|2|pokar|3ja hólfa poki|B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|20075|26861|lyfsjukr|||00|3840|0|4|Icepharma hf|Fresenius Kabi|||20075||20075|26861 002194|B05BA1010|Kabiven Peripheral|irþ|0| |1440|ml|4|pokar|3ja hólfa poki|B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|32850|42766|lyfsjukr|||00|5760|0|6|Icepharma hf|Fresenius Kabi|||32850||32850|42766 002197|A02BC0501|Nexium|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|14000|19615|lyfalmen|V0087|19265|00|100|0|67|Vistor hf|AstraZeneca A/S DK|||14000||14000|19615 002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|veski|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|8421|12268|lyfalmen|||00|50|0|67|Vistor hf|AstraZeneca A/S DK|||8421||8421|12268 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|A|2|0|0|*|0|NON|0|0|0|100|DKK|4099|6403|lyfalmen|||02|10|0|25|Vistor hf|Novo-Nordisk|||4099||4099|6403 002219|A02BC0501|Nexium|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|18820|25616|lyfalmen|V0089|25244|00|100|0|133|Vistor hf|AstraZeneca A/S DK|||18820||18820|25616 002237|D05AX0201|Daivonex|smyrsli|50|mcg/g|60|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|4360|6757|lyfalmen|||00|60|0|0|Vistor hf|LEO Pharma A/S|||4360||4360|6757 002263|D05AX0201|Daivonex|smyrsli|50|mcg/g|120|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7128|10513|lyfalmen|||00|120|0|0|Vistor hf|LEO Pharma A/S|||7128||7128|10513 002265|D05AX0201|Daivonex|krem|50|mcg/g|120|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7470|10978|lyfalmen|||00|120|0|120|Vistor hf|LEO Pharma A/S|||7470||7470|10978 002276|D05AX0201|Daivonex|krem|50|mcg/g|60|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|4348|6741|lyfalmen|||00|60|0|60|Vistor hf|LEO Pharma A/S|||4348||4348|6741 002312|D01AE1501|Lamisil|hlaup|10|mg/g|15|g|1|túpa||D01AE15|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|15|0|15|Artasan ehf|Novartis Healthcare A/S-A||||||0 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.08.2002||R|A|2|0|0|B|0|MSD|0|0|0|100|XEU|21985|29556|lyfalmen|||00|98|0|39|Icepharma hf|M.S.D.|||21985||21985|29556 002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|103149|130288|lyfsjukr|||00|1|0|2|ZLB Behring AB|Bayer HealthCare AG-|||103149||103149|130288 002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|51814|66376|lyfsjukr|||00|1|0|1|ZLB Behring AB|Bayer HealthCare AG-|||51814||51814|66376 002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|29700|38844|lyfsjukr|||00|1|0|0|ZLB Behring AB|Bayer HealthCare AG-|||29700||29700|38844 002391|G03AA1201|Yasmin|töflur|0||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.02.2001||R|A|3|0|0|0|0|BAP|0|0|0|100|SEK|2770|4599|lyfalmen|||00|63|0|84|Icepharma hf|Bayer Schering Pharma AG|||||2770|4599 002405|C09AA0206|Enalapril Merck NM|töflur|2,5|mg|50|stk|1|þpakki||C09AA02|01.10.2007||R|A||0|0|B|0|PCO|0|0|0|100|IKR|510|1532|lyfalmen|||00|50|1|12|Distica|Distica - óskráð lyf|||510||510|1532 002413|G03AA1204|Yasmin 28|töflur|0| |84|stk|1|þpakki|3+0,03 mg|G03AA12|01.10.2007||R|A|3|0|0|0|0|BAP|0|0|0|100|SEK|2770|4599|lyfalmen|||00|84|0|0|Icepharma hf|Bayer Schering Pharma AG|||2770||2770|4599 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.10.2000||L|A|3|0|0|E|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|10|0|10|Actavis Group hf|Actavis hf||||||1241 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.10.2000||L|A|3|0|0|E|0|ACA|0|0|1|100|IKR|||lyfalmen|V0982|1895|00|30|0|30|Actavis Group hf|Actavis hf||||||1895 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.10.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|2079|3662|lyfalmen|V0984|3662|00|100|0|100|Actavis Group hf|Actavis hf|||2079||2079|3662 002616|S01LA0101|Visudyne|irs|15|mg/hgl|1|hgl|1|pakki||S01LA01|01.12.2000||R|A|4|0|1|0|1|NOO|0|0|0|100|DKK|207864|260658|lyfsjukr|||00|1|0|0|Vistor hf|Novartis Ophthalmics Europe Ltd.|||207864||207864|260658 002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|204|0|7|Artasan ehf|Novartis Healthcare A/S-A||||||0 002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|A|1,5|0|0|*|0|SAO|0|0|0|100|XEU|1439|2793|lyfalmen|||07|5|0|25|Icepharma hf|Santen Oy|||1439||1439|2793 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|K|3|0|1|0|1|ALL|0|0|0|100|SEK|30350|39653|lyfsjukr|||02|1|0|0|Vistor hf|Allergan|||30350||30350|39653 002966|G03GA0502|Gonal-f|sts|1050|ae|1|hgl|1|pakki|á 1,75 ml + leysir |G03GA05|01.02.2002||R|A|1|0|1|E|0|SEN|0|0|0|100|SEK|66329|84765|lyfalmen|||00|1|0|14|Gróco ehf|Serono Nordic|||66329||66329|84765 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.06.2007||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|16937|15898|lyfalmen|V0193|15898|00|98|0|196|Icepharma hf|M.S.D.|||11096||11096|15898 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|14107|19748|lyfalmen|||00|100|0|12|Vistor hf|U.C.B|||14107||14107|19748 003099|L01DB0104|Myocet|irl|50|mg|2|sett|1|pakki||L01DB01|01.07.2006||R|K|1,5|0|1|0|1|ZEP|0|0|0|100|DKK|292328|365816|lyfsjukr|||02|2|0|0|Icepharma hf|Zeneus Pharma Limited-|||292328||292328|365816 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|20789|28067|lyfalmen|V1710|28066|00|100|0|25|Vistor hf|U.C.B|||20789||20789|28067 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|47360|61148|lyfalmen|||00|100|0|50|Vistor hf|U.C.B|||47360||47360|61148 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|8914|12937|lyfalmen|||00|1|0|0|Vistor hf|Pierre Fabre Pharma|||8914||8914|12937 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|13299|18742|lyfalmen|||00|1|0|0|Vistor hf|Pierre Fabre Pharma|||13299||13299|18742 003195|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|19690|26382|lyfsjukr|||00|2|0|9|Vistor hf|Amgen|||19690||19690|26382 003208|B03XA0201|Aranesp|stl|15|mcg/spr|0,375|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|29333|38387|lyfsjukr|||00|2|0|13|Vistor hf|Amgen|||29333||29333|38387 003230|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|33150|43139|lyfsjukr|||00|2|0|18|Vistor hf|Amgen|||33150||33150|43139 003238|J07AM0101|Tetavax|stl|40|ae|0,5|ml|1|lykja||J07AM01|01.03.2006||R|K||0|0|0|0|LDR|0|0|1|100|IKR|557|1596|lyfalmen|||00|0|1|0|Parlogis hf|Parlogis - óskráð lyf|||557||557|1596 003252|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|49217|63143|lyfsjukr|||00|1|0|27|Vistor hf|Amgen|||49217||49217|63143 003274|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|64577|82266|lyfsjukr|||00|2|0|36|Vistor hf|Amgen|||64577||64577|82266 003296|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|79499|100844|lyfsjukr|||00|2|0|44|Vistor hf|Amgen|||79499||79499|100844 003298|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.04.2007||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|208300|261201|lyfsjukr|||02|150|0|0|Icepharma hf|Bayer Schering Pharma AG|||208300||208300|261201 003310|R03AK0701|Symbicort Turbuhaler|innúðadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|8173|11932|lyfalmen|||00|120|0|30|Vistor hf|AstraZeneca A/S DK|||8173||8173|11932 003318|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|97220|122906|lyfsjukr|||00|1|0|53|Vistor hf|Amgen|||97220||97220|122906 003325|R03AK0702|Symbicort mite Turbuhaler|innúðadu|84,5|mcg/sk|120|sk|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|7469|10976|lyfalmen|||00|120|0|15|Vistor hf|AstraZeneca A/S DK|||7469||7469|10976 003340|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|144649|181956|lyfsjukr|||00|2|0|71|Vistor hf|Amgen|||144649||144649|181956 003353|L04AA1001|Rapamune|töflur|1|mg|100|stk|1|þpakki||L04AA10|01.04.2004||R|A|1,5|0|1|*|0|WTE|0|0|0|100|USD|71130|90742|lyfalmen|||00|100|0|33|Icepharma hf|Wyeth Europe|||71130||71130|90742 003355|D01AE1501|Lamisil|úðalausn|10|mg/g|15|ml|1|fl|úðalausn á húð|D01AE15|01.04.2002||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|15|0|15|Artasan ehf|Novartis Healthcare A/S-A||||||0 003362|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|154641|194396|lyfsjukr|||00|2|0|89|Vistor hf|Amgen|||154641||154641|194396 003386|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|231553|290151|lyfsjukr|||00|1|0|133|Vistor hf|Amgen|||231553||231553|290151 003395|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|spr|áfyllt sprauta|B03XA02|01.12.2003||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|115859|146112|lyfsjukr|||00|1|0|67|Vistor hf|Amgen|||115859||115859|146112 003423|A10BG0301|Actos|töflur|15|mg|28|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|4368|6768|lyfalmen|||00|28|0|14|Eli Lilly Danmark A/S|Takeda Europe -|||4368||4368|6768 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|þpakki||A02BB01|01.08.2002||R|A|3|0|0|E|0|PFI|0|0|0|30|DKK|3750|5929|lyfalmen|||00|60|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3750||3750|5929 003800|A10BG0301|Actos|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|15045|20916|lyfalmen|||00|98|0|49|Eli Lilly Danmark A/S|Takeda Europe -|||15045||15045|20916 003809|A10BG0301|Actos|töflur|30|mg|28|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|6716|9954|lyfalmen|||00|28|0|28|Eli Lilly Danmark A/S|Takeda Europe -|||6716||6716|9954 003831|A10BG0301|Actos|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|22453|30139|lyfalmen|||00|98|0|98|Eli Lilly Danmark A/S|Takeda Europe -|||||22453|30139 003869|R01BA5202|Clarinase|forðatfl|10|mg|10|stk|1|pakki|þp 10+240 mg|R01BA52|01.09.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|926|2097|lyfalmen|||00|10|0|10|Vistor hf|Schering-Plough|||926||926|2097 003910|B03XA0102|Eprex|stl|6000|ae/spr|0,6|ml|6|spr||B03XA01|01.01.2002|31.01.2009|R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|65489|83401|lyfsjukr|||51|4|0|36|Vistor hf|Janssen-Cilag AB|||65489||65489|83401 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|1170|2428|lyfalmen|V0931|2428|00|28|0|28|Actavis Group hf|Actavis hf|||1170||1170|2428 003932|B03XA0102|Eprex|stl|8000|ae/spr|0,8|ml|6|spr||B03XA01|01.01.2002|31.01.2009|R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|81874|103801|lyfsjukr|||51|5|0|48|Vistor hf|Janssen-Cilag AB|||81874||81874|103801 003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|þpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|676|1758|lyfalmen|||67|20|0|10|Vistor hf|Novartis Healthcare A/S-|||676||676|1758 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|4068|6361|lyfalmen|V0933|6361|00|98|0|98|Actavis Group hf|Actavis hf|||4068||4068|6361 003974|J05AE0601|Kaletra|mixtúra|100|mg/ml|60|ml|1|glas|80 + 20 mg/ml|J05AE06|01.08.2003||R|A|2|0|1|0|1|ABL|0|0|0|100|DKK|99816|126138|lyfsjukr|||00|60|0|8|Vistor hf|Abbott Laboratories A/S|||99816||99816|126138 003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2848|4705|lyfalmen|V0608|2063|67|100|0|50|Vistor hf|Novartis Healthcare A/S-|||2848||2848|4705 004002|L04AD0101|Sandimmun|irþ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|35201|45693|lyfsjukr|||00|50|0|10|Vistor hf|Novartis Healthcare A/S-|||35201||35201|45693 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|8408|12250|lyfalmen|||00|250|0|15|Vistor hf|Novartis Healthcare A/S-|||8408||8408|12250 004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|A|5|0|0|0|0|JAS|0|0|0|100|SEK|||lyfalmen|||00|100|0|2|Vistor hf|Janssen-Cilag AB||||||0 004050|R03AK0601|Seretide|innúðal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|A|1|0|0|B|0|GSK|0|0|0|100|GBP|4033|6313|lyfalmen|||23|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||4033||4033|6313 004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|þpakki||N06AB06|01.05.2003||R|A|5|0|0|B|0|PFI|0|1|0|30|DKK|629|1694|lyfalmen|||00|7|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||629||629|1694 004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|þpakki||N05CD01|01.12.2000||R|A|5|0|0|0|0|VAL|0|0|1|100|DKK|1125|2367|lyfalmen|||10|30|0|15|Icepharma hf|Valeant Pharmaceuticals B.V.|||1125||1125|2367 004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|þpakki|hart hylki|N05AE04|01.03.2003||R|A|4|0|0|0|0|PFI|0|1|0|100|DKK|6570|9756|lyfalmen|||00|14|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6570||6570|9756 004282|R03AK0601|Seretide|innúðal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|5885|8827|lyfalmen|||23|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||5885||5885|8827 004293|R03AK0601|Seretide|innúðal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|8191|11956|lyfalmen|||23|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||8191||8191|11956 004298|R06AX2701|Aerius|töflur|5|mg|10|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|796|1921|lyfalmen|||00|10|0|10|Vistor hf|Schering-Plough|||796||796|1921 004301|N06AX1101|Remeron|mixtúra|15|mg/ml|66|ml|1|fl|lausn|N06AX11|01.01.2003||R|A|2|0|0|B|0|ORG|0|1|0|100|DKK|6297|9386|lyfalmen|||00|66|0|33|Vistor hf|N.V. Organon|||6297||6297|9386 004338|B03XA0102|Eprex|stl|1000|ae/spr|0,5|ml|6|spr|einnotaspr|B03XA01|01.10.1994|31.01.2009|R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|11358|16008|lyfsjukr|||51|3|0|6|Vistor hf|Janssen-Cilag AB|||11358||11358|16008 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|25831|34027|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||25831||25831|34027 004364|B03XA0102|Eprex|stl|2000|ae/spr|0,5|ml|6|spr|einnotaspr|B03XA01|01.10.1994|31.01.2009|R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|22733|30170|lyfsjukr|||51|3|0|12|Vistor hf|Janssen-Cilag AB|||22733||22733|30170 004370|R06AX2701|Aerius|töflur|5|mg|30|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|2300|3962|lyfalmen|V1901|3901|00|30|0|30|Vistor hf|Schering-Plough|||2300||2300|3962 004372|B03XA0102|Eprex|stl|4000|ae/spr|0,4|ml|6|spr|einnotaspr|B03XA01|01.10.1994|31.01.2009|R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|44983|57871|lyfsjukr|||51|2|0|24|Vistor hf|Janssen-Cilag AB|||44983||44983|57871 004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|glas||A04AA01|01.01.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|8197|11964|lyfalmen|||0|10|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||8197||8197|11964 004375|B03XA0102|Eprex|stl|3000|ae/spr|0,3|ml|6|spr|einnotaspr|B03XA01|01.10.1994|31.01.2009|R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|34016|44217|lyfsjukr|||51|2|0|18|Vistor hf|Janssen-Cilag AB|||34016||34016|44217 004378|R06AX2701|Aerius|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|5397|8164|lyfalmen|||00|100|0|100|Vistor hf|Schering-Plough|||||5397|8164 004383|B03XA0102|Eprex|stl|10000|ae/spr|1|ml|6|spr|einnotaspr|B03XA01|01.10.1994|31.01.2009|R|K|2.5|0|1|0|1|JAS|0|0|0|100|SEK|90448|114475|lyfsjukr|||51|6|0|60|Vistor hf|Janssen-Cilag AB|||90448||90448|114475 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|0| |5|ml|20|spr||QJ51RC25|01.12.1978||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|4852|9414|vetalmen|||16|100|0|0|Vistor hf|Boehringer Ingelheim|||4852||4852|9414 004455|N02AX0208|Zytram|forðatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|3449|5521|lyfalmen|||00|56|0|14|Icepharma hf|Norpharma |||3449||3449|5521 004465|C01DA0801|Sorbangil|töflur|5|mg|100|stk|1|þpakki||C01DA08|01.06.1980||R|A|3|0|0|B|0|REP|0|0|0|100|DKK|947|1747|lyfalmen|||00|100|0|8|Vistor hf|Recip AB|||668||668|1747 004468|J07BC0203|Vaqta|bóluefni|25|ein|0,5|ml|1|spr|áfyllt spr. án nálar|J07BC02|01.03.2001||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|3391|5442|lyfalmen|||51|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||3391||3391|5442 004478|N02AX0208|Zytram|forðatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|4601|7084|lyfalmen|||00|56|0|19|Icepharma hf|Norpharma |||4601||4601|7084 004487|L01BC0301|Uft|hylki|324|mg|21|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|34891|45307|lyfsjukr|||00|21|0|0|Merck AB|Merck KgaA (M)|||34891||34891|45307 004489|N02AX0208|Zytram|forðatfl|150|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|6498|9658|lyfalmen|||00|56|0|28|Icepharma hf|Norpharma |||6498||6498|9658 004500|N02AX0208|Zytram|forðatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|8649|12578|lyfalmen|||00|56|0|37|Icepharma hf|Norpharma |||8649||8649|12578 004502|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|0,5|ml|1|dæla|einnota dæla|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1949|3485|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1949||1949|3485 004532|L01BC0301|Uft|hylki|324|mg|35|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|58151|74265|lyfsjukr|||00|35|0|0|Merck AB|Merck KgaA (M)|||58151||58151|74265 004543|L01BC0301|Uft|hylki|324|mg|42|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|69782|88746|lyfsjukr|||00|42|0|0|Merck AB|Merck KgaA (M)|||69782||69782|88746 004565|L01BC0301|Uft|hylki|324|mg|28|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|46522|59787|lyfsjukr|||00|28|0|0|Merck AB|Merck KgaA (M)|||46522||46522|59787 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.06.2005||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|7026|10375|lyfalmen|||00|90|0|180|Vistor hf|Aventis Pharma |||7026||7026|10375 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|2556|4309|lyfalmen|V0926|4309|00|100|0|100|Actavis Group hf|Actavis hf|||2556||2556|4309 004611|H01AC0104|Saizen|sts|8|mg/hgl|1|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|A|3|0|1|0|1|EME|0|0|0|100|SEK|38889|50284|lyfsjukr|||00|1|0|4|MedFarm ehf|E. Merck AB|||38889||38889|50284 004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|A|2|0|0|0|0|AGT|0|0|1|100|DKK|2041|3610|lyfalmen|||20|25|0|25|Actavis Group hf|Actavis Group hf|||2041||2041|3610 004613|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|1|ml|1|dæla|einnotadæl|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2526|4268|lyfalmen|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2526||2526|4268 004623|J07BC0203|Vaqta|bóluefni|50|ein|1|ml|1|spr|áfyllt spr. án nálar|J07BC02|01.03.2001||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|5066|7715|lyfalmen|||51|1|0|0|Icepharma hf|Sanofi Pasteur MSD|||5066||5066|7715 004625|N06AB0402|Oropram|töflur|40|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|1836|3332|lyfalmen|V0927|3332|00|28|0|56|Actavis Group hf|Actavis hf|||1836||1836|3332 004636|N06AB0402|Oropram|töflur|40|mg|56|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|5188|7881|lyfalmen|V0929|7881|00|56|0|112|Actavis Group hf|Actavis hf|||5188||5188|7881 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|5614|8459|lyfalmen|V0930|8459|00|100|0|200|Actavis Group hf|Actavis hf|||5614||5614|8459 004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|776|1893|lyfalmen|V0921|1893|00|28|0|14|Actavis Group hf|Actavis hf|||776||776|1893 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|2703|4508|lyfalmen|V0922|4508|00|100|0|50|Actavis Group hf|Actavis hf|||2703||2703|4508 004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|1269|2562|lyfalmen|V0923|2562|00|28|0|28|Actavis Group hf|Actavis hf|||1269||1269|2562 004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|A|3|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|100|0|0|Vistor hf|Medic Team||||||0 004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|K|2|0|1|0|1|BIA|0|0|0|100|DKK|45400|58391|lyfsjukr|||00|5|0|7|Vistor hf|Biovitrum AB (publ)|||45400||45400|58391 004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|1778|3253|lyfalmen|V0925|3253|00|56|0|56|Actavis Group hf|Actavis hf|||1778||1778|3253 004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|150|0|5|Actavis Group hf|Actavis hf||||||0 004699|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|spr||L04AC03|01.04.2007||R|K|2|0|1|0|1|BIA|0|0|0|100|DKK|174783|219472|lyfsjukr|||00|19|0|28|Vistor hf|Biovitrum AB (publ)|||174783||174783|219472 004733|H01AC0104|Saizen|sts|8|mg/hgl|5|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|A|3|0|1|0|1|EME|0|0|0|100|SEK|194449|243957|lyfsjukr|||00|5|0|20|MedFarm ehf|E. Merck AB|||194449||194449|243957 004746|A10AE0401|Lantus [OptiPen]|stl|100|ein/ml|3|ml|5|rörlyk|fyrir OptiPen|A10AE04|01.06.2004||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|9377|13565|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|||9377||9377|13565 004811|J01XD0105|Metronidazol Actavis|irl|5|mg/ml|100|ml|10|poki||J01XD01|01.04.1990||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|11564|16265|lyfsjukr|||00|1000|0|3|Actavis Group hf|Actavis Group hf|||11564||11564|16265 004822|J01XD0105|Metronidazol Actavis|irl|5|mg/ml|200|ml|10|poki||J01XD01|01.04.1990||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|21541|28684|lyfsjukr|||00|2000|0|7|Actavis Group hf|Actavis Group hf|||21539||21539|28684 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|þpakki||P01AB01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|690|1777|lyfalmen|||41|24|0|3|Actavis Group hf|Actavis Group hf|||690||690|1777 004863|R03DX0501|Xolair|sts|150|mg|2|ml|1|hgl|+ leysir, lausn|R03DX05|01.01.2006||R|A|4|0|1|0|1|NOE|0|0|0|100|XEU|73282|93104|lyfsjukr|||00|2|0|9|Vistor hf|Novartis Europharm Ltd|||73282||73282|93104 004880|J01FA1001|Zitromax|irs|500|mg/hgl|1|hgl|1|pakki||J01FA10|01.05.2003||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|5753|8237|lyfsjukr|||00|1|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5753||5753|8237 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|408|1394|lyfalmen|||41|8|0|2|Actavis Group hf|Actavis Group hf|||408||408|1394 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|697|1786|lyfalmen|||41|14|0|4|Actavis Group hf|Actavis Group hf|||697||697|1786 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|1319|2630|lyfalmen|||41|30|0|8|Actavis Group hf|Actavis Group hf|||1319||1319|2630 005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|36|0|2|Artasan ehf|Novartis Healthcare A/S-A||||||0 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|96|0|6|Artasan ehf|Novartis Healthcare A/S-A||||||0 005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|204|0|14|Artasan ehf|Novartis Healthcare A/S-A||||||0 005085|J07AJ5205|Boostrix|stl|0| |0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1701|3149|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1701||1701|3149 005089|J07AL0103|Pneumovax|stl|0||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2462|4181|lyfalmen|||00|1|0|0|Icepharma hf|Sanofi Pasteur MSD|||||2462|4181 005108|G04CA0201|Omnic|forðahlk|0,4|mg|90|stk|1|þpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|10900|10702|lyfalmen|V0437|9478|00|90|0|90|Vistor hf|Yamanouchi Europe|||7267||7267|10702 005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|754|1864|lyfalmen|||10|30|0|4|Actavis Group hf|Actavis hf|||754||754|1864 005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|763|1876|lyfalmen|||10|20|0|5|Actavis Group hf|Actavis hf|||763||763|1876 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1076|2301|lyfalmen|||10|30|0|8|Actavis Group hf|Actavis hf|||1076||1076|2301 005241|R03AK0701|Symbicort Turbuhaler|innúðadu|164,5|mcg/sk|360|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|24520|32712|lyfalmen|||00|360|0|90|Vistor hf|AstraZeneca A/S DK|||24520||24520|32712 005296|N05AH0401|Seroquel|filmhtfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2002||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|44414|57480|lyfalmen|||00|100|0|75|Vistor hf|AstraZeneca UK Ltd|||44414||44414|57480 005303|N02CC0303|Zomig Nasal|nefúði|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|A|2,5|0|0|E|0|ASZ|0|0|0|100|SEK|2930|4817|lyfalmen|||00|10|0|4|Vistor hf|AstraZeneca UK Ltd|||2930||2930|4817 005330|D08AG0201|Betadine|áburður|100|mg/ml|500|ml|1|fl|sprittl.|D08AG02|01.09.1982||L|A|3|0|0|0|0|NAP|0|0|0|100|IKR|||lyfalmen|||00|500|0|500|Icepharma hf|Napp||||||0 005336|R01AA0704|Otrivin ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.07.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||06|10|0|6|Artasan ehf|Novartis Healthcare A/S-A||||||0 005355|S01AA1301|Fucithalmic|augndr|10|mg/g|0,2|g|12|sk-hyl|2 mg/sk|S01AA13|01.04.1992||R|A|2|0|0|E|0|LEP|0|0|1|100|DKK|1196|2463|lyfalmen|||00|2|0|0|Vistor hf|LEO Pharma A/S|||1196||1196|2463 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|stk|1|glas|+ dæla|L02AE03|01.04.1996||R|A|3|0|1|*|0|ASZ|0|0|0|100|SEK|59245|75945|lyfalmen|||00|1|0|84|Vistor hf|AstraZeneca UK Ltd|||||59245|75945 005380|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.04.2004||R|K|1|0|1|*|0|PHO|0|0|0|100|NOK|37556|48942|lyfalmen|||00|2|0|0|Icepharma hf|PhotoCure ASA|||37556||37556|48942 005390|R03BB0101|Atrovent|innúðal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|1578|2982|lyfalmen|||24|200|0|33|Vistor hf|Boehringer Ingelheim|||1578||1578|2982 005503|N05AH0301|Zyprexa|húðuðtfl|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|31424|19010|lyfalmen|V0815|17328|00|28|0|42|Icepharma hf|Eli Lilly Nederland -|||13514||13514|19010 005507|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|4|stk|1|þpakki||M05BA04|01.08.2001||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|5637|8490|lyfalmen|||00|4|0|28|Icepharma hf|M.S.D.|||5637||5637|8490 005526|N05AH0301|Zyprexa|húðuðtfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|39966|51943|lyfalmen|||00|28|0|56|Icepharma hf|Eli Lilly Nederland -|||39966||39966|51943 005538|G03AA0702|Microgyn|töflur|0| |63|stk|1|þpakki||G03AA07|01.06.1977||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1075|2299|lyfalmen|||23|63|0|84|Icepharma hf|Bayer Schering Pharma AG|||1075||1075|2299 005565|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.08.2001||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|15632|21647|lyfalmen|V0718|21647|00|12|0|84|Icepharma hf|M.S.D.|||15632||15632|21647 005576|R05CA1002|Tussol|mixtúra|0| |150|ml|1|glas||R05CA10|01.10.2001||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||01|150|0|0|Actavis Group hf|Actavis hf|||||| 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|A|2|0|0|B|0|BII|0|0|0|100|DKK|7270|10706|lyfalmen|||00|30|0|30|Vistor hf|Boehringer Ingelheim International|||7270||7270|10706 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|A|2|0|0|B|0|BII|0|0|0|100|DKK|7656|11230|lyfalmen|||00|30|0|30|Vistor hf|Boehringer Ingelheim International|||7656||7656|11230 005606|J07AH0703|NeisVac-C|bóluefni|0| |0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|K|3,5|0|0|0|0|BAX|0|0|0|100|USD|4218|6564|lyfalmen|||00|0|0|0|Icepharma hf|Baxter|||4218||4218|6564 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|1697|3143|lyfalmen|||00|30|0|6|Icepharma hf|Servier|||1697||1697|3143 005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|2957|4853|lyfalmen|||00|60|0|11|Icepharma hf|Servier|||2957||2957|4853 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|7852|11496|lyfalmen|||00|180|0|34|Icepharma hf|Servier|||7852||7852|11496 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|4315|6696|lyfalmen|||00|90|0|17|Icepharma hf|Servier|||4315||4315|6696 005689|B01AC0601|Hjartamagnyl|töflur|75|mg|100|stk|1|plglas||B01AC06|01.06.2007||L|A|2|0|0|0|0|ACA|0|0|0|100|IKR|||lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf||||||1456 005747|G03CA0317|Aerodiol|nefúði|150|mcg/sk|180|skammtar|1|pakki|60 skammtar x 3|G03CA03|01.01.2003||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|6532|9705|lyfalmen|||00|180|0|90|Icepharma hf|Servier|||6532||6532|9705 005757|N06AB1001|Cipralex|töflur|5|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|30|DKK|2528|4271|lyfalmen|||00|28|0|14|Lundbeck Export A/S|H. Lundbeck A/S|||2528||2528|4271 005766|H01CC0201|Cetrotide|sts|0,25|mg/hgl|1|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|4640|6643|lyfsjukr|||00|1|0|0|Gróco ehf|Serono Nordic|||4640||4640|6643 005782|L01BB0501|Fludara|filmhtfl|10|mg|15|stk|1|þpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|70858|90086|lyfsjukr|||00|15|0|0|Icepharma hf|Bayer Schering Pharma AG|||70858||70858|90086 005787|H01CC0201|Cetrotide|sts|0,25|mg/hgl|7|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|36375|47154|lyfsjukr|||00|7|0|0|Gróco ehf|Serono Nordic|||36375||36375|47154 005789|H01CC0201|Cetrotide|sts|3|mg/hgl|1|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|36375|47154|lyfsjukr|||00|1|0|0|Gróco ehf|Serono Nordic|||36375||36375|47154 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|30|DKK|7734|11336|lyfalmen|||00|100|0|50|Lundbeck Export A/S|H. Lundbeck A/S|||7734||7734|11336 005812|N06AB1001|Cipralex|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|30|DKK|3439|5507|lyfalmen|V0939|5416|00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|||3439||3439|5507 005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|17567|30401|vetorma|||16|5|0|0|Vistor hf|Merial (MSD)|||17567||17567|30401 005823|N06AB1001|Cipralex|töflur|10|mg|56|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|30|DKK|6817|10091|lyfalmen|||00|56|0|56|Lundbeck Export A/S|H. Lundbeck A/S|||6817||6817|10091 005836|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|79001|100224|lyfsjukr|||00|20|0|0|Icepharma hf|Bayer Schering Pharma AG|||79001||79001|100224 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|30|DKK|12075|17218|lyfalmen|||00|100|0|100|Lundbeck Export A/S|H. Lundbeck A/S|||12075||12075|17218 005867|N06AB1001|Cipralex|töflur|15|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|30|DKK|6013|9000|lyfalmen|||00|28|0|42|Lundbeck Export A/S|H. Lundbeck A/S|||6013||6013|9000 005872|C09DA0701|MicardisPlus|töflur|52,5|mg|28|stk|1|þpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|3337|5369|lyfalmen|||00|28|0|28|Vistor hf|Boehringer Ingelheim International |||3337||3337|5369 005884|P01BC0201|Lariam|töflur|250|mg|8|stk|1|þpakki||P01BC02|01.01.1993||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|3168|5140|lyfalmen|||59|8|0|2|Icepharma hf|Roche|||3168||3168|5140 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|938|2113|lyfalmen|||00|1|0|1|Icepharma hf|Eli Lilly Nederland -|||938||938|2113 005894|C09DA0701|MicardisPlus|töflur|52,5|mg|98|stk|1|þpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|10920|15659|lyfalmen|||00|98|0|98|Vistor hf|Boehringer Ingelheim International |||10920||10920|15659 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|30|DKK|22937|30742|lyfalmen|||00|100|0|150|Lundbeck Export A/S|H. Lundbeck A/S|||22937||22937|30742 005910|C09CA0301|Diovan|töflur|80|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|3907|6142|lyfalmen|||00|28|0|28|Vistor hf|Novartis Healthcare A/S-|||3907||3907|6142 005922|N06AB1001|Cipralex|töflur|20|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|30|DKK|7350|10815|lyfalmen|V1039|10615|00|28|0|56|Lundbeck Export A/S|H. Lundbeck A/S|||7350||7350|10815 005932|C09CA0301|Diovan|töflur|80|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|10619|12972|lyfalmen|V1110|10402|00|98|0|98|Vistor hf|Novartis Healthcare A/S-|||8940||8940|12972 005933|N06AB1001|Cipralex|töflur|20|mg|56|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|30|DKK|14933|20777|lyfalmen|||00|56|0|112|Lundbeck Export A/S|H. Lundbeck A/S|||14933||14933|20777 005954|C09CA0301|Diovan|töflur|160|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|4982|7601|lyfalmen|||00|28|0|56|Vistor hf|Novartis Healthcare A/S-|||4982||4982|7601 005976|C09CA0301|Diovan|töflur|160|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|15003|18293|lyfalmen|V1111|14680|00|98|0|196|Vistor hf|Novartis Healthcare A/S-|||12938||12938|18293 006000|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|90462|114493|lyfsjukr|||00|2|0|1|Gróco ehf|Nycomed Danmark A/S|||90462||90462|114493 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|6681|9907|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|||6681||6681|9907 006026|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|33637|43746|lyfsjukr|||00|60|0|0|Icepharma hf|Mayne Pharma Plc|||33637||33637|43746 006079|J02AX0403|Cancidas|irþ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|XEU|131526|165617|lyfsjukr|||00|1|0|1|Icepharma hf|M.S.D.|||131526||131526|165617 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|A|2,5|0|0|*|0|NON|0|0|0|100|DKK|6537|9711|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|||6537||6537|9711 006111|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|181050|227275|lyfsjukr|||00|3|0|2|Gróco ehf|Nycomed Danmark A/S|||181050||181050|227275 006115|J02AX0403|Cancidas|irþ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|XEU|91723|116063|lyfsjukr|||00|1|0|1|Icepharma hf|M.S.D.|||91723||91723|116063 006172|S01XA2007|Simplex|augnsm|0| |4|g|1|túpa|paraf+vasel án ullarf.|S01XA20|01.07.2003||R|A||0|0|E|0|LDR|0|0|0|100|IKR|760|1872|lyfalmen|||00|4|1|0|Parlogis hf|Parlogis - óskráð lyf|||760||760|1872 006178|A10AE0402|Lantus [Optiset]|stl|100|ein/ml|3|ml|5|pennar||A10AE04|01.11.2005||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|8312|12120|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|||8312||8312|12120 006212|J01MA0202|Ciproxin|irl|2|mg/ml|100|ml|12|pokar||J01MA02|01.12.2001||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|38821|50200|lyfsjukr|||00|1200|0|0|Vistor hf|Bayer HealthCare AG|||38821||38821|50200 006226|J01MA0202|Ciproxin|irl|2|mg/ml|200|ml|12|pokar||J01MA02|01.12.2001||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|66745|84965|lyfsjukr|||00|2400|0|0|Vistor hf|Bayer HealthCare AG|||66745||66745|84965 006346|N03AG0101|Depakine|sh-tfl|500|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|2350|4029|lyfalmen|||43|40|0|13|Vistor hf|Sanofi-aventis Norge AS|||2350||2350|4029 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|9362|18004|vetalmen|||00|50|0|0|Vistor hf|Boehringer Ingelheim|||9362||9362|18004 006579|D05AX5201|Daivobet|smyrsli|0| |60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|9939|14328|lyfalmen|V0391|14068|00|60|0|0|Vistor hf|LEO Pharma A/S|||9939||9939|14328 006637|D05AX5201|Daivobet|smyrsli|0| |120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|14755|20555|lyfalmen|V2001|20188|00|120|0|0|Vistor hf|LEO Pharma A/S|||14755||14755|20555 006650|A04AA0301|Navoban|stl|1|mg/ml|5|ml|10|lykjur||A04AA03|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|DKK|37221|48525|lyfalmen|||02|50|0|10|Vistor hf|Novartis Healthcare A/S-|||37221||37221|48525 006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyfalmen|||00|10|0|2|Icepharma hf|GlaxoSmithKline CH A/S||||||0 006785|G03AC0303|NorLevo|töflur|750|mcg|2|stk|1|þpakki||G03AC03|01.01.2005||L|A|3|0|0|0|0|LHP|0|0|0|100|SEK|||lyfalmen|||23|2|0|0|Gróco ehf|Laboratoire HRA Pharma||||||0 006825|A04AA0301|Navoban|hylki|5|mg|5|stk|1|þpakki||A04AA03|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|DKK|16490|22715|lyfalmen|||10|5|0|5|Vistor hf|Novartis Healthcare A/S-|||16490||16490|22715 006903|L03AX1301|Copaxone|sts|20|mg/hgl|28|hgl|1|pakki|+ leysir|L03AX13|01.01.2001|30.11.2008|R|K|2|0|1|0|1|TEP|0|0|0|100|NOK|138485|174281|lyfsjukr|||00|28|0|28|Vistor hf|Teva Pharmaceuticals Limited|||138485||138485|174281 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|þpakki||C09CA01|01.05.2002||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|18580|25317|lyfalmen|||00|98|0|196|Icepharma hf|M.S.D.|||18580||18580|25317 007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|3968|6225|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca A/S DK|||3968||3968|6225 007104|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|712|1807|lyfalmen|||00|100|0|2|Vistor hf|Sanofi-aventis Norge AS|||712||712|1807 007123|V03AE0201|Renagel|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.01.2004||R|A|2|0|0|0|0|GZE|0|0|0|100|XEU|32624|42802|lyfalmen|||00|180|0|22|Vistor hf|Genzyme Europe B.V.|||32624||32624|42802 007126|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|20|hgl|1|pakki|+ leysir|QJ01CE90|01.12.2002||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|25698|49122|vetalmen|||27|20|0|0|Vistor hf|Boehringer Ingelheim Danmark|||25698||25698|49122 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|12622|17899|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca A/S DK|||12622||12622|17899 007138|N05AA0201|Nozinan|töflur|25|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|1777|3252|lyfalmen|||00|100|0|8|Vistor hf|Sanofi-aventis Norge AS|||1777||1777|3252 007144|C10AA0701|Crestor|filmhtfl|20|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|5945|8908|lyfalmen|||00|28|0|56|Vistor hf|AstraZeneca A/S DK|||5945||5945|8908 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|18915|25734|lyfalmen|||00|98|0|196|Vistor hf|AstraZeneca A/S DK|||18915||18915|25734 007161|N05AA0201|Nozinan|töflur|100|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|5748|8641|lyfalmen|||00|100|0|33|Vistor hf|Sanofi-aventis Norge AS|||5748||5748|8641 007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|7892|11550|lyfalmen|||00|28|0|112|Vistor hf|AstraZeneca A/S DK|||7892||7892|11550 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|27620|36572|lyfalmen|||00|98|0|392|Vistor hf|AstraZeneca A/S DK|||27620||27620|36572 007223|B01AX0001|Ceprotin|sts|500|ae/hgl|1|hgl|1|pakki|+ 5 ml leysir|B01AX00|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|157392|197821|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter|||157392||157392|197821 007268|B01AX0001|Ceprotin|sts|1000|ae/hgl|1|hgl|1|pakki|+ 10 ml leysir|B01AX00|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|278027|348011|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter|||278027||278027|348011 007278|C08CA0302|Lomir Retard|forðahlk|2,5|mg|30|stk|1|þpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|2239|3879|lyfalmen|||10|30|0|15|Vistor hf|Novartis Healthcare A/S-|||2239||2239|3879 007292|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|1|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|2779|4612|lyfalmen|||00|3|0|30|Vistor hf|Allergan|||2779||2779|4612 007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A||||||0 007337|H01CB0302|Ipstyl Autogel|stl|60|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|158689|199435|lyfsjukr|||00|1|0|20|Icepharma hf|Institut Produits Synthése (IPSEN) AB|||158689||158689|199435 007360|H01CB0302|Ipstyl Autogel|stl|120|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|244224|305926|lyfsjukr|||00|1|0|40|Icepharma hf|Institut Produits Synthése (IPSEN) AB|||244224||244224|305926 007363|H01CB0302|Ipstyl Autogel|stl|90|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|212328|266216|lyfsjukr|||00|1|0|30|Icepharma hf|Institut Produits Synthése (IPSEN) AB|||212328||212328|266216 007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A||||||0 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|138549|174361|lyfsjukr|||00|3000|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||138549||138549|174361 007385|A02BA0205|Zantac|töflur|150|mg|20|stk|1|þpakki||A02BA02|01.09.1983||L|A|5|0|0|E|0|GSK|0|0|0|30|IKR|||lyfalmen|||00|20|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf||||||1580 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|þpakki||J01XX08|01.12.2001||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|349054|436440|lyfsjukr|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||349054||349054|436440 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|K|2|0|0|*|0|PFI|0|0|0|100|DKK|3760|5943|lyfalmen|V0988|5841|06|2|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3760||3760|5943 007448|B05XC04|Cernevit|sts|0| |5|ml|10|hgl||B05XC|01.05.2002||R|A|3|0|0|0|1|CPS|0|0|0|100|SEK|7484|10715|lyfsjukr|||02|50|0|0|Icepharma hf|Clintec parenteral SA|||7484||7484|10715 007449|V03AB0001|Fomepizole OPi|irþ|5|mg/ml|20|ml|5|hgl||V03AB00|01.09.2003||R|A|2|0|0|0|1|OPO|0|0|0|100|XEU|128255|161545|lyfsjukr|||00|100|0|0|Swedish Orphan International AB|OPi Orphan Pharma international (S)|||128255||128255|161545 007462|N01AB0801|Sevorane|innönd.l|0| |250|ml|1|plastf||N01AB08|01.03.2002||R|A|3|0|0|0|1|ABS|0|0|0|100|DKK|27329|35892|lyfsjukr|||00|250|0|0|Vistor hf|Abbott Scandinavia AB|||27329||27329|35892 007494|QP52AA0101|Droncit, vet.|hlaup|9|%|6,67|g|1|dæla|til inntöku|QP52AA01|01.04.2002||L|A|2|0|0|0|0|BAN|0|0|0|0|DKK|||vetorma|||16|7|0|0|Vistor hf|Bayer Animal Health GmbH||||||3617 007505|G04BD0702|Detrusitol Retard|forðahlk|1,4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|7309|10759|lyfalmen|||00|30|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||7309||7309|10759 007516|R03BA0701|Asmanex Twisthaler|innúðadu|200|mcg|60|skammtar|1|pakki||R03BA07|01.04.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|5264|7984|lyfalmen|||00|60|0|30|Vistor hf|Schering-Plough Europe|||5264||5264|7984 007534|C09CA0601|Atacand|töflur|16|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3167|5138|lyfalmen|||00|28|0|56|Vistor hf|AstraZeneca A/S DK|||3167||3167|5138 007538|R03BA0701|Asmanex Twisthaler|innúðadu|400|mcg|30|skammtar|1|pakki||R03BA07|01.04.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|5264|7984|lyfalmen|||00|30|0|30|Vistor hf|Schering-Plough Europe|||5264||5264|7984 007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|A|2|0|0|0|1|BRS|0|0|0|100|DKK|9662|13834|lyfsjukr|||00|1200|0|4|Vistor hf|Bristol-Myers Squibb|||9662||9662|13834 007541|J07BL0101|Stamaril|bóluefni|0| |0,5|ml|10|lykjur|+leysir|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|22844|30626|lyfalmen|||02|5|0|0|Icepharma hf|Sanofi Pasteur MSD|||22844||22844|30626 007549|R03BA0701|Asmanex Twisthaler|innúðadu|400|mcg|60|skammtar|1|pakki||R03BA07|01.03.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|10260|14764|lyfalmen|||00|60|0|60|Vistor hf|Schering-Plough Europe|||10260||10260|14764 007559|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|10077|14515|lyfalmen|||00|98|0|196|Vistor hf|AstraZeneca A/S DK|||10077||10077|14515 007575|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|0| |1000|ml|9|plpok|Exel umbúðir|B05BB02|01.04.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2686|3846|lyfsjukr|||02|9000|0|0|Icepharma hf|Fresenius Kabi|||2686||2686|3846 007609|C09CA0601|Atacand|töflur|4|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2413|4115|lyfalmen|||00|28|0|14|Vistor hf|AstraZeneca A/S DK|||2413||2413|4115 007657|QH02AB0602|Prednisolonacetat, vet."Intervet"|stl|10|mg/ml|50|ml|1|hgl||QH02AB06|01.05.1998||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|2000|3947|vetalmen|||58|50|0|0|Icepharma hf|Intervet International B.V.|||2000||2000|3947 007760|G04BD0702|Detrusitol Retard|forðahlk|2,8|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|8137|11883|lyfalmen|||00|30|0|21|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||8137||8137|11883 007769|G04BD0702|Detrusitol Retard|forðahlk|2,8|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|24709|32948|lyfalmen|||00|100|0|70|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||24709||24709|32948 007778|N05AX0802|Rison|töflur|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|1728|3185|lyfalmen|V1075|3185|00|60|0|6|Actavis Group hf|Actavis hf|||1728||1728|3185 007852|G02BB0101|NuvaRing|sk-hring|0| |3|stk|1|pakki|með forðaverkun|G02BB01|01.11.2002||R|A|3,3|0|0|0|0|ORG|0|0|0|100|DKK|4320|6703|lyfalmen|||00|3|0|84|Vistor hf|N.V. Organon|||4320||4320|6703 007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|0| |50|ml|50|pokar|leysir f.stungulyf|V07AB00|01.08.2005||L|A|1,5|0|0|0|0|BAM|0|0|0|100|IKR|||lyfalmen|||00|2500|0|0|Icepharma hf|Baxter Medical AB||||||0 007889|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|0| |100|ml|50|pokar|leysir f.stungulyf|V07AB00|01.02.2006||L|A|1,5|0|0|0|0|BAX|0|0|0|100|IKR|||lyfalmen|||00|5000|0|0|Icepharma hf|Baxter||||||0 007920|S01EX0601|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EX06|01.02.2004||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|2665|4457|lyfalmen|||00|2|0|0|K.Pétursson hf|Alcon|||2665||2665|4457 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|A|3|0|0|0|0|ALC|0|0|0|100|USD|1340|2659|lyfalmen|||00|5|0|0|K.Pétursson hf|Alcon|||1340||1340|2659 007978|B01AD1001|Xigris|irs|20|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|169253|212587|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Nederland -|||169253||169253|212587 007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|XEU|||lyfalmen|||20|15|0|15|Vistor hf|Astellas Pharma A/S||||||0 007995|R07AX0101|INOmax|innö.gas|400|ppm|10|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|23639|31298|lyfsjukr|||00|10|0|0|Ísaga ehf|AGA AB|||23639||23639|31298 007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|glas||H02AB01|01.09.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|729|1830|lyfalmen|||00|30|1|10|Lyfjaver ehf|Lyfjaver - óskráð lyf|||729||729|1830 008010|B01AD1001|Xigris|irs|5|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|42647|54963|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Nederland -|||42647||42647|54963 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|þpakki||A10BA02|01.01.2002||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|703|1794|lyfalmen|||00|30|0|15|Icepharma hf|Merck Santé s.a.s.|||703||703|1794 008028|J05AH0201|Tamiflu|mixtduft|12|mg/ml|1|stk|1|fl|750 mg í flösku|J05AH02|01.11.2002||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|3763|5947|lyfalmen|||00|1|0|5|Icepharma hf|Roche Registration Limited|||3763||3763|5947 008058|B05BA1011|Oliclinomel N4 550E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|25468|33575|lyfsjukr|||00|6000|0|0|Icepharma hf|Baxter Medical AB|||25468||25468|33575 008069|B05BA1011|Oliclinomel N4 550E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|31836|41503|lyfsjukr|||00|8000|0|0|Icepharma hf|Baxter Medical AB|||31836||31836|41503 008086|D07AC0101|Betnovat|krem|1|mg/g|30|g|1|túpa||D07AC01|01.01.1985||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|433|1428|lyfalmen|||20|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||433||433|1428 008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|þpakki||N02CC04|01.03.2003||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|7162|10560|lyfalmen|||00|6|0|3|Icepharma hf|M.S.D.|||7162||7162|10560 008101|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|98206|124134|lyfsjukr|||00|4|0|27|Vistor hf|Schering-Plough|||98206||98206|124134 008102|D07AC0101|Betnovat|krem|1|mg/g|100|g|1|túpa||D07AC01|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1369|2698|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1369||1369|2698 008108|L03AB1001|PegIntron|sts|100|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|197435|247674|lyfsjukr|||00|4|0|53|Vistor hf|Schering-Plough|||197435||197435|247674 008123|J07AH0701|Meningitec|stl|10|mcg/hgl|0,5|ml|1|hgl||J07AH07|01.05.2002|31.12.2008|R|K|3|0|0|0|0|WAB|0|0|0|100|USD|4031|6311|lyfalmen|||00|0|0|0|Icepharma hf|Wyeth AB|||4031||4031|6311 008131|L03AB1001|PegIntron|sts|80|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|143171|180115|lyfsjukr|||00|4|0|43|Vistor hf|Schering-Plough|||143171||143171|180115 008134|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|210741|264240|lyfsjukr|||00|4|0|64|Vistor hf|Schering-Plough|||210741||210741|264240 008145|L03AB1001|PegIntron|sts|150|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|246018|308160|lyfsjukr|||00|4|0|80|Vistor hf|Schering-Plough|||246018||246018|308160 008182|J07AH0701|Meningitec|stl|10|mcg/hgl|0,5|ml|10|hgl||J07AH07|01.05.2002|31.12.2008|R|K|3|0|0|0|0|WAB|0|0|0|100|USD|40319|52381|lyfalmen|||00|5|0|0|Icepharma hf|Wyeth AB|||40319||40318|52381 008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|XEU|||lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S||||||0 008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2159|3770|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|||2159||2159|3770 008197|R06AX2701|Aerius|saft|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2002||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1233|2514|lyfalmen|||00|120|0|12|Vistor hf|Schering-Plough|||1233||1233|2514 008219|D07AC0101|Betnovat|áburður|1|mg/ml|20|ml|1|glas||D07AC01|01.12.1980||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|276|1215|lyfalmen|||20|20|0|20|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||276||276|1215 008223|B05BA1013|Oliclinomel N6 900E|irl|0| |1000|ml|6|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|33539|43624|lyfsjukr|||00|6000|0|0|Icepharma hf|Baxter Medical AB|||33539||33539|43624 008234|B05BA1013|Oliclinomel N6 900E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|26189|34470|lyfsjukr|||00|6000|0|0|Icepharma hf|Baxter Medical AB|||26187||26187|34470 008243|D07AC0101|Betnovat|áburður|1|mg/g|30|ml|1|glas|í hársvörð|D07AC01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|452|1454|lyfalmen|||33|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||452||452|1454 008245|B05BA1013|Oliclinomel N6 900E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|32820|42728|lyfsjukr|||00|8000|0|0|Icepharma hf|Baxter Medical AB|||32820||32820|42728 008300|C09CA0601|Atacand|töflur|4|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|8176|11936|lyfalmen|||00|98|0|49|Vistor hf|AstraZeneca A/S DK|||8176||8176|11936 008301|N02AX0209|Tramol-L|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|1250|2537|lyfalmen|V0733|2537|00|20|0|7|Actavis Group hf|Actavis hf|||1250||1250|2537 008318|C09CA0601|Atacand|töflur|8|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2591|4356|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca A/S DK|||2591||2591|4356 008326|D07AC0101|Betnovat|áburður|1|mg/g|100|ml|1|glas|í hársvörð|D07AC01|01.07.1988||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|1348|2670|lyfalmen|||33|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1348||1348|2670 008334|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|8247|12032|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca A/S DK|||8247||8247|12032 008338|N02AX0209|Tramol-L|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|4894|7482|lyfalmen|V0734|7482|00|100|0|33|Actavis Group hf|Actavis hf|||4894||4894|7482 008360|N02AX0209|Tramol-L|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|7511|11033|lyfalmen|V0736|11033|00|100|0|50|Actavis Group hf|Actavis hf|||7511||7511|11033 008368|N02AX0209|Tramol-L|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|9890|14262|lyfalmen|V0738|14262|00|100|0|67|Actavis Group hf|Actavis hf|||9890||9890|14262 008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|K|3|0|1|0|1|GEZ|0|0|0|100|XEU|219823|275547|lyfsjukr|||02|2|0|0|Vistor hf|Genzyme BV|||219823||219823|275547 008383|D07AC0101|Betnovat|smyrsli|1|mg/g|30|g|1|túpa||D07AC01|01.01.1985||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|433|1428|lyfalmen|||20|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||433||433|1428 008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MAC|0|0|0|100|XEU|827|1963|lyfalmen|V0431|1963|00|100|0|33|Actavis Group PTC ehf|Merck KgaA (A) |||827||827|1963 008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MAC|0|0|0|100|XEU|699|1789|lyfalmen|V0430|1789|00|100|0|67|Actavis Group PTC ehf|Merck KgaA (A) |||699||699|1789 008466|D07AC0101|Betnovat|smyrsli|1|mg/g|100|g|1|túpa||D07AC01|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1369|2698|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1369||1369|2698 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|A|3|0|0|0|0|CHP|1|0|0|100|USD|5167|8942|vetorma|||00|1000|0|0|Icepharma hf|Chanelle Pharmaceuticals |||5167||5167|8942 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|A|5|0|0|0|0|CHP|1|0|0|100|XEU|11589|22246|vetalmen|||00|50|0|0|Icepharma hf|Chanelle Pharmaceuticals |||11589||11589|22246 008498|R06AX2201|Kestine|töflur|10|mg|10|stk|1|þpakki||R06AX22|01.04.1998||L|A|3|0|0|E|0|ALF|0|0|1|100|NOK|||lyfalmen|||00|10|0|10|Gróco ehf|Almirall-Prodesfarma S.A.||||||1575 008523|R06AX2201|Kestine|töflur|10|mg|100|stk|1|þpakki||R06AX22|01.04.1998||R|A|3|0|0|E|0|ALF|0|0|1|100|NOK|4467|6902|lyfalmen|||00|100|0|100|Gróco ehf|Almirall-Prodesfarma S.A.|||4467||4467|6902 008534|R06AX2201|Kestine|töflur|10|mg|30|stk|1|þpakki||R06AX22|01.04.1998||L|A|3|0|0|E|0|ALF|0|0|1|100|NOK|||lyfalmen|||00|30|0|30|Gróco ehf|Almirall-Prodesfarma S.A.||||||2808 008545|G03FB0506|NovoFem|filmhtfl|0| |84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|3069|5005|lyfalmen|||23|84|0|84|Vistor hf|Novo-Nordisk|||3069||3069|5005 008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A||||||0 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|139549|175606|lyfsjukr|||00|2|0|0|Icepharma hf|Roche Registration Limited|||139549||139549|175606 008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A||||||0 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|145465|182971|lyfsjukr|||00|2|0|28|Icepharma hf|Roche Registration Limited|||145465||145465|182971 008785|QP52AC1303|Zerofen, vet.|mixtúra|10|%|500|ml|1|plbrús||QP52AC13|01.11.2001||R|A|3|0|0|0|0|CHP|1|0|0|100|USD|2647|4581|vetorma|||00|500|0|0|Icepharma hf|Chanelle Pharmaceuticals |||2647||2647|4581 008831|D11AX1501|Elidel|krem|1|%|15|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|0|0|NOH|0|0|1|100|DKK|3268|5275|lyfalmen|||00|15|0|15|Vistor hf|Novartis Healthcare A/S-|||3268||3268|5275 008888|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3167|5138|lyfalmen|||00|28|0|56|Vistor hf|AstraZeneca A/S DK|||3167||3167|5138 008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburður, lausn|D10AF01|01.01.1994||R|A|2,5|0|0|0|0|PFI|0|0|0|100|DKK|2429|4137|lyfalmen|||20|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2429||2429|4137 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|6423|9557|lyfalmen|||00|4|0|8|Icepharma hf|Lilly ICOS Limited|||||6423|9557 008938|H02AB0104|Betapred|stl|4|mg/ml|1|ml|5|lykjur||H02AB01|01.07.2004||R|A||0|0|0|0|LVE|0|0|1|100|IKR|950|2130|lyfalmen|||02|5|1|13|Lyfjaver ehf|Lyfjaver - óskráð lyf|||950||950|2130 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|12654|17939|lyfalmen|||00|8|0|16|Icepharma hf|Lilly ICOS Limited|||||12654|17939 009065|D11AX1501|Elidel|krem|1|%|30|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|0|0|NOH|0|0|1|100|DKK|5830|8752|lyfalmen|||00|30|0|30|Vistor hf|Novartis Healthcare A/S-|||5830||5830|8752 009079|D11AX1501|Elidel|krem|1|%|100|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|0|0|NOH|0|0|1|100|DKK|17113|23491|lyfalmen|||00|100|0|100|Vistor hf|Novartis Healthcare A/S-|||17113||17113|23491 009137|M05BA0302|Pamidronatdinatrium Mayne 3 mg/ml|irþ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|29717|38865|lyfsjukr|||00|25|0|1|Icepharma hf|Mayne Pharma Plc|||29717||29717|38865 009192|M01AH0401|Dynastat|sts|40|mg/hgl|5|hgl|1|pakki|+leysir 2ml/lykju |M01AH04|01.06.2002||R|A|3|0|0|0|0|PFL|0|0|1|100|DKK|7801|11427|lyfalmen|||03|5|0|5|Vistor hf|Pfizer Limited|||7801||7801|11427 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|A|3|0|0|0|0|PFL|0|0|1|100|DKK|14808|20621|lyfalmen|||03|10|0|10|Vistor hf|Pfizer Limited|||14808||14808|20621 009275|M05BA0302|Pamidronatdinatrium Mayne 3 mg/ml|irþ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|12255|17125|lyfsjukr|||00|10|0|0|Icepharma hf|Mayne Pharma Plc|||12255||12255|17125 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|64704|82424|lyfsjukr|||00|30|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||64704||64704|82424 009282|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyflausa|||02|400|0|0|Icepharma hf|Fresenius Kabi|||||| 009285|D11AX1401|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AX14|01.07.2003||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|5897|8843|lyfalmen|||00|30|0|0|Vistor hf|Astellas Pharma A/S|||5897||5897|8843 009286|M05BA0303|Pamidronatdinatrium Mayne 6 mg/ml|irþ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|16065|21868|lyfsjukr|||00|10|0|1|Icepharma hf|Mayne Pharma Plc|||16065||16065|21868 009297|M05BA0304|Pamidronatdinatrium Mayne 9 mg/ml|irþ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|21109|28148|lyfsjukr|||00|10|0|2|Icepharma hf|Mayne Pharma Plc|||21109||21109|28148 009340|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||00|400|0|0|Icepharma hf|Fresenius Kabi||||||0 009409|G03CA0316|Vivelle Dot|forðapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1446|2803|lyfalmen|||23|8|0|21|Vistor hf|Novartis Healthcare A/S-|||1446||1446|2803 009443|G03CA0316|Vivelle Dot|forðapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1554|2949|lyfalmen|||23|8|0|28|Vistor hf|Novartis Healthcare A/S-|||1554||1554|2949 009465|G03CA0316|Vivelle Dot|forðapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1831|3325|lyfalmen|||23|8|0|42|Vistor hf|Novartis Healthcare A/S-|||1831||1831|3325 009489|G03CA0316|Vivelle Dot|forðapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|2106|3698|lyfalmen|||23|8|0|56|Vistor hf|Novartis Healthcare A/S-|||2106||2106|3698 009522|N02BE0101|Panodil|eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|A|5|0|0|0|0|GCH|0|0|1|100|DKK|||lyfalmen|||04|10|0|2|Icepharma hf|GlaxoSmithKline CH A/S||||||0 009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|258463|323654|lyfsjukr|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||258463||258463|323654 009649|D11AX1401|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AX14|01.07.2003||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|6550|9729|lyfalmen|||00|30|0|0|Vistor hf|Astellas Pharma A/S|||6550||6550|9729 009672|J05AB0102|Zovir|töflur|400|mg|55|stk|1|þpakki||J05AB01|01.09.2003||R|A|5|0|0|E|0|GSK|0|0|1|30|GBP|9796|14134|lyfalmen|||00|55|0|6|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||9796||9796|14134 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|A|3|0|1|0|1|GSC|0|0|0|100|DKK|74660|94819|lyfsjukr|||00|30|0|30|Swedish Orphan International AB|Gilead Science International (S) |||74660||74660|94819 009688|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|10076|14514|lyfalmen|||00|98|0|196|Vistor hf|AstraZeneca A/S DK|||10076||10076|14514 009830|B03XA0103|NeoRecormon|stl|20000|ae/spr|0,6|ml|1|spr||B03XA01|01.05.2006||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|43865|56479|lyfsjukr|||00|1|0|20|Icepharma hf|Roche|||43865||43865|56479 009881|A10BD0201|Glucovance|filmhtfl|502,5|mg|30|stk|1|þpakki|500+2,5 mg|A10BD02|01.03.2003||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|894|2054|lyfalmen|||00|30|0|15|Icepharma hf|Merck Santé s.a.s.|||894||894|2054 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|6987|10322|lyfalmen|||02|180|0|0|Vistor hf|Dentsply Limited|||6987||6987|10322 009905|N01BB5402|Citanest Dental Octapressin|stl|0| |1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|6859|10148|lyfalmen|||00|180|0|0|Vistor hf|Dentsply Limited|||6859||6859|10148 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|8129|11872|lyfalmen|||17|180|0|0|Vistor hf|Dentsply Limited|||8129||8129|11872 009913|N06AX1102|Remeron Smelt|munndr.t|15|mg|6|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|583|1632|lyfalmen|||00|6|0|3|Vistor hf|N.V. Organon|||583||583|1632 009942|N01BB5402|Citanest Dental Octapressin|stl|0| |1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|7401|10884|lyfalmen|||00|180|0|0|Vistor hf|Dentsply Limited|||7401||7401|10884 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|8159|11913|lyfalmen|||17|180|0|0|Vistor hf|Dentsply Limited|||8159||8159|11913 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|6277|9359|lyfalmen|||02|180|0|0|Vistor hf|Dentsply Limited|||6277||6277|9359 010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|2475|4199|lyfalmen|V1151|2999|00|30|0|15|Vistor hf|N.V. Organon|||2475||2475|4199 010035|N06AX1102|Remeron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|4392|6801|lyfalmen|V1152|4347|00|30|0|30|Vistor hf|N.V. Organon|||4392||4392|6801 010057|N06AX1102|Remeron Smelt|munndr.t|45|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|9379|13568|lyfalmen|||00|30|0|45|Vistor hf|N.V. Organon|||9379||9379|13568 010070|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|áfyllt sprauta, lausn|L03AA13|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|199865|250699|lyfsjukr|||00|1|0|20|Vistor hf|Amgen Europe B.V.|||199865||199865|250699 010102|G03GA0502|Gonal-f|sts|75|ae|1|hgl|1|pakki|(5,5 mcg) + leysir|G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|4751|7288|lyfalmen|||00|1|0|1|Gróco ehf|Serono Europe|||4751||4751|7288 010135|A10BD0201|Glucovance|filmhtfl|505|mg|30|stk|1|þpakki|500+5 mg|A10BD02|01.03.2003||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|1280|2577|lyfalmen|||00|30|0|15|Icepharma hf|Merck Santé s.a.s.|||1280||1280|2577 010159|G03GA0502|Gonal-f|sts|75|ae|10|hgl|1|pakki|(5,5 mcg) + leysir |G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|48807|62950|lyfalmen|||00|10|0|10|Gróco ehf|Serono Europe|||48807||48807|62950 010164|G03GA0502|Gonal-f|sts|450|ae|1|hgl|1|pakki|á 0,75ml + leysir|G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|29286|38646|lyfalmen|||00|1|0|6|Gróco ehf|Serono Europe|||29286||29286|38646 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|A|3|0|0|0|1|RRL|0|0|0|30|DKK|257716|322724|lyfsjukr|||00|60|0|30|Icepharma hf|Roche Registration Limited|||257716||257716|322724 010187|H01AX0101|Somavert|sts|10|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|445482|556493|lyfsjukr|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||445482||445482|556493 010203|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|spr|áfyllt sprauta|B03XA02|01.04.2005||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|186566|234142|lyfsjukr|||00|1|0|111|Vistor hf|Amgen|||186566||186566|234142 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|A|2|0|1|0|1|MSD|0|0|0|100|XEU|8705|12463|lyfsjukr|||00|1|0|0|Icepharma hf|M.S.D.|||8705||8705|12463 010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|13632|19157|lyfalmen|V1153|13317|00|96|0|96|Vistor hf|N.V. Organon|||13632||13632|19157 010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|20652|27897|lyfalmen|||00|96|0|144|Vistor hf|N.V. Organon|||20652||20652|27897 010312|N06DX0101|Ebixa|töflur|10|mg|30|stk|1|þpakki||N06DX01|01.10.2002||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|9116|13211|lyfalmen|||00|30|0|15|Lundbeck Export A/S|H. Lundbeck A/S|||9116||9116|13211 010323|N06DX0101|Ebixa|töflur|10|mg|50|stk|1|þpakki||N06DX01|01.10.2002||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|14890|20723|lyfalmen|||00|50|0|25|Lundbeck Export A/S|H. Lundbeck A/S|||14890||14890|20723 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|þpakki||N06DX01|01.10.2002||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|26808|35561|lyfalmen|||00|100|0|50|Lundbeck Export A/S|H. Lundbeck A/S|||26808||26808|35561 010339|C09DA0701|MicardisPlus|töflur|92,5|mg|28|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|4125|6438|lyfalmen|||00|28|0|56|Vistor hf|Boehringer Ingelheim International |||4125||4125|6438 010348|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1995||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|9499|13731|lyfalmen|||51|5|0|0|Icepharma hf|Sanofi Pasteur MSD|||9499||9499|13731 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|13325|18775|lyfalmen|||00|98|0|196|Vistor hf|Boehringer Ingelheim International |||13325||13325|18775 010437|QI09AB1301|Stellamune One|stl|0| |100|ml|10|glös|fleyti|QI09AB13|01.09.2008||R|K|3|0|0|0|0|PZR|0|0|0|100|DKK|78626|149942|vetalmen|||00|1000|0|0|Icepharma hf|Pfizer A/S (Í)|||78626||78626|149942 010464|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|1,5|0|0|0|1|BAM|0|0|0|100|SEK|12791|17792|lyfsjukr|||00|2500|0|0|Icepharma hf|Baxter Medical AB|||12791||12791|17792 010534|B05BA0108|Vaminolac|irl|0| |100|ml|10|fl||B05BA01|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|8874|12705|lyfsjukr|||00|1000|0|1|Icepharma hf|Fresenius Kabi|||8874||8874|12705 010573|S01AX1901|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AX19|01.08.2002||R|A|3|0|0|0|0|SAO|0|0|1|100|XEU|1414|2759|lyfalmen|||00|5|0|0|Icepharma hf|Santen Oy|||1414||1414|2759 010591|M05BA0702|Optinate Septimum|filmhtfl|35|mg|4|stk|1|þpakki||M05BA07|01.12.2002||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|4783|7331|lyfalmen|||00|4|0|28|Vistor hf|Sanofi-aventis Norge AS|||4783||4783|7331 010669|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|6776|9702|lyfsjukr|||00|7500|0|8|Icepharma hf|Baxter Medical AB|||6776||6776|9702 010672|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|12426|17338|lyfsjukr|||00|5000|0|5|Icepharma hf|Baxter Medical AB|||12426||12426|17338 010683|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|4729|6771|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|||4729||4729|6771 010691|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2710|3880|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|||2710||2710|3880 010706|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|3|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|7728|11328|lyfalmen|||00|9|0|90|Vistor hf|Allergan|||7728||7728|11328 010707|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|12426|17338|lyfsjukr|||00|5000|0|5|Icepharma hf|Baxter Medical AB|||12426||12426|17338 010729|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|6821|9766|lyfsjukr|||00|7500|0|8|Icepharma hf|Baxter Medical AB|||6821||6821|9766 010740|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|4547|6510|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|||4547||4547|6510 010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.12.2002||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|12404|17628|lyfalmen|V1080|17628|00|12|0|84|Vistor hf|Sanofi-aventis Norge AS|||12404||12404|17628 010760|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2524|3614|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|||2524||2524|3614 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACR|0|0|0|100|SEK|450110|562254|lyfsjukr|||00|56|0|14|Swedish Orphan International AB|Actelion Registration Ltd. (S)|||450110||450110|562254 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACR|0|0|0|100|SEK|450110|562254|lyfsjukr|||00|56|0|28|Swedish Orphan International AB|Actelion Registration Ltd. (S)|||450110||450110|562254 010837|H01AX0101|Somavert|sts|15|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|665796|830784|lyfsjukr|||00|30|0|45|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||665796||665796|830784 010848|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|886103|1105066|lyfsjukr|||00|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||886103||886103|1105066 010890|A02BC0107|Lomex-T|sh-tfl|20|mg|28|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|30|IKR|1785|3263|lyfalmen|||10|28|0|28|Actavis Group hf|Actavis hf|||1785||1785|3263 010900|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|A|3|0|0|0|0|GCH|0|0|1|100|SEK|||lyflausa|||00|300|0|20|Icepharma hf|GlaxoSmithKline CH A/S|||||| 010912|A02BC0107|Lomex-T|sh-tfl|20|mg|100|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|30|IKR|6037|9033|lyfalmen|V1803|7131|10|100|0|100|Actavis Group hf|Actavis hf|||6037||6037|9033 010923|A02BC0107|Lomex-T|sh-tfl|20|mg|56|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|30|IKR|3384|5433|lyfalmen|V1802|4287|10|56|0|56|Actavis Group hf|Actavis hf|||3384||3384|5433 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|K|3,5|0|1|0|1|BAM|0|0|0|100|SEK|49315|63265|lyfsjukr|||03|10|0|0|Icepharma hf|Baxter Medical AB|||49315||49315|63265 010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|A|3|0|0|0|1|REP|0|0|0|100|SEK|2837|4062|lyfsjukr|||03|10|0|5|Vistor hf|Recip AB|||2837||2837|4062 010938|A02BC0304|Lanzo Melt|munndr.t|15|mg|28|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|E|0|WAB|0|0|0|30|USD|2986|4893|lyfalmen|||00|28|0|14|Icepharma hf|Wyeth AB|||2986||2986|4893 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|23614|31584|lyfalmen|||00|28|0|19|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|||23614||23614|31584 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|23614|31584|lyfalmen|||00|28|0|28|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|||23614||23614|31584 010959|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.09.1982||L|A|3|0|0|0|0|GCH|0|0|1|100|SEK|||lyflausa|||00|50|0|17|Icepharma hf|GlaxoSmithKline CH A/S|||||| 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|39519|51386|lyfalmen|V1702|51385|00|56|0|37|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|||39519||39519|51386 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|39519|51386|lyfalmen|V1703|51385|00|56|0|56|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|||39519||39519|51386 011078|B05AA0702|Hemohes 6%|irl|60|mg/ml|500|ml|1|plpoki|án PVC (Ecobag)|B05AA07|01.05.2002||R|A|2|0|0|0|1|BRA|0|0|0|100|XEU|1703|2438|lyfsjukr|||00|500|0|0|Actavis Group hf|Braun|||1703||1703|2438 011163|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|17626|24129|lyfalmen|||00|100|0|33|Vistor hf|AstraZeneca A/S DK|||17626||17626|24129 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|0|0|MSD|0|0|1|100|XEU|6272|9352|lyfalmen|||00|28|0|28|Icepharma hf|M.S.D.|||6272||6272|9352 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|0|0|MSD|0|0|1|100|XEU|6272|9352|lyfalmen|||00|28|0|42|Icepharma hf|M.S.D.|||6272||6272|9352 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|30|DKK|25563|34011|lyfalmen|||00|100|0|200|Lundbeck Export A/S|H. Lundbeck A/S|||25563||25563|34011 011335|C09CA0102|Lopress|töflur|12,5|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|992|2187|lyfalmen|V0195|2187|00|28|0|7|Actavis Group hf|Actavis hf|||992||992|2187 011353|N05AF0502|Cisordinol Depot|stl|500|mg/ml|1|ml|5|lykjur||N05AF05|01.10.1988||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|13091|18483|lyfalmen|||02|5|0|167|Lundbeck Export A/S|H. Lundbeck A/S|||13091||13091|18483 011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1427|2777|lyfalmen|||00|28|0|28|Actavis Group hf|Actavis hf|||1427||1427|2777 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|4069|6362|lyfalmen|V0197|6335|00|98|0|98|Actavis Group hf|Actavis hf|||4069||4069|6362 011409|R03AK0703|Symbicort forte Turbuhaler|innúðadu|329|mcg/sk|60|sk|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|8151|11902|lyfalmen|||00|60|0|30|Vistor hf|AstraZeneca A/S DK|||8151||8151|11902 011453|G04BE0901|Levitra|filmhtfl|5|mg|12|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|12389|17609|lyfalmen|||00|12|0|6|Vistor hf|Bayer AG-|||12389||12389|17609 011489|N06BA0402|Concerta|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|6738|9984|lyfalmen|||00|30|0|18|Vistor hf|Janssen-Cilag AB|||6738||6738|9984 011532|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.11.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|7915|11332|lyfsjukr|||02|10000|0|0|Icepharma hf|Baxter Medical AB|||7915||7915|11332 011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PFI|0|0|0|100|DKK|2570|3680|lyfsjukr|||00|50|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2570||2570|3680 011547|M01AH0501|Arcoxia|filmhtfl|120|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|0|0|MSD|0|0|1|100|XEU|6272|9352|lyfalmen|||00|28|0|56|Icepharma hf|M.S.D.|||6272||6272|9352 011555|N06BA0402|Concerta|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|8802|12785|lyfalmen|||00|30|0|36|Vistor hf|Janssen-Cilag AB|||8802||8802|12785 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|A|5|0|0|0|0|CHP|1|0|0|100|USD|1666|3288|vetalmen|||00|25|0|0|Icepharma hf|Chanelle Pharmaceuticals |||1666||1666|3288 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PFI|0|0|0|100|DKK|5140|7359|lyfsjukr|||00|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5140||5140|7359 011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|sk|1|fl|með skammtadælu|G03CA03|01.03.2000||R|A|2|0|0|E|0|OLF|0|0|0|100|SEK|1392|2729|lyfalmen|||00|64|0|29|Gróco ehf|Oy Leiras Finland Ab|||1392||1392|2729 011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|A|3|0|1|0|1|RRL|0|0|0|30|DKK|113046|142610|lyfsjukr|||00|168|0|34|Icepharma hf|Roche Registration Limited|||113046||113046|142610 011810|D11AX1501|Elidel|krem|1|%|60|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|0|0|NOH|0|0|1|100|DKK|10969|15726|lyfalmen|||00|60|0|60|Vistor hf|Novartis Healthcare A/S-|||10969||10969|15726 011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|glas||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|2003|3559|lyfalmen|V0935|3559|00|28|0|56|Actavis Group hf|Actavis hf|||2003||2003|3559 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|glas||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|7008|10351|lyfalmen|V0937|10351|00|98|0|196|Actavis Group hf|Actavis hf|||7008||7008|10351 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|4159|5955|lyfsjukr|||02|20|0|0|Vistor hf|AstraZeneca A/S DK|||4159||4159|5955 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|3778|5409|lyfsjukr|||02|20|0|0|Vistor hf|AstraZeneca A/S DK|||3778||3778|5409 011986|C10AA0403|Lescol depot|forðatfl|80|mg|28|stk|1|þpakki||C10AA04|01.06.2004||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|4757|7296|lyfalmen|||00|28|0|56|Vistor hf|Novartis Healthcare A/S-|||4757||4757|7296 011997|C10AA0403|Lescol depot|forðatfl|80|mg|98|stk|1|þpakki||C10AA04|01.06.2004||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|16373|22569|lyfalmen|||00|98|0|196|Vistor hf|Novartis Healthcare A/S-|||16373||16373|22569 012030|J05AG0301|Stocrin|töflur|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|A|2|0|1|0|1|MSD|0|0|0|100|XEU|48046|61685|lyfsjukr|||00|30|0|30|Icepharma hf|M.S.D.|||48046||48046|61685 012209|G04CB0201|Avodart|hylki|0,5|mg|90|stk|1|pakki|mjúk hylki|G04CB02|01.05.2003||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|11006|15776|lyfalmen|||00|90|0|90|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||11006||11006|15776 012260|R01AC0301|Lastin|nefúði|1|mg/ml|20|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|IKR|84|954|lyfalmen|||00|20|0|36|Vistor hf|Meda AB|||84||84|954 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|6401|9527|lyfalmen|||00|4|0|4|Icepharma hf|Lilly ICOS Limited|||6401||6401|9527 012278|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|7|0|4|Artasan ehf|Novartis Healthcare A/S-A||||||0 012309|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|þpakki|50+500 mg|QP52AA51|01.12.2003||R|A|3|0|0|0|0|ICE|0|0|0|100|USD|5847|10119|vetorma|||00|20|0|0|Icepharma hf|Icepharma hf|||5847||5847|10119 012310|A10BB1201|Amaryl|töflur|1|mg|30|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|797|1922|lyfalmen|||00|30|0|15|Vistor hf|Aventis Pharma |||797||797|1922 012326|N06BA0402|Concerta|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|10432|14997|lyfalmen|||00|30|0|54|Vistor hf|Janssen-Cilag AB|||10432||10432|14997 012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A||||||0 012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A||||||0 012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A||||||0 012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A||||||0 012640|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|þpakki|50+500 mg|QP52AA51|01.12.2003||R|A|3|0|0|0|0|ICE|0|0|0|100|USD|27478|47552|vetorma|||00|100|0|0|Icepharma hf|Icepharma hf|||27478||27478|47552 012716|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|7|0|7|Artasan ehf|Novartis Healthcare A/S-A||||||0 012738|M05BC0101|InductOs|ígr.sett|12|mg|1|stk|1|pakki||M05BC01|01.09.2003||R|A|3|0|1|0|1|WTE|0|0|0|100|USD|539408|673430|lyfsjukr|||00|1|0|0|Icepharma hf|Wyeth Europe|||539408||539408|673430 012770|G04BE0901|Levitra|filmhtfl|5|mg|4|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|4417|6834|lyfalmen|||00|4|0|2|Vistor hf|Bayer AG-|||4417||4417|6834 012792|G04BE0901|Levitra|filmhtfl|10|mg|4|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|4887|7472|lyfalmen|||00|4|0|4|Vistor hf|Bayer AG-|||4887||4887|7472 012799|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|7|0|10|Artasan ehf|Novartis Healthcare A/S-A||||||0 012816|G04BE0901|Levitra|filmhtfl|10|mg|12|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|14398|20110|lyfalmen|||00|12|0|12|Vistor hf|Bayer AG-|||14398||14398|20110 012838|G04BE0901|Levitra|filmhtfl|20|mg|4|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|6059|9063|lyfalmen|||00|4|0|8|Vistor hf|Bayer AG-|||6059||6059|9063 012860|G04BE0901|Levitra|filmhtfl|20|mg|12|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|17520|23997|lyfalmen|||00|12|0|24|Vistor hf|Bayer AG-|||17520||17520|23997 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|718|1815|lyfalmen|||08|80|0|4|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||718||718|1815 012921|G03AA1301|Evra|forðapl|0| |9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|A|2|0|0|0|0|JCI|0|0|0|100|SEK|4176|6507|lyfalmen|||00|9|0|0|Vistor hf|Janssen-Cilag International N.V.|||4176||4176|6507 012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|A|3|0|0|E|0|LBI|0|0|0|100|SEK|6321|9418|lyfalmen|||00|30|0|30|Icepharma hf|Laboratoires Besins International|||6321||6321|9418 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|6570|9756|lyfalmen|||00|30|0|20|Vistor hf|Novartis Healthcare A/S-|||6570||6570|9756 013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|7205|13896|vetalmen|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||7205||7205|13896 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|10722|15391|lyfalmen|||00|30|0|40|Vistor hf|Novartis Healthcare A/S-|||10722||10722|15391 013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|1868|3686|vetalmen|||00|20|0|0|Icepharma hf|Pfizer Oy Animal Health|||1868||1868|3686 013097|A02BC0301|Lanzo|munndr.t|15|mg|14|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|E|0|WAB|0|0|0|30|USD|1365|2693|lyfalmen|||00|14|0|7|Icepharma hf|Wyeth AB|||1365||1365|2693 013100|R07AX0101|INOmax|innö.gas|400|ppm|2|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|23639|31298|lyfsjukr|||00|2|0|0|Ísaga ehf|AGA AB|||23639||23639|31298 013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|K|3|0|0|0|1|ZLB|0|0|0|100|SEK|9250|13244|lyfsjukr|||17|2|0|0|Icepharma hf|ZLB GmbH|||9250||9250|13244 013259|B02BD0402|BeneFIX|sts|0| |250|ae|1|hgl|+leysir|B02BD04|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|USD|35658|46262|lyfsjukr|||00|250|0|1|Icepharma hf|Wyeth Europe|||35658||35658|46262 013270|B02BD0402|BeneFIX|sts|0| |500|ae|1|hgl|+leysir|B02BD04|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|USD|71320|90661|lyfsjukr|||00|500|0|1|Icepharma hf|Wyeth Europe|||71320||71320|90661 013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|4732|9185|vetalmen|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||4732||4732|9185 013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|11373|21835|vetalmen|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||11373||11373|21835 013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|1193|2354|vetalmen|||00|20|0|0|Icepharma hf|Pfizer Oy Animal Health|||1193||1193|2354 013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BAL|0|0|0|100|SEK|189751|238107|lyfsjukr|||00|1|0|3|Lyfjaver ehf|Baxter Medical AB (L)|||189751||189751|238107 013362|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|31625|41241|lyfsjukr|||00|1|0|0|Lyfjaver ehf|Baxter AG (L)|||31625||31625|41241 013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|126500|159360|lyfsjukr|||00|1|0|2|Lyfjaver ehf|Baxter AG (L)|||126500||126500|159360 013373|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|61604|78564|lyfsjukr|||00|1|0|2|Lyfjaver ehf|Baxter AG (L)|||61604||61604|78564 013485|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.05.2003||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|21738|29249|lyfalmen|||00|98|0|98|Icepharma hf|M.S.D.|||21738||21738|29249 013544|L04AB0401|Humira|stl|40|mg/spr|0,8|ml|2|spr||L04AB04|01.12.2003||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|197670|247967|lyfsjukr|||00|2|0|28|Vistor hf|Abbott|||197670||197670|247967 013593|A01AA3001|Xerodent|munnstfl|0| |90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|A|2|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||00|90|0|0|Actavis Group hf|Actavis Group hf||||||1367 013660|A10AD0116|Mixtard 30 InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar sprautur|A10AD01|01.03.2002||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|7407|10892|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|||7407||7407|10892 013672|N03AG0101|Depakine|mixtúra|200|mg/ml|40|ml|1|glas||N03AG01|01.12.1978||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1230|2510|lyfalmen|||00|40|0|5|Vistor hf|Sanofi-aventis Norge AS|||1230||1230|2510 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|482|1494|lyfalmen|||00|30|0|0|Vistor hf|AstraZeneca A/S DK|||482||482|1494 013718|M05BA0801|Zometa|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.05.2004||R|A|3|0|1|0|1|NOE|0|0|0|100|DKK|48745|62555|lyfsjukr|||00|5|0|1|Vistor hf|Novartis Europharm Ltd|||48745||48745|62555 013720|A10AD0118|Mixtard 30|stl|100|ae/ml|10|ml|1|hgl||A10AD01|01.10.1985|31.12.2008|R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|2934|4822|lyfalmen|||50|10|0|25|Vistor hf|Novo-Nordisk|||2934||2934|4822 013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|þpakki||C09DA03|01.04.2005||R|A|2|0|0|B|0|NOH|0|0|0|100|DKK|5002|7628|lyfalmen|||00|28|0|56|Vistor hf|Novartis Healthcare A/S-|||5002||5002|7628 013767|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|98|stk|1|þpakki||C09DA03|01.04.2005||R|A|2|0|0|B|0|NOH|0|0|0|100|DKK|17201|23600|lyfalmen|||00|98|0|196|Vistor hf|Novartis Healthcare A/S-|||17201||17201|23600 013804|A10AC0105|Insulatard Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AC01|01.07.1993|31.01.2009|R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|4875|7456|lyfalmen|||50|15|0|38|Vistor hf|Novo-Nordisk|||4875||4875|7456 013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.01.2003||R|A|3|0|0|0|0|GSK|0|0|1|100|IKR|1215|2489|lyfalmen|V0465|2489|00|20|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1215||1215|2489 013879|A10AD0120|Mixtard 40 NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AD01|01.10.1992|31.12.2008|R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|5842|8767|lyfalmen|||50|15|0|38|Vistor hf|Novo-Nordisk|||5842||5841|8767 013890|A10AD0119|Mixtard 50 NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AD01|01.10.1992|31.12.2008|R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|5999|8980|lyfalmen|||50|15|0|38|Vistor hf|Novo-Nordisk|||5999||5998|8980 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|7407|10892|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|||7407||7407|10892 013909|A10AB0107|Actrapid NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AB01|01.08.2003||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|5754|8649|lyfalmen|||51|15|0|38|Vistor hf|Novo-Nordisk|||5754||5754|8649 013913|A10AD0121|Mixtard 30 NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AD01|01.10.1992|31.12.2008|R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|5523|8334|lyfalmen|||50|15|0|38|Vistor hf|Novo-Nordisk|||5523||5522|8334 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|2819|4666|lyfalmen|||51|10|0|25|Vistor hf|Novo-Nordisk|||2819||2819|4666 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|5302|8035|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|||5302||5302|8035 013958|A10AB0103|Actrapid Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AB01|01.02.2004|31.01.2009|R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|4836|7403|lyfalmen|||51|15|0|38|Vistor hf|Novo-Nordisk|||4836||4836|7403 013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.05.2004||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|234565|293901|lyfsjukr|||00|60|0|0|Vistor hf|Novartis Europharm Ltd|||234565||234565|293901 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.05.2004||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|414741|518220|lyfsjukr|||00|30|0|0|Vistor hf|Novartis Europharm Ltd|||414741||414741|518220 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|2794|4632|lyfalmen|||71|10|0|25|Vistor hf|Novo-Nordisk|||2794||2794|4632 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|A|2|0|0|0|1|AZD|0|0|0|30|SEK|13228|18336|lyfsjukr|||00|50|0|13|Vistor hf|AstraZeneca A/S DK|||13228||13228|18336 014081|N03AX1401|Keppra|mixtúra|100|mg|300|ml|1|glas||N03AX14|01.12.2006||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|24984|33290|lyfalmen|||00|300|0|20|Vistor hf|U.C.B|||24984||24984|33290 014094|H05AA0202|Forsteo|stl|250|mcg/ml|3|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|K|2|0|0|0|0|ELD|0|0|0|100|XEU|64131|82028|lyfalmen|||AC|3|0|38|Icepharma hf|Eli Lilly Nederland -|||64131||64131|82028 014138|B05BA1020|StructoKabiven elektrolyfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|38284|49531|lyfsjukr|||00|5908|0|0|Icepharma hf|Fresenius Kabi|||38284||38284|49531 014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|A|3|0|0|0|0|IGB|0|0|0|100|SEK|1335|2652|lyfalmen|||00|30|0|30|Icepharma hf|Intendis GmbH Berlin|||1335||1335|2652 014285|B05BA1020|StructoKabiven elektrolyfri|irl|2100|kcal|1970|ml|2|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|23583|31228|lyfsjukr|||00|3940|0|0|Icepharma hf|Fresenius Kabi|||23583||23583|31228 014290|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.10.1991||L|A|2|0|0|0|0|JAS|0|0|0|100|SEK|||lyfalmen|||29|4|0|0|Vistor hf|Janssen-Cilag AB||||||0 014352|B05BA1015|StructoKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|25968|34198|lyfsjukr|||00|3944|0|0|Icepharma hf|Fresenius Kabi|||25968||25968|34198 014361|B05BA1015|StructoKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|33985|44179|lyfsjukr|||00|5908|0|0|Icepharma hf|Fresenius Kabi|||33985||33985|44179 014372|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|2|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|23583|31228|lyfsjukr|||00|3940|0|0|Icepharma hf|Fresenius Kabi|||23583||23583|31228 014453|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.04.1994||R|A|3|0|0|0|0|SCH|0|0|0|100|SEK|16062|22182|lyfalmen|||23|1|0|1825|Icepharma hf|Schering Oy|||16062||16062|22182 014541|QA02BX1201|Orbeseal|spenalyf|2,6|g/dælu|24|dælur|1|pakki||QA02BX12|01.04.2005||R|A|5|0|0|0|0|PFI|0|0|0|100|XEU|6072|11737|vetalmen|||16|24|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6072||6072|11737 014583|J05AX0701|Fuzeon|sts|90|mg/ml|60|hgl|1|pakki|+ leysir|J05AX07|01.12.2003||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|311731|389973|lyfsjukr|||00|60|0|0|Icepharma hf|Roche Registration Limited|||311731||311731|389973 014679|N02AA0501|Oxycontin|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.12.2005||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2568|4325|lyfalmen|||10|28|0|2|Icepharma hf|Norpharma |||2568||2568|4325 014702|C09CA0601|Atacand|töflur|32|mg|28|stk|1|þpakki||C09CA06|01.06.2005||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|4508|6958|lyfalmen|||00|28|0|112|Vistor hf|AstraZeneca A/S DK|||4508||4508|6958 014713|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.06.2005||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|15255|21177|lyfalmen|||00|98|0|392|Vistor hf|AstraZeneca A/S DK|||15255||15255|21177 014728|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2|0|1|0|1|AEU|0|0|0|100|DKK|80354|101908|lyfsjukr|||00|2|0|4|Vistor hf|Amgen Europe B.V.|||80354||80354|101908 014739|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2|0|1|0|1|AEU|0|0|0|100|DKK|124391|156734|lyfsjukr|||00|2|0|7|Vistor hf|Amgen Europe B.V.|||124391||124391|156734 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|0|0|NOV|0|0|0|100|DKK|24345|32495|lyfalmen|||00|60|0|10|Icepharma hf|Novartis Healthcare A/S|||24345||24345|32495 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|0|0|NOV|0|0|0|100|DKK|73036|93115|lyfalmen|||00|60|0|30|Icepharma hf|Novartis Healthcare A/S|||73036||73036|93115 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|0|0|NOV|0|0|0|100|DKK|48692|62807|lyfalmen|||00|60|0|20|Icepharma hf|Novartis Healthcare A/S|||48692||48692|62807 015037|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyfalmen|||00|90|0|24|Icepharma hf|Pharma Nord ApS||||||0 015230|R01AC0301|Lastin|nefúði|1|mg/ml|10|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|IKR|43|899|lyfalmen|||00|10|0|18|Vistor hf|Meda AB|||43||43|899 015301|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyfalmen|||00|270|0|72|Icepharma hf|Pharma Nord ApS||||||0 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|IKR|4886|7471|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|||4886||4886|7471 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|10051|14480|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|||10051||10051|14480 015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|IKR|2563|4318|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|||2563||2563|4318 015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|2760|4586|lyfalmen|||00|100|1|33|Lyfjaver ehf|Lyfjaver - óskráð lyf|||2760||2760|4586 015419|G03CA0316|Vivelle Dot|forðapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1161|2416|lyfalmen|||23|8|0|14|Vistor hf|Novartis Healthcare A/S-|||1161||1161|2416 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|þpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2084|3442|lyfalmen|V0832|3442|00|6|0|12|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1917||1917|3442 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|þpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|3042|4556|lyfalmen|V0831|4556|00|12|0|12|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2738||2738|4556 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|11283|16152|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|||11283||11283|16152 015532|L01CX0101|Yondelis|irþ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|368287|460385|lyfsjukr|||00|1|0|0|Lyfjaver ehf|Pharma Mar S.A.|||368287||368287|460385 015598|L01CX0101|Yondelis|irþ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|97889|123739|lyfsjukr|||00|1|0|0|Lyfjaver ehf|Pharma Mar S.A.|||97889||97889|123739 015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|6531|9703|lyfalmen|||00|30|0|3|Vistor hf|Orion Corporation|||6531||6531|9703 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|14393|20104|lyfalmen|V1732|20104|00|100|0|11|Vistor hf|Orion Corporation|||14393||14393|20104 015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|6531|9703|lyfalmen|||00|30|0|10|Vistor hf|Orion Corporation|||6531||6531|9703 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|21675|29170|lyfalmen|V1731|29169|00|100|0|33|Vistor hf|Orion Corporation|||21675||21675|29170 015677|N05CF0201|Stilnoct|töflur|10|mg|1000|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|32790|43009|lyfalmen|||00|1000|0|1000|Vistor hf|Sanofi-aventis Norge AS|||32790||32790|43009 015679|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|85199|107940|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|||85199||85199|107940 015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|85199|107940|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|||85199||85199|107940 015699|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|85199|107940|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|||85199||85199|107940 015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|6531|9703|lyfalmen|||00|30|0|7|Vistor hf|Orion Corporation|||6531||6531|9703 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|14241|19915|lyfalmen|V1730|19915|00|100|0|22|Vistor hf|Orion Corporation|||14241||14241|19915 015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|85199|107940|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|||85199||85199|107940 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|29584|39017|lyfalmen|||00|120|0|10|Vistor hf|Novartis Healthcare A/S-|||29584||29584|39017 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|51452|66243|lyfalmen|||00|120|0|22|Vistor hf|Novartis Healthcare A/S-|||51452||51452|66243 015800|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA04|01.01.1977||R|A|2|0|0|E|0|ALC|0|0|0|100|USD|1000|2197|lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon|||1000||1000|2197 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3396|5877|vetorma|||16|2|0|0|Vistor hf|Bayer HealthCare AG|||3396||3396|5877 015855|QP54AB5206|Advocate yfirstærðar hundar|bl.lausn|125|mg|4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|4772|8258|vetorma|||16|12|0|0|Vistor hf|Bayer HealthCare AG|||4772||4772|8258 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3030|5244|vetorma|||16|1|0|0|Vistor hf|Bayer HealthCare AG|||3030||3030|5244 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3799|6574|vetorma|||16|3|0|0|Vistor hf|Bayer HealthCare AG|||3799||3799|6574 015883|M01CC0101|Atamir|hylki|250|mg|50|stk|1|þpakki||M01CC01|01.05.1978||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|4840|7408|lyfalmen|||10|50|0|25|Swedish Orphan International AB|Sandoz GmbH (S)|||4840||4840|7408 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|4256|7365|vetorma|||16|8|0|0|Vistor hf|Bayer HealthCare AG|||4256||4256|7365 015923|D11AX1401|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AX14|01.10.2007||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|2404|4103|lyfalmen|||00|10|0|0|Vistor hf|Astellas Pharma A/S|||2404||2404|4103 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1500|2876|lyfalmen|||02|10|0|3|Icepharma hf|Martindale Pharmaceuticals|||1500||1500|2876 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3396|5877|vetorma|||16|1|0|0|Vistor hf|Bayer HealthCare AG|||3396||3396|5877 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|þpakki||N06AB05|01.12.2006||R|A|3|0|0|B|0|GSK|0|1|0|30|GBP|1444|2800|lyfalmen|||00|28|0|14|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1444||1444|2800 015985|C09AA0401|Coversyl|töflur|8|mg|90|stk|1|þpakki||C09AA04|01.06.2005||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|16509|22739|lyfalmen|||00|90|0|180|Icepharma hf|Servier|||16509||16509|22739 016000|N02CC0501|Almogran|töflur|12,5|mg|6|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|XEU|55669|7997|lyfalmen|||00|6|0|6|Vistor hf|Laboratorios Almirall S.A.|||5274||5274|7997 016003|C09AA0401|Coversyl|töflur|8|mg|30|stk|1|þpakki||C09AA04|01.06.2005||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|5553|8376|lyfalmen|||00|30|0|60|Icepharma hf|Servier|||5553||5553|8376 016011|N02CC0501|Almogran|töflur|12,5|mg|9|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|XEU|78819|10973|lyfalmen|||00|9|0|9|Vistor hf|Laboratorios Almirall S.A.|||7467||7467|10973 016017|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|12889|18232|lyfalmen|||00|100|0|100|Vistor hf|AstraZeneca A/S DK|||12889||12889|18232 016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1115|2353|lyfalmen|||02|10|0|1|Icepharma hf|Martindale Pharmaceuticals|||1115||1115|2353 016028|C10AA0701|Crestor|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|19311|26227|lyfalmen|||00|100|0|200|Vistor hf|AstraZeneca A/S DK|||19311||19311|26227 016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1182|2444|lyfalmen|||02|20|0|2|Icepharma hf|Martindale Pharmaceuticals|||1182||1182|2444 016038|N02CC0501|Almogran|töflur|12,5|mg|3|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|XEU|28742|4533|lyfalmen|||00|3|0|3|Vistor hf|Laboratorios Almirall S.A.|||2721||2721|4533 016066|R02AA0303|Strepsils Sukkerfri med Citron og Örter|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.10.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|||||| 016125|M02AA1001|Orudis|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.03.2000||L|A|2|0|0|0|0|SNO|0|0|1|100|NOK|||lyfalmen|||00|60|0|0|Vistor hf|Sanofi-aventis Norge AS||||||0 016178|A10BD0301|Avandamet|filmhtfl|502|mg|112|stk|1|þpakki|500+2mg|A10BD03|01.03.2004||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|7771|11386|lyfalmen|||00|112|0|56|GlaxoSmithKline ehf|SmithKline Beecham PLC|||7771||7771|11386 016209|N05AX0801|Risperdal|töflur|2|mg|28|stk|1|þpakki|frostþ. töflur|N05AX08|01.09.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|7709|11302|lyfalmen|||00|28|0|11|Vistor hf|Janssen-Cilag AB|||7709||7709|11302 016228|A10BD0301|Avandamet|filmhtfl|501|mg|56|stk|1|þpakki|500+1mg|A10BD03|01.03.2004|31.12.2008|R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|2566|4323|lyfalmen|||00|56|0|28|GlaxoSmithKline ehf|SmithKline Beecham PLC|||2566||2566|4323 016239|A10BD0301|Avandamet|filmhtfl|501|mg|112|stk|1|þpakki|500+1mg|A10BD03|01.03.2004||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|4347|6739|lyfalmen|||00|112|0|56|GlaxoSmithKline ehf|SmithKline Beecham PLC|||4347||4347|6739 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|3503|5594|lyfalmen|||00|14|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3503||3503|5594 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|7441|10938|lyfalmen|||00|56|0|14|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||7441||7441|10938 016296|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|spr|lausn|G03GA08|01.03.2004||R|K|2|0|1|E|0|SEE|0|0|0|100|SEK|4794|7346|lyfalmen|||00|0|0|1|Gróco ehf|Serono Europe|||4794||4794|7346 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|11328|16213|lyfalmen|||00|56|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||11328||11328|16213 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2353|4034|lyfalmen|||00|14|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2353||2353|4034 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|16614|22869|lyfalmen|||00|56|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||16614||16614|22869 016337|C08CA0302|Lomir Retard|forðahlk|5|mg|100|stk|1|þpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|11896|16984|lyfalmen|||10|100|0|100|Vistor hf|Novartis Healthcare A/S-|||11896||11896|16984 016353|N05AX0801|Risperdal|töflur|1|mg|28|stk|1|þpakki|frostþ. töflur|N05AX08|01.08.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|4342|6733|lyfalmen|||00|28|0|6|Vistor hf|Janssen-Cilag AB|||4342||4342|6733 016363|L01BC0108|Cytarabine Pfizer|stl/irl|20|mg/ml|5|ml|5|hgl||L01BC01|01.11.2000||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|4943|7077|lyfsjukr|||00|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4943||4943|7077 016364|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|2|ml|5|hgl||L01BA01|01.10.1995||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|6257|8958|lyfsjukr|||00|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6257||6257|8958 016374|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|20|ml|1|hgl||L01BC01|01.10.1995||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|18172|24492|lyfsjukr|||00|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||18172||18172|24492 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|A|1,5|0|0|0|1|PFI|0|0|0|100|DKK|149832|188408|lyfsjukr|||00|70|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||149832||149832|188408 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|9087|13010|lyfsjukr|||00|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||9087||9087|13010 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|3500|5590|lyfalmen|||00|56|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3500||3500|5590 016396|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1995||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|8402|12030|lyfsjukr|||00|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||8402||8402|12030 016474|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|5|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|28484|37330|lyfsjukr|||00|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||28484||28484|37330 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|2|Vistor hf|McNeil Denmark ApS||||||0 016506|N07BA0111|Nicorette Classic|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|4|Vistor hf|McNeil Denmark ApS||||||0 016516|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|45|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|239207|299680|lyfsjukr|||00|225|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||239207||239207|299680 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|210|0|14|Vistor hf|McNeil Denmark ApS||||||0 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|210|0|28|Vistor hf|McNeil Denmark ApS||||||0 016534|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|15|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|83893|106314|lyfsjukr|||00|75|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||83893||83893|106314 016561|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|105|0|7|Vistor hf|McNeil Denmark ApS||||||0 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|210|0|14|Vistor hf|McNeil Denmark ApS||||||0 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|4|Vistor hf|McNeil Denmark ApS||||||0 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|2|Vistor hf|McNeil Denmark ApS||||||0 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|19859|26909|lyfalmen|V1701|26415|00|28|0|6|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|||19859||19859|26909 016605|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|105|0|14|Vistor hf|McNeil Denmark ApS||||||0 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|210|0|28|Vistor hf|McNeil Denmark ApS||||||0 016622|A06AG1101|Microlax|innhl|0| |5|ml|50|túpa||A06AG11|01.09.2005||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|250|0|50|Vistor hf|McNeil Denmark ApS||||||7373 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|39717|51633|lyfalmen|||00|56|0|12|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|||39717||39717|51633 016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1026|2233|lyfalmen|V0466|2233|00|12|0|12|Actavis Group hf|LEK Pharmaceuticals d.d.|||1026||1026|2233 016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|K|2|0|1|0|1|ROC|0|0|0|100|DKK|256072|320677|lyfsjukr|||00|2|0|180|Icepharma hf|Roche|||256072||256072|320677 016671|N05AH0303|Zyprexa (Lyfjaver)|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.09.2003|31.12.2008|R|A|2|0|0|*|0|LVR|0|1|0|100|IKR|||lyfalmen|||00|28|0|7|Lyfjaver ehf|Lyfjaver ehf|||3911||| 016680|N07BA0112|Nicorette Orange|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004|31.12.2008|L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|210|0|28|Vistor hf|McNeil Denmark ApS||||||0 016682|N05AH0303|Zyprexa (Lyfjaver)|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.09.2003|31.12.2008|R|A|3|0|0|*|0|LVR|0|1|0|100|IKR|||lyfalmen|||00|28|0|14|Lyfjaver ehf|Lyfjaver ehf|||5412||| 016686|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|3|rörlyk||H01AC01|01.03.2005||R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|223866|280581|lyfsjukr|||00|6|0|0|Icepharma hf|Ipsen Ltd.|||223866||223866|280581 016688|N05AH0303|Zyprexa (Lyfjaver)|húðuðtfl|10|mg|56|stk|1|glas||N05AH03|01.09.2003|31.12.2008|R|A|3|0|0|*|0|LVR|0|1|0|100|IKR|||lyfalmen|||00|56|0|56|Lyfjaver ehf|Lyfjaver ehf|||20990||| 016693|N05AH0303|Zyprexa (Lyfjaver)|húðuðtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.09.2003|31.12.2008|R|A|3|0|0|*|0|LVR|0|1|0|100|IKR|||lyfalmen|||00|56|0|42|Lyfjaver ehf|Lyfjaver ehf|||16502||| 016699|A10BA0202|Glucophage (Lyfjaver)|töflur|500|mg|400|stk|1|plglas||A10BA02|01.09.2003||R|A|5|0|0|*|0|LVR|0|0|0|100|NOK|2688|4488|lyfalmen|||00|400|0|100|Lyfjaver ehf|Lyfjaver ehf|||2688||2688|4488 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|8756|12723|lyfalmen|||00|30|0|30|Vistor hf|Novartis Healthcare A/S-|||8756||8756|12723 016728|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|1|rörlyk||H01AC01|01.03.2005||R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|74623|94773|lyfsjukr|||00|2|0|0|Icepharma hf|Ipsen Ltd.|||74623||74623|94773 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|3975|6235|lyfalmen|V0789|6235|10|200|0|40|Lyfjaver ehf|Lyfjaver ehf|||3975||3975|6235 016739|N07BA0112|Nicorette Orange|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004|31.12.2008|L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|2|Vistor hf|McNeil Denmark ApS||||||0 016761|N07BA0112|Nicorette Orange|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004|31.12.2008|L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|210|0|14|Vistor hf|McNeil Denmark ApS||||||0 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|7247|10675|lyfalmen|V0713|10675|10|200|0|80|Lyfjaver ehf|Lyfjaver ehf|||7247||7247|10675 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|68770|87804|lyfalmen|||00|28|0|28|Vistor hf|Amgen Europe B.V.|||68770||68770|87804 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|101651|128740|lyfalmen|||00|28|0|42|Vistor hf|Amgen Europe B.V.|||101651||101651|128740 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|33079|43368|lyfalmen|||00|28|0|0|Vistor hf|Amgen Europe B.V.|||33079||33079|43368 016892|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|54766|70369|lyfalmen|||00|2|0|12|Gróco ehf|Serono Europe|||54766||54766|70369 016927|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|20948|28265|lyfalmen|||00|0|0|4|Gróco ehf|Serono Europe|||20948||20948|28265 016938|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|31420|41303|lyfalmen|||00|1|0|6|Gróco ehf|Serono Europe|||31420||31420|41303 016943|A02BC0301|Lanzo|munndr.t|30|mg|14|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|E|0|WAB|0|0|0|30|USD|2529|4272|lyfalmen|||00|14|0|14|Icepharma hf|Wyeth AB|||2529||2529|4272 016954|A02BC0301|Lanzo|munndr.t|30|mg|28|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|E|0|WAB|0|0|0|30|USD|4909|7502|lyfalmen|||00|28|0|28|Icepharma hf|Wyeth AB|||4909||4909|7502 016957|A02BC0301|Lanzo|munndr.t|15|mg|98|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|E|0|WAB|0|0|0|30|USD|9559|13812|lyfalmen|||00|98|0|49|Icepharma hf|Wyeth AB|||9559||9559|13812 016965|A02BC0301|Lanzo|munndr.t|30|mg|56|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|E|0|WAB|0|0|0|30|USD|9630|13909|lyfalmen|||00|56|0|56|Icepharma hf|Wyeth AB|||9630||9630|13909 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|A|3|0|1|0|1|GSC|0|0|0|100|XEU|43012|55417|lyfsjukr|||00|30|0|30|Swedish Orphan International AB|Gilead Science International (S) |||43012||43012|55417 016976|A02BC0301|Lanzo|munndr.t|30|mg|98|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|E|0|WAB|0|0|0|30|USD|16871|23189|lyfalmen|||00|98|0|98|Icepharma hf|Wyeth AB|||16871||16871|23189 016979|N02AE0103|Norspan|forðapl|5|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|3709|5874|lyfalmen|||00|4|0|17|Icepharma hf|Norpharma |||3709||3709|5874 016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|60|dælur|1|pakki||QA02BX12|01.12.2006||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|20091|38442|vetalmen|||16|60|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||20091||20091|38442 017006|B05BA1019|StructoKabiven Perifer|irl|830|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.06.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|34761|45145|lyfsjukr|||00|4824|0|0|Icepharma hf|Fresenius Kabi|||34761||34761|45145 017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|1636|3061|lyfalmen|||03|3|0|21|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1636||1636|3061 017111|A09AA0201|Combizym|töflur|0| |100|stk|1|þpakki||A09AA02|01.07.1988||R|A|2|0|0|E|0|DSG|0|0|0|100|XEU|1656|3088|lyfalmen|||10|100|0|25|Icepharma hf|Daiichi Sankyo Europe GmbH|||1656||1656|3088 017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|K|2|0|1|0|1|SKY|0|0|0|100|DKK|307912|385218|lyfsjukr|||00|5|0|0|Icepharma hf|SkyPharma PLC|||307912||307912|385218 017145|C08DB0102|Cardizem Retard|forðatfl|180|mg|60|stk|1|glas||C08DB01|01.04.1990||R|A|2|0|0|B|0|FRO|0|0|0|100|DKK|7412|10899|lyfalmen|||10|60|0|45|Vistor hf|Ferrosan A/S|||7412||7412|10899 017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|A|3|0|1|0|1|JCI|0|0|0|100|SEK|168554|211717|lyfsjukr|||00|1|0|0|Vistor hf|Janssen-Cilag International N.V.|||168554||168554|211717 017203|M05BA0601|Bondronat|irþ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|48545|62306|lyfsjukr|||00|6|0|1|Icepharma hf|Roche|||48545||48545|62306 017204|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|3|pokar|fleyti|B05BA10|01.06.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|35928|46598|lyfsjukr|||00|5712|0|0|Icepharma hf|Fresenius Kabi|||35928||35928|46598 017210|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|1541|2932|lyfalmen|V0221|2932|00|100|0|33|Gróco ehf|Nycomed Danmark A/S|||1541||1541|2932 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|K|1,5|0|1|0|1|BIN|0|0|0|100|XEU|160897|202184|lyfsjukr|||00|2|0|28|Icepharma hf|Biogen Idec Ltd|||160897||160897|202184 017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|þpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|54175|69633|lyfalmen|||00|28|0|0|Icepharma hf|Roche|||54175||54175|69633 017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|þpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|161704|203506|lyfalmen|||00|84|0|0|Icepharma hf|Roche|||161704||161704|203506 017260|L01XX1903|Irinotecan Mayne|irþ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.04.2007||R|A|3|0|1|0|1|MAY|0|0|0|100|SEK|9649|13815|lyfsjukr|||00|2|0|0|Icepharma hf|Mayne Pharma Plc|||9649||9649|13815 017266|N02AE0103|Norspan|forðapl|10|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|6566|9751|lyfalmen|||00|4|0|33|Icepharma hf|Norpharma |||6566||6566|9751 017271|L01XX1903|Irinotecan Mayne|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.04.2007||R|A|3|0|1|0|1|MAY|0|0|0|100|SEK|22857|30324|lyfsjukr|||00|5|0|0|Icepharma hf|Mayne Pharma Plc|||22857||22857|30324 017294|N03AX1202|Gabapentin NM Pharma|hylki|300|mg|100|stk|1|glas||N03AX12|01.10.2007||R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|5359|8113|lyfalmen|V0714|8113|00|100|0|17|Actavis Group PTC ehf|Merck NM AB|||5359||5359|8113 017305|N03AX1202|Gabapentin NM Pharma|hylki|400|mg|100|stk|1|glas||N03AX12|01.10.2007|31.01.2009|R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|||lyfalmen|||00|100|0|22|Actavis Group PTC ehf|Merck NM AB|||7470||| 017326|N02AE0103|Norspan|forðapl|20|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|12261|17450|lyfalmen|||00|4|0|67|Icepharma hf|Norpharma |||12261||12261|17450 017327|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|2885|4755|lyfalmen|||00|100|0|67|Gróco ehf|Nycomed Danmark A/S|||2885||2885|4755 017331|A04AD1201|Emend|hylki|0| |3|stk|1|þpakki|samsett pakkning|A04AD12|01.04.2004||R|A|2,5|0|0|0|1|MSD|0|0|0|100|XEU|12212|17071|lyfsjukr|||00|3|0|0|Icepharma hf|M.S.D.|||12212||12212|17071 017365|J01CR0201|Amoksiklav|töflur|375|mg|20|stk|1|glas|250+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|792|1915|lyfalmen|||00|20|0|5|Actavis Group hf|LEK Pharmaceuticals d.d.|||792||792|1915 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|A|2|0|0|E|0|REP|0|0|1|100|SEK|2986|4893|lyfalmen|||00|30|0|150|Vistor hf|Recip AB|||2986||2986|4893 017541|N07CA0101|Betaserc|töflur|16|mg|100|stk|1|þpakki||N07CA01|01.06.1999||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|7737|11340|lyfalmen|||00|100|0|67|Medico ehf|Solvay Duphar |||7737||7737|11340 017556|J01CR0201|Amoksiklav|töflur|625|mg|20|stk|1|glas|500+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1215|2489|lyfalmen|V0465|2489|00|20|0|12|Actavis Group hf|LEK Pharmaceuticals d.d.|||1215||1215|2489 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|A|2|0|0|0|0|BOI|0|0|0|100|DKK|7170|13829|vetalmen|||00|100|0|0|Vistor hf|Boehringer Ingelheim|||7170||7170|13829 017763|N06DA0401|Reminyl|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|36984|48230|lyfalmen|V1371|48230|00|84|0|84|Vistor hf|Janssen-Cilag AB|||36984||36984|48230 017773|N06DA0401|Reminyl|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|12019|17149|lyfalmen|V1370|17137|00|28|0|14|Vistor hf|Janssen-Cilag AB|||12019||12019|17149 017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|11999|17124|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||11999||11999|17124 017809|N06DA0401|Reminyl|forðahlk|24|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|46209|59715|lyfalmen|||00|84|0|126|Vistor hf|Janssen-Cilag AB|||46209||46209|59715 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|11999|17124|lyfalmen|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||11999||11999|17124 018044|D06BX0103|Rozex|hlaup|7,5|mg/g|30|g|1|túpa||D06BX01|01.01.1998||R|A||0|0|0|0|LDR|0|0|1|100|IKR|922|2092|lyfalmen|||00|30|1|30|Parlogis hf|Parlogis - óskráð lyf|||922||922|2092 018268|G03FA1701|Angemin|töflur|0| |84|stk|1|þpakki|2+1 mg|G03FA17|01.06.2005||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|6238|9306|lyfalmen|||00|84|0|84|Icepharma hf|Bayer Schering Pharma AG|||6238||6238|9306 018311|C09CA0801|Olmetec|filmhtfl|10|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|2893|4766|lyfalmen|||00|28|0|14|Gróco ehf|Daiichi Sankyo Europe GmbH-|||2893||2893|4766 018446|C09CA0801|Olmetec|filmhtfl|40|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|4272|6638|lyfalmen|||00|28|0|56|Gróco ehf|Daiichi Sankyo Europe GmbH-|||4272||4272|6638 018453|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|1|spr||L02BA03|01.06.2004||R|K|3|0|1|0|1|ASZ|0|0|0|100|SEK|61350|78248|lyfsjukr|||00|5|0|0|Vistor hf|AstraZeneca UK Ltd|||61350||61350|78248 018502|C09CA0801|Olmetec|filmhtfl|40|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|13378|18841|lyfalmen|||00|98|0|196|Gróco ehf|Daiichi Sankyo Europe GmbH-|||13378||13378|18841 018512|C09CA0801|Olmetec|filmhtfl|10|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|9396|13591|lyfalmen|||00|98|0|49|Gróco ehf|Daiichi Sankyo Europe GmbH-|||9396||9396|13591 018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|3374|5419|lyfalmen|||02|0|0|0|Icepharma hf|Baxter AG|||3374||3374|5419 018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|3685|5841|lyfalmen|||02|0|0|0|Icepharma hf|Baxter AG|||3685||3685|5841 018534|C09CA0801|Olmetec|filmhtfl|20|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|11035|15815|lyfalmen|||00|98|0|98|Gróco ehf|Daiichi Sankyo Europe GmbH-|||11035||11035|15815 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.11.2004||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|1499|2875|lyfalmen|||00|42|0|4|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1499||1499|2875 018558|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|5|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|16966|22990|lyfsjukr|||00|5|0|0|Icepharma hf|Mayne Pharma Plc|||16966||16966|22990 018569|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|83891|106312|lyfsjukr|||00|25|0|0|Icepharma hf|Mayne Pharma Plc|||83891||83891|106312 018586|C09CA0801|Olmetec|filmhtfl|20|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|3592|5715|lyfalmen|||00|28|0|28|Gróco ehf|Daiichi Sankyo Europe GmbH-|||3592||3592|5715 018591|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|34172|44412|lyfsjukr|||00|17|0|0|Icepharma hf|Mayne Pharma Plc|||34172||34172|44412 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|8855|12857|lyfalmen|||00|30|0|60|Vistor hf|Astellas Pharma A/S|||8855||8855|12857 018617|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|98045|123934|lyfsjukr|||00|50|0|0|Icepharma hf|Mayne Pharma Plc|||98045||98045|123934 018663|J01DD0401|Rocephalin|stþ|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|14643|20098|lyfsjukr|||03|5|0|2|Icepharma hf|Roche|||14643||14643|20098 018670|C09CA0301|Diovan|filmhtfl|40|mg|14|stk|1|þpakki||C09CA03|01.07.2005||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|1562|2960|lyfalmen|||00|14|0|7|Vistor hf|Novartis Healthcare A/S-|||1562||1562|2960 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|24073|32156|lyfalmen|||00|90|0|180|Vistor hf|Astellas Pharma A/S|||24073||24073|32156 018681|C09CA0301|Diovan|filmhtfl|40|mg|28|stk|1|þpakki||C09CA03|01.07.2005||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|3126|5083|lyfalmen|||00|28|0|14|Vistor hf|Novartis Healthcare A/S-|||3126||3126|5083 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|þpakki||H02AB06|11.06.2004||R|A|3|0|0|B|0|MAC|0|0|1|100|XEU|1189|2454|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck KgaA (A) |||1189||1189|2454 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|7087|10458|lyfalmen|||00|30|0|30|Vistor hf|Astellas Pharma A/S|||7087||7087|10458 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|19387|26322|lyfalmen|||00|90|0|90|Vistor hf|Astellas Pharma A/S|||19387||19387|26322 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|40003|51989|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||40003||40003|51989 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|K|2|0|1|0|1|TEP|0|0|0|100|NOK|132062|166285|lyfsjukr|||00|28|0|0|Vistor hf|Teva Pharmaceuticals Limited|||||132062|166285 018803|C10AA0502|Lipitor (Lyfjaver)|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.01.2005|31.12.2008|R|A|3|0|0|0|0|LVR|0|0|0|100|DKK|||lyfalmen|||00|100|0|200|Lyfjaver ehf|Lyfjaver ehf|||22673||| 018814|C10AA0502|Lipitor (Lyfjaver)|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.01.2005|31.12.2008|R|A|3|0|0|0|0|LVR|0|0|0|100|DKK|||lyfalmen|||00|100|0|400|Lyfjaver ehf|Lyfjaver ehf|||26641||| 018894|N06DA0202|Aricept (Lyfjaver)|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.01.2005||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|51320|65546|lyfalmen|V0375|65546|00|98|0|65|Lyfjaver ehf|Lyfjaver ehf|||50892||50892|65546 018908|N06DA0202|Aricept (Lyfjaver)|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.01.2005||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|55709|70740|lyfalmen|V0376|70740|00|98|0|131|Lyfjaver ehf|Lyfjaver ehf|||55064||55064|70740 018927|M05BA0402|Fosamax (Lyfjaver)|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.03.2004||R|A|2|0|0|E|0|LVR|0|0|0|100|XEU|15632|21647|lyfalmen|V0718|21647|00|12|0|84|Lyfjaver ehf|Lyfjaver ehf|||15632||15632|21647 018956|R06AX2201|Kestine|töflur|20|mg|30|stk|1|þpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|3333|5363|lyfalmen|||00|30|0|60|Gróco ehf|Almirall-Prodesfarma S.A.|||3333||3333|5363 018967|R06AX2201|Kestine|töflur|20|mg|100|stk|1|þpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|10309|14830|lyfalmen|||00|100|0|200|Gróco ehf|Almirall-Prodesfarma S.A.|||10309||10309|14830 018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|57456|73400|lyfsjukr|||43|60|0|30|GlaxoSmithKline ehf|Glaxo Group Limited|||57456||57456|73400 018978|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|638|1706|lyfalmen|||00|100|0|50|Gróco ehf|Nycomed Danmark A/S|||638||638|1706 018979|C10AA0502|Lipitor (Lyfjaver)|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.01.2005|31.12.2008|R|A|3|0|0|0|0|LVR|0|0|0|100|DKK|||lyfalmen|||00|100|0|100|Lyfjaver ehf|Lyfjaver ehf|||15692||| 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|S|2|0|0|0|0|KEL|1|0|0|100|NOK|1121|2212|vetalmen|||27|100|0|0|Icepharma hf|Kela Laboratoria NV|||1121||1121|2212 018995|N02AB0301|Durogesic|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|13679|19215|lyfalmen|V1052|14579|00|5|0|62|Vistor hf|Janssen-Cilag AB|||13679||13679|19215 019065|N06DA0302|Exelon (Lyfjaver)|hylki|6|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|15734|21774|lyfalmen|||00|56|0|37|Lyfjaver ehf|Lyfjaver ehf|||15734||15734|21774 019079|N06DA0302|Exelon (Lyfjaver)|hylki|4,5|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|15734|21774|lyfalmen|||00|56|0|28|Lyfjaver ehf|Lyfjaver ehf|||15734||15734|21774 019082|N06DA0302|Exelon (Lyfjaver)|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|15424|20653|lyfalmen|V1372|20652|00|56|0|19|Lyfjaver ehf|Lyfjaver ehf|||14834||14834|20653 019094|N02AB0301|Durogesic|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|8873|12881|lyfalmen|V1051|10659|00|5|0|42|Vistor hf|Janssen-Cilag AB|||8873||8873|12881 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|20662|27592|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||20662||20662|27592 019102|N06DA0302|Exelon (Lyfjaver)|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|7867|11516|lyfalmen|||00|28|0|5|Lyfjaver ehf|Lyfjaver ehf|||7867||7867|11516 019108|N02AB0301|Durogesic|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|4795|7347|lyfalmen|V1050|5939|00|5|0|21|Vistor hf|Janssen-Cilag AB|||4795||4795|7347 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|23122|30654|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||23122||23122|30654 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|13480|18650|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||13480||13480|18650 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|15297|20912|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||15297||15297|20912 019167|N02AB0301|Durogesic|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|15333|21275|lyfalmen|V1053|17338|00|5|0|83|Vistor hf|Janssen-Cilag AB|||15333||15333|21275 019293|B02BC0001|TachoSil|svampur|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC00|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|DKK|60908|77698|lyfsjukr|||00|1|0|0|Gróco ehf|Nycomed Danmark A/S|||60908||60908|77698 019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|þykkni, lausn|B01AE06|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|XEU|794736|991314|lyfsjukr|||00|10|0|0|Gróco ehf|Nycomed Danmark A/S|||794736||794736|991314 019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A||||||0 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|7310|10760|lyfalmen|||00|56|0|0|Icepharma hf|Eli Lilly Nederland -|||7310||7310|10760 019445|L01XC0701|Avastin|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|63557|80996|lyfsjukr|||AC|4|0|0|Icepharma hf|Roche Registration Limited|||63557||63557|80996 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|7310|10760|lyfalmen|||00|56|0|0|Icepharma hf|Eli Lilly Nederland -|||7310||7310|10760 019491|N06AX2102|Yentreve|hylki|40|mg|140|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|17987|24579|lyfalmen|||00|140|0|0|Icepharma hf|Eli Lilly Nederland -|||17987||17987|24579 019513|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|640|1709|lyfalmen|||00|100|0|100|Gróco ehf|Nycomed Danmark A/S|||640||640|1709 019589|C09CA0401|Aprovel|filmhtfl|150|mg|28|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|3593|5716|lyfalmen|||00|28|0|28|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||3593||3593|5716 019600|C09CA0401|Aprovel|filmhtfl|150|mg|98|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|8976|13021|lyfalmen|||00|98|0|98|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||8976||8976|13021 019611|C09CA0401|Aprovel|filmhtfl|300|mg|28|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|5121|7790|lyfalmen|||00|28|0|56|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||5121||5121|7790 019622|C09CA0401|Aprovel|filmhtfl|300|mg|98|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|17096|23469|lyfalmen|||00|98|0|196|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||17096||17096|23469 019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|13|Artasan ehf|Novartis Healthcare A/S-A||||||0 019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|0|Artasan ehf|Novartis Healthcare A/S-A||||||0 019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|13|Artasan ehf|Novartis Healthcare A/S-A||||||0 019681|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A||||||0 019699|C09DA0401|CoAprovel|filmhtfl|162,5|mg|28|stk|1|þpakki|150+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|3593|5716|lyfalmen|||00|28|0|28|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||3593||3593|5716 019710|C09DA0401|CoAprovel|filmhtfl|162,5|mg|98|stk|1|þpakki|150+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|12545|17804|lyfalmen|||00|98|0|98|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||12545||12545|17804 019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|6473|9268|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Danmark A/S|||6473||6473|9268 019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A||||||0 019721|C09DA0401|CoAprovel|filmhtfl|312,5|mg|28|stk|1|þpakki|300+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|5121|7790|lyfalmen|||00|28|0|56|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||5121||5121|7790 019724|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A||||||0 019732|C09DA0401|CoAprovel|filmhtfl|312,5|mg|98|stk|1|þpakki|300+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|17096|23469|lyfalmen|||00|98|0|196|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||17096||17096|23469 019739|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A||||||0 019745|C03CA0101|Furix|töflur|40|mg|250|stk|1|glas|til vélskömmtunar|C03CA01|01.04.2005||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|669|1748|lyfalmen|||00|250|0|250|Gróco ehf|Nycomed Danmark A/S|||669||669|1748 019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|32244|42011|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Danmark A/S|||32244||32244|42011 019781|L01XC0701|Avastin|irþ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|232556|291400|lyfsjukr|||AC|16|0|0|Icepharma hf|Roche Registration Limited|||232556||232556|291400 019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A||||||0 019786|J01CA0410|Amoxicillin Merck NM|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|972|2159|lyfalmen|||10|20|0|10|Actavis Group PTC ehf|Merck NM AB|||972||972|2159 019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A||||||0 019797|L01BA0401|Alimta|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|A|2|0|1|0|1|ELD|0|0|0|100|XEU|234449|293757|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Nederland -|||234449||234449|293757 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13384|18848|lyfalmen|||00|28|0|4|Icepharma hf|Eli Lilly Danmark A/S|||13384||13384|18848 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13384|18848|lyfalmen|||00|28|0|6|Icepharma hf|Eli Lilly Danmark A/S|||13384||13384|18848 019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|63876|81711|lyfalmen|||00|1|0|12|Vistor hf|N.V. Organon|||63876||63876|81711 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13384|18848|lyfalmen|||00|28|0|9|Icepharma hf|Eli Lilly Danmark A/S|||13384||13384|18848 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13384|18848|lyfalmen|||00|28|0|14|Icepharma hf|Eli Lilly Danmark A/S|||13384||13384|18848 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13384|18848|lyfalmen|||00|28|0|21|Icepharma hf|Eli Lilly Danmark A/S|||13384||13384|18848 019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|K|4|0|1|0|1|BIA|0|0|0|100|DKK|839784|1047399|lyfsjukr|||02|6|0|9|Vistor hf|Biovitrum AB (publ)|||839784||839784|1047399 019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|þpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|379|1355|lyfalmen|||00|12|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||379||379|1355 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|þpakki|600+300 mg|J05AR02|01.05.2004||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|65108|82927|lyfsjukr|||00|30|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||65108||65108|82927 019968|J01CA0410|Amoxicillin Merck NM|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|1455|2815|lyfalmen|||10|30|0|15|Actavis Group PTC ehf|Merck NM AB|||1455||1455|2815 020016|B03AA0704|Duroferon|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|A|3|0|0|0|0|AZD|0|0|1|100|SEK|||lyfalmen|||43|100|0|50|Vistor hf|AstraZeneca A/S DK||||||1336 020134|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|13|Artasan ehf|Novartis Healthcare A/S-A||||||0 020180|C03CC0101|Edecrin|sts|0| |50|mg|1|hgl||C03CC01|01.05.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|19615|26288|lyfsjukr|||00|50|1|1|Parlogis hf|Parlogis - óskráð lyf|||19615||19615|26288 020193|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A||||||0 020238|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|30|stk|1|þpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|4766|7308|lyfalmen|||00|30|0|30|Vistor hf|Astellas Pharma A/S|||4766||4766|7308 020244|J07CA0204|Boostrix Polio|stl|0| |0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|25386|33791|lyfalmen|||00|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||25386||25386|33791 020261|A10BD0301|Avandamet|filmhtfl|1002|mg|56|stk|1|þpakki|1000+2mg|A10BD03|01.10.2005|31.12.2008|R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|4899|7489|lyfalmen|||00|56|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||4899||4899|7489 020272|A10BD0301|Avandamet|filmhtfl|1004|mg|56|stk|1|þpakki|1000+4mg|A10BD03|01.10.2005|31.12.2008|R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|8798|12780|lyfalmen|||00|56|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||8798||8798|12780 020276|A06AB0203|Dulcolax (Lyfjaver)|eþ-stil|10|mg|50|stk|1|þpakki||A06AB02|01.07.2005||R|A|5|0|0|0|0|LVR|0|0|0|100|NOK|2385|4077|lyfalmen|||04|50|0|50|Lyfjaver ehf|Lyfjaver ehf|||2385||2385|4077 020277|N06AX1602|Efexor Depot|forðahlk|37,5|mg|7|stk|1|þpakki||N06AX16|01.02.2007||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|873|2022|lyfalmen|||00|7|0|3|Icepharma hf|Wyeth AB|||871||871|2022 020338|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|90|stk|1|þpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|10478|15060|lyfalmen|||00|90|0|90|Vistor hf|Astellas Pharma A/S|||10478||10478|15060 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|74413|94829|lyfalmen|||02|2|0|0|Vistor hf|Astellas Pharma A/S|||74413||74413|94829 020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.06.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|3993|6259|lyfalmen|||00|84|0|7|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3993||3993|6259 020398|N06AB1001|Cipralex|dropar|10|mg/ml|28|ml|1|glas||N06AB10|01.11.2005||R|A|2|0|0|B|0|LBK|0|1|0|30|DKK|3876|6100|lyfalmen|||00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|||3876||3876|6100 020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|þpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|11545|16508|lyfalmen|||00|84|0|28|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||11545||11545|16508 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|26336|34973|lyfalmen|||02|2|0|0|Vistor hf|Astellas Pharma A/S|||26336||26336|34973 020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|775|1892|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|||775||775|1892 020456|M05BX0301|Protelos|mixt.kyr|2|g|28|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|7394|10874|lyfalmen|||00|28|0|28|Icepharma hf|Servier|||7394||7394|10874 020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2261|3909|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|||2261||2261|3909 020472|C09CA0103|Cozaar (Lyfjaver)|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.09.2004|31.12.2008|R|A|3|0|0|B|0|LVR|0|0|0|100|XEU|||lyfalmen|||00|98|0|98|Lyfjaver ehf|Lyfjaver ehf|||12208||| 020483|C09DA0103|Cozaar Comp (Lyfjaver)|töflur|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.08.2004|31.12.2008|R|A|3|0|0|B|0|LVR|0|0|0|100|XEU|||lyfalmen|||00|98|0|98|Lyfjaver ehf|Lyfjaver ehf|||12226||| 020494|N03AX1102|Topimax (Lyfjaver)|töflur|25|mg|60|stk|1|plglas||N03AX11|01.08.2004||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|4497|6943|lyfalmen|V0709|6161|00|60|0|5|Lyfjaver ehf|Lyfjaver ehf|||4497||4497|6943 020510|N03AX1102|Topimax (Lyfjaver)|töflur|50|mg|60|stk|1|plglas||N03AX11|01.07.2005||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|6554|9734|lyfalmen|V0710|9599|00|60|0|10|Lyfjaver ehf|Lyfjaver ehf|||6554||6554|9734 020516|N03AX1102|Topimax (Lyfjaver)|töflur|100|mg|60|stk|1|plglas||N03AX11|01.09.2004||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|13064|18450|lyfalmen|V0711|16342|00|60|0|20|Lyfjaver ehf|Lyfjaver ehf|||13064||13064|18450 020523|N06AB1002|Cipralex (D.A.C.)|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.07.2004||R|A|3|0|0|B|0|DAC|0|1|0|30|DKK|3372|5416|lyfalmen|V0939|5416|00|28|0|28|D.A.C. ehf|D.A.C. ehf|||3372||3372|5416 020533|M05BX0301|Protelos|mixt.kyr|2|g|84|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|21691|29190|lyfalmen|||00|84|0|84|Icepharma hf|Servier|||21691||21691|29190 020616|G03CA0319|Vagifem (D.A.C.)|sk-tfl|25|mcg|15|stk|1|þpakki|+stjaka|G03CA03|01.07.2004|31.01.2009|R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|||lyfalmen|||05|15|0|15|D.A.C. ehf|D.A.C. ehf|||2137||| 020648|R06AX2201|Kestine|töflur|20|mg|10|stk|1|þpakki||R06AX22|01.10.2005||L|A|3|0|0|0|0|ALF|0|0|1|100|DKK|||lyfalmen|||00|10|0|20|Gróco ehf|Almirall-Prodesfarma S.A.||||||2328 020649|N03AX1203|Neurontin (D.A.C.)|hylki|300|mg|50|stk|1|þpakki||N03AX12|01.07.2004|31.01.2009|R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|4561|5287|lyfalmen|||10|50|0|8|D.A.C. ehf|D.A.C. ehf|||3277||3277|5287 020700|L04AA2101|Raptiva|sts|100|mg/ml|125|mg|4|hgl|+ leysir|L04AA21|01.05.2005||R|K|4|0|1|0|1|SEE|0|0|0|100|SEK|166489|209146|lyfsjukr|||00|500|0|50|Gróco ehf|Serono Europe|||166489||166489|209146 020711|G03AC0302|Postinor|töflur|1500|mcg|1|stk|1|þpakki||G03AC03|01.01.2007||L|A|4|0|0|0|0|MEI|0|0|0|100|IKR|||lyfalmen|||23|1|0|0|Icepharma hf|Medimpex UK Limited||||||0 020763|R03AK0704|Symbicort Turbuhaler (D.A.C.)|innúðadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.08.2004|31.01.2009|R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|||lyfalmen|||00|120|0|30|D.A.C. ehf|D.A.C. ehf|||8303||| 020770|QP54AA5101|Eqvalan Duo|pasta|0| |7,74|g|1|sk-dæl||QP54AA51|01.10.2006||R|A|3|0|0|0|0|MES|0|0|0|100|XEU|2375|4110|vetorma|||16|8|0|0|Vistor hf|Merial SAS|||2375||2375|4110 020774|L04AB0101|Enbrel|sts|0| |50|mg|4|hgl|+ leysir|L04AB01|01.10.2005||R|K|3|0|1|0|1|WTE|0|0|0|100|USD|220038|275815|lyfsjukr|||00|200|0|29|Icepharma hf|Wyeth Europe|||220038||220038|275815 020826|N06AX1601|Efexor|töflur|37,5|mg|28|stk|1|þpakki||N06AX16|01.10.1996||R|A|3|0|0|B|0|WLN|0|1|0|100|USD|2604|4374|lyfalmen|||00|28|0|10|Icepharma hf|Wyeth Lederle Nordiska|||||2604|4374 020924|J01FA1003|Zithromax (D.A.C.)|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.09.2007||R|A|2|0|0|0|0|DAC|0|0|1|100|DKK|2943|4834|lyfalmen|V0429|4834|00|3|0|5|D.A.C. ehf|D.A.C. ehf|||2943||2943|4834 021031|R05CB0102|Mucomyst|lausn|200|mg/ml|10|ml|10|hgl|innöndunarvökvi|R05CB01|01.11.2006||R|K|3|0|0|E|0|BIP|0|0|0|100|SEK|5808|8722|lyfalmen|||00|100|0|0|Vistor hf|BioPhausia AB|||5808||5808|8722 021048|R03DC0301|Singulair|filmhtfl|10|mg|28|stk|1|þpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|6449|9592|lyfalmen|||63|28|0|28|Icepharma hf|M.S.D.|||6449||6449|9592 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|A|3|0|0|0|0|GAN|0|0|0|100|SEK|2235|3873|lyfalmen|||00|60|0|60|Icepharma hf|Galderma Nordic AB|||2235||2235|3873 021057|J01CR0203|Augmentine (D.A.C.)|töflur|625|mg|12|stk|1|þpakki|500+125 mg|J01CR02|01.05.2005||R|A|2|0|0|0|0|DAC|0|0|1|100|IKR|714|1809|lyfalmen|||00|12|0|8|D.A.C. ehf|D.A.C. ehf|||714||714|1809 021091|S01ED5107|Xalacom (D.A.C.)|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.11.2004||R|K|2|0|0|*|0|DAC|0|0|0|100|DKK|3685|5841|lyfalmen|V0988|5841|06|2|0|0|D.A.C. ehf|D.A.C. ehf|||3685||3685|5841 021107|N05AH0403|Seroquel (D.A.C.)|töflur|100|mg|60|stk|1|þpakki||N05AH04|01.05.2005||R|A|3|0|0|*|0|DAC|0|1|0|100|SEK|9541|12139|lyfalmen|||00|60|0|15|D.A.C. ehf|D.A.C. ehf|||8326||8326|12139 021120|N03AX1103|Topamax (D.A.C.)|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.11.2004||R|A|3|0|0|E|0|DAC|0|0|0|100|SEK|12622|16342|lyfalmen|V0711|16342|00|60|0|20|D.A.C. ehf|D.A.C. ehf|||11423||11423|16342 021149|J01CR0203|Augmentine (D.A.C.)|töflur|1000|mg|12|stk|1|þpakki|875+125 mg|J01CR02|01.05.2005||R|A|1,5|0|0|0|0|DAC|0|0|1|100|IKR|1093|2233|lyfalmen|V0466|2233|00|12|0|12|D.A.C. ehf|D.A.C. ehf|||1026||1026|2233 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.03.2005||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|453|1455|lyfalmen|V0609|1444|00|30|0|15|Actavis Group hf|Actavis hf|||453||453|1455 021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|A|2|0|0|E|0|GEM|0|0|0|100|XEU|1087|2315|lyfalmen|||00|10|0|0|Actavis Group hf|Gerhard Mann|||1087||1087|2315 021221|R03AC0303|Terbasmin Turbuhaler (D.A.C.)|innönddu|0,5|mg/sk|200|sk|1|stauk||R03AC03|01.11.2004||R|A|2|0|0|B|0|DAC|0|0|1|100|SEK|1797|3279|lyfalmen|V0987|3279|23|200|0|50|D.A.C. ehf|D.A.C. ehf|||1797||1797|3279 021226|N06AB0603|Zoloft (D.A.C.)|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.09.2007||R|A|5|0|0|B|0|DAC|0|1|0|30|DKK|4145|3578|lyfalmen|V0931|2428|00|28|0|28|D.A.C. ehf|D.A.C. ehf|||2017||2017|3578 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.2005||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|1187|2451|lyfalmen|V0610|2451|00|100|0|50|Actavis Group hf|Actavis hf|||1187||1187|2451 021232|N06AB0603|Zoloft (D.A.C.)|filmhtfl|100|mg|28|stk|1|þpakki||N06AB06|01.11.2004||R|A|5|0|0|B|0|DAC|0|1|0|30|DKK|6468|5445|lyfalmen|V0935|3559|00|28|0|56|D.A.C. ehf|D.A.C. ehf|||3393||3393|5445 021257|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2005||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|15859|21929|lyfalmen|||02|4|0|56|Icepharma hf|Bayer Schering Pharma AG|||15859||15859|21929 021325|R03BB0402|Spiriva (D.A.C.)|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.11.2004|31.01.2009|R|A|2|0|0|B|0|DAC|0|0|0|100|DKK|||lyfalmen|||00|30|0|30|D.A.C. ehf|D.A.C. ehf|||7502||| 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|19753|26777|lyfalmen|||63|98|0|98|Icepharma hf|M.S.D.|||19753||19753|26777 021373|A02BC0504|Nexium Mups (D.A.C.)|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.04.2006||R|A|3|0|0|E|0|DAC|0|0|0|30|SEK|5196|7892|lyfalmen|V0085|7892|00|28|0|37|D.A.C. ehf|D.A.C. ehf|||5196||5196|7892 021375|M01AB0512|Voltaren Dolo|töflur|12,5|mg|20|stk|1|þpakki||M01AB05|01.10.2004||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|20|0|2|Artasan ehf|Novartis Healthcare A/S-A||||||0 021398|L02BB0303|Casodex (D.A.C.)|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.11.2004||R|A|5|0|0|*|0|DAC|0|0|0|100|SEK|19354|26281|lyfalmen|V0560|22054|00|30|0|30|D.A.C. ehf|D.A.C. ehf|||19354||19354|26281 021417|R01AD0504|Rhinocort (D.A.C.)|nefúði|64|mcg/sk|120|sk|1|fl||R01AD05|01.11.2004||R|A|2|0|0|E|0|DAC|0|0|1|100|SEK|1451|2809|lyfalmen|V0965|2809|24|120|0|38|D.A.C. ehf|D.A.C. ehf|||1451||1451|2809 021426|N04BX0203|Comtan (D.A.C.)|filmhtfl|200|mg|100|stk|1|glas||N04BX02|01.11.2004|31.01.2009|R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|||lyfalmen|||00|100|0|20|D.A.C. ehf|D.A.C. ehf|||12913||| 021428|A06AB0201|Dulcolax|eþ-stil|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|A|5|0|0|0|0|BOI|0|0|0|100|DKK|||lyfalmen|||04|6|0|6|Vistor hf|Boehringer Ingelheim||||||1494 021447|N04BC0402|Requip (D.A.C.)|töflur|2|mg|84|stk|1|plglas||N04BC04|01.11.2004||R|A|2|0|0|E|0|DAC|0|0|0|100|GBP|11409|16323|lyfalmen|V0728|16323|00|84|0|28|D.A.C. ehf|D.A.C. ehf|||11409||11409|16323 021469|R03DC0301|Singulair|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|A|2|0|0|B|0|MSD|0|0|0|100|XEU|24139|32238|lyfalmen|||63|98|0|49|Icepharma hf|M.S.D.|||24139||24139|32238 021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2973|4257|lyfsjukr|||02|100|0|0|Icepharma hf|Fresenius Kabi|||2973||2973|4257 021548|R03BA0204|Pulmicort Turbuhaler (D.A.C.)|innúðadu|200|mcg/sk|100|sk|1|stauk||R03BA02|01.05.2005||R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|3012|4928|lyfalmen|||23|100|0|25|D.A.C. ehf|D.A.C. ehf|||3012||3012|4928 021559|R03BA0204|Pulmicort Turbuhaler (D.A.C.)|innúðadu|400|mcg/sk|100|sk|1|stauk||R03BA02|01.05.2005||R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|4929|7529|lyfalmen|||23|100|0|50|D.A.C. ehf|D.A.C. ehf|||4929||4929|7529 021593|H01BA0201|Minirin|frþ.tfl|60|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|4963|7575|lyfalmen|||00|30|0|4|Vistor hf|Ferring Lægemidler A/S|||4963||4963|7575 021604|H01BA0201|Minirin|frþ.tfl|60|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|15682|21709|lyfalmen|||00|100|0|15|Vistor hf|Ferring Lægemidler A/S|||15682||15682|21709 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|12623|17901|lyfalmen|||00|98|0|49|Vistor hf|AstraZeneca A/S DK|||12623||12623|17901 021614|H01BA0201|Minirin|frþ.tfl|120|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FAB|0|0|0|100|DKK|9248|13390|lyfalmen|||00|30|0|9|Vistor hf|Ferring AB, Svíþjóð|||9248||9248|13390 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|29793|38960|lyfsjukr|||02|1000|0|0|Icepharma hf|Fresenius Kabi|||29793||29793|38960 021641|H01BA0201|Minirin|frþ.tfl|120|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|26695|35420|lyfalmen|||00|100|0|30|Vistor hf|Ferring Lægemidler A/S|||26695||26695|35420 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|38935|50342|lyfsjukr|||02|500|0|0|Icepharma hf|Fresenius Kabi|||38935||38935|50342 021659|V01AA0304|Alutard SQ, derm. pter.|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|25980|34530|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|||25980||25980|34530 021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|þpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|3968|6225|lyfalmen|||00|28|0|14|Vistor hf|AstraZeneca A/S DK|||3968||3968|6225 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|18323|24680|lyfsjukr|||02|500|0|0|Icepharma hf|Fresenius Kabi|||18323||18323|24680 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|4898|7013|lyfsjukr|||02|50|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4898||4898|7013 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20799|28080|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||20799||20799|28080 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|XEU|4429|6851|lyfalmen|||00|28|0|14|Icepharma hf|Eli Lilly Nederland -|||4429||4429|6851 021829|H01BA0203|Minirin (D.A.C.)|töflur|0,2|mg|30|stk|1|plglas||H01BA02|01.08.2006||R|A|2|0|0|E|0|DAC|0|0|0|100|DKK|9538|13784|lyfalmen|||00|30|0|15|D.A.C. ehf|D.A.C. ehf|||9538||9538|13784 021862|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.02.2007||R|A|3|0|0|E|0|DAC|0|0|0|30|SEK|5196|7892|lyfalmen|V0085|7892|00|28|0|37|D.A.C. ehf|D.A.C. ehf|||5196||5196|7892 021950|B05AA0705|HyperHAES|irl|0| |250|ml|10|pokar||B05AA07|01.07.2005||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|27300|35856|lyfsjukr|||00|2500|0|2|Icepharma hf|Fresenius Kabi|||27300||27300|35856 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|XEU|5946|8909|lyfalmen|||00|28|0|28|Icepharma hf|Eli Lilly Nederland -|||5946||5946|8909 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|XEU|20797|28077|lyfalmen|||00|98|0|98|Icepharma hf|Eli Lilly Nederland -|||20797||20797|28077 022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|20799|28080|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||20799||20799|28080 022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|96935|122552|lyfsjukr|||00|30|0|0|Icepharma hf|Roche Registration Limited|||96935||96935|122552 022087|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|þpakki||QG03DA02|01.10.1995||R|A|5|0|0|0|0|LAH|0|0|0|100|DKK|759|1498|vetalmen|||16|20|0|0|Vistor hf|LEO Animal Health A/S|||759||759|1498 022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||00|200|0|45|Actavis Group hf|Actavis Group hf||||||0 022132|C10BA0201|Inegy|töflur|30|mg|98|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|31168|40989|lyfalmen|||00|98|0|131|Icepharma hf|M.S.D.|||31168||31168|40989 022159|C10BA0201|Inegy|töflur|50|mg|98|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|36439|47552|lyfalmen|||00|98|0|261|Icepharma hf|M.S.D.|||36439||36439|47552 022181|C10BA0201|Inegy|töflur|90|mg|98|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|38516|50137|lyfalmen|||00|98|0|523|Icepharma hf|M.S.D.|||38516||38516|50137 022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|335281|419292|lyfsjukr|||00|30|0|0|Icepharma hf|Roche Registration Limited|||335281||335281|419292 022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|399144|498802|lyfsjukr|||00|30|0|0|Icepharma hf|Roche Registration Limited|||399144||399144|498802 022215|N06AB0504|Paxetin|töflur|20|mg|20|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|584|1554|lyfalmen|V0917|1489|00|20|0|20|Actavis Group hf|Actavis hf|||526||526|1554 022218|QP52AA5102|Drontal Comp.vet.|töflur|0| |24|stk|1|þpakki||QP52AA51|01.01.2006||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|10960|18967|vetorma|||00|24|0|0|Vistor hf|Bayer Animal Health GmbH|||10960||10960|18967 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|K|2|0|1|0|0|ALL|0|0|0|100|SEK|25112|33449|lyfalmen|||02|1|0|0|Vistor hf|Allergan|||25112||25112|33449 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|2424|4195|vetorma|||00|2|0|0|Vistor hf|Bayer HealthCare AG|||2424||2424|4195 022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|3113|5065|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3113||3113|5065 022281|QP52AA5102|Drontal Comp.vet.|töflur|0| |2|stk|1|þpakki||QP52AA51|01.10.1991||L|A|5|0|0|0|0|BAN|0|0|0|100|DKK|||vetorma|||00|2|0|0|Vistor hf|Bayer Animal Health GmbH||||||2020 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|7267|4755|lyfalmen|V0308|3043|00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2885||2885|4755 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|11272|7065|lyfalmen|V0310|4428|00|100|0|200|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4587||4587|7065 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|2295|3972|vetorma|||00|1|0|0|Vistor hf|Bayer HealthCare AG|||2295||2295|3972 022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|794|1918|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|||794||794|1918 022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2309|3974|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|||2309||2309|3974 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|1486|2572|vetorma|||00|1|0|0|Vistor hf|Bayer HealthCare AG|||1486||1486|2572 022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|þpakki||C09DA03|01.11.2003||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|5000|7626|lyfalmen|||00|28|0|56|Vistor hf|Novartis Healthcare A/S-|||5000||5000|7626 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|2400|3772|lyfalmen|V0919|3506|00|100|0|100|Actavis Group hf|Actavis hf|||2160||2160|3772 022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|1554|2727|lyfalmen|V0918|2556|00|60|0|60|Actavis Group hf|Actavis hf|||1390||1390|2727 022585|L04AX0304|Metotrexato Lederle (D.A.C.)|töflur|2,5|mg|50|stk|1|glas||L04AX03|01.08.2005||R|A|3|0|0|*|0|DAC|0|0|0|100|USD|1480|2849|lyfalmen|||00|50|0|50|D.A.C. ehf|D.A.C. ehf|||1480||1480|2849 022609|A07EC0205|Pentasa (D.A.C)|forðatfl|500|mg|60|stk|1|þpakki||A07EC02|01.08.2006||R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|4194|6532|lyfalmen|||10|60|0|20|D.A.C. ehf|D.A.C. ehf|||4194||4194|6532 022708|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.11.2003||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|16465|22684|lyfalmen|V0192|18626|00|98|0|196|Vistor hf|Novartis Healthcare A/S-|||16465||16465|22684 022802|L01XC0401|MabCampath|irþ|30|mg/ml|1|ml|3|hgl||L01XC04|01.07.2007||R|K|2|0|1|0|1|GEU|0|0|0|100|SEK|237675|297773|lyfsjukr|||00|3|0|0|Icepharma hf|Genzyme Europe B.V. (I)|||237675||237675|297773 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|A|3|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy||||||2805 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|1407|2750|lyfalmen|||67|30|0|10|Actavis Group hf|Actavis hf|||1407||1407|2750 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|2450|4165|lyfalmen|||67|30|0|20|Actavis Group hf|Actavis hf|||2450||2450|4165 022962|V01AA1104|Alutard SQ, hrossaværur|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|25980|34530|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|||25980||25980|34530 022970|V01AA1104|Alutard SQ, hrossaværur|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20799|28080|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||20799||20799|28080 023036|R03BB0101|Atrovent|innúðadu|40|mcg|100|stk|1|pakki|þp+M-úðari|R03BB01|01.07.1992||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|4205|6547|lyfalmen|||19|100|0|33|Vistor hf|Boehringer Ingelheim|||4205||4205|6547 023047|G04BD1001|Emselex|forðatfl|7,5|mg|28|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|6046|9045|lyfalmen|||00|28|0|28|Vistor hf|Novartis Europharm Ltd|||6046||6046|9045 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|A|3|0|1|0|1|GSI|0|0|0|100|DKK|128509|161861|lyfsjukr|||00|30|0|0|Lyfjaver ehf|Gilead Science International (L)|||128509||128509|161861 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|32133|42191|lyfalmen|||00|90|0|20|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|||32133||32133|42191 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|42927|55629|lyfalmen|||00|90|0|30|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|||42927||42927|55629 023124|G04BD1001|Emselex|forðatfl|7,5|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|21738|29249|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||21738||21738|29249 023146|G04BD1001|Emselex|forðatfl|15|mg|28|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|6107|9128|lyfalmen|||00|28|0|56|Vistor hf|Novartis Europharm Ltd|||6107||6107|9128 023193|G04BD1001|Emselex|forðatfl|15|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|21959|29524|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||21959||21959|29524 023325|V03AB2501|Lanexat|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.07.1989||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|22289|29617|lyfsjukr|||02|25|0|0|Icepharma hf|Roche|||22289||22289|29617 023329|N03AX1204|Gabapentin Merck NM|hylki|300|mg|100|stk|1|glas||N03AX12|01.05.2004|31.01.2009|R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|||lyfalmen|||00|100|0|17|Actavis Group PTC ehf|Merck NM AB|||5471||| 023376|N03AX1204|Gabapentin Merck NM|hylki|400|mg|100|stk|1|glas||N03AX12|01.05.2004||R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|7317|10770|lyfalmen|V0715|10770|00|100|0|22|Actavis Group PTC ehf|Merck NM AB|||7317||7317|10770 023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|A|3|0|0|0|0|DED|0|0|0|100|XEU|17649|24158|lyfalmen|||00|34|0|0|Vistor hf|Dentsply DeTrey GmbH|||17649||17649|24158 023414|B03XA0201|Aranesp|stl|20|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|9187|13153|lyfsjukr|||00|0|0|4|Vistor hf|Amgen|||9187||9187|13153 023419|B03XA0201|Aranesp|stl|80|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|36164|46892|lyfsjukr|||00|0|0|18|Vistor hf|Amgen|||36164||36164|46892 023425|B03XA0201|Aranesp|stl|60|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|27370|35943|lyfsjukr|||00|0|0|13|Vistor hf|Amgen|||27370||27370|35943 023441|B03XA0201|Aranesp|stl|150|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|65157|82988|lyfsjukr|||00|0|0|33|Vistor hf|Amgen|||65157||65157|82988 023447|B03XA0201|Aranesp|stl|100|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|43501|56026|lyfsjukr|||00|0|0|22|Vistor hf|Amgen|||43501||43501|56026 023448|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|8676|12422|lyfsjukr|||00|10|0|0|Icepharma hf|Baxter AG|||8676||8676|12422 023452|B03XA0201|Aranesp|stl|300|mcg/pen|0,6|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|130231|164005|lyfsjukr|||00|1|0|67|Vistor hf|Amgen|||130231||130231|164005 023459|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|21691|28873|lyfsjukr|||00|25|0|0|Icepharma hf|Baxter AG|||21691||21691|28873 023463|B03XA0201|Aranesp|stl|40|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|17889|24139|lyfsjukr|||00|0|0|9|Vistor hf|Amgen|||17889||17889|24139 023468|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|20|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|12488|17733|lyfalmen|||00|10|0|20|GlaxoSmithKline ehf|Glaxo Group Limited|||12488||12488|17733 023470|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|43381|55877|lyfsjukr|||00|50|0|0|Icepharma hf|Baxter AG|||43381||43381|55877 023476|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|86761|109885|lyfsjukr|||00|100|0|0|Icepharma hf|Baxter AG|||86761||86761|109885 023479|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|8742|12704|lyfalmen|||00|3|0|14|GlaxoSmithKline ehf|Glaxo Group Limited|||8742||8742|12704 023480|B03XA0201|Aranesp|stl|500|mcg/pen|1|ml|1|penni|áfyllur penni|B03XA02|01.07.2007||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|208287|261185|lyfsjukr|||00|1|0|111|Vistor hf|Amgen|||208287||208287|261185 023487|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|173523|217904|lyfsjukr|||00|200|0|0|Icepharma hf|Baxter AG|||173523||173523|217904 023491|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|17483|23951|lyfalmen|||00|6|0|28|GlaxoSmithKline ehf|Glaxo Group Limited|||17483||17483|23951 023501|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|13112|18509|lyfalmen|||00|4|0|21|GlaxoSmithKline ehf|Glaxo Group Limited|||13112||13112|18509 023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|149029|187409|lyfsjukr|||00|120|0|30|Vistor hf|Boehringer Ingelheim International |||149029||149029|187409 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.07.2007||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|23383|31297|lyfalmen|||00|100|0|100|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||23383||23383|31297 023544|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|4255|6615|lyfalmen|||00|4|0|7|GlaxoSmithKline ehf|Glaxo Group Limited|||4255||4255|6615 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|A|2,5|0|0|*|0|SAO|0|0|0|100|XEU|3857|6075|lyfalmen|||00|12|0|60|Icepharma hf|Santen Oy|||3857||3857|6075 023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|68806|87531|lyfsjukr|||00|120|0|100|Icepharma hf|Roche|||68806||68806|87531 023809|A10AE0404|Lantus [OptiClik]|stl|100|ein/ml|3|ml|5|rörlyk|fyrir OptiClik|A10AE04|01.04.2007||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|9372|13559|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|||9372||9372|13559 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.08.2006||R|A|5|0|1|0|1|PFL|0|0|0|100|DKK|117710|148416|lyfsjukr|||00|90|0|36|Vistor hf|Pfizer Limited|||117710||117710|148416 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|4080|6377|lyfalmen|||00|100|0|17|Icepharma hf|M.S.D.|||4080||4080|6377 024024|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.02.2007||R|A|1,5|0|0|0|1|WTE|0|0|0|100|USD|93791|118635|lyfsjukr|||00|10|0|5|Icepharma hf|Wyeth Europe|||93789||93789|118635 024037|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.09.2005||R|A|2|0|0|0|1|NOM|0|0|0|100|IKR|5443|7793|lyfsjukr|||03|10|0|3|Icepharma hf|NordMedica ApS|||5443||5443|7793 024056|N02AB0301|Durogesic|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.02.2006||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|4140|6459|lyfalmen|||00|5|0|10|Vistor hf|Janssen-Cilag AB|||4140||4140|6459 024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|21124|28484|lyfalmen|||00|30|0|30|Lundbeck Export A/S|Teva Pharma GmbH|||21124||21124|28484 024135|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|0| |1000|ml|10|pokar|lausn|B05BB01|01.10.2005||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2166|3101|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|||2166||2166|3101 024147|A10BD0301|Avandamet|filmhtfl|1002|mg|112|stk|1|þpakki|1000+2mg|A10BD03|01.10.2005||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|8755|12721|lyfalmen|||00|112|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||8755||8755|12721 024169|A10BD0301|Avandamet|filmhtfl|1004|mg|112|stk|1|þpakki|1000+4mg|A10BD03|01.10.2005||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|15308|21243|lyfalmen|||00|112|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||15308||15308|21243 024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|70413|89849|lyfalmen|||00|100|0|100|Lundbeck Export A/S|Teva Pharma GmbH|||70413||70413|89849 024307|V01AA1105|Alutard SQ, hundahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|25980|34530|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|||25980||25980|34530 024478|V04CL0024|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8179|11940|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||8179||8179|11940 024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|387|1366|lyfalmen|||00|100|0|2|Vistor hf|AstraZeneca A/S DK|||387||387|1366 024482|V04CL0025|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8179|11940|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||8179||8179|11940 024504|V04CL0011|Soluprick SQ ALK106 - Rauðölur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13780|19341|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||13780||13780|19341 024510|V04CL0012|Soluprick SQ ALK107 - Gráölur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13780|19341|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||13780||13780|19341 024526|V04CL0014|Soluprick SQ ALK113 - Hesliviður|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13804|19371|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||13804||13804|19371 024530|N05AH0304|Zyprexa (D.A.C.)|húðuðtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.08.2005|31.01.2009|R|A|3|0|0|*|0|DAC|0|1|0|100|IKR|||lyfalmen|||00|56|0|42|D.A.C. ehf|D.A.C. ehf|||22041||| 024532|V04CL0015|Soluprick SQ ALK203 - Háliðagras|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13780|19341|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||13780||13780|19341 024559|V04CL0016|Soluprick SQ ALK214 -Axhnoðapunktur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13780|19341|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||13780||13780|19341 024565|V04CL0017|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13945|19547|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||13945||13945|19547 024576|V04CL0018|Soluprick SQ ALK223 - Vallarrýgresi|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13780|19341|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||13780||13780|19341 024583|V04CL0019|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8179|11940|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||8179||8179|11940 024589|V04CL0020|Soluprick SQ ALK228 - Vallarsveifgras|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13780|19341|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||13780||13780|19341 024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|A|3|0|1|E|0|NOE|0|0|0|100|DKK|77847|99104|lyfalmen|||00|100|0|125|Vistor hf|Novartis Europharm Ltd|||77847||77847|99104 024600|V04CL0021|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13945|19547|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||13945||13945|19547 024603|V04CL0009|Soluprick Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1679|3119|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||1679||1679|3119 024622|V04CL0013|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8179|11940|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||8179||8179|11940 024644|V04CL0023|Soluprick SQ ALK552 - Hrossaværur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8179|11940|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||8179||8179|11940 024670|V04CL0022|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8179|11940|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||8179||8179|11940 024681|V04CL0010|Soluprick Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1679|3119|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|||1679||1679|3119 025093|C01BD0102|Trangorex (D.A.C.)|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.08.2006||R|A|3|0|0|B|0|DAC|0|0|0|100|NOK|1007|2207|lyfalmen|V0143|2147|70|30|0|30|D.A.C. ehf|D.A.C. ehf|||1007||1007|2207 025126|M05BB0301|Fosavance|töflur|0| |4|stk|1|þpakki|70mg+70mcg|M05BB03|01.10.2006||R|A|1,5|0|0|E|0|MSD|0|0|0|100|XEU|6156|9194|lyfalmen|||00|4|0|0|Icepharma hf|M.S.D.|||6156||6156|9194 025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húð|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|981|2172|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|||981||981|2172 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20799|28080|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||20799||20799|28080 025174|D07AB0202|Locoid Crelo|lausn|1|mg/g|100|g|1|glas|á húð|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|2808|4651|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|||2808||2808|4651 025180|R03BA0201|Pulmicort|innúðal|100|mcg/sk|120|sk|1|stauk||R03BA02|01.01.2009||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|1898|3416|lyfalmen|||0|120|0|15|Vistor hf|AstraZeneca A/S DK|||1898||1898|3416 025191|R03BA0201|Pulmicort|innúðal|200|mcg/sk|120|sk|1|stauk||R03BA02|01.01.2009||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|3612|5742|lyfalmen|||0|120|0|30|Vistor hf|AstraZeneca A/S DK|||3612||3612|5742 025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|20799|28080|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||20799||20799|28080 025300|J01DB0101|Keflex|mixtúrud|50|mg/ml|100|ml|1|glas||J01DB01|01.03.1983||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|722|1820|lyfalmen|||08|100|0|2|Icepharma hf|NordMedica A/S|||722||722|1820 025306|M05BB0301|Fosavance|töflur|0| |12|stk|1|þpakki|70mg+70mcg|M05BB03|01.10.2006||R|A|1,5|0|0|E|0|MSD|0|0|0|100|XEU|18193|24835|lyfalmen|||00|12|0|0|Icepharma hf|M.S.D.|||18193||18193|24835 025311|J01DB0101|Keflex|töflur|500|mg|14|stk|1|þpakki||J01DB01|01.07.1988||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|794|1918|lyfalmen|||00|14|0|4|Icepharma hf|NordMedica A/S|||794||794|1918 025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|106986|135065|lyfsjukr|||00|30|0|60|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |||106986||106986|135065 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|105768|133549|lyfsjukr|||00|30|0|30|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |||105768||105768|133549 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|10306|19803|vetalmen|||00|20|0|0|Vistor hf|Boehringer Ingelheim|||10306||10306|19803 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|19092|25955|lyfalmen|||00|30|0|0|Vistor hf|ALK-Abello A/S|||19092||19092|25955 025444|C09CA0301|Diovan|filmhtfl|320|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.04.2007||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|23221|31095|lyfalmen|||00|98|0|392|Vistor hf|Novartis Healthcare A/S-|||23221||23221|31095 025455|C09CA0301|Diovan|töflur|320|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.04.2007||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|6773|10032|lyfalmen|||00|28|0|112|Vistor hf|Novartis Healthcare A/S-|||6773||6773|10032 025471|N06AB1002|Cipralex (D.A.C.)|töflur|20|mg|28|stk|1|þpakki||N06AB10|01.12.2006||R|A|3|0|0|B|0|DAC|0|1|0|30|DKK|7203|10615|lyfalmen|V1039|10615|00|28|0|56|D.A.C. ehf|D.A.C. ehf|||7203||7203|10615 025555|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|30460|40108|lyfalmen|||00|1|0|28|Vistor hf|Janssen-Cilag AB|||30460||30460|40108 025578|S01EC0302|Trusopt (D.A.C.)|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.01.2007||R|A|2|0|0|*|0|DAC|0|0|0|100|XEU|2013|3572|lyfalmen|V1090|3572|06|5|0|17|D.A.C. ehf|D.A.C. ehf|||2013||2013|3572 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|þpakki||M05BA06|01.01.2006||R|A|2|0|0|E|0|RRL|0|0|0|100|DKK|5644|8500|lyfalmen|||00|1|0|30|Icepharma hf|Roche Registration Limited|||5644||5644|8500 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2006||R|A|2|0|0|E|0|RRL|0|0|0|100|DKK|16118|22252|lyfalmen|||00|3|0|90|Icepharma hf|Roche Registration Limited|||16118||16118|22252 025676|L01CB0201|Vumon|stl|10|mg/ml|5|ml|10|lykjur||L01CB02|01.05.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|34429|44732|lyfsjukr|||00|50|1|0|Distica|Distica - óskráð lyf|||34429||34429|44732 025677|S01ED5109|Cosopt (D.A.C.)|augndr|5|mg/ml|5|ml|1|glas||S01ED51|01.04.2006||R|A|2|0|0|*|0|DAC|0|0|0|100|XEU|2884|4546|lyfalmen|V0989|4546|06|5|0|0|D.A.C. ehf|D.A.C. ehf|||2731||2731|4546 025698|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|16261|22430|lyfalmen|||00|1|0|14|Vistor hf|Janssen-Cilag AB|||16261||16261|22430 025709|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|23520|31467|lyfalmen|||00|1|0|21|Vistor hf|Janssen-Cilag AB|||23520||23520|31467 025725|R01AD0505|Rhinocort Turbuhaler (D.A.C.)|nefúðad|100|mcg/sk|200|sk|1|stauk||R01AD05|01.01.2007||R|A|2|0|0|E|0|DAC|0|0|1|100|SEK|3819|6023|lyfalmen|V0966|6023|23|200|0|100|D.A.C. ehf|D.A.C. ehf|||3819||3819|6023 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|59607|76396|lyfalmen|||00|100|0|0|Vistor hf|ALK-Abello A/S|||59607||59607|76396 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|5562|7963|lyfsjukr|||02|25|0|0|Vistor hf|AstraZeneca A/S DK|||5562||5562|7963 025841|V01AA1106|Alutard SQ, kattahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|25980|34530|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|||25980||25980|34530 025958|M01AE0215|Naproxen Merck NM|töflur|250|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|882|2037|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|||882||882|2037 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|3757|6502|vetorma|||16|1|0|0|Vistor hf|Merial (MSD)|||3757||3757|6502 025985|M01AE0215|Naproxen Merck NM|töflur|500|mg|50|stk|1|þpakki||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|909|2074|lyfalmen|||00|50|0|50|Actavis Group PTC ehf|Merck NM AB|||909||909|2074 025994|M01AE0215|Naproxen Merck NM|töflur|500|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|1621|3040|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|||1621||1621|3040 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|8503|14715|vetorma|||16|2|0|0|Vistor hf|Merial (MSD)|||8503||8503|14715 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20799|28080|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||20799||20799|28080 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1820|3310|lyfalmen|||00|100|0|25|Vistor hf|Recip AB|||1820||1820|3310 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|378|1353|lyfalmen|||00|50|0|1|Vistor hf|Recip AB|||378||378|1353 027144|M01CC0101|Atamir|hylki|150|mg|50|stk|1|þpakki||M01CC01|01.06.1982||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|2904|4781|lyfalmen|||10|50|0|15|Swedish Orphan International AB|Sandoz GmbH (S)|||2904||2904|4781 027235|G03HA0103|Cyproteron Merck NM|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|7280|10720|lyfalmen|||00|50|0|25|Actavis Group PTC ehf|Merck NM AB|||7280||7280|10720 027559|N03AX1501|Zonegran|hylki|25|mg|14|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|1850|3351|lyfalmen|||00|14|0|2|Vistor hf|Eisai Ltd|||1850||1850|3351 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|7401|10884|lyfalmen|||00|56|0|7|Vistor hf|Eisai Ltd|||7401||7401|10884 027595|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|9906|14283|lyfalmen|||00|56|0|14|Vistor hf|Eisai Ltd|||9906||9906|14283 027604|N03AX1501|Zonegran|hylki|100|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|13084|18475|lyfalmen|||00|56|0|28|Vistor hf|Eisai Ltd|||13084||13084|18475 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|948|2127|lyfalmen|V0431|1963|00|100|0|33|Gróco ehf|Nycomed Danmark A/S|||948||948|2127 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|903|2066|lyfalmen|V0430|1789|00|100|0|67|Gróco ehf|Nycomed Danmark A/S|||903||903|2066 027795|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.08.2006||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|132448|166765|lyfsjukr|||00|105|0|1|Icepharma hf|SP Europe|||132448||132448|166765 027938|C07AA0701|Sotacor|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1992|31.12.2008|R|A|4|0|0|B|0|BRS|0|0|0|100|DKK|||lyfalmen|||00|100|0|50|Vistor hf|Bristol-Myers Squibb|||1427||| 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|25492|33923|lyfalmen|||00|28|0|19|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|||25492||25492|33923 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|25492|33923|lyfalmen|||00|28|0|28|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|||25492||25492|33923 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ aðsk. nál|J07AP03|01.05.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2721|4533|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||2721||2721|4533 028351|J07BL0101|Stamaril|sts|0| |0,5|ml|10|hgl|+ 10 áf.spr. með leysi|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|22844|30626|lyfalmen|||02|5|0|0|Icepharma hf|Sanofi Pasteur MSD|||22844||22844|30626 028360|J07BG0101|Rabies - Imovax|bóluefni|0| |1|ml|1|hgl||J07BG01|01.01.1996||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|8741|12702|lyfalmen|||02|1|0|0|Icepharma hf|Aventis Pasteur MSD A/S|||8741||8741|12702 028387|M03BX0104|Baklofen Merck NM|töflur|25|mg|50|stk|1|glas|0|M03BX01|01.10.2008||R|A|3|0|0|E|0|MNA|0|0|1|100|SEK|1306|2613|lyfalmen|V0712|2613|00|50|0|25|Actavis Group PTC ehf|Merck NM AB|||1306||1306|2613 028405|M01AE0216|Naproxen-E Merck NM|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|1861|3366|lyfalmen|||10|50|0|50|Actavis Group PTC ehf|Merck NM AB|||1861||1861|3366 028498|C08DB0102|Cardizem Retard|forðatfl|120|mg|60|stk|1|glas||C08DB01|01.04.1987||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|3533|5635|lyfalmen|V0351|3898|10|60|0|30|Vistor hf|Ferrosan A/S|||3533||3533|5635 028597|D07BB0401|Locoidol|krem|0| |30|g|1|túpa||D07BB04|01.01.1990||R|A|4|0|0|B|0|ASP|0|0|1|100|XEU|971|2158|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|||971||971|2158 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|A|3|0|0|0|0|OCO|0|0|0|100|DKK|8554|16465|vetalmen|||27|10|0|0|Icepharma hf|Orion Corporation (I)|||8554||8554|16465 028761|A03FA0101|Primperan|stl|5|mg/ml|2|ml|12|lykjur||A03FA01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|888|2045|lyfalmen|||02|24|0|4|Vistor hf|Sanofi-aventis Norge AS|||888||888|2045 028787|A04AA0201|Kytril|töflur|1|mg|10|stk|1|þpakki||A04AA02|01.10.1994||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|12772|18086|lyfalmen|||00|10|0|5|Icepharma hf|Roche as|||12772||12772|18086 029025|D07AC0301|Ibaril|smyrsli|2,5|mg/g|50|g|1|túpa||D07AC03|01.12.1978||R|A|1,5|0|0|B|0|SNO|0|0|1|100|NOK|2036|3603|lyfalmen|||20|50|0|50|Vistor hf|Sanofi-aventis Norge AS|||2036||2036|3603 029066|R01AD0801|Flixonase|nefúði|50|mcg/sk|16|ml|1|stauk|120 sk|R01AD08|01.04.1992||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|1057|2275|lyfalmen|||24|16|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||1057|2275 029116|A03FA0101|Primperan|töflur|10|mg|40|stk|1|þpakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|940|2116|lyfalmen|||00|40|0|13|Vistor hf|Sanofi-aventis Norge AS|||940||940|2116 029298|D07AB0101|Emovat|krem|0,5|mg/g|25|g|1|túpa||D07AB01|01.01.1985||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|470|1478|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||470||470|1478 029307|A07EA0603|Entocort enema (D.A.C.)|endaþ.dr|0,02|mg/ml|7|stk|1|þpakki||A07EA06|01.01.2007||R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|7044|10399|lyfalmen|V0297|10399|00|7|0|0|D.A.C. ehf|D.A.C. ehf|||7044||7044|10399 029334|J05AG0302|Stocrin (Lyfjaver)|töflur|600|mg|30|stk|1|glas||J05AG03|01.09.2005|31.12.2008|R|A|2|0|1|0|1|LVR|0|0|0|100|XEU|53513|68490|lyfsjukr|||00|30|0|30|Lyfjaver ehf|Lyfjaver ehf|||53513||53512|68490 029343|L03AB0802|Betaferon (Lyfjaver)|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.09.2005|31.12.2008|R|A|2|0|1|0|1|LVR|0|0|0|100|SEK|163112|204942|lyfsjukr|||00|15|0|30|Lyfjaver ehf|Lyfjaver ehf|||163112||163112|204942 029352|C10AA0103|Zocor (Lyfjaver)|töflur|10|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|9001|6137|lyfalmen|V0358|2018|00|98|0|65|Lyfjaver ehf|Lyfjaver ehf|||3903||3903|6137 029361|C10AA0103|Zocor (Lyfjaver)|töflur|20|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|8146|9671|lyfalmen|V0365|2265|00|98|0|131|Lyfjaver ehf|Lyfjaver ehf|||6507||6507|9671 029370|C10AA0103|Zocor (Lyfjaver)|töflur|40|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|12801|13065|lyfalmen|V0367|3035|00|98|0|261|Lyfjaver ehf|Lyfjaver ehf|||9008||9008|13065 029379|C10AA0103|Zocor (Lyfjaver)|töflur|80|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|1,5|0|0|0|0|LVR|0|0|0|100|XEU|18001|24596|lyfalmen|||00|98|0|523|Lyfjaver ehf|Lyfjaver ehf|||18001||18001|24596 029769|D07AB0101|Emovat|krem|0,5|mg/g|100|g|1|túpa||D07AB01|01.07.1995|31.12.2008|R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|2127|3727|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2127||2127|3727 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|2|Vistor hf|McNeil Denmark ApS||||||0 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|105|0|7|Vistor hf|McNeil Denmark ApS||||||0 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|210|0|14|Vistor hf|McNeil Denmark ApS||||||0 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|4|Vistor hf|McNeil Denmark ApS||||||0 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|105|0|14|Vistor hf|McNeil Denmark ApS||||||0 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|210|0|28|Vistor hf|McNeil Denmark ApS||||||0 030054|J05AE0302|Norvir (D.A.C.)|hylki|100|mg|84|stk|1|glas|mjúk hylki|J05AE03|01.12.2008||R|K|2|0|1|0|1|DAC|0|0|0|100|DKK|20194|27009|lyfsjukr|||00|84|0|7|D.A.C. ehf|D.A.C. ehf|||||20194|27009 030315|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|22887|30679|lyfalmen|||00|98|0|49|Vistor hf|Eisai Ltd|||22887||22887|30679 030361|D07AB0101|Emovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AB01|01.01.1985||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|470|1478|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||470||470|1478 030387|D07AB0101|Emovat|smyrsli|0,5|mg/g|100|g|1|túpa||D07AB01|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1850|3351|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1850||1850|3351 030588|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|þpakki||M01AX05|01.07.2006||L|A|3|0|0|0|0|NAV|0|0|1|100|IKR|||lyfalmen|||00|60|0|25|Icepharma hf|Navamedic ASA||||||0 030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|11214|16058|lyfalmen|V1400|16057|00|100|0|33|Vistor hf|Novartis Healthcare A/S-|||11214||11214|16058 030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|3807|6007|lyfalmen|V1401|6005|00|100|0|8|Vistor hf|Novartis Healthcare A/S-|||||3807|6007 030940|C07AB0207|Metoprolol Merck NM|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MNA|0|0|0|100|SEK|872|2024|lyfalmen|||00|100|0|33|Actavis Group PTC ehf|Merck NM AB|||872||872|2024 031039|C07AB0207|Metoprolol Merck NM|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MNA|0|0|0|100|SEK|1271|2565|lyfalmen|||00|100|0|67|Actavis Group PTC ehf|Merck NM AB|||1271||1271|2565 031070|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||R|A|2|0|0|E|0|NHE|0|0|1|100|DKK|897|2058|lyfalmen|||23|2|0|2|Artasan ehf|Novartis Healthcare A/S-A|||897||897|2058 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|3398|5452|lyfalmen|||17|10|0|25|Icepharma hf|Eli Lilly Nederland -|||3398||3398|5452 031261|A10AB0604|Apidra [opticlik]|stl|100|ein/ml|3|ml|5|rörlyk||A10AB06|01.04.2007||R|K|2|0|0|*|0|SAA|0|0|0|100|NOK|4523|6978|lyfalmen|||02|15|0|38|Vistor hf|Sanofi - Aventis|||4523||4523|6978 031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|A|3|0|0|B|0|REP|0|0|0|100|DKK|2966|3681|lyfalmen|||00|100|0|33|Vistor hf|Recip AB|||2093||2093|3681 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|6759|10013|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|||6759||6759|10013 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|A|3|0|0|0|1|FEL|0|0|0|100|DKK|39799|51417|lyfsjukr|||00|5|0|0|Vistor hf|Ferring Lægemidler A/S|||39799||39799|51417 031971|C07AA0704|Sotalol Merck NM|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|1781|3257|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|||1781||1781|3257 031997|C07AA0704|Sotalol Merck NM|töflur|80|mg|100|stk|1|glas||C07AA07|01.03.2000|31.12.2008|R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|||lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|||1145||| 032122|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|10377|14787|lyfsjukr|||0|4|0|0|Strandmöllen A/S|Strandmöllen A/S|||||10377|14787 032145|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|15168|20752|lyfsjukr|||0|10|0|0|Strandmöllen A/S|Strandmöllen A/S|||||15168|20752 032179|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|52482|67208|lyfsjukr|||0|50|0|0|Strandmöllen A/S|Strandmöllen A/S|||||52482|67208 032190|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|1|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|1|0|0|0|0|STM|0|0|0|100|IKR|||lyfalmen|||0|1|0|0|Strandmøllen A/S|Strandmøllen A/S|||||| 032202|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|2|0|0|0|0|STM|0|0|0|100|IKR|||lyfalmen|||0|2|0|0|Strandmøllen A/S|Strandmøllen A/S|||||| 032236|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyfalmen|||0|4|0|0|Strandmøllen A/S|Strandmøllen A/S|||||| 032247|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyfalmen|||0|5|0|0|Strandmøllen A/S|Strandmøllen A/S|||||| 032258|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|10|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyfalmen|||0|10|0|0|Strandmöllen A/S|Strandmöllen A/S|||||| 032270|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyfalmen|||0|20|0|0|Strandmøllen A/S|Strandmøllen A/S|||||| 032281|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyfalmen|||0|50|0|0|Strandmøllen A/S|Strandmøllen A/S|||||| 032304|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyfalmen|||0|600|0|0|Strandmøllen A/S|Strandmøllen A/S|||||| 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|K|2|0|0|*|0|OTS|0|1|0|100|DKK|26472|35143|lyfalmen|||00|150|0|10|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|||26472||26472|35143 032649|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|50|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|4097|7090|vetorma|||27|50|0|0|Vistor hf|Merial (MSD)|||4097||4097|7090 032660|L03AB0702|Rebif|stl|0||0,5|ml|12|áf.spr|8,88+22 mcg|L03AB07|01.02.2009||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|135892|171053|lyfsjukr|||0|6|0|0|Gróco ehf|Serono Nordic|||||135892|171053 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|14571|25216|vetorma|||27|200|0|0|Vistor hf|Merial (MSD)|||14571||14571|25216 033159|S01FA0103|Isopto Atropin 1 %|augndr|1|%|5|ml|1|glas||S01FA01|01.05.1983||R|A|3|0|0|E|0|ALC|0|0|0|100|USD|484|1494|lyfalmen|||06|5|0|0|K.Pétursson hf|Alcon|||482||482|1494 033251|S01CA0102|Tobradex|augndr|0| |5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|A|3|0|0|E|0|ALC|0|0|1|100|USD|1295|2598|lyfalmen|||00|5|0|0|K.Pétursson hf|Alcon|||1295||1295|2598 034066|V07AB09|Sterilt Vatten Braun|leysir|0| |5|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997|31.01.2009|L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||00|100|0|0|Actavis Group hf|Braun||||||0 034157|J07AM5104|Diftavax|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|K|3|0|0|0|0|SPM|0|0|1|100|XEU|806|1934|lyfalmen|||AC|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||806||806|1934 034616|N05CM0201|Heminevrin|mixtúra|50|mg/ml|300|ml|1|glas||N05CM02|01.07.2006||R|K|2|0|0|0|0|ARA|0|0|1|100|SEK|2082|3666|lyfalmen|||00|300|0|10|Vistor hf|Astra|||2082||2082|3666 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|1976|3522|lyfalmen|||00|6|0|0|Vistor hf|Novartis Healthcare A/S-|||1976||1976|3522 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|3389|5439|lyfalmen|||00|12|0|0|Vistor hf|Novartis Healthcare A/S-|||3389||3389|5439 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|9556|13682|lyfsjukr|||02|25|0|0|Vistor hf|LEO Pharma A/S|||9556||9556|13682 035212|A07EC0202|Pentasa|forðatfl|500|mg|300|stk|1|þpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|18723|25495|lyfalmen|||10|300|0|100|Vistor hf|Ferring|||18723||18723|25495 035333|L01BB0502|Fludara (Lyfjaver)|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.05.2006|31.12.2008|R|A|2|0|1|0|1|LVR|0|0|0|100|SEK|103293|130467|lyfsjukr|||00|20|0|0|Lyfjaver ehf|Lyfjaver ehf|||103293||103293|130467 035342|L01BB0502|Fludara (Lyfjaver)|filmhtfl|10|mg|15|stk|1|þpakki||L01BB05|01.05.2006|31.12.2008|R|A|2|0|1|0|1|LVR|0|0|0|100|SEK|77319|98130|lyfsjukr|||00|15|0|0|Lyfjaver ehf|Lyfjaver ehf|||77319||77319|98130 035351|L01BB0502|Fludara (Lyfjaver)|sts|50|mg/hgl|50|mg|5|hgl||L01BB05|01.05.2006|31.12.2008|R|A|3|0|1|0|1|LVR|0|0|0|100|SEK|157994|198570|lyfsjukr|||00|250|0|0|Lyfjaver ehf|Lyfjaver ehf|||157994||157994|198570 035506|N03AX0903|Lamotrin|dreifit.|25|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1435|2788|lyfalmen|||00|56|0|5|Actavis Group hf|Actavis hf|||1435||1435|2788 035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1844|3343|lyfalmen|V0703|3343|00|56|0|9|Actavis Group hf|Actavis hf|||1844||1844|3343 035524|N03AX0903|Lamotrin|dreifit.|100|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|3321|5347|lyfalmen|V0705|5347|00|56|0|19|Actavis Group hf|Actavis hf|||3321||3321|5347 035533|N03AX0903|Lamotrin|dreifit.|200|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|5919|8873|lyfalmen|V0706|8873|00|56|0|37|Actavis Group hf|Actavis hf|||5919||5919|8873 035542|S01LA0301|Macugen|stl|0,3|mg/spr|1|spr|1|pakki|lausn|S01LA03|01.06.2006||R|A|1,5|0|1|0|1|PFI|0|0|0|100|DKK|129864|163548|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||129864||129864|163548 035824|C01AA0503|Lanoxin|stl|0,25|mg/ml|2|ml|5|lykjur||C01AA05|01.07.2000||R|A||0|0|0|1|LDR|0|0|0|100|IKR|926|1326|lyfsjukr|||00|10|1|0|Parlogis hf|Parlogis - óskráð lyf|||926||926|1326 035832|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|500|ml|12|fl||B05BA02|01.08.1980||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|48644|62429|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|||48644||48644|62429 035840|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.03.1978||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|929|2101|lyfalmen|||00|60|0|12|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||929||929|2101 035865|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.08.1978||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|496|1513|lyfalmen|||00|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||496||496|1513 036145|M01AC0202|Tilcotil|töflur|20|mg|60|stk|1|glas||M01AC02|01.04.1988||R|A|3|0|0|E|0|MAS|0|0|1|100|DKK|8162|8658|lyfalmen|||00|60|0|60|Vistor hf|Meda AS|||5761||5761|8658 036332|L01XE0401|Sutent|hylki|12,5|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|235985|295669|lyfsjukr|||00|30|0|0|Vistor hf|Pfizer Limited|||235985||235985|295669 036341|L01XE0401|Sutent|hylki|25|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|452966|565810|lyfsjukr|||00|30|0|0|Vistor hf|Pfizer Limited|||452966||452966|565810 036351|L01XE0401|Sutent|hylki|50|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|905339|1129015|lyfsjukr|||00|30|0|0|Vistor hf|Pfizer Limited|||905339||905339|1129015 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|þpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|795|1919|lyfalmen|||00|20|0|8|Vistor hf|Recip AB|||795||795|1919 036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1270|2564|lyfalmen|||08|60|0|3|Vistor hf|Recip AB|||1270||1270|2564 036541|A03AX1301|Minifom|dropar|0| |30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|S|3|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||00|30|0|6|Vistor hf|AstraZeneca A/S DK|||||| 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|2506|4241|lyfalmen|||08|125|0|6|Vistor hf|Recip AB|||2506||2506|4241 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|þpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|760|1872|lyfalmen|||00|30|0|12|Vistor hf|Recip AB|||760||760|1872 037176|M01AB0507|Vostar|sþ-tfl|50|mg|30|stk|1|glas||M01AB05|01.04.1988|31.12.2008|R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|||lyfalmen|||10|30|0|15|Actavis Group hf|Actavis hf||361|361|361|| 037192|M01AB0507|Vostar|sþ-tfl|50|mg|100|stk|1|glas||M01AB05|01.04.1988|31.12.2008|R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|||lyfalmen|||10|100|0|50|Actavis Group hf|Actavis hf|||890||| 037278|N04BC0404|Requip Depot|forðatfl|2|mg|42|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|6634|9843|lyfalmen|||00|42|0|14|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||6634||6634|9843 037287|N04BC0404|Requip Depot|forðatfl|2|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|13268|18704|lyfalmen|||00|84|0|28|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||13268||13268|18704 037305|N04BC0404|Requip Depot|forðatfl|4|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|26021|34581|lyfalmen|||00|84|0|56|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||26021||26021|34581 037323|N04BC0404|Requip Depot|forðatfl|8|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|51118|65827|lyfalmen|||00|84|0|112|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||51118||51118|65827 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|A|4|0|0|E|0|ROC|0|0|0|100|DKK|3048|4977|lyfalmen|||00|100|0|17|Icepharma hf|Roche|||3048||3048|4977 037531|D07AC1301|Elocon|húðlausn|0,1|%|30|ml|1|glas||D07AC13|01.01.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1206|2477|lyfalmen|||0|30|0|30|Vistor hf|Schering-Plough|||1206||1206|2477 037754|J01EA0102|Monotrim|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.1980||R|A|5|0|0|0|0|HEX|0|0|1|100|DKK|726|1826|lyfalmen|||00|30|0|8|Vistor hf|Hexal A/S|||726||726|1826 037846|A12BA0101|Kaleorid|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|100|0|25|Vistor hf|LEO Pharma A/S||||||2204 037853|A12BA0101|Kaleorid|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|250|0|62|Vistor hf|LEO Pharma A/S||||||3700 037861|C03AA0301|Aquazið|töflur|25|mg|100|stk|1|glas||C03AA03|01.05.1983|31.12.2008|R|A|4|0|0|E|0|ACA|0|0|0|100|IKR|||lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf||812|812|812|| 037929|J01EA0102|Monotrim|töflur|100|mg|100|stk|1|glas||J01EA01|01.03.1980||R|A|5|0|0|0|0|HEX|0|0|1|100|DKK|1952|3489|lyfalmen|||00|100|0|25|Vistor hf|Hexal A/S|||1952||1952|3489 038174|N06AB0501|Seroxat|töflur|20|mg|20|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|30|IKR|664|1554|lyfalmen|V0917|1489|00|20|0|20|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||526||526|1554 038257|N06AB0501|Seroxat|töflur|20|mg|60|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|30|IKR|1766|2727|lyfalmen|V0918|2556|00|60|0|60|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1390||1390|2727 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|30|IKR|2667|3772|lyfalmen|V0919|3506|00|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2160||2160|3772 038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|1124|2366|lyfalmen|||00|50|0|50|Icepharma hf|Smith & Nephew|||1124||1124|2366 038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|229995|288211|lyfsjukr|||00|1|0|0|Vistor hf|Amgen Europe B.V.|||229995||229995|288211 038828|C09AA0401|Coversyl|töflur|4|mg|90|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|10744|15421|lyfalmen|||00|90|0|90|Icepharma hf|Servier|||10744||10744|15421 038877|N07CA0101|Betaserc|töflur|8|mg|100|stk|1|þpakki||N07CA01|01.12.1982||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|4732|7262|lyfalmen|||00|100|0|33|Medico ehf|Solvay Duphar |||4732||4732|7262 038915|J01FA1004|Zitromax UNO|forðakyr|0| |2|g|1|fl||J01FA10|01.10.2007||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|3198|5180|lyfalmen|||00|2|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3198||3198|5180 039005|L01XA0301|Eloxatin|irþ|5|mg/ml|10|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|37322|48333|lyfsjukr|||00|10|0|0|Vistor hf|Sanofi-aventis Norge AS|||37322||37322|48333 039014|L01XA0301|Eloxatin|irþ|5|mg/ml|20|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|64942|82720|lyfsjukr|||00|20|0|0|Vistor hf|Sanofi-aventis Norge AS|||64942||64942|82720 039669|C01BA0302|Durbis Retard|forðatfl|250|mg|100|stk|1|glas||C01BA03|01.05.1983||R|A|1|0|0|B|0|SNO|0|0|0|100|NOK|5794|8703|lyfalmen|||10|100|0|62|Vistor hf|Sanofi-aventis Norge AS|||5794||5794|8703 039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1585|2991|lyfalmen|||00|15|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1585||1585|2991 039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|2432|4141|lyfalmen|||00|22|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2432||2432|4141 039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|372|533|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|||372||372|533 039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|855|1224|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|||855||855|1224 040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|1517|2172|lyfsjukr|||02|1|0|0|Icepharma hf|Baxter Medical AB|||1517||1517|2172 040287|N03AF0104|Tegretol|töflur|200|mg|200|stk|1|þpakki||N03AF01|01.04.1993||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|4032|6312|lyfalmen|||00|200|0|40|Vistor hf|Novartis Healthcare A/S-|||4032||4032|6312 040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|A|4|0|0|E|0|ALC|0|0|0|100|IKR|||lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon||||||1233 041005|L04AB0102|Enbrel (Lyjaver)|sts|0| |25|mg|4|hgl|+ leysir|L04AB01|01.05.2006|31.12.2008|R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|95412|120655|lyfsjukr|||00|100|0|14|Lyfjaver ehf|Lyfjaver ehf|||95412||95412|120655 041059|J07BH0101|Rotarix|mixtduft|0| |1|hgl|1|pakki|+áf.munnspr.m/leysi|J07BH01|01.07.2007||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|8597|12507|lyfalmen|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|||8597||8597|12507 041423|G03AA1203|Yasminelle|töflur|0||63|stk|1|þpakki|3+0,02 mg|G03AA12|01.12.2006||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|2932|4819|lyfalmen|||00|63|0|0|Icepharma hf|Bayer Schering Pharma AG|||2932||2932|4819 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|K|3|0|0|0|0|INI|0|0|0|100|DKK|4725|8177|vetorma|||AA|100|0|0|Icepharma hf|Intervet International B.V.|||4725||4725|8177 041815|V08CA1101|Vasovist|stl|0,25|mmol/ml|10|ml|10|hgl|lausn|V08CA11|01.12.2006||R|A|3|0|0|0|0|SAG|0|0|0|100|SEK|180066|226367|lyfalmen|||02|100|0|0|Icepharma hf|Schering AG|||180066||180066|226367 041996|A06AG1101|Microlax|innhl|0| |5|ml|4|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|20|0|4|Vistor hf|McNeil Denmark ApS||||||0 042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|1349|2671|lyfalmen|||02|25|0|0|Vistor hf|AstraZeneca A/S DK|||1349||1349|2671 042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|10114|14459|lyfsjukr|||00|500|0|0|Vistor hf|AstraZeneca A/S DK|||10114||10114|14459 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3917|5608|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|||3917||3917|5608 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4940|7073|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|||4940||4940|7073 042323|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4668|6683|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|||4668||4668|6683 042332|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7078|10134|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|||7078||7078|10134 042360|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|8125|11633|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|||8125||8125|11633 042369|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|40|plpok|Excel umbúðir|B05BA03|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|8887|12724|lyfsjukr|||00|4000|0|4|Icepharma hf|Fresenius Kabi|||8887||8887|12724 042387|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4719|6756|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|||4719||4719|6756 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3462|4957|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|||3462||3462|4957 042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2985|4274|lyfsjukr|||02|10000|0|0|Icepharma hf|Fresenius Kabi|||2985||2985|4274 042442|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|50|ml|40|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|10431|14854|lyfsjukr|||00|2000|0|0|Icepharma hf|Fresenius Kabi|||10431||10431|14854 042460|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|4223|6046|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|||4223||4223|6046 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|2354|3370|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|||2354||2354|3370 042478|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|plpok|Excel umbúðir|B05BB01|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7785|11146|lyfsjukr|||00|4000|0|4|Icepharma hf|Fresenius Kabi|||7785||7785|11146 042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2640|3780|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|||2640||2640|3780 042549|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|1|dæla|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|832|1969|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||832||832|1969 042556|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|20|dælur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|15891|21969|lyfalmen|||02|10|0|0|Icepharma hf|Sanofi Pasteur MSD|||15891||15891|21969 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3669|5253|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|||3669||3669|5253 042669|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||00|4000|0|0|Icepharma hf|Fresenius Kabi||||||0 043232|N05CD0305|Flunitrazepam Merck NM|töflur|1|mg|30|stk|1|þpakki||N05CD03|01.10.1992||R|A|5|1|0|0|0|MNA|0|0|0|100|SEK|333|1292|lyfalmen|||00|30|0|30|Actavis Group PTC ehf|Merck NM AB|||333||333|1292 043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|3157|4520|lyfsjukr|||00|100|0|0|Vistor hf|AstraZeneca A/S DK|||3157||3157|4520 043379|R03AC1201|Serevent|innúðal|25|mcg/sk|120|sk|1|stauk|HFA 134a|R03AC12|01.04.2007||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|3687|5844|lyfalmen|||24|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3687||3687|5844 043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|5803|8308|lyfsjukr|||00|100|0|0|Vistor hf|AstraZeneca A/S DK|||5803||5803|8308 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|þpakki||N05CD05|01.12.1983||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|606|1663|lyfalmen|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||606||606|1663 043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.07.1989||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|1296|2599|lyfalmen|||10|30|0|30|Vistor hf|N.V. Organon|||1296||1296|2599 043919|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyflausa|||02|200|0|0|Icepharma hf|Fresenius Kabi|||||| 043935|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||00|200|0|0|Icepharma hf|Fresenius Kabi||||||0 044114|J01DH0202|Meronem (Lyfjaver)|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.02.2008|31.12.2008|R|A|4|0|0|0|1|LVR|0|0|0|100|NOK|28835|37766|lyfsjukr|||00|5000|0|2|Lyfjaver ehf|Lyfjaver ehf|||28835||28834|37766 044124|J01DH0202|Meronem (Lyfjaver)|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.02.2008|31.12.2008|R|A|4|0|0|0|1|LVR|0|0|0|100|NOK|55229|70628|lyfsjukr|||00|10|0|5|Lyfjaver ehf|Lyfjaver ehf|||55229||55229|70628 044360|B03AC0203|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.05.2006||R|A|3|0|0|E|0|LVR|0|0|1|100|NOK|12771|18085|lyfalmen|V0011|18085|00|25|0|5|Lyfjaver ehf|Lyfjaver ehf|||12771||12771|18085 044624|G04BE0303|Viagra (D.A.C.)|filmhtfl|100|mg|4|stk|1|þpakki||G04BE03|01.11.2006||R|A|5|0|0|0|0|DAC|0|0|0|100|DKK|5959|8927|lyfalmen|V1300|8927|00|4|0|8|D.A.C. ehf|D.A.C. ehf|||5959||5959|8927 045013|L01XX1902|Campto|irþ|20|mg/ml|5|ml|1|hgl||L01XX19|01.01.1999||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|40705|52545|lyfsjukr|||00|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||40705||40705|52545 045104|L04AX0102|Imurel|töflur|25|mg|50|stk|1|þpakki||L04AX01|01.10.1995||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|1304|2610|lyfalmen|||10|50|0|8|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1304||1304|2610 045379|N07BA0128|Nicorette Classic (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|210|0|14|Lyfjaver ehf|Lyfjaver ehf||||||0 045385|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|10|dælur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|7944|11621|lyfalmen|||02|5|0|0|Icepharma hf|Sanofi Pasteur MSD|||7944||7944|11621 045388|N07BA0128|Nicorette Classic (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|210|0|28|Lyfjaver ehf|Lyfjaver ehf||||||0 045397|N07BA0127|Nicorette Mint (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|210|0|14|Lyfjaver ehf|Lyfjaver ehf||||||0 045406|N07BA0127|Nicorette Mint (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|210|0|28|Lyfjaver ehf|Lyfjaver ehf||||||0 045578|N07BA0122|Nicorette (Lyfjaver)|nefúði|500|mcg/sk|200|skammtar|1|glas||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|200|0|3|Lyfjaver ehf|Lyfjaver ehf||||||0 045587|N07BA0122|Nicorette (Lyfjaver)|tungur.t|2|mg|105|stk|1|þpakki||N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|105|0|7|Lyfjaver ehf|Lyfjaver ehf||||||0 045596|N07BA0122|Nicorette (Lyfjaver)|innsogsl|10|mg|18|rör|1|þpakki|+ munnstk|N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|18|0|3|Lyfjaver ehf|Lyfjaver ehf||||||0 045605|N07BA0122|Nicorette (Lyfjaver)|innsogsl|10|mg|42|rör|1|þpakki|+ munnstk|N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|42|0|7|Lyfjaver ehf|Lyfjaver ehf||||||0 045614|N07BA0123|Nicotinell (Lyfjaver)|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|21|0|32|Lyfjaver ehf|Lyfjaver ehf||||||0 045896|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|2|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|84|0|6|Lyfjaver ehf|Lyfjaver ehf||||||0 045905|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|204|0|14|Lyfjaver ehf|Lyfjaver ehf||||||0 045915|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|4|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|84|0|11|Lyfjaver ehf|Lyfjaver ehf||||||0 045924|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|204|0|27|Lyfjaver ehf|Lyfjaver ehf||||||0 045933|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|2|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|84|0|6|Lyfjaver ehf|Lyfjaver ehf||||||0 045942|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|204|0|14|Lyfjaver ehf|Lyfjaver ehf||||||0 045951|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|4|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|84|0|11|Lyfjaver ehf|Lyfjaver ehf||||||0 045960|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|204|0|27|Lyfjaver ehf|Lyfjaver ehf||||||0 046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|K|2|0|0|0|0|PFV|0|0|0|100|DKK|22727|43463|vetalmen|||27|10|0|0|Icepharma hf|Pfizer vet.|||22727||22727|43463 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.03.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1943|3477|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|||1943||1943|3477 046396|A04AA0102|Ondansetron Vian|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|IKR|5076|7729|lyfalmen|V1088|7729|02|10|0|1|Icepharma hf|Vian SA|||5076||5076|7729 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|769|1884|lyfalmen|V0001|1884|00|90|0|45|Actavis Group hf|Actavis hf|||769||769|1884 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|1215|2489|lyfalmen|V0002|2489|00|90|0|90|Actavis Group hf|Actavis hf|||1215||1215|2489 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|1622|3042|lyfalmen|V0003|3042|00|90|0|135|Actavis Group hf|Actavis hf|||1622||1622|3042 046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|IKR|8305|12111|lyfalmen|V1089|12111|02|20|0|2|Icepharma hf|Vian SA|||8305||8305|12111 047042|L04AB0101|Enbrel|stl|0| |25|mg|4|áf.spr|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|USD|114298|144169|lyfsjukr|||00|100|0|14|Icepharma hf|Wyeth Europe|||114298||114298|144169 047159|C07AA0704|Sotalol Merck NM|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|899|2060|lyfalmen|||00|100|0|25|Actavis Group PTC ehf|Merck NM AB|||899||899|2060 047340|J01CA0406|Flemoxin Solutab|lausnart|500|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1188|2453|lyfalmen|||23|14|0|7|Vistor hf|Astellas Pharma A/S|||1188||1188|2453 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|13388|18536|lyfsjukr|||00|10|0|0|Ísaga ehf|AGA AB|||13388||13388|18536 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|47555|61073|lyfsjukr|||00|50|0|0|Ísaga ehf|AGA AB|||47555||47555|61073 047560|L04AB0101|Enbrel|stl|0| |50|mg|4|áf.spr|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|USD|227504|285110|lyfsjukr|||00|200|0|29|Icepharma hf|Wyeth Europe|||227504||227504|285110 047563|R03DC0101|Accolate|töflur|20|mg|98|stk|1|þpakki||R03DC01|01.04.1998||R|A|3|0|0|B|0|ASZ|0|0|0|100|SEK|9157|13267|lyfalmen|||00|98|0|49|Vistor hf|AstraZeneca UK Ltd|||9157||9157|13267 048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|4672|6689|lyfsjukr|||02|250|0|0|Icepharma hf|Baxter Medical AB|||4672||4672|6689 048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|7374|10558|lyfsjukr|||02|100|0|0|Icepharma hf|Baxter Medical AB|||7374||7374|10558 048199|A03CA0201|Librax|töflur|0| |100|stk|1|glas||A03CA02|01.12.1972||R|A|5|0|0|E|0|VAL|0|0|0|100|DKK|2373|4061|lyfalmen|||00|100|0|0|Icepharma hf|Valeant Pharmaceuticals B.V.|||2373||2373|4061 048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|þpakki|100+12,5 mg|C09DA01|01.06.2007||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|18576|25312|lyfalmen|||00|98|0|196|Icepharma hf|M.S.D.|||18576||18576|25312 048355|C01DA0801|Sorbangil|töflur|40|mg|100|stk|1|glas||C01DA08|01.10.1988||R|A|3|0|0|B|0|REP|0|0|0|100|DKK|6038|6623|lyfalmen|||00|100|0|67|Vistor hf|Recip AB|||4261||4261|6623 048447|G03AA0901|Marvelon|töflur|0| |63|stk|1|þpakki||G03AA09|01.07.1986||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1929|3458|lyfalmen|||23|63|0|84|Vistor hf|N.V. Organon|||1929||1929|3458 048452|M01AE5101|Ibukod|töflur|0| |30|stk|1|glas|10+200 mg|M01AE51|01.11.2006||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|650|1722|lyfalmen|||00|30|0|5|Actavis Group hf|Actavis hf|||650||650|1722 048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|þpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|69778|89059|lyfalmen|||00|150|0|38|Icepharma hf|Roche|||69778||69778|89059 048520|N04BD0104|Selegilin Merck NM|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|A|1.5|0|0|E|0|MNA|0|0|0|100|SEK|2629|4408|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|||2629||2629|4408 048611|N04BD0104|Selegilin Merck NM|töflur|10|mg|100|stk|1|glas||N04BD01|01.07.1994||R|A|1.5|0|0|E|0|MNA|0|0|0|100|SEK|8667|12602|lyfalmen|||00|100|0|200|Actavis Group PTC ehf|Merck NM AB|||8667||8667|12602 048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|A|4|0|0|0|0|GCH|0|0|1|100|DKK|518|1543|lyfalmen|V0772|1355|00|100|0|17|Icepharma hf|GlaxoSmithKline CH A/S|||518||518|1543 049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|þpakki||A02BA02|01.10.1987||R|A|3|0|0|E|0|ACA|0|0|0|30|IKR|3269|5277|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|||3269||3269|5277 049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|A|2|0|0|E|0|RRL|0|0|0|100|DKK|20528|27742|lyfalmen|||00|3|0|0|Icepharma hf|Roche Registration Limited|||20528||20528|27742 049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2939|4829|lyfalmen|||00|100|0|25|Vistor hf|Boehringer Ingelheim|||2939||2939|4829 049502|D01AC0801|Fungoral|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1993||L|A|3|0|0|0|0|JAS|0|0|1|100|SEK|||lyfalmen|||23|60|0|60|Vistor hf|Janssen-Cilag AB||||||0 049524|S01ED5110|Duotrav|augndr|0| |2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|3649|5792|lyfalmen|||00|2|0|0|K.Pétursson hf|Alcon|||3649||3649|5792 049533|S01ED5110|Duotrav|augndr|0| |2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|10739|15414|lyfalmen|||00|8|0|0|K.Pétursson hf|Alcon|||10739||10739|15414 049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|A|3|0|0|0|0|GAN|0|0|1|100|CHF|8574|12476|lyfalmen|||23|5|0|5|Icepharma hf|Galderma Nordic AB|||8574||8574|12476 049561|C10AA0104|Simvastatin (Portfarma)|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|0|0|POF|0|0|0|100|IKR|954|2018|lyfalmen|V0358|2018|00|98|0|65|PortFarma ehf|PortFarma |||868||868|2018 049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|0|0|POF|0|0|0|100|IKR|1154|2265|lyfalmen|V0365|2265|00|98|0|131|PortFarma ehf|PortFarma |||1050||1050|2265 049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|0|0|POF|0|0|0|100|IKR|1827|3097|lyfalmen|V0367|3097|00|100|0|267|PortFarma ehf|PortFarma |||1663||1663|3097 049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|8006|4829|lyfalmen|V0343|4435|00|28|0|28|Vistor hf|Novartis Healthcare A/S-|||2939||2939|4829 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.04.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2519|4259|lyfalmen|||00|100|0|200|Actavis Group hf|Actavis hf|||2519||2519|4259 049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||R|A|5|0|0|0|0|NHE|0|0|1|100|DKK|2173|3789|lyfalmen|||00|30|0|30|Artasan ehf|Novartis Healthcare A/S-A|||2173||2173|3789 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.08.2005||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|4132|6448|lyfalmen|||00|100|0|400|Actavis Group hf|Actavis hf|||4132||4132|6448 049750|L04AD0103|Sandimmun Neoral (D.A.C.)|hylki|25|mg|30|stk|1|þpakki||L04AD01|01.04.2006||R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|5394|8160|lyfalmen|||10|30|0|3|D.A.C. ehf|D.A.C. ehf|||5394||5394|8160 049760|L04AD0103|Sandimmun Neoral (D.A.C.)|hylki|100|mg|30|stk|1|þpakki||L04AD01|01.04.2006||R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|19794|26829|lyfalmen|||10|30|0|12|D.A.C. ehf|D.A.C. ehf|||19794||19794|26829 049778|M05BA0405|Fosamax (D.A.C.)|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.04.2006|31.01.2009|R|A|3|0|0|E|0|DAC|0|0|0|100|XEU|||lyfalmen|||00|12|0|84|D.A.C. ehf|D.A.C. ehf|||15241||| 049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|þpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|84636|107557|lyfalmen|||00|300|0|38|Icepharma hf|Roche|||84636||84636|107557 050179|N01AF0301|Pentothal Natrium|sts|2,5|g|1|stk|12|hgl||N01AF03|01.07.1990||R|A|4|0|0|0|1|HOS|0|0|0|100|DKK|8574|12276|lyfsjukr|||02|12|0|0|Vistor hf|Hospira Enterprises B.V.|||8574||8574|12276 050342|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.12.2006||R|A|2,5|0|1|0|1|BHC|0|0|0|100|SEK|581841|704528|lyfsjukr|||00|112|0|0|Vistor hf|Bayer HealthCare AG|||564386||564386|704528 050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|þpakki||N03AX16|01.04.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|4034|6315|lyfalmen|||00|14|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4034||4034|6315 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|14386|20096|lyfalmen|||00|56|0|42|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||14386||14386|20096 050651|C02CA0402|Carduran Retard|forðatfl|4|mg|30|stk|1|þpakki||C02CA04|01.01.2007||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|3341|5374|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3341||3341|5374 050660|C02CA0402|Carduran Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.01.2007||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|10080|14519|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||10080||10080|14519 050914|N02BE0101|Panodil|eþ-stil|1|g|10|stk|1|pakki||N02BE01|01.10.1989||R|A|5|0|0|0|0|GCH|0|0|1|100|DKK|514|1538|lyfalmen|||04|10|0|3|Icepharma hf|GlaxoSmithKline CH A/S|||514||514|1538 051011|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.07.1994||L|A|2|0|0|0|0|GCH|0|0|1|100|IKR|||lyfalmen|||00|2|0|2|Icepharma hf|GlaxoSmithKline CH A/S||||||0 051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|1832|3326|lyfalmen|||10|100|0|10|Vistor hf|Desitin Artzneimittel|||1832||1832|3326 051058|M02AA1002|Orudis (D.A.C.)|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.01.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyfalmen|||00|60|0|0|D.A.C. ehf|D.A.C. ehf||||||0 051076|D05AX5202|Daivobet (D.A.C.)|smyrsli|0| |60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.01.2007||R|A|2|0|0|B|0|DAC|0|0|0|100|DKK|9747|14068|lyfalmen|V0391|14068|00|60|0|0|D.A.C. ehf|D.A.C. ehf|||9747||9747|14068 051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|2433|4142|lyfalmen|||10|100|0|20|Vistor hf|Desitin Artzneimittel|||2433||2433|4142 051193|R05CB0102|Mucomyst|freyðit|200|mg|25|stk|1|glas||R05CB01|01.01.1986||R|A|2|0|0|E|0|BIP|0|0|1|100|SEK|491|1507|lyfalmen|||72|25|0|10|Vistor hf|BioPhausia AB|||491||491|1507 051331|R06AX2602|Nefoxef|töflur|120|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|1052|2268|lyfalmen|V1910|2268|00|30|0|30|Actavis Group PTC ehf|Mylan AB|||1052||1052|2268 051340|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|3172|5145|lyfalmen|V1911|5145|00|100|0|100|Actavis Group PTC ehf|Mylan AB|||3172||3172|5145 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|1621|3040|lyfalmen|V1912|3040|00|30|0|45|Actavis Group PTC ehf|Mylan AB|||1621||1621|3040 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|4687|7201|lyfalmen|V1913|7201|00|100|0|150|Actavis Group PTC ehf|Mylan AB|||4687||4687|7201 051425|R05CB0102|Mucomyst|freyðit|200|mg|100|stk|1|glas||R05CB01|01.01.1986||R|A|2|0|0|E|0|BIP|0|0|1|100|SEK|1860|3364|lyfalmen|||72|100|0|40|Vistor hf|BioPhausia AB|||1860||1860|3364 051550|N03AX1401|Keppra|irþ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|A|2|0|1|0|1|UCB|0|0|0|100|DKK|37651|48743|lyfsjukr|||00|50|0|3|Vistor hf|U.C.B|||37651||37651|48743 051713|A02BC0504|Nexium Mups (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.04.2006||R|A|3|0|0|E|0|DAC|0|0|0|30|SEK|3938|6184|lyfalmen|V0084|6184|00|28|0|19|D.A.C. ehf|D.A.C. ehf|||3938||3938|6184 051732|C08CA0104|Amlódipín PortFarma|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|A|2,5|0|0|B|0|POF|0|0|0|100|IKR|1909|3043|lyfalmen|V0308|3043|00|100|0|0|PortFarma ehf|PortFarma |||1623||1623|3043 051750|C08CA0104|Amlódipín PortFarma|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|A|2,5|0|0|B|0|POF|0|0|0|100|IKR|3111|4428|lyfalmen|V0310|4428|00|100|0|0|PortFarma ehf|PortFarma |||2644||2644|4428 052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|414624|518074|lyfsjukr|||00|60|0|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |||414624||414624|518074 052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|835400|1041941|lyfsjukr|||00|60|0|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |||835400||835400|1041941 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|844955|1053836|lyfsjukr|||00|60|0|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |||844955||844955|1053836 052478|D06BB0305|Zovirax (D.A.C.)|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.03.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyfalmen|||00|2|0|2|D.A.C. ehf|D.A.C. ehf||||||0 052498|V03AF0302|Rescuvolin|sts|15|mg|1|stk|25|hgl||V03AF03|01.01.1995||R|A|3|0|0|0|1|PHC|0|0|0|100|XEU|35659|46263|lyfsjukr|||63|25|0|6|Actavis Group hf|Pharmachemie|||35659||35659|46263 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|43945|56579|lyfsjukr|||00|8212|0|8|Icepharma hf|Fresenius Kabi|||43945||43945|56579 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|35307|45825|lyfsjukr|||00|7698|0|8|Icepharma hf|Fresenius Kabi|||35307||35307|45825 052522|V03AF0302|Rescuvolin|sts|50|mg|1|stk|10|hgl||V03AF03|01.01.1995||R|A|3|0|0|0|1|PHC|0|0|0|100|XEU|47609|61141|lyfsjukr|||63|10|0|8|Actavis Group hf|Pharmachemie|||47609||47609|61141 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|40854|52731|lyfsjukr|||00|7680|0|8|Icepharma hf|Fresenius Kabi|||40854||40854|52731 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|33940|44123|lyfsjukr|||00|7200|0|7|Icepharma hf|Fresenius Kabi|||33940||33940|44123 052542|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|46016|59157|lyfsjukr|||00|7880|0|8|Icepharma hf|Fresenius Kabi|||46016||46016|59157 052560|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|42811|55167|lyfsjukr|||00|7616|0|8|Icepharma hf|Fresenius Kabi|||42811||42811|55167 052944|C01DA1402|Monit-L|forðahlk|30|mg|100|stk|1|glas||C01DA14|01.01.1994|31.12.2008|R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|1770|3242|lyfalmen|||10|100|0|75|Actavis Group hf|Actavis hf|||1770||1770|3242 053006|N05CF0203|Zolpidem Merck NM|filmhtfl|10|mg|100|stk|1|þpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|0|100|SEK|2629|4408|lyfalmen|V0903|4408|00|100|0|100|Actavis Group PTC ehf|Mylan AB|||2629||2629|4408 053025|G03HB0102|Diane mite|töflur|0| |63|stk|1|þpakki||G03HB01|01.07.1989||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|2610|4382|lyfalmen|||23|63|0|63|Icepharma hf|Bayer Schering Pharma AG|||2610||2610|4382 053043|J05AE0601|Kaletra|filmhtfl|250|mg|120|stk|1|glös|200+50 mg|J05AE06|01.11.2006||R|A|2|0|1|0|1|ABT|0|0|0|100|DKK|82262|104284|lyfsjukr|||00|120|0|30|Vistor hf|Abbott Laboratories Ltd|||82262||82262|104284 053231|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|5940|8901|lyfalmen|||02|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||5940||5940|8901 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|33784|44246|lyfalmen|||00|100|0|50|Vistor hf|Sanofi - aventis Deutschland GmbH|||33784||33784|44246 053397|L04AA1301|Arava|töflur|20|mg|30|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|10467|15045|lyfalmen|||00|30|0|30|Vistor hf|Sanofi - aventis Deutschland GmbH|||10467||10467|15045 053413|L04AA1301|Arava|töflur|20|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|32320|42423|lyfalmen|||00|100|0|100|Vistor hf|Sanofi - aventis Deutschland GmbH|||32320||32320|42423 053546|L04AA1301|Arava|töflur|100|mg|3|stk|1|þpakki||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|5022|7655|lyfalmen|||00|3|0|20|Vistor hf|Sanofi - aventis Deutschland GmbH|||5022||5022|7655 053680|J05AE1001|Prezista|filmhtfl|300|mg|120|stk|1|plglas||J05AE10|01.04.2007||R|A|2|0|1|0|1|JCI|0|0|0|100|SEK|118810|149783|lyfsjukr|||43|120|0|0|Vistor hf|Janssen-Cilag International N.V.|||118808||118808|149783 053689|N05CF0203|Zolpidem Merck NM|filmhtfl|10|mg|20|stk|1|þpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|560|1600|lyfalmen|V0902|1600|00|20|0|20|Actavis Group PTC ehf|Mylan AB|||560||560|1600 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|A|2|1|0|0|0|MAP|0|0|0|100|GBP|15178|21082|lyfalmen|||00|10|0|50|Icepharma hf|Martindale Pharmaceuticals|||15178||15178|21082 053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburður, lausn|D10AF01|01.07.1985||R|A|2,5|0|0|0|0|PFI|0|0|0|100|DKK|1245|2530|lyfalmen|||20|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1245||1245|2530 054130|J01CA0405|Flemoxin|mixtúrud|50|mg/ml|100|ml|1|glas||J01CA04|01.11.1979||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1479|2847|lyfalmen|V0451|2805|08|100|0|5|Vistor hf|Astellas Pharma A/S|||1479||1479|2847 054148|J01CA0405|Flemoxin|dropar|100|mg/ml|20|ml|1|glas||J01CA04|01.11.1979||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|860|2007|lyfalmen|||28|20|0|2|Vistor hf|Astellas Pharma A/S|||860||860|2007 054213|J07AG0101|Act-Hib|bóluefni|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|2816|4662|lyfalmen|||02|0|0|0|Icepharma hf|Aventis Pasteur MSD A/S|||2816||2816|4662 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyfalmen|||23|2|0|1|Vistor hf|AstraZeneca A/S DK||||||0 054278|D01AE1502|Lamisil Once|húðlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|4|0|0|Artasan ehf|Novartis Healthcare A/S-A||||||0 054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|A|3|0|1|0|1|RRL|0|0|0|30|DKK|77776|98699|lyfsjukr|||00|56|0|22|Icepharma hf|Roche Registration Limited|||77776||77776|98699 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyfalmen|||23|2|0|2|Vistor hf|AstraZeneca A/S DK||||||0 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|A|3|0|0|0|0|UCB|0|0|1|100|SEK|1304|2610|lyfalmen|||00|200|0|5|Vistor hf|U.C.B|||1304||1304|2610 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|þpakki||N06AB03|01.10.2006||R|A|3|0|0|B|0|ACA|0|1|0|30|IKR|949|2128|lyfalmen|V0914|2128|10|30|0|30|Actavis Group hf|Actavis hf|||949||949|2128 054601|QB03AC9001|Idofer, vet.|stl|200|mg/ml|100|ml|5|fl|plastfl.|QB03AC90|01.05.1999||R|A|2|0|0|0|0|BID|1|0|0|100|DKK|13870|26591|vetalmen|||27|500|0|0|Vistor hf|Boehringer Ingelheim Danmark|||13870||13870|26591 054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|8386|14512|vetorma|||16|20|0|0|Icepharma hf|Pfizer Oy Animal Health|||8386||8386|14512 055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|þpakki||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|733|1835|lyfalmen|||10|20|0|5|Vistor hf|Recip AB|||733||733|1835 055277|N02AA0101|Contalgin|forðatfl|60|mg|100|stk|1|þpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|12688|17982|lyfalmen|||10|100|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||12688||12688|17982 055392|J04AK0102|Pyrazinamid|töflur|500|mg|100|stk|1|glas||J04AK01|01.04.2005||R|A||0|0|E|0|LDR|0|0|0|100|IKR|3734|5908|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||3734||3734|5908 055434|P03AC0401|Nix|krem|50|mg/g|30|g|1|túpa||P03AC04|01.01.1996|31.12.2008|R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|1526|2911|lyfalmen|||00|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1526||1526|2911 055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|36|0|1|Artasan ehf|Novartis Healthcare A/S-A||||||0 055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|96|0|3|Artasan ehf|Novartis Healthcare A/S-A||||||0 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|4359|6756|lyfalmen|V0337|6756|00|100|0|100|Actavis Group hf|Actavis hf|||4359||4359|6756 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|6185|9234|lyfalmen|V0338|9234|00|100|0|200|Actavis Group hf|Actavis hf|||6185||6185|9234 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|7867|11516|lyfalmen|V0339|11516|00|100|0|400|Actavis Group hf|Actavis hf|||7867||7867|11516 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|þpakki||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1195|2462|lyfalmen|||10|40|0|10|Vistor hf|Recip AB|||1195||1195|2462 056879|V07AY02|Palacos cum Gentamicin (Paranova)|sement|500|mg|40,5|g|2|pakkar|+ leysir|V07AY|01.06.1997||R|A|4|0|0|0|1|PAN|0|0|0|100|DKK|28463|37304|lyfsjukr|||00|81|0|0|xxxxx|Paranova A/S|||28463||28463|37304 056915|L04AA2301|Tysabri|irþ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|K|4|0|1|0|1|EPI|0|0|0|100|XEU|323011|404016|lyfsjukr|||00|15|0|30|Meda AB|Elan Pharma International|||323011||323011|404016 056961|J05AF0702|Viread (Paranova)|filmhtfl|245|mg|30|stk|1|plglas||J05AF07|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|72420|92030|lyfsjukr|||00|30|0|30|PortFarma ehf|PortFarma |||72420||72420|92030 057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|K|4|0|1|0|1|NOH|0|0|0|100|DKK|20270|27104|lyfsjukr|||02|5|0|1|Vistor hf|Novartis Healthcare A/S-|||20270||20270|27104 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|5|0|1|0|1|NOH|0|0|0|100|DKK|10771|15277|lyfsjukr|||02|5|0|1|Vistor hf|Novartis Healthcare A/S-|||10771||10771|15277 057422|B05XA3102|Tracel|irþ|0| |10|ml|20|plastl||B05XA31|01.01.1987||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7013|10041|lyfsjukr|||00|200|0|0|Icepharma hf|Fresenius Kabi|||7013||7013|10041 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|5|0|1|0|1|NOH|0|0|0|100|DKK|5798|8301|lyfsjukr|||02|5|0|0|Vistor hf|Novartis Healthcare A/S-|||5798||5798|8301 057703|J01DD0401|Rocephalin|irþ|2|g|5|hgl|1|pakki|lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|26998|35480|lyfsjukr|||00|5|0|5|Icepharma hf|Roche|||26998||26998|35480 057924|C09DA0401|CoAprovel|filmhtfl|325|mg|28|stk|1|þpakki|300+25 mg|C09DA04|01.03.2007||R|A|2|0|0|B|0|SBM|0|0|0|100|NOK|4901|7491|lyfalmen|||00|28|0|56|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||4901||4901|7491 057933|C09DA0401|CoAprovel|filmhtfl|325|mg|98|stk|1|þpakki|300+25 mg|C09DA04|01.03.2007||R|A|2|0|0|B|0|SBM|0|0|0|100|NOK|17438|23895|lyfalmen|||00|98|0|196|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||17438||17438|23895 057978|N07BA0301|Champix|filmhtfl|0| |25|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.01.2007||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|5462|8253|lyfalmen|||00|25|0|10|Vistor hf|Pfizer Limited|||5462||5462|8253 057987|N07BA0301|Champix|filmhtfl|1|mg|28|stk|1|þpakki||N07BA03|01.01.2007||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|6103|9122|lyfalmen|||00|28|0|14|Vistor hf|Pfizer Limited|||6103||6103|9122 057996|N07BA0301|Champix|filmhtfl|1|mg|56|stk|1|þpakki||N07BA03|01.01.2007||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|12266|17456|lyfalmen|||00|56|0|28|Vistor hf|Pfizer Limited|||12266||12266|17456 058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|465|1471|lyfalmen|||02|5|0|2|Vistor hf|Boehringer Ingelheim|||465||465|1471 058397|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.01.2007||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|21929|29487|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||21929||21929|29487 058503|J01EA0105|Trimetoprim AstraZeneca|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|908|2073|lyfalmen|||00|100|0|2|Vistor hf|Recip AB|||908||908|2073 058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|123395|155494|lyfsjukr|||00|210|0|21|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |||123395||123395|155494 058735|C03CA0105|Lasix Retard|forðahlk|30|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|1425|2774|lyfalmen|||43|100|0|75|Vistor hf|Sanofi-aventis Norge AS|||1425||1425|2774 058768|C03CA0105|Lasix Retard|forðahlk|60|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|2247|3890|lyfalmen|||43|100|0|150|Vistor hf|Sanofi-aventis Norge AS|||2247||2247|3890 058958|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07CA06|01.03.1999||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|4202|6543|lyfalmen|||51|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||4202||4202|6543 059204|C01DA0801|Sorbangil|töflur|5|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|DKK|2203|2951|lyfalmen|||00|250|0|21|Vistor hf|Recip AB|||1555||1555|2951 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|113031|142909|lyfalmen|||02|2|0|0|Vistor hf|Astellas Pharma A/S|||113031||113031|142909 059659|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|10|spr||J07CA06|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|32083|42128|lyfalmen|||51|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||32083||32083|42128 059687|J05AR0302|Truvada (Paranova)|filmhtfl|445|mg|30|stk|1|plglas|200+245 mg|J05AR03|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|124655|157063|lyfsjukr|||00|30|0|0|PortFarma ehf|PortFarma |||124655||124655|157063 059823|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.05.2007||R|A|3|1|1|0|1|SCP|0|0|0|100|DKK|7878|11279|lyfsjukr|||00|28|0|7|Vistor hf|Schering-Plough|||7878||7878|11279 059824|C07AB0310|Atenolol Merck NM|töflur|25|mg|98|stk|1|þpakki||C07AB03|01.04.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|809|1938|lyfalmen|V0290|1589|00|98|0|33|Actavis Group PTC ehf|Merck NM AB|||809||809|1938 059842|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.07.2007||R|A|3|1|1|0|1|SCP|0|0|0|100|DKK|17863|24107|lyfsjukr|||00|28|0|28|Vistor hf|Schering-Plough|||17863||17863|24107 060087|L04AC0101|Zenapax|irþ|5|mg/ml|5|ml|3|hgl||L04AC01|01.04.2005|31.12.2008|R|K|3|0|0|0|1|RRL|0|0|0|100|DKK|184933|232109|lyfsjukr|||00|15|0|0|Icepharma hf|Roche Registration Limited|||184933||184933|232109 060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|426080|532655|lyfalmen|||00|84|0|0|Vistor hf|Novartis Europharm Ltd|||426080||426080|532655 060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|215780|270831|lyfalmen|||00|84|0|0|Vistor hf|Novartis Europharm Ltd|||215780||215780|270831 060578|V03AC0301|Exjade|dreifit.|125|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|107891|136509|lyfalmen|||00|84|0|0|Vistor hf|Novartis Europharm Ltd|||107891||107891|136509 060848|N06AA0402|Anafranil Retard|forðatfl|75|mg|100|stk|1|þpakki||N06AA04|01.10.1989||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|8294|12096|lyfalmen|||10|100|0|75|Vistor hf|Novartis Healthcare A/S-|||8294||8294|12096 060905|C01DA0204|Nitromex|tungur.t|0,5|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|120|0|24|Actavis Group hf|Actavis Group hf||||||1963 060913|C01DA0204|Nitromex|tungur.t|0,25|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|120|0|12|Actavis Group hf|Actavis Group hf||||||1963 061414|QA04AD901|Cerenia|töflur|60|mg|4|stk|1|þpakki||QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|0|0|0|100|DKK|2993|5872|vetalmen|||0|4|0|0|Icepharma hf|Pfizer Animal Health|||||2993|5872 061442|QA04AD901|Cerenia|töflur|24|mg|4|stk|1|þpakki||QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|0|0|0|100|DKK|1568|3094|vetalmen|||0|4|0|0|Icepharma hf|Pfizer Animal Health|||||1568|3094 061451|QA04AD901|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|1|0|0|100|DKK|9264|17818|vetalmen|||00|20|0|0|Icepharma hf|Pfizer Animal Health|||||9264|17818 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PFI|0|0|1|100|DKK|||lyfalmen|||23|50|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||||||0 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|8313|12122|lyfalmen|||00|84|0|84|Vistor hf|N.V. Organon|||||8313|12122 061580|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdæla|26|g|1|spr||QP52AF02|01.04.1992||L|A|1|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|26|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||1995 061715|L01XE0901|Torisel|irþ|25|mg/ml|1|hgl|1|pakki||L01XE09|01.05.2008||R|A|2|0|1|0|1|WTE|0|0|0|100|USD|192490|241518|lyfsjukr|||00|1|0|0|Icepharma hf|Wyeth Europe|||192490||192490|241518 061762|N02BA0106|Magnyl|töflur|500|mg|50|stk|1|þpakki||N02BA01|01.12.1983||L|A|1|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|50|0|8|Actavis Group hf|Actavis hf||||||0 061937|L04AD0101|Sandimmun|irþ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|7180|10280|lyfsjukr|||00|10|0|2|Vistor hf|Novartis Healthcare A/S-|||7180||7180|10280 061961|J01XX0901|Cubicin|irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|18864|25353|lyfsjukr|||00|1|0|1|Vistor hf|Novartis Europharm Ltd|||18864||18864|25353 061970|J01XX0901|Cubicin|irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|26701|35110|lyfsjukr|||00|1|0|2|Vistor hf|Novartis Europharm Ltd|||26701||26701|35110 062117|N05BA1204|Tafil Retard|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|551|1588|lyfalmen|||10|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||551||551|1588 062343|A10BD0401|Avaglim|filmhtfl|0| |28|stk|1|þpakki|4+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|4877|7459|lyfalmen|||00|28|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||4877||4877|7459 062379|A10BD0401|Avaglim|filmhtfl|0| |28|stk|1|þpakki|8+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|7297|10743|lyfalmen|||00|28|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||7297||7297|10743 062638|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|8208|11752|lyfsjukr|||02|20|0|0|Icepharma hf|Wyeth AB|||8208||8208|11752 062661|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|930|1332|lyfsjukr|||02|1|0|0|Icepharma hf|Wyeth AB|||930||930|1332 062711|J01EE0103|Primazol|töflur|480|mg|30|stk|1|glas|80+400 mg|J01EE01|01.10.1995||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|694|1782|lyfalmen|||00|30|0|8|Actavis Group hf|Actavis hf|||694||694|1782 062729|N05BA1204|Tafil Retard|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|1160|2415|lyfalmen|||10|60|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1160||1160|2415 062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|A|5|0|0|E|0|AGT|0|0|1|100|XEU|2227|3863|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis Group hf|||2227||2227|3863 062745|QP53AF0102|Sebacil vet.|húðlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|19607|33931|vetorma|||16|1000|0|0|Vistor hf|Bayer Animal Health GmbH|||19607||19607|33931 062935|G03AA1005|Harmonet|töflur|0| |63|stk|1|pakki|þp 20+75 mcg|G03AA10|01.11.1998||R|A|3|0|0|0|0|WEM|0|0|0|100|USD|2135|3738|lyfalmen|||23|63|0|63|Icepharma hf|Wyeth Medica|||2135||2135|3738 062987|J07BM0201|Cervarix|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|16144|22284|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|||16144||16144|22284 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|30|DKK|5592|8429|lyfalmen|||00|10|0|2|Vistor hf|Novartis Healthcare A/S-|||5592||5592|8429 063453|J01CA0406|Flemoxin Solutab|lausnart|750|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|2257|3903|lyfalmen|||23|14|0|10|Vistor hf|Astellas Pharma A/S|||2257||2257|3903 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|A|2|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|500|0|50|Vistor hf|Medic Team||||||0 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|glas||D01BA02|01.11.2006||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|2649|4435|lyfalmen|V0343|4435|00|28|0|28|Actavis Group hf|Actavis hf|||2649||2649|4435 063706|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|30|stk|1|þpakki||R06AX27|01.11.2006||R|A|2|0|0|E|0|DAC|0|0|1|100|DKK|2255|3901|lyfalmen|V1901|3901|00|30|0|30|D.A.C. ehf|D.A.C. ehf|||2255||2255|3901 063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|K|2,5|0|0|0|1|OCT|0|0|0|100|DKK|11958|16755|lyfsjukr|||17|2|0|0|Vistor hf|Octapharma AB|||11958||11958|16755 063923|QP54AB5207|Equest Pramox vet|hlaup|0| |11,8|g|1|sk-dæl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|A|2|0|0|0|0|FDV|0|0|0|100|XEU|2761|4778|vetorma|||16|12|0|0|Vistor hf|Fort Dodge Veterinär GmbH|||2761||2761|4778 063941|N05BA1204|Tafil Retard|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|1160|2415|lyfalmen|||10|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1160||1160|2415 063958|N05BA1204|Tafil Retard|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|2360|4043|lyfalmen|||10|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2360||2360|4043 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|1181819|1473232|lyfsjukr|||00|1|0|12|Icepharma hf|United Therapeutics Europe Ltd.|||||1181819|1473232 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|472727|590413|lyfsjukr|||00|1|0|5|Icepharma hf|United Therapeutics Europe Ltd.|||||472727|590413 064170|N05BA1204|Tafil Retard|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|2552|4304|lyfalmen|||10|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2552||2552|4304 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|4727277|5887327|lyfsjukr|||00|1|0|47|Icepharma hf|United Therapeutics Europe Ltd.|||||4727277|5887327 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|2363639|2944598|lyfsjukr|||00|1|0|23|Icepharma hf|United Therapeutics Europe Ltd.|||||2363639|2944598 064733|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1985||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|951|2131|lyfalmen|||51|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||951||951|2131 065032|D10AF5101|Duac|hlaup|0| |25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|A|1,5|0|0|0|0|SLL|0|0|0|100|DKK|2646|4431|lyfalmen|||38|25|0|0|Vistor hf|Stiefel Laboratories (UK) Ltd.|||2646||2646|4431 065060|J07BD5202|MMR II|bóluefni|0| |0,5|ml|10|hgl|+ leysir|J07BD52|01.11.1998||R|K|2|0|0|0|0|MEX|0|0|0|100|XEU|14235|19908|lyfalmen|||51|5|0|0|Icepharma hf|Aventis Pasteur MSD A/S|||14235||14235|19908 065094|V08AB0901|Visipaque|stl|150|mg J/ml|50|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|5486|7855|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||5486||5486|7855 065314|G01AF0201|Canesten|sk-stil|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|A|4|0|0|0|0|BAS|0|0|0|100|DKK|||lyfalmen|||25|6|0|6|Vistor hf|Bayer A/S||||||0 065332|G01AF0201|Canesten|sk-stil|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|A|5|0|0|0|0|BAS|0|0|0|100|DKK|||lyfalmen|||25|1|0|5|Vistor hf|Bayer A/S||||||0 065540|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|15297|20912|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||15297||15297|20912 065706|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.10.1999||R|K|3|0|0|*|0|PFI|0|0|0|100|DKK|2970|4871|lyfalmen|||06|2|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2970||2970|4871 065979|C09CA0101|Cozaar|töflur|12,5|mg|28|stk|1|þpakki||C09CA01|01.03.1999||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|2323|3993|lyfalmen|V0195|2187|00|28|0|7|Icepharma hf|M.S.D.|||2323||2323|3993 066142|N05BA0204|Klordiazepoxið Actavis|töflur|10|mg|50|stk|1|glas||N05BA02|01.10.1995|31.12.2008|R|A|5|0|0|0|0|ACA|0|0|0|100|IKR|345|1309|lyfalmen|||00|50|0|17|Actavis Group hf|Actavis hf|||345||345|1309 066241|C03EA0103|Hydramil|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.08.1984||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|238|1163|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|||238||238|1163 066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|A|2|0|0|B|0|BII|0|0|0|100|DKK|7844|11485|lyfalmen|||00|60|0|8|Vistor hf|Boehringer Ingelheim International |||7844||7844|11485 066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05AA07|01.05.2008||R|A|5|0|0|0|1|FRP|0|0|0|100|DKK|36081|46788|lyfsjukr|||00|10000|0|10|Icepharma hf|Fresenius Kabi|||36081||36081|46788 066399|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|21|0|10|Artasan ehf|Novartis Healthcare A/S-A||||||0 066407|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|21|0|21|Artasan ehf|Novartis Healthcare A/S-A||||||0 066423|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||23|21|0|32|Artasan ehf|Novartis Healthcare A/S-A||||||0 066548|QG03FA0401|Prid, vet.|lykkja|10|mg|10|stk|1|pakki|m. hylki|QG03FA04|01.08.1984||R|A|2|0|0|0|0|CES|1|0|0|100|XEU|22792|43587|vetalmen|||16|10|0|0|Icepharma hf|Ceva Sante Animale|||22792||22792|43587 066563|N06AA0405|Klomipramin Merck NM|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.1992||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|561|1602|lyfalmen|||00|100|0|10|Actavis Group PTC ehf|Merck NM AB|||561||561|1602 066621|N06AA0405|Klomipramin Merck NM|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|837|1667|lyfalmen|V0908|1667|00|100|0|25|Actavis Group PTC ehf|Merck NM AB|||609||609|1667 066688|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|6|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|4575|6550|lyfsjukr|||02|120|0|0|Icepharma hf|GE Healthcare AS|||4575||4575|6550 066751|C01BD0103|Cordarone (D.A.C.)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.11.2006||R|K|5|0|0|B|0|DAC|0|0|0|100|NOK|2263|3911|lyfalmen|V0144|3911|70|30|0|15|D.A.C. ehf|D.A.C. ehf|||2263||2263|3911 067025|J01CA0406|Flemoxin Solutab|lausnart|125|mg|20|stk|1|þpakki||J01CA04|01.01.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|700|1790|lyfalmen|||23|20|0|2|Vistor hf|Astellas Pharma A/S|||700||700|1790 067124|N07CA0101|Betaserc|töflur|16|mg|84|stk|1|þpakki||N07CA01|01.04.1993||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|7737|11340|lyfalmen|||00|84|0|56|Medico ehf|Solvay Duphar |||7737||7737|11340 067579|N05BB0101|Atarax|töflur|25|mg|25|stk|1|þpakki||N05BB01|01.04.1995|31.01.2009|R|A|5|0|0|0|0|UCB|0|0|1|100|SEK|381|1357|lyfalmen|||00|25|0|8|Vistor hf|U.C.B|||381||381|1357 067587|N05BB0101|Atarax|töflur|25|mg|100|stk|1|þpakki||N05BB01|01.07.1994||R|A|5|0|0|0|0|UCB|0|0|0|100|SEK|1304|2610|lyfalmen|||00|100|0|33|Vistor hf|U.C.B|||1304||1304|2610 067641|N05CD0204|Mogadon (D.A.C.)|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.11.2006||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|824|1959|lyfalmen|V0901|1959|00|50|0|50|D.A.C. ehf|D.A.C. ehf|||824||824|1959 067751|J02AC0102|Candizol|hylki|50|mg|7|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1740|3202|lyfalmen|V0551|3202|10|7|0|2|Actavis Group hf|Actavis hf|||1740||1740|3202 067769|J02AC0102|Candizol|hylki|50|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|7143|10534|lyfalmen|V0552|10534|10|30|0|8|Actavis Group hf|Actavis hf|||7143||7143|10534 067785|J02AC0102|Candizol|hylki|150|mg|1|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|754|1864|lyfalmen|V0554|1864|10|1|0|1|Actavis Group hf|Actavis hf|||754||754|1864 067793|J02AC0102|Candizol|hylki|150|mg|2|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1441|2796|lyfalmen|V0555|2796|10|2|0|2|Actavis Group hf|Actavis hf|||1441||1441|2796 067801|J02AC0102|Candizol|hylki|150|mg|4|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|2500|4233|lyfalmen|V0556|4233|10|4|0|3|Actavis Group hf|Actavis hf|||2500||2500|4233 067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|26738|35474|lyfalmen|V0557|35474|10|30|0|30|Actavis Group hf|Actavis hf|||26738||26738|35474 068312|QN01AX0302|Narketan, vet.|stl|100|mg/ml|50|ml|1|hgl||QN01AX03|01.01.1991||R|A|2,5|1|0|0|0|VEQ|1|0|0|100|XEU|6646|12831|vetalmen|||27|50|0|0|Icepharma hf|Vétoquinol AG|||6646||6646|12831 068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|þpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|DKK|3187|3892|lyfalmen|||00|20|0|10|Vistor hf|Meda AB (V)|||2249||2249|3892 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|DKK|9398|9842|lyfalmen|||00|100|0|50|Vistor hf|Meda AB (V)|||6633||6633|9842 068923|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|200|0|0|Actavis Group hf|Braun|||||| 068933|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|400|0|0|Actavis Group hf|Braun|||||| 068951|V07AB09|Sterilt Vatten Braun|leysir|0||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|200|0|0|Actavis Group hf|Braun|||||| 068960|V07AB09|Sterilt Vatten Braun|leysir|0||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|400|0|0|Actavis Group hf|Braun|||||| 069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|A|5|0|0|0|0|NHE|0|0|1|100|DKK|||lyfalmen|||00|15|0|15|Artasan ehf|Novartis Healthcare A/S-A||||||0 069807|D01BA0201|Lamisil|töflur|250|mg|14|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|4952|3211|lyfalmen|||00|14|0|14|Vistor hf|Novartis Healthcare A/S-|||1747||1747|3211 069815|D01BA0201|Lamisil|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|31896|16993|lyfalmen|||00|98|0|98|Vistor hf|Novartis Healthcare A/S-|||11903||11903|16993 069833|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.07.2007||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|1849|3350|lyfalmen|||00|40|0|10|Icepharma hf|NordMedica A/S|||1849||1849|3350 069842|J01DB0101|Keflex|töflur|500|mg|20|stk|1|þpakki||J01DB01|01.07.2007||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|932|2105|lyfalmen|||00|20|0|5|Icepharma hf|NordMedica A/S|||932||932|2105 070342|V08AB0201|Omnipaque|stl|350|mg J/ml|100|ml|10|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|44276|56991|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|||44276||44276|56991 070359|L01DB0701|Novantrone|irþ|2|mg/ml|10|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|34464|44775|lyfsjukr|||00|10|0|0|Icepharma hf|Wyeth AB|||34464||34464|44775 070514|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|7705|11032|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|||7705||7705|11032 070523|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|5481|7847|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|||5481||5481|7847 070533|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|9626|13782|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|||9626||9626|13782 070542|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6126|8771|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|||6126||6126|8771 070557|QH01BB0203|Partoxin vet.|stl|17|mcg|10|ml|10|hgl||QH01BB02|01.12.2006||R|A|2|0|0|0|0|PSW|1|0|0|100|SEK|5245|10162|vetalmen|||27|100|0|0|Vistor hf|Pharmaxim Sweden AB|||5245||5245|10162 070623|C03AA0301|Aquazið|töflur|12,5|mg|100|stk|1|glas||C03AA03|01.03.1984||R|A|4|0|0|E|0|ACA|0|0|0|100|IKR|748|1855|lyfalmen|||00|100|0|50|Actavis Group hf|Actavis hf|||748||748|1855 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|með skammtasprautu|N05AX08|01.01.1997||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|16532|22767|lyfalmen|||00|100|0|20|Vistor hf|Janssen-Cilag AB|||16532||16532|22767 071076|QA12CE9902|Selevitan, vet.|kyrni|0| |1250|g|1|plbrús||QA12CE99|01.12.2006||R|A|3|0|0|0|0|PSW|0|0|0|100|SEK|5554|10751|vetalmen|||16|1250|0|0|Vistor hf|Pharmaxim Sweden AB|||5554||5554|10751 071134|N05AN0104|Litiumsitrat Actavis|töflur|500|mg|100|stk|1|glas||N05AN01|01.10.1995||R|A|5|0|0|*|0|ACA|0|1|0|100|IKR|728|1828|lyfalmen|||00|100|0|22|Actavis Group hf|Actavis hf|||728||728|1828 071217|C03EA0104|Hydramil mite|töflur|27,5|mg|100|stk|1|glas|2.5+25 mg|C03EA01|01.08.1984||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|158|1055|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|||158||158|1055 071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|58644|74879|lyfsjukr|||00|1|0|8|Vistor hf|Eisai Ltd|||58644||58644|74879 071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|293220|366926|lyfsjukr|||00|5|0|42|Vistor hf|Eisai Ltd|||293220||293220|366926 071670|J01CF0101|Diclocil|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.07.1991|31.12.2008|R|A|1,5|0|0|0|0|BRS|0|0|1|100|DKK|||lyfalmen|||10|30|0|4|Vistor hf|Bristol-Myers Squibb|||2043||| 071712|J01CF0101|Diclocil|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.07.1991|31.12.2008|R|A|1,5|0|0|0|0|BRS|0|0|1|100|DKK|||lyfalmen|||10|30|0|8|Vistor hf|Bristol-Myers Squibb|||2501||| 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|A|3|0|0|0|0|ORF|1|0|0|100|DKK|8474|16313|vetalmen|||27|5|0|0|Vistor hf|Orion-Farmos|||8474||8474|16313 072371|A04AA0201|Kytril|stl|1|mg/ml|3|ml|5|lykjur||A04AA02|01.04.1993||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|14830|20648|lyfalmen|||00|15|0|5|Icepharma hf|Roche as|||14830||14830|20648 072520|V01AA1104|Alutard SQ, hrossaværur|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|20799|28080|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||20799||20799|28080 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|589|843|lyfsjukr|||02|10|0|0|Vistor hf|Janssen-Cilag AB|||589||589|843 072770|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar||L04AB04|01.06.2007||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|197670|247967|lyfsjukr|||00|2|0|28|Vistor hf|Abbott|||197670||197670|247967 072892|N01AH0301|Sufenta|stl|50|mcg/ml|1|ml|5|lykjur||N01AH03|01.10.1992||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|1805|2584|lyfsjukr|||02|5|0|0|Vistor hf|Janssen-Cilag AB|||1805||1805|2584 072978|A10BX0401|Byetta|stl|5|mcg/sk|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELN|0|0|0|100|XEU|16209|22365|lyfalmen|||00|1|0|20|Icepharma hf|Eli Lilly Nederland|||16209||16209|22365 072996|A10BX0401|Byetta|stl|10|mcg/sk|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELN|0|0|0|100|XEU|16209|22365|lyfalmen|||00|2|0|40|Icepharma hf|Eli Lilly Nederland|||16209||16209|22365 073205|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1421|2769|lyfalmen|||00|100|0|8|Lundbeck Export A/S|H. Lundbeck A/S|||1421||1421|2769 073224|A09AA0205|Creon|sh-hylki|150|mg|100|stk|1|plglas||A09AA02|01.01.2008||R|A|2|0|0|E|0|SOY|0|0|0|100|XEU|3511|5605|lyfalmen|||10|100|0|100|Medico ehf|Solvay Pharmaceuticals GmbH|||3511||3511|5605 073684|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1780|3256|lyfalmen|||00|100|0|17|Lundbeck Export A/S|H. Lundbeck A/S|||1780||1780|3256 073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|332|1291|lyfalmen|V0844|999|00|20|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||332||332|1291 073833|N05BA1203|Tafil|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|894|2054|lyfalmen|||00|50|0|12|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||894||894|2054 073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|1296|2599|lyfalmen|||00|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1296||1296|2599 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|561|1602|lyfalmen|V0856|1110|00|20|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||561||561|1602 073866|N05BA1203|Tafil|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|974|2162|lyfalmen|V0860|1437|00|50|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||974||974|2162 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|1933|3464|lyfalmen|||00|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1933||1933|3464 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|3905|6140|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||3905||3905|6140 074051|C09DB0101|Exforge|filmhtfl|85|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|11373|16274|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||11373||11373|16274 074060|C09DB0101|Exforge|filmhtfl|165|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|4983|7603|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||4983||4983|7603 074069|C09DB0101|Exforge|filmhtfl|165|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|16462|22680|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||16462||16462|22680 074078|C09DB0101|Exforge|filmhtfl|170|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|4983|7603|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||4983||4983|7603 074087|C09DB0101|Exforge|filmhtfl|170|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|16462|22680|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||16462||16462|22680 074229|A08AA1001|Reductil|hylki|10|mg|28|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|6936|10253|lyfalmen|||00|28|0|28|Vistor hf|Abbott Laboratories A/S|||6936||6936|10253 074443|V08CA0301|Omniscan|stl|0,5|mmol/ml|5|ml|10|hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|22740|30179|lyfsjukr|||00|50|0|0|Icepharma hf|GE Healthcare AS|||22740||22740|30179 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|250|1180|lyfalmen|||00|25|0|12|Actavis Group hf|Actavis Group hf|||250||250|1180 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|506|1527|lyfalmen|||00|50|0|25|Actavis Group hf|Actavis Group hf|||506||506|1527 074617|QI06AA0402|Fel-O-Vax PCT vet.|bóluefni|0| |1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|K|2|0|0|0|0|SCA|1|0|0|100|DKK|22520|38972|vetorma|||58|25|0|0|Vistor hf|Scan Vet Animal Health AS|||22520||22520|38972 074674|D06BB0401|Condyline|áburður|5|mg/ml|3,5|ml|1|glas|til penslu|D06BB04|01.07.1988||R|A|2|0|0|0|0|GAN|0|0|1|100|IKR|1251|2538|lyfalmen|||23|4|0|4|Icepharma hf|Galderma Nordic AB|||1251||1251|2538 074732|A08AA1001|Reductil|hylki|15|mg|28|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|6936|10253|lyfalmen|||00|28|0|42|Vistor hf|Abbott Laboratories A/S|||6936||6936|10253 074922|R06AX2601|Telfast|töflur|120|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1353|2349|lyfalmen|V1910|2268|00|30|0|30|Vistor hf|Sanofi-aventis Norge AS|||1112||1112|2349 075028|C09AA0901|Monopril|töflur|10|mg|98|stk|1|þpakki||C09AA09|01.04.1995|31.12.2008|R|A|2|0|0|B|0|BRS|0|0|0|100|DKK|9828|14177|lyfalmen|||00|98|0|65|Vistor hf|Bristol-Myers Squibb|||9828||9828|14177 075044|J02AB0201|Fungoral|töflur|200|mg|10|stk|1|þpakki||J02AB02|01.01.1985||R|A|5|0|0|0|0|JAS|0|0|1|100|SEK|1496|2871|lyfalmen|||69|10|0|10|Vistor hf|Janssen-Cilag AB|||1496||1496|2871 075068|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|20|stk|1|þpakki||N07BA01|01.10.2008||L|A|2.5|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|20|0|1|Vistor hf|McNeil Denmark ApS|||||| 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1914|3161|lyfalmen|V1912|3040|00|30|0|45|Vistor hf|Sanofi-aventis Norge AS|||1710||1710|3161 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|90|0|6|Vistor hf|McNeil Denmark ApS|||||| 075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|IKR|1500|2876|lyfalmen|||00|300|0|50|Actavis Group hf|Actavis hf|||1500||1500|2876 075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|NOK|2415|4118|lyfalmen|||00|300|0|300|Actavis Group hf|Actavis hf|||2415||2415|4118 075101|C09AA0901|Monopril|töflur|20|mg|98|stk|1|þpakki||C09AA09|01.04.1995|31.12.2008|R|A|2|0|0|B|0|BRS|0|0|0|100|DKK|14983|20839|lyfalmen|||00|98|0|131|Vistor hf|Bristol-Myers Squibb|||14983||14983|20839 075305|N02BE0108|Paratabs Retard|forðatfl|500|mg|300|stk|1|plglas||N02BE01|01.10.2007||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|1536|2925|lyfalmen|||10|300|0|50|Actavis Group hf|Actavis hf|||1536||1536|2925 075382|V01AA0503|Soluprick SQ, rauðölur|lausn|10|HEP|3|ml|1|hgl||V01AA05|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8075|11799|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8075||8075|11799 075408|V01AA0504|Soluprick SQ, graölur|lausn|10|HEP|3|ml|1|hgl||V01AA05|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8075|11799|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8075||8075|11799 075424|V01AA0501|Soluprick SQ, birkifrjo|lausn|10|HEP|3|ml|1|hgl||V01AA05|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8075|11799|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8075||8075|11799 075440|V01AA0502|Soluprick SQ, hesliviður|lausn|10|HEP|3|ml|1|hgl||V01AA05|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8075|11799|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8075||8075|11799 075465|V04CL0006|Soluprick SQ, haliðagras|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8075|11799|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8075||8075|11799 075481|V04CL0004|Soluprick SQ, hafrar|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8075|11799|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8075||8075|11799 075507|V04CL0005|Soluprick SQ, axhnoðapunktur|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8075|11799|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8075||8075|11799 075523|V04CL0002|Soluprick SQ, havingull|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8075|11799|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8075||8075|11799 075549|V04CL0008|Soluprick SQ, vallarrygresi|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8075|11799|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8075||8075|11799 075564|V04CL0003|Soluprick SQ, vallarfoxgras|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8075|11799|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8075||8075|11799 075580|V04CL0007|Soluprick SQ, vallarsveifgras|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8075|11799|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8075||8075|11799 075606|V04CL0001|Soluprick SQ, rugur|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8075|11799|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8075||8075|11799 075663|V01AA0302|Soluprick SQ, derm.pter.|lausn|10|HEP|3|ml|1|hgl||V01AA03|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8075|11799|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8075||8075|11799 075689|V01AA1103|Soluprick SQ, hrossaværur|lausn|10|HEP|3|ml|1|hgl||V01AA11|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8075|11799|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8075||8075|11799 075705|V01AA1102|Soluprick SQ, hundahar|lausn|10|HEP|3|ml|1|hgl||V01AA11|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8075|11799|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8075||8075|11799 075721|V01AA1101|Soluprick SQ, kattahar|lausn|10|HEP|3|ml|1|hgl||V01AA11|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8075|11799|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8075||8075|11799 075724|B02BD0402|BeneFIX|sts|0| |1000|ae|1|hgl|+leysir|B02BD04|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|USD|142637|179451|lyfsjukr|||00|1000|0|3|Icepharma hf|Wyeth Europe|||142637||142637|179451 075787|QS02CA0102|Canaural|eyrnadr|0| |25|ml|1|glas||QS02CA01|01.12.1982||R|A|3|0|0|0|0|VEX|0|0|0|100|DKK|2263|4466|vetalmen|||13|25|0|0|Vistor hf|VetXX A/S|||2263||2263|4466 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|þpakki||A10BH01|01.11.2007||R|A|3|0|0|*|0|MSD|0|0|0|100|XEU|29299|38662|lyfalmen|||00|98|0|0|Icepharma hf|M.S.D.|||29299||29299|38662 076281|R01AX0301|Atrovent|nefúði|21|mcg/sk|30|ml|1|stauk|380 sk.|R01AX03|01.01.2000||R|A|2|0|0|E|0|BOI|0|0|1|100|DKK|2787|4622|lyfalmen|||24|30|0|33|Vistor hf|Boehringer Ingelheim|||2787||2787|4622 076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|738|1792|lyfalmen|V1070|1792|00|20|0|2|PortFarma ehf|PortFarma |||701||701|1792 076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|2033|3185|lyfalmen|V1075|3185|00|60|0|6|PortFarma ehf|PortFarma |||1728||1728|3185 076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|2876|4040|lyfalmen|V0791|4040|00|60|0|12|PortFarma ehf|PortFarma |||2358||2358|4040 076752|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|100|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|7757|13424|vetorma|||27|100|0|0|Vistor hf|Merial (MSD)|||7757||7757|13424 077215|A03000001|Relistor|stl|20|mg/ml|0,6|ml|1|hgl|lausn|A03|01.01.2009||R|A|2|0|0|0|0|WTE|0|0|0|100|USD|6911|10219|lyfalmen|||0|12|0|0|Icepharma hf|Wyeth Europe|||6911||6911|10219 077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|200|1112|lyfalmen|||00|30|0|5|Actavis Group hf|Actavis hf|||200||200|1112 077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|505|1526|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|||505||505|1526 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|A|3|0|0|E|0|GSK|0|0|0|30|GBP|691|1778|lyfalmen|||02|10|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||691||691|1778 077951|M01AB0514|Voltfast (D.A.C.)|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.04.2007||R|A|5|0|0|0|0|DAC|0|0|1|100|IKR|955|1444|lyfalmen|V0609|1444|10|30|0|15|D.A.C. ehf|D.A.C. ehf|||445||445|1444 078121|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|A|3|0|1|0|1|HON|0|0|0|100|SEK|22310|29643|lyfsjukr|||00|1|0|0|Vistor hf|Hospira Nordic AB (V)|||22310||22310|29643 078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|468|1475|lyfalmen|||00|20|0|2|Vistor hf|Recip AB|||468||468|1475 078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|713|1808|lyfalmen|||00|40|0|5|Vistor hf|Recip AB|||713||713|1808 078709|N06AB0303|Serol|töflur|10|mg|30|stk|1|glas||N06AB03|01.04.1994||R|A|5|0|0|B|0|ACA|0|1|0|30|IKR|1226|2504|lyfalmen|||00|30|0|15|Actavis Group hf|Actavis hf|||1226||1226|2504 078717|N06AB0303|Serol|töflur|10|mg|100|stk|1|glas||N06AB03|01.04.1994||R|A|5|0|0|B|0|ACA|0|1|0|30|IKR|4110|6418|lyfalmen|||00|100|0|50|Actavis Group hf|Actavis hf|||4110||4110|6418 078741|N06AX0306|Mianserin Merck NM|töflur|30|mg|100|stk|1|glas||N06AX03|01.01.1994||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|2933|4821|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|||2933||2933|4821 078766|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.10.1992||R|A|3|0|1|0|1|MAY|0|0|0|100|SEK|4481|6416|lyfsjukr|||00|5|0|0|Icepharma hf|Mayne Pharma Plc|||4481||4481|6416 078774|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1992||R|A|3|0|1|0|1|MAY|0|0|0|100|SEK|3780|5412|lyfsjukr|||00|10|0|0|Icepharma hf|Mayne Pharma Plc|||3780||3780|5412 078782|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|5531|7919|lyfsjukr|||00|5|0|0|Icepharma hf|Mayne Pharma Plc|||5531||5531|7919 078790|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|16294|22154|lyfsjukr|||00|15|0|0|Icepharma hf|Mayne Pharma Plc|||16294||16294|22154 078824|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|18094|24395|lyfsjukr|||00|45|0|0|Icepharma hf|Mayne Pharma Plc|||18094||18094|24395 078933|L03AB0801|Betaferon|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.01.2002||R|A|2|0|1|0|1|SAG|0|0|0|100|SEK|142060|178732|lyfsjukr|||00|15|0|30|Icepharma hf|Schering AG|||142060||142060|178732 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.01.1995||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|9656|6335|lyfalmen|V0197|6335|00|98|0|98|Icepharma hf|M.S.D.|||4049||4049|6335 079103|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|2118|3032|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|||2118||2118|3032 079111|L01AA0601|Holoxan|sts/irs|1|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|3657|5236|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|||3657||3657|5236 079129|L01AA0601|Holoxan|sts/irs|2|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|6570|9407|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|||6570||6570|9407 079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|þpakki||J05AH02|01.11.2002||R|A|5|0|0|0|0|RRL|0|0|0|100|DKK|3634|5772|lyfalmen|||00|10|0|5|Icepharma hf|Roche Registration Limited|||3634||3634|5772 079236|L01CA0206|Vincristine Mayne|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|K|2|0|1|0|1|MAY|0|0|0|100|SEK|7392|10583|lyfsjukr|||02|5|0|0|Icepharma hf|Mayne Pharma Plc|||7392||7392|10583 079269|N05AB0302|Trilafon decanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|A|3|0|0|*|0|SCP|0|1|0|100|DKK|21699|29200|lyfalmen|||02|10|0|155|Vistor hf|Schering-Plough|||21699||21699|29200 079616|L01CA0206|Vincristine Mayne|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|K|2|0|1|0|1|MAY|0|0|0|100|SEK|11569|16271|lyfsjukr|||02|10|0|0|Icepharma hf|Mayne Pharma Plc|||11569||11569|16271 079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|A|3|0|0|0|1|BRS|0|0|0|100|DKK|2246|3216|lyfsjukr|||03|5|0|2|Vistor hf|Bristol-Myers Squibb|||2246||2246|3216 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|393|1374|lyfalmen|V0514|1374|00|10|0|2|Actavis Group hf|Actavis hf|||393||393|1374 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|638|1706|lyfalmen|V0518|1706|00|20|0|5|Actavis Group hf|Actavis hf|||638||638|1706 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.05.2008||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|647|1718|lyfalmen|V0522|1718|00|10|0|5|Actavis Group hf|Actavis hf|||647||647|1718 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1994||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1168|2425|lyfalmen|V0526|2425|00|20|0|10|Actavis Group hf|Actavis hf|||1168||1168|2425 080424|G01AF0502|Pevaryl Depot|sk-stil|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|A|3|0|0|0|0|JAS|0|0|0|100|SEK|||lyfalmen|||05|1|0|2|Vistor hf|Janssen-Cilag AB||||||0 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|2437|4148|lyfalmen|||00|100|0|67|Lundbeck Export A/S|H. Lundbeck A/S|||2437||2437|4148 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|þpakki|m/br. losunarhraða|N06AX12|01.07.2007||R|A|1,5|0|0|B|0|GSK|0|1|1|100|GBP|6027|9019|lyfalmen|||00|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||6027||6027|9019 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|þpakki|m/br. losunarhraða|N06AX12|01.07.2007||R|A|1,5|0|0|B|0|GSK|0|1|1|100|GBP|3249|5249|lyfalmen|||00|30|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3249||3249|5249 080549|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|500|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|33019|57141|vetorma|||27|500|0|0|Vistor hf|Merial (MSD)|||33019||33019|57141 080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|26059|34311|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||26059||26059|34311 080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|51768|66319|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||51768||51768|66319 081315|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dælur|einnota dælur plast|M09AX01|01.11.1998||R|A|3,5|0|0|E|0|AZD|0|0|0|100|SEK|28339|37467|lyfalmen|||02|12|0|35|Vistor hf|AstraZeneca A/S DK|||28339||28339|37467 081513|M01AE0102|Ibufen|töflur|200|mg|100|stk|1|glas||M01AE01|01.01.1988|31.12.2008|R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|336|1296|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|||336||336|1296 081525|V03AN0101|Conoxia|innö.gas|100|%|10|l|1|hylki|MO10|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|10|0|0|Ísaga ehf|AGA AB||||||0 081534|V03AN0101|Conoxia|innö.gas|100|%|20|l|1|hylki|MO20|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|20|0|0|Ísaga ehf|AGA AB||||||0 081539|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|glas||M01AE01|01.01.1988||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|357|1325|lyfalmen|||00|100|0|33|Actavis Group hf|Actavis hf|||357||357|1325 081543|V03AN0101|Conoxia|innö.gas|100|%|50|l|1|hylki|Mo50|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|50|0|0|Ísaga ehf|AGA AB||||||0 081552|V03AN0101|Conoxia|innö.gas|100|%|5|l|1|hylki|MO5|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|5|0|0|Ísaga ehf|AGA AB||||||0 081561|V03AN0101|Conoxia|innö.gas|100|%|50|l|12|hylki|MS5I|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|600|0|0|Ísaga ehf|AGA AB||||||0 081571|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|2|0|0|Ísaga ehf|AGA AB||||||0 081588|C10AA0302|Pravachol|töflur|40|mg|28|stk|1|þpakki||C10AA03|01.06.1998||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|7733|11334|lyfalmen|||00|28|0|56|Vistor hf|Bristol-Myers Squibb|||7733||7733|11334 081589|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|1|0|0|Ísaga ehf|AGA AB||||||0 081598|V03AN0101|Conoxia|innö.gas|100|%|2,5|l|1|hylki|MO2,5c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|2|0|0|Ísaga ehf|AGA AB||||||0 081625|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|2|0|0|Ísaga ehf|AGA AB||||||0 081634|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4b|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|4|0|0|Ísaga ehf|AGA AB||||||0 081671|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|4|0|0|Ísaga ehf|AGA AB||||||0 081680|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|4|0|0|Ísaga ehf|AGA AB||||||0 081689|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|1|0|0|Ísaga ehf|AGA AB||||||0 081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|2240|3207|lyfsjukr|||02|10|0|3|Icepharma hf|Roche|||2240||2240|3207 081897|N05AH0305|Zyprexa Velotab (D.A.C.)|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.05.2007||R|A|3|0|0|*|0|DAC|0|1|0|100|XEU|20798|28078|lyfalmen|V0813|28078|00|28|0|28|D.A.C. ehf|D.A.C. ehf|||20798||20798|28078 081987|A10AB0602|Apidra [solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áflylltir|A10AB06|01.01.2008||R|K|2|0|0|*|0|SAA|0|0|0|100|NOK|5059|7706|lyfalmen|||02|15|0|38|Vistor hf|Sanofi - Aventis|||5059||5059|7706 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap||A10AE04|01.01.2008||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|8829|12822|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|||8829||8829|12822 082233|V03AN0101|Conoxia|innö.gas|100|%|36|l|1|hylki|Hemlox|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|36|0|0|Ísaga ehf|AGA AB||||||0 082685|R03BA0502|Flixotide Diskus|innúðadu|250|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|3090|5034|lyfalmen|||23|60|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3090||3090|5034 082701|J01CA0410|Amoxicillin Merck NM|mixt.kyr|50|mg/ml|60|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|618|1679|lyfalmen|||00|60|0|3|Actavis Group PTC ehf|Merck NM AB|||618||618|1679 082719|R03BA0502|Flixotide Diskus|innúðadu|500|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|5048|7691|lyfalmen|||23|60|0|50|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||5048||5048|7691 082792|J01CA0410|Amoxicillin Merck NM|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|967|2153|lyfalmen|||00|125|0|6|Actavis Group PTC ehf|Merck NM AB|||967||967|2153 082842|J01CA0410|Amoxicillin Merck NM|mixt.kyr|50|mg/ml|200|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|1545|2937|lyfalmen|||00|200|0|10|Actavis Group PTC ehf|Merck NM AB|||1545||1545|2937 082883|R03BA0201|Pulmicort|innúðal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|DRL|0|0|0|100|SEK|4856|7430|lyfalmen|||00|100|0|6|Vistor hf|Draco Lakemedel AB|||4856||4856|7430 082933|R03BA0201|Pulmicort|innúðal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|DRL|0|0|0|100|SEK|5335|8078|lyfalmen|||00|40|0|12|Vistor hf|Draco Lakemedel AB|||5333||5333|8078 082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|14203|19868|lyfalmen|||00|56|0|9|Vistor hf|Novartis Healthcare A/S-|||14203||14203|19868 082990|N06DA0301|Exelon|hylki|1,5|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|32188|42259|lyfalmen|||00|112|0|19|Vistor hf|Novartis Healthcare A/S-|||32188||32188|42259 083113|L02BG0301|Arimidex|töflur|1|mg|28|stk|1|þpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|ASZ|0|0|0|100|SEK|16911|23239|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca UK Ltd|||16911||16911|23239 083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|14833|20652|lyfalmen|V1372|20652|00|56|0|19|Vistor hf|Novartis Healthcare A/S-|||14833||14833|20652 083154|R03BA0201|Pulmicort|innúðal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|DRL|0|0|0|100|SEK|6784|10047|lyfalmen|||00|40|0|25|Vistor hf|Draco Lakemedel AB|||6784||6784|10047 083204|N06DA0301|Exelon|hylki|3|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|30849|40592|lyfalmen|||00|112|0|37|Vistor hf|Novartis Healthcare A/S-|||30849||30849|40592 083360|G03GA0501|Gonal-F|sts|75|ae/lykju|10|lykjur|1|pakki|+ leysir 1 ml|G03GA05|01.04.1997||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|46501|60079|lyfalmen|||03|10|0|10|Gróco ehf|Serono Nordic|||46501||46501|60079 083451|G03GA0501|Gonal-F|sts|150|ae/lykju|10|lykjur|1|pakki|+ leysir 1 ml|G03GA05|01.04.1997||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|94477|119809|lyfalmen|||03|10|0|20|Gróco ehf|Serono Nordic|||94477||94477|119809 083592|J05AE0301|Norvir|mixtúra|80|mg/ml|90|ml|5|glös||J05AE03|01.08.2003||R|K|0,5|0|1|0|1|ABL|0|0|0|100|DKK|82892|105068|lyfsjukr|||00|450|0|30|Vistor hf|Abbott Laboratories A/S|||82892||82892|105068 083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|32188|42259|lyfalmen|||00|112|0|75|Vistor hf|Novartis Healthcare A/S-|||32188||32188|42259 083964|L02AE0101|Suprefact|nefúði|0,1|mg/sk|10|g|4|stk|+ sk-dæla|L02AE01|01.10.1987||R|A|2.5|0|1|0|1|SNO|0|0|0|100|NOK|38404|49680|lyfsjukr|||23|40|0|33|Vistor hf|Sanofi-aventis Norge AS|||38404||38404|49680 083980|L02AE0101|Suprefact|stl|1|mg/ml|5,5|ml|2|hgl||L02AE01|01.10.1987||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|7754|11102|lyfsjukr|||02|11|0|7|Vistor hf|Sanofi-aventis Norge AS|||7754||7754|11102 084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|290|1234|lyfalmen|||02|10|0|2|Gróco ehf|Nycomed Danmark A/S|||290||290|1234 084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|560|1600|lyfalmen|||02|20|0|5|Gróco ehf|Nycomed Danmark A/S|||560||560|1600 084669|B03XA0301|Mircera|stl|150|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|68545|87206|lyfsjukr|||00|0|0|0|Icepharma hf|Roche Registration Limited|||68545||68545|87206 084673|P01BC0103|Kinin Actavis|töflur|100|mg|100|stk|1|glas||P01BC01|01.10.1995||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1161|2416|lyfalmen|||00|100|0|7|Actavis Group hf|Actavis hf|||1161||1161|2416 084678|B03XA0301|Mircera|stl|200|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|89381|113147|lyfsjukr|||00|0|0|0|Icepharma hf|Roche Registration Limited|||89381||89381|113147 084687|B03XA0301|Mircera|stl|250|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|106566|134542|lyfsjukr|||00|0|0|0|Icepharma hf|Roche Registration Limited|||106566||106566|134542 084696|B03XA0301|Mircera|stl|50|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|22989|30489|lyfsjukr|||00|0|0|0|Icepharma hf|Roche Registration Limited|||22989||22989|30489 084699|P01BC0103|Kinin Actavis|töflur|250|mg|100|stk|1|glas||P01BC01|01.10.1995||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|2458|4176|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|||2458||2458|4176 084705|B03XA0301|Mircera|stl|75|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|34401|44697|lyfsjukr|||00|0|0|0|Icepharma hf|Roche Registration Limited|||34401||34401|44697 084714|B03XA0301|Mircera|stl|100|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|45760|58839|lyfsjukr|||00|0|0|0|Icepharma hf|Roche Registration Limited|||45760||45760|58839 084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|994|2189|lyfalmen|||00|10|0|0|Vistor hf|Eisai Ltd|||994||994|2189 084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|11492|16436|lyfalmen|||00|60|0|0|Vistor hf|Eisai Ltd|||11492||11492|16436 084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|38312|49883|lyfalmen|||00|100|0|0|Vistor hf|Eisai Ltd|||38312||38312|49883 085068|N02AA0101|Contalgin|forðatfl|100|mg|100|stk|1|þpakki||N02AA01|01.10.1985||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|21043|28384|lyfalmen|||10|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||21043||21043|28384 085105|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|98|stk|1|glas||A02BC01|01.02.2009||R|A|3|0|0|E|0|AGT|0|0|0|30|IKR|6411|9540|lyfalmen|V1800|9540|0|98|0|49|Actavis Group hf|Actavis Group hf|||||6411|9540 085132|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|glas||A02BC01|01.02.2009||R|A|3|0|0|E|0|AGT|0|0|0|30|IKR|2540|4287|lyfalmen|V1802|4287|0|56|0|56|Actavis Group hf|Actavis Group hf|||||2540|4287 085141|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|98|stk|1|glas||A02BC01|01.02.2009||R|A|3|0|0|E|0|AGT|0|0|0|30|IKR|4530|6988|lyfalmen|V1803|6988|0|98|0|98|Actavis Group hf|Actavis Group hf|||||4530|6988 085160|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|28|stk|1|glas||A02BC01|01.02.2009||R|A|3|0|0|E|0|AGT|0|0|0|30|IKR|3291|5306|lyfalmen|||0|28|0|56|Actavis Group hf|Actavis Group hf|||||3291|5306 085205|S01AX1901|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AX19|01.03.2008||R|A|2|0|0|0|0|SAO|0|0|1|100|XEU|3280|5291|lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy|||3280||3280|5291 085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|32188|42259|lyfalmen|||00|112|0|56|Vistor hf|Novartis Healthcare A/S-|||32188||32188|42259 085407|R03AC0206|Ventoline|lausn|1|mg/ml|2,5|ml|20|lykjur|f. vél|R03AC02|01.04.1992||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|760|1872|lyfalmen|||00|50|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||760||760|1872 085423|B01AB0401|Fragmin|stl|25000|ae/ml|4|ml|1|hgl|með rotvörn|B01AB04|01.04.1993||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|14128|19457|lyfsjukr|||00|4|0|40|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||14128||14128|19457 085542|G03GA0202|Menopur|sts|0| |75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|21904|29455|lyfalmen|||00|375|0|12|Vistor hf|Ferring Lægemidler A/S|||21904||21904|29455 085551|G03GA0202|Menopur|sts|0| |75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|38970|50703|lyfalmen|||00|750|0|25|Vistor hf|Ferring Lægemidler A/S|||38970||38970|50703 085829|S01EB0104|Pilokarpin|augndr|2|%|0,15|ml|20|skammt|án rotvarnar|S01EB01|01.01.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|1929|3458|lyfalmen|||00|3|1|8|Parlogis hf|Parlogis - óskráð lyf|||1929||1929|3458 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|4700|5385|lyfalmen|V1911|5145|00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|||3349||3349|5385 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|5652|7559|lyfalmen|V1913|7201|00|100|0|150|Vistor hf|Sanofi-aventis Norge AS|||4951||4951|7559 086199|J01DD0202|Fortum|sts|500|mg/hgl|5|hgl|1|pakki||J01DD02|01.08.2002|31.12.2008|R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|5703|8165|lyfsjukr|||03|5|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||5703||5703|8165 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|8419|12054|lyfsjukr|||03|5|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||8419||8419|12054 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|13902|19175|lyfsjukr|||03|5|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||13902||13902|19175 086434|L04AA2401|Orencia|stl/irþ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|K|2|0|1|0|1|BSP|0|0|0|100|DKK|68503|87154|lyfsjukr|||00|1|0|9|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |||68503||68503|87154 087014|J05AF1101|Sebivo|filmhtfl|600|mg|28|stk|1|þpakki||J05AF11|01.07.2008||R|A|2|0|1|0|1|NOH|0|0|0|100|DKK|79939|101392|lyfsjukr|||00|28|0|0|Vistor hf|Novartis Healthcare A/S-|||79939||79939|101392 087114|G03CX0101|Livial|töflur|2,5|mg|28|stk|1|þpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|3488|5574|lyfalmen|||00|28|0|28|Vistor hf|N.V. Organon|||3488||3488|5574 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|þpakki|mjúk hylki|A03AX13|01.12.2008||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|30|0|14|Vistor hf|Janssen-Cilag AB|||||| 087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|173424|217780|lyfsjukr|||00|60|0|0|Vistor hf|Pfizer Limited|||173424||173424|217780 087270|C07AB0309|Atenolol Actavis|töflur|50|mg|100|stk|1|glas||C07AB03|01.10.1985|31.12.2008|R|A|4|0|0|B|0|ACA|0|0|0|100|IKR|||lyfalmen|||00|100|0|67|Actavis Group hf|Actavis hf||610|610|610|| 087296|C07AB0309|Atenolol Actavis|töflur|100|mg|100|stk|1|glas||C07AB03|01.10.1985||R|A|4|0|0|B|0|ACA|0|0|0|100|IKR|815|1946|lyfalmen|V0306|1946|00|100|0|133|Actavis Group hf|Actavis hf|||815||815|1946 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|252|1182|lyfalmen|||00|10|0|10|Vistor hf|Sanofi-aventis Norge AS|||252||252|1182 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|222|1142|lyfalmen|V0886|1142|00|30|0|30|Vistor hf|Sanofi-aventis Norge AS|||222||222|1142 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|2629|4408|lyfalmen|||00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|||2629||2629|4408 087445|A02BX1301|Gaviscon|mixtúra|0| |500|ml|1|glas||A02BX13|01.08.1984||L|A|2|0|0|0|0|NDR|0|0|0|30|IKR|||lyfalmen|||01|500|0|0|Vistor hf|Nordic Drugs AB||||||0 087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|þpakki||G03GB02|01.07.1986||R|A|5|0|0|E|0|EME|0|0|0|100|SEK|773|1889|lyfalmen|||00|5|0|28|MedFarm ehf|E. Merck AB|||773||773|1889 087760|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|105|0|7|Lyfjaver ehf|Lyfjaver ehf||||||0 087769|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.06.2004||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|210|0|14|Lyfjaver ehf|Lyfjaver ehf||||||0 087778|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|105|0|14|Lyfjaver ehf|Lyfjaver ehf||||||0 087787|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|210|0|28|Lyfjaver ehf|Lyfjaver ehf||||||0 087796|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|105|0|7|Lyfjaver ehf|Lyfjaver ehf||||||0 087805|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|210|0|14|Lyfjaver ehf|Lyfjaver ehf||||||0 087814|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||23|105|0|14|Lyfjaver ehf|Lyfjaver ehf||||||0 087823|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|210|0|28|Lyfjaver ehf|Lyfjaver ehf||||||0 087832|L02BB0304|Bicalutamid Actavis|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.09.2007||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|15959|22054|lyfalmen|V0560|22054|00|30|0|30|Actavis Group hf|Actavis Group PTC ehf|||15959||15959|22054 087932|A02BX1301|Gaviscon|tuggutfl|0| |20|stk|1|þpakki||A02BX13|01.10.1993||L|A|1,5|0|0|0|0|NDR|0|0|0|30|DKK|||lyflausa|||00|20|0|0|Vistor hf|Nordic Drugs AB|||||| 088006|N07BA0126|Nicotinell Mint (Lyfjaver)|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|96|0|6|Lyfjaver ehf|Lyfjaver ehf||||||0 088015|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|96|0|6|Lyfjaver ehf|Lyfjaver ehf||||||0 088051|L03AB0503|IntronA (Lyfjaver)|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|24525|32401|lyfsjukr|||00|1|0|9|Lyfjaver ehf|Lyfjaver ehf|||24525||24525|32401 088224|L03AB0503|IntronA (Lyfjaver)|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|39947|51602|lyfsjukr|||00|1|0|15|Lyfjaver ehf|Lyfjaver ehf|||39947||39947|51602 088233|L03AB0503|IntronA (Lyfjaver)|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|81767|103667|lyfsjukr|||00|1|0|30|Lyfjaver ehf|Lyfjaver ehf|||81767||81767|103667 088261|R01AD1201|Avamys|nefúði|27,5|mcg/sk|120|sk|1|glas||R01AD12|01.04.2008||R|A|3|0|0|E|0|GGL|0|0|1|100|GBP|1324|2637|lyfalmen|||00|120|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||1324||1324|2637 088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1625|3046|lyfalmen|||14|20|0|20|Icepharma hf|Meda AB|||1625||1625|3046 088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|8054|11770|lyfalmen|||14|100|0|100|Icepharma hf|Meda AB|||8054||8054|11770 088393|A03FA0101|Primperan|eþ-stil|20|mg|6|stk|1|pakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|461|1466|lyfalmen|||04|6|0|4|Vistor hf|Sanofi-aventis Norge AS|||461||461|1466 088632|C09CA0302|Diovan (D.A.C.)|töflur|160|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.05.2007||R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|16133|17974|lyfalmen|V1111|14680|00|98|0|196|D.A.C. ehf|D.A.C. ehf|||12682||12682|17974 088723|L01XE0701|Tyverb|filmhtfl|250|mg|70|stk|1|þpakki||L01XE07|01.11.2008||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|163477|205396|lyfsjukr|||00|70|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||||163477|205396 088814|L02BB0304|Bicalutamid Actavis|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.12.2008||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|53112|65665|lyfalmen|V0561|60714|00|30|0|30|Actavis Group hf|Actavis Group PTC ehf|||50988||50988|65665 089003|G03CA0308|Progynon|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.12.1972||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|1290|2591|lyfalmen|V0408|2140|00|84|0|84|Icepharma hf|Bayer Schering Pharma AG|||1290||1290|2591 089094|A02BX1301|Gaviscon|tuggutfl|0| |120|stk|1|þpakki||A02BX13|01.01.1989||L|A|1,5|0|0|0|0|NDR|0|0|0|30|DKK|||lyflausa|||00|120|0|0|Vistor hf|Nordic Drugs AB|||||| 089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|173424|217780|lyfsjukr|||00|60|0|0|Vistor hf|Pfizer Limited|||173424||173424|217780 090159|C08DB0101|Cardizem|töflur|60|mg|100|stk|1|glas||C08DB01|01.10.1995||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|2239|3879|lyfalmen|V0352|1798|00|100|0|25|Vistor hf|Ferrosan A/S|||2239||2239|3879 090232|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.04.2007||R|K|3|0|1|0|1|MRK|0|0|0|100|XEU|43871|56487|lyfsjukr|||00|20|0|0|Vistor hf|Merck KgaA (V)|||43871||43871|56487 090242|L01XC0601|Erbitux|irl|5|mg/ml|100|ml|1|hgl|lausn|L01XC06|01.04.2007||R|K|3|0|1|0|1|MRK|0|0|0|100|XEU|219354|274963|lyfsjukr|||00|100|0|0|Vistor hf|Merck KgaA (V)|||219354||219354|274963 090451|L04AB0102|Enbrel (Lyjaver)|sts|0| |50|mg|4|hgl|+ leysir|L04AB01|01.06.2007|31.12.2008|R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|186155|233630|lyfsjukr|||00|200|0|29|Lyfjaver ehf|Lyfjaver ehf|||186155||186155|233630 090460|L04AB0102|Enbrel (Lyjaver)|stl|0| |25|mg|4|áf.spr|lausn|L04AB01|01.06.2007||R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|79865|101299|lyfsjukr|||00|100|0|14|Lyfjaver ehf|Lyfjaver ehf|||79865||79865|101299 090469|L04AB0102|Enbrel (Lyjaver)|stl|0| |50|mg|4|áf.spr|lausn|L04AB01|01.06.2007||R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|166534|209202|lyfsjukr|||00|200|0|29|Lyfjaver ehf|Lyfjaver ehf|||166534||166534|209202 090662|R01AD1101|Nasacort|nefúði|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1745|3208|lyfalmen|||24|16|0|30|Vistor hf|Sanofi-aventis Norge AS|||1745||1745|3208 090688|A06AB0602|Senokot|töflur|7,5|mg|60|stk|1|þpakki||A06AB06|01.10.1990||R|A|3|0|0|0|0|REB|0|0|0|100|GBP|397|1379|lyfalmen|||00|60|0|0|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|||397||397|1379 091360|C08DB0108|Korzem-R|forðatfl|120|mg|60|stk|1|þpakki||C08DB01|01.04.2008||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2253|3898|lyfalmen|V0351|3898|10|60|0|30|Actavis Group hf|Actavis hf|||2253||2253|3898 091642|L03AX1302|Copaxone (Lyfjaver)|stl|20|mg/spr|28|spr|1|pakki|lausn|L03AX13|01.06.2007||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|131206|165219|lyfsjukr|||00|28|0|0|Lyfjaver ehf|Lyfjaver ehf|||131206||131206|165219 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|1711|2215|lyfalmen|V0001|1884|00|90|0|45|Vistor hf|Aventis Pharma |||1013||1013|2215 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|3079|3021|lyfalmen|V0002|2489|00|90|0|90|Vistor hf|Aventis Pharma |||1607||1607|3021 092014|L03AB0703|Rebif (Lyfjaver)|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.06.2007||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|131224|165241|lyfsjukr|||00|6|0|61|Lyfjaver ehf|Lyfjaver ehf|||131224||131224|165241 092024|L03AB0703|Rebif (Lyfjaver)|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.06.2007||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|168979|212246|lyfsjukr|||00|6|0|123|Lyfjaver ehf|Lyfjaver ehf|||168979||168979|212246 092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|7845|15115|vetalmen|||16|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||7845||7845|15115 092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|þpakki||B01AC04|01.12.1999||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|7147|10539|lyfalmen|||00|28|0|28|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|||7147||7147|10539 092750|N05AH0203|Leponex (D.A.C.)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007|31.01.2009|R|A|5|0|0|*|0|DAC|0|1|0|100|DKK|||lyfalmen|||00|100|0|33|D.A.C. ehf|D.A.C. ehf|||10995||| 092769|C09DA0305|Diovan Comp 320/12,5 mg|filmhtfl|332,5|mg|98|stk|1|þpakki|320/12,5 mg|C09DA03|01.11.2008||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|28416|37563|lyfalmen|||00|98|0|392|Vistor hf|Novartis Healthcare A/S-|||||28416|37563 092787|C09DA0306|Diovan Comp 320/25 mg|filmhtfl|345|mg|98|stk|1|þpakki|320/25 mg|C09DA03|01.11.2008||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|28416|37563|lyfalmen|||00|98|0|392|Vistor hf|Novartis Healthcare A/S-|||||28416|37563 093215|L01XC0602|Erbitux (Lyfjaver)|irl|2|mg/ml|50|ml|1|hgl|lausn|L01XC06|01.06.2007|31.12.2008|R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|40675|52508|lyfsjukr|||00|50|0|0|Lyfjaver ehf|Lyfjaver ehf|||40675||40675|52508 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|5244|7957|lyfalmen|||00|1|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||5244||5244|7957 093496|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.01.2003||R|A|2|0|0|B|0|SCH|0|0|0|100|SEK|6644|9857|lyfalmen|||00|60|0|32|Icepharma hf|Schering Oy|||6644||6644|9857 093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|28375|49104|vetorma|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||28375||28375|49104 093625|B03AA0702|Ferlen-R|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.04.1993||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||10|100|0|50|Actavis Group hf|Actavis hf|||||| 093641|QN05CM9202|Xylapan, vet.|stl|20|mg/ml|50|ml|1|hgl||QN05CM92|01.04.1992|31.12.2008|R|A|3|0|0|0|0|VEQ|1|0|0|100|CHF|5124|9932|vetalmen|||00|50|0|0|Icepharma hf|Vétoquinol AG|||5124||5124|9932 093708|L01DB0701|Novantrone|irþ|2|mg/ml|5|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|17377|23502|lyfsjukr|||00|5|0|0|Icepharma hf|Wyeth AB|||17377||17377|23502 093757|N02AA0501|Oxycontin|forðatfl|80|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|19006|25847|lyfalmen|||10|28|0|30|Icepharma hf|Norpharma |||19006||19006|25847 093799|N02AA0501|Oxycontin|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|62661|80198|lyfalmen|||10|98|0|261|Icepharma hf|Norpharma |||62661||62661|80198 093823|S01EC0102|Diamox Depot|forðahlk|250|mg|100|stk|1|hylki||S01EC01|01.04.1998||R|A|2|0|0|*|0|GPL|0|0|0|100|USD|2168|3782|lyfalmen|||10|100|0|33|Icepharma hf|Goldshield Pharmaceuticals Ltd|||2168||2168|3782 093849|S01EC0102|Diamox Depot|forðahlk|500|mg|100|stk|1|hylki||S01EC01|01.12.1972||R|A|2|0|0|*|0|GPL|0|0|0|100|USD|4336|6725|lyfalmen|||10|100|0|67|Icepharma hf|Goldshield Pharmaceuticals Ltd|||4336||4336|6725 093969|G03FB0507|Trisekvens (D.A.C.)|töflur|0| |84|stk|1|skífup||G03FB05|01.05.2007||R|A|4|0|0|E|0|DAC|0|0|0|100|DKK|2812|4656|lyfalmen|V0385|4656|23|84|0|84|D.A.C. ehf|D.A.C. ehf|||2812||2812|4656 094132|QM01A0001|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|1912|3773|vetalmen|||00|8|0|0|Vistor hf|Boehringer Ingelheim|||1912||1912|3773 094287|L04AD0201|Advagraf|forðahlk|0,5|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|13958|19563|lyfalmen|||00|50|0|5|Vistor hf|Astellas Phama Europe B.V.|||13958||13958|19563 094296|L04AD0201|Advagraf|forðahlk|1|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|19994|27078|lyfalmen|||00|50|0|10|Vistor hf|Astellas Phama Europe B.V.|||19994||19994|27078 094305|L04AD0201|Advagraf|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|89968|114195|lyfalmen|||00|50|0|10|Vistor hf|Astellas Phama Europe B.V.|||89968||89968|114195 094933|A03000001|Relistor|stl|20|mg/ml|0,6|ml|7|hgl|lausn|A03|01.01.2009||R|A|2|0|0|0|0|WTE|0|0|0|100|USD|48328|62353|lyfalmen|||0|84|0|0|Icepharma hf|Wyeth Europe|||48328||48328|62353 095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1577|2980|lyfalmen|||00|100|1|50|Distica|Distica - óskráð lyf|||1577||1577|2980 095588|N07BB0101|Antabus|freyðit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|0|100|DKK|3548|5655|lyfalmen|||00|50|0|100|Actavis Group hf|Actavis Group hf|||3548||3548|5655 095652|N05AX1301|Invega|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|15712|21746|lyfalmen|||00|28|0|0|Vistor hf|Janssen-Cilag International N.V.|||15712||15712|21746 095662|N05AX1301|Invega|forðatfl|3|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|37838|49293|lyfalmen|||00|56|0|0|Vistor hf|Janssen-Cilag International N.V.|||37838||37838|49293 095680|N05AX1301|Invega|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|15712|21746|lyfalmen|||00|28|0|0|Vistor hf|Janssen-Cilag International N.V.|||15712||15712|21746 095689|N05AX1301|Invega|forðatfl|6|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|34287|44872|lyfalmen|||00|56|0|0|Vistor hf|Janssen-Cilag International N.V.|||34287||34287|44872 095707|N05AX1301|Invega|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|15712|21746|lyfalmen|||00|28|0|0|Vistor hf|Janssen-Cilag International N.V.|||15712||15712|21746 095716|N05AX1301|Invega|forðatfl|9|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|60370|77346|lyfalmen|||00|56|0|0|Vistor hf|Janssen-Cilag International N.V.|||60370||60370|77346 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|3906|7612|vetalmen|||00|100|0|0|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||3906||3906|7612 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|5154|9989|vetalmen|||00|100|0|0|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||5154||5154|9989 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|9385|18048|vetalmen|||00|100|0|0|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||9385||9385|18048 096115|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|2438|3491|lyfsjukr|||02|60|0|0|Icepharma hf|Baxter Medical AB|||2438||2438|3491 096169|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|1|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|14663|20123|lyfsjukr|||17|10|0|0|Vistor hf|Octapharma AB|||14663||14663|20123 096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|146628|184419|lyfsjukr|||17|100|0|0|Vistor hf|Octapharma AB|||146628||146628|184419 096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|A|2|0|0|0|0|GGL|0|0|1|100|GBP|1404|2746|lyfalmen|||00|5|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||1404||1404|2746 096260|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|17243|23653|lyfalmen|||00|30|0|0|Vistor hf|Novartis Europharm Ltd|||17243||17243|23653 096351|S01AA1302|Fucithalmic (D.A.C.)|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.06.2007||R|A|3|0|0|E|0|DAC|0|0|1|100|DKK|847|1861|lyfalmen|V1500|1861|07|5|0|0|D.A.C. ehf|D.A.C. ehf|||752||752|1861 096679|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|17243|23653|lyfalmen|||00|30|0|0|Vistor hf|Novartis Europharm Ltd|||17243||17243|23653 096685|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|30|stk|1|þpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|1649|3078|lyfalmen|||00|30|0|18|Icepharma hf|Servier|||1649||1649|3078 096688|N06DA0301|Exelon|forðapl|9,5|mg/sólh|60|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|34487|45121|lyfalmen|||00|60|0|0|Vistor hf|Novartis Europharm Ltd|||34487||34487|45121 096896|J02AX0601|Ecalta|irs|100|mg/hgl|1|hgl|1|pakki|+ leysir, lausn|J02AX06|01.03.2008||R|A|3|0|1|0|1|PFL|0|0|0|100|DKK|95094|120260|lyfsjukr|||00|1|0|0|Vistor hf|Pfizer Limited|||95094||95094|120260 097269|J01FF0103|Dalacin (D.A.C.)|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.06.2007||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|3681|3951|lyfalmen|V0426|3951|00|20|0|5|D.A.C. ehf|D.A.C. ehf|||2292||2292|3951 097288|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2008||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1191|2457|lyfalmen|||00|120|0|12|Vistor hf|Schering-Plough|||1191||1191|2457 097442|L01CB0101|Vepesid|hylki|50|mg|20|stk|1|glas||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|13690|18912|lyfsjukr|||00|20|1|0|Distica|Distica - óskráð lyf|||13690||13690|18912 097642|J07AJ5201|Infanrix|bóluefni|0| |0,5|ml|1|spr|einnota glerspr.|J07AJ52|01.04.1998||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1745|3208|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1745||1745|3208 097790|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.04.1995||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|9351|9779|lyfalmen|V0714|8113|10|100|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6587||6587|9779 097816|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.04.1995||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|12250|12845|lyfalmen|V0715|10770|10|100|0|22|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||8846||8846|12845 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|3998|3724|lyfalmen|V0003|3042|00|90|0|135|Vistor hf|Aventis Pharma |||2125||2125|3724 097887|N02CC0104|Sumacta|húðuðtfl|50|mg|12|stk|1|þpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|2738|4556|lyfalmen|V0831|4556|00|12|0|12|Actavis Group hf|Actavis Group PTC ehf|||2738||2738|4556 097896|N02CC0104|Sumacta|húðuðtfl|100|mg|6|stk|1|þpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1917|3442|lyfalmen|V0832|3442|00|6|0|12|Actavis Group hf|Actavis Group PTC ehf|||1917||1917|3442 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|1591|2999|lyfalmen|V1151|2999|00|30|0|15|Actavis Group hf|Actavis Group PTC ehf|||1591||1591|2999 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|7046|10402|lyfalmen|V1110|10402|00|98|0|98|Actavis Group hf|Actavis hf|||7046||7046|10402 098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|10198|14680|lyfalmen|V1111|14680|00|98|0|196|Actavis Group hf|Actavis hf|||10198||10198|14680 098228|J07AJ5201|Infanrix|bóluefni|0| |0,5|ml|10|spr|einnota glerspr.|J07AJ52|01.04.1998||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|16975|23319|lyfalmen|||02|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||16975||16975|23319 098582|S01ED0201|Betoptic|augndr|5|mg/ml|5|ml|1|glas||S01ED02|01.04.2006||R|A|3|0|0|*|0|PCO|0|0|0|100|IKR|669|1748|lyfalmen|||06|5|1|25|Distica|Distica - óskráð lyf|||669||669|1748 098722|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|21699|29200|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||21699||21699|29200 099242|S01AA1301|Fucithalmic|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.04.1988||R|A|3|0|0|E|0|LEP|0|0|1|100|DKK|767|1881|lyfalmen|V1500|1861|07|5|0|0|Vistor hf|LEO Pharma A/S|||767||767|1881 099476|N05AH0404|Quetiapin Merck NM|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MEK|0|1|0|100|SEK|5430|8209|lyfalmen|V0725|8209|00|100|0|6|Actavis Group PTC ehf|Merck NM AB (A)|||5430||5430|8209 099485|N05AH0404|Quetiapin Merck NM|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MEK|0|1|0|100|SEK|12400|17623|lyfalmen|V0726|17623|00|100|0|25|Actavis Group PTC ehf|Merck NM AB (A)|||12400||12400|17623 099494|N05AH0404|Quetiapin Merck NM|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MEK|0|1|0|100|SEK|20065|27166|lyfalmen|V0727|27166|00|100|0|50|Actavis Group PTC ehf|Merck NM AB (A)|||20065||20065|27166 099620|N02AX0210|Nobligan (D.A.C.)|hylki|50|mg|20|stk|1|pakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|612|1671|lyfalmen|V0730|1238|10|20|0|3|D.A.C. ehf|D.A.C. ehf|||612||612|1671 099705|D08AG0201|Betadine|áburður|100|mg/ml|500|ml|1|brusar|vatnsl|D08AG02|01.04.1985||L|A|3|0|0|0|0|MUN|0|0|0|100|IKR|||lyfalmen|||00|500|0|500|Icepharma hf|Mundipharma||||||0 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|A|3|0|0|0|0|MUN|0|0|0|100|IKR|||lyfalmen|||00|500|0|500|Icepharma hf|Mundipharma||||||0 099746|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.09.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|96|0|13|Lyfjaver ehf|Lyfjaver ehf||||||0 099755|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.09.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyfalmen|||00|96|0|13|Lyfjaver ehf|Lyfjaver ehf||||||0 099861|H01AC0104|Saizen|sts|0| |3,33|mg|10|hgl|+ leysir|H01AC01|01.07.1992|31.12.2008|R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|143350|180338|lyfsjukr|||02|33|0|50|Gróco ehf|Serono Nordic|||143350||143350|180338 100008|V08AB0501|Ultravist|stl/irl|300|mg J/ml|50|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|45481|58491|lyfsjukr|||02|500|0|0|Icepharma hf|Bayer Schering Pharma AG|||45481||45481|58491 100016|V08AB0501|Ultravist|stl/irl|300|mg J/ml|100|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|67325|85687|lyfsjukr|||02|1000|0|0|Icepharma hf|Bayer Schering Pharma AG|||67325||67325|85687 100024|V08AB0501|Ultravist|stl/irl|370|mg J/ml|50|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|49246|63179|lyfsjukr|||02|500|0|0|Icepharma hf|Bayer Schering Pharma AG|||49246||49246|63179 100032|V08AB0501|Ultravist|stl/irl|370|mg J/ml|100|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|109344|138001|lyfsjukr|||02|1000|0|0|Icepharma hf|Bayer Schering Pharma AG|||109344||109344|138001 100291|G04BE0801|Cialis|filmhtfl|2,5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|14073|19706|lyfalmen|||00|28|0|7|Icepharma hf|Lilly ICOS Limited|||||14073|19706 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|14073|19706|lyfalmen|||00|28|0|14|Icepharma hf|Lilly ICOS Limited|||||14073|19706 100305|G03GA0701|Luveris|sts|75|ae/hgl|1|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|13150|18557|lyfalmen|||00|1|0|1|Gróco ehf|Ares-Serono|||13150||13150|18557 100412|M01AC0101|Felden|töflur|20|mg|30|stk|1|þpakki||M01AC01|01.01.1997||R|A|4|0|0|E|0|PFI|0|0|1|100|DKK|2187|3808|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2187||2187|3808 101386|R06AX1301|Clarityn|mixtúra|1|mg/ml|100|ml|1|glas||R06AX13|01.10.1995||L|A|3|0|0|E|0|SCP|0|0|1|100|DKK|||lyfalmen|||00|100|0|10|Vistor hf|Schering-Plough||||||2025 101543|G03GA0701|Luveris|sts|75|ae/hgl|3|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|39450|51300|lyfalmen|||00|3|0|3|Gróco ehf|Ares-Serono|||39450||39450|51300 101550|G03GA0701|Luveris|sts|75|ae/hgl|10|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|131502|165905|lyfalmen|||00|10|0|10|Gróco ehf|Ares-Serono|||131502||131502|165905 101691|C08CA0502|Adalat Oros|forðatfl|20|mg|28|stk|1|þpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|1963|3504|lyfalmen|||00|28|0|19|Vistor hf|Bayer HealthCare AG|||1963||1963|3504 101709|C08CA0502|Adalat Oros|forðatfl|20|mg|98|stk|1|þpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|6159|9198|lyfalmen|||00|98|0|65|Vistor hf|Bayer HealthCare AG|||6159||6159|9198 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|2584|4347|lyfalmen|V1152|4347|00|30|0|30|Actavis Group hf|Actavis Group PTC ehf|||2584||2584|4347 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|9194|13317|lyfalmen|V1153|13317|00|96|0|96|Actavis Group hf|Actavis Group PTC ehf|||9194||9194|13317 101769|N02AX0211|Nobligan Retard (D.A.C.)|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|9431|13639|lyfalmen|V0736|11033|00|100|0|50|D.A.C. ehf|D.A.C. ehf|||9431||9431|13639 101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|A|2|0|0|0|0|BOI|0|0|0|100|DKK|11794|22637|vetalmen|||0|250|0|0|Vistor hf|Boehringer Ingelheim|||||11794|22637 102863|C01DA1401|Imdur|forðatfl|60|mg|28|stk|1|þpakki||C01DA14|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1430|2781|lyfalmen|||43|28|0|42|Vistor hf|AstraZeneca A/S DK|||1430||1430|2781 102871|C01DA1401|Imdur|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2930|4817|lyfalmen|V0139|2746|43|98|0|147|Vistor hf|AstraZeneca A/S DK|||2930||2930|4817 102905|N01AX1001|Diprivan|stl|10|mg/ml|50|ml|1|dæla|einnota dæla|N01AX10|01.01.1994||R|A|2|0|0|0|1|ASZ|0|0|0|100|SEK|2284|3270|lyfsjukr|||02|50|0|0|Vistor hf|AstraZeneca UK Ltd|||2284||2284|3270 102939|N01AX1001|Diprivan|stl|20|mg/ml|50|ml|1|dæla|einnota dæla|N01AX10|01.01.1988||R|A|2|0|0|0|1|ASZ|0|0|0|100|SEK|4740|6786|lyfsjukr|||00|50|0|0|Vistor hf|AstraZeneca UK Ltd|||4740||4740|6786 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2008||R|A|1,25|0|0|B|0|POF|0|0|0|100|XEU|7595|10028|lyfalmen|V0198|9935|00|98|0|98|PortFarma ehf|PortFarma |||6770||6770|10028 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.02.2008||R|A|1,25|0|0|B|0|POF|0|0|0|100|XEU|12576|16049|lyfalmen|V0193|15898|00|98|0|196|PortFarma ehf|PortFarma |||11207||11207|16049 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.02.2008||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|4295|6362|lyfalmen|V0197|6335|00|98|0|98|PortFarma ehf|PortFarma |||4069||4069|6362 103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|30|GBP|2451|3685|lyfalmen|V0507|3685|00|10|0|2|PortFarma ehf|PortFarma |||2096||2096|3685 103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|þpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|30|GBP|10191|12656|lyfalmen|V0508|12617|00|40|0|7|PortFarma ehf|PortFarma |||8707||8707|12656 103678|N06AX1604|Venlafaxin Portfarma|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|USD|15175|19006|lyfalmen|V0955|19006|00|100|0|75|PortFarma ehf|PortFarma |||13511||13511|19006 103687|N06AX1604|Venlafaxin Portfarma|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|USD|28880|34196|lyfalmen|V0956|34196|00|100|0|150|PortFarma ehf|PortFarma |||25712||25712|34196 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|A|2|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||56|25|0|5|Vistor hf|Orion Pharma||||||1828 103952|A06AG0201|Toilax|innhl/tf|0| |1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|A|2|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||00|1|0|1|Vistor hf|Orion Pharma||||||0 104034|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|13480|18650|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||13480||13480|18650 104356|N05BA0204|Klordiazepoxið Actavis|töflur|5|mg|30|stk|1|glas||N05BA02|01.10.1995|31.12.2008|R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|193|1102|lyfalmen|||00|30|0|5|Actavis Group hf|Actavis hf|||193||193|1102 104372|N05BA0204|Klordiazepoxið Actavis|töflur|5|mg|100|stk|1|glas||N05BA02|01.10.1995|31.12.2008|R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|475|1485|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|||475||475|1485 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|K|3|0|0|E|0|FEL|0|0|0|100|DKK|3977|6237|lyfalmen|||23|2|0|10|Vistor hf|Ferring Lægemidler A/S|||3977||3977|6237 104498|N05CH0101|Circadin|forðatfl|2|mg|21|stk|1|þpakki||N05CH01|01.11.2007||R|A|5|0|0|0|0|NEU|0|0|1|100|DKK|2745|4565|lyfalmen|||00|21|0|0|Gróco ehf|Neurim Pharmaceuticals EEC Ltd|||2745||2745|4565 104760|A07EC0202|Pentasa|eþ-stil|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|10035|14458|lyfalmen|||04|28|0|19|Vistor hf|Ferring|||10035||10035|14458 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|5823|8742|lyfalmen|||56|700|0|5|Vistor hf|Ferring|||5823||5823|8742 104851|A07EC0202|Pentasa|forðatfl|500|mg|100|stk|1|þpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|7134|10522|lyfalmen|||10|100|0|33|Vistor hf|Ferring|||7134||7134|10522 105023|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|5432|7777|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|||5432||5432|7777 105278|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.09.2007||R|A|3|0|0|E|0|DAC|0|0|0|30|SEK|3938|6184|lyfalmen|V0084|6184|00|28|0|19|D.A.C. ehf|D.A.C. ehf|||3938||3938|6184 105287|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.09.2007||R|A|3|0|0|E|0|DAC|0|0|0|30|SEK|7763|11375|lyfalmen|V0086|11375|00|56|0|37|D.A.C. ehf|D.A.C. ehf|||7763||7763|11375 105297|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A|3|0|0|E|0|DAC|0|0|0|30|SEK|13719|19265|lyfalmen|V0087|19265|00|100|0|67|D.A.C. ehf|D.A.C. ehf|||13719||13719|19265 105306|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A|3|0|0|E|0|DAC|0|0|0|30|SEK|18521|25244|lyfalmen|V0089|25244|00|100|0|133|D.A.C. ehf|D.A.C. ehf|||18521||18521|25244 105379|N03AG0601|Gabitril|töflur|10|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|19199|26088|lyfalmen|||00|100|0|33|Icepharma hf|Cephalon France|||19199||19199|26088 105387|N03AG0601|Gabitril|töflur|15|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|15839|21905|lyfalmen|||00|50|0|25|Icepharma hf|Cephalon France|||15839||15839|21905 105395|N03AG0601|Gabitril|töflur|15|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|28800|38041|lyfalmen|||00|100|0|50|Icepharma hf|Cephalon France|||28800||28800|38041 105403|N03AG0601|Gabitril|töflur|5|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|7920|11588|lyfalmen|||00|50|0|8|Icepharma hf|Cephalon France|||7920||7920|11588 105437|N03AG0601|Gabitril|töflur|5|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|14399|20112|lyfalmen|||00|100|0|17|Icepharma hf|Cephalon France|||14399||14399|20112 105445|N03AG0601|Gabitril|töflur|10|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|10559|15169|lyfalmen|||00|50|0|17|Icepharma hf|Cephalon France|||10559||10559|15169 105586|C09XA02|Rasilez|filmhtfl|150|mg|28|stk|1|þpakki||C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|4983|7603|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||4983||4983|7603 105597|C09XA02|Rasilez|filmhtfl|150|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|15457|21429|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||15457||15457|21429 105608|C09XA02|Rasilez|filmhtfl|300|mg|28|stk|1|þpakki||C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|4983|7603|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||4983||4983|7603 105620|C09XA02|Rasilez|filmhtfl|300|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|16462|22680|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||16462||16462|22680 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2310|3975|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|||2310||2310|3975 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2516|4255|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|||2516||2516|4255 106021|J01FA0901|Klacid|töflur|250|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|3572|5688|lyfalmen|||63|14|0|7|Vistor hf|Abbott Scandinavia AB|||3572||3572|5688 106486|C09AA0207|Enalapril Portfarma|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|802|1929|lyfalmen|V0167|1929|0|100|0|50|PortFarma ehf|PortFarma|||802||802|1929 106497|C09AA0207|Enalapril Portfarma|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|1153|2405|lyfalmen|V0168|2405|0|100|0|100|PortFarma ehf|PortFarma|||1153||1153|2405 106508|C09AA0207|Enalapril Portfarma|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|2725|4538|lyfalmen|V0169|4538|0|100|0|200|PortFarma ehf|PortFarma|||2725||2725|4538 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|A|5|0|0|0|1|GSK|0|0|0|30|GBP|18018|24300|lyfsjukr|||00|5|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||18018||18018|24300 106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|A|5|0|0|0|1|GSK|0|0|0|30|GBP|9964|14266|lyfsjukr|||00|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||9964||9964|14266 106963|M05BA0201|Bonefos|töflur|800|mg|30|stk|1|þpakki||M05BA02|01.03.2004||R|A|3|0|0|E|0|LEI|0|0|0|100|SEK|17570|24060|lyfalmen|||10|30|0|15|Icepharma hf|Leiras Oy|||17570||17570|24060 107050|A10BD0401|Avaglim|filmhtfl|0| |84|stk|1|þpakki|4+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|14450|20175|lyfalmen|||00|84|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||14450||14450|20175 107061|A10BD0401|Avaglim|filmhtfl|0| |84|stk|1|þpakki|8+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|21755|29270|lyfalmen|||00|84|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||21755||21755|29270 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|A|5|0|0|B|0|PFI|0|0|0|100|DKK|2082|3666|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2082||2082|3666 107268|M05BA0201|Bonefos|töflur|800|mg|30|stk|1|glas||M05BA02|01.01.1997||R|A|3|0|0|E|0|LEI|0|0|0|100|SEK|17570|24060|lyfalmen|||10|30|0|15|Icepharma hf|Leiras Oy|||17570||17570|24060 107532|N02BE0106|Parasupp|eþ-stil|60|mg|10|stk|1|pakki||N02BE01|01.06.1984||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||04|10|0|0|Actavis Group hf|Actavis hf||||||0 107581|N02BE0106|Parasupp|eþ-stil|125|mg|10|stk|1|pakki||N02BE01|01.06.1984|31.12.2008|L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||04|10|0|0|Actavis Group hf|Actavis hf||||||0 107594|QP54AA0104|Bimectin Horse Oral Paste|pasta|18,7|mg/g|6,42|g|1|áf.spr||QP54AA01|01.04.2008||L|A|2|0|0|0|0|ICV|0|0|0|100|XEU|||vetorma|||16|6|0|0|Icepharma hf|Icevet ehf||||||2859 107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|þpakki||A02BA02|01.07.1986||R|A|3|0|0|E|0|ACA|0|0|0|30|IKR|1117|2356|lyfalmen|||00|60|0|30|Actavis Group hf|Actavis hf|||1117||1117|2356 108183|N02BE0106|Parasupp|eþ-stil|250|mg|10|stk|1|pakki||N02BE01|01.06.1984|31.12.2008|L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||04|10|0|1|Actavis Group hf|Actavis hf||||||0 108209|N02BE0106|Parasupp|eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.06.1984||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||04|10|0|2|Actavis Group hf|Actavis hf||||||0 108308|C08CA0501|Adalat|töflur|10|mg|100|stk|1|þpakki||C08CA05|01.01.1991||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|3015|4932|lyfalmen|||63|100|0|33|Vistor hf|Bayer HealthCare AG|||3015||3015|4932 108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|þpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|4682|7194|lyfalmen|||00|30|0|0|Vistor hf|Novartis Europharm Ltd|||4682||4682|7194 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|þpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|12771|18085|lyfalmen|||00|90|0|0|Vistor hf|Novartis Europharm Ltd|||12771||12771|18085 108803|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|12|hgl|20mg/ml+36mcg/ml|QN01BB52|01.12.2003||R|S|2|0|0|0|0|KEL|1|0|0|100|NOK|1113|2196|vetalmen|||27|1200|0|0|Icepharma hf|Kela Laboratoria NV|||1113||1113|2196 108845|R01AD0501|Rhinocort Aqua|nefúði|32|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1029|2237|lyfalmen|||24|120|0|19|Vistor hf|AstraZeneca A/S DK|||1029||1029|2237 108852|R01AD0501|Rhinocort Aqua|nefúði|64|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1508|2887|lyfalmen|V0965|2809|24|120|0|38|Vistor hf|AstraZeneca A/S DK|||1508||1508|2887 108860|N02AX0203|Tramol|hylki|50|mg|20|stk|1|glas||N02AX02|01.03.1998||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|293|1238|lyfalmen|V0730|1238|00|20|0|3|Actavis Group hf|Actavis hf|||293||293|1238 108878|N02AX0203|Tramol|hylki|50|mg|100|stk|1|glas||N02AX02|01.03.1998||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|504|1524|lyfalmen|V0731|1524|00|100|0|17|Actavis Group hf|Actavis hf|||504||504|1524 109207|N02AA5901|Panocod|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|213|1129|lyfalmen|V0775|1120|00|20|0|7|Vistor hf|Sanofi-aventis Norge AS|||213||213|1129 109223|N02AA5901|Panocod|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|5|1|0|0|0|SNO|0|0|1|100|NOK|813|1944|lyfalmen|V0780|1925|00|100|0|33|Vistor hf|Sanofi-aventis Norge AS|||813||813|1944 109421|V01AA0303|Alutard SQ, derm.farinae|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|25980|34530|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|||25980||25980|34530 109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20799|28080|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||20799||20799|28080 109462|V01AA0301|Soluprick SQ, derm.farinae|lausn|10|HEP|3|ml|1|hgl||V01AA03|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8075|11799|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|||8075||8075|11799 109678|N02BE0107|Paratabs|töflur|500|mg|20|stk|1|þpakki||N02BE01|01.12.1983||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|20|0|3|Actavis Group hf|Actavis hf||||||0 109728|N02BE0107|Paratabs|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.07.1992||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|30|0|5|Actavis Group hf|Actavis hf||||||0 109751|N02BE0107|Paratabs|töflur|500|mg|100|stk|1|þpakki||N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|379|1355|lyfalmen|V0772|1355|00|100|0|17|Actavis Group hf|Actavis hf|||379||379|1355 110072|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|685|1770|lyfalmen|||06|5|0|25|Icepharma hf|Santen Oy|||685||685|1770 110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|764|1877|lyfalmen|||06|5|0|25|Icepharma hf|Santen Oy|||764||764|1877 110242|V03AN0101|Conoxia|innö.gas|100|%|3|l|1|hylki|MO3c|V03AN01|01.04.2008||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyfalmen|||00|3|0|0|Ísaga ehf|AGA AB||||||0 110395|G03AA0902|Mercilon|töflur|0| |63|stk|1|þpakki||G03AA09|01.07.1990||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1648|3077|lyfalmen|||23|63|0|84|Vistor hf|N.V. Organon|||1648||1648|3077 110635|C08DA0104|Veraloc Retard|forðatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|A|4|0|0|B|0|ORC|0|0|0|100|DKK|4827|7391|lyfalmen|||10|100|0|83|Vistor hf|Orion Corporation|||4827||4827|7391 111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|A|5|0|0|0|0|GCH|0|0|1|100|DKK|802|1929|lyfalmen|||00|100|0|33|Icepharma hf|GlaxoSmithKline CH A/S|||802||802|1929 112359|S01AA1101|Garamycin|augndr|3|mg/ml|5|ml|1|glas||S01AA11|01.03.1977||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|863|2012|lyfalmen|||06|5|0|0|Vistor hf|Schering-Plough|||863||863|2012 112441|A10BB0701|Mindiab|töflur|2,5|mg|100|stk|1|þpakki||A10BB07|01.07.1990||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|1371|2701|lyfalmen|||68|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1371||1371|2701 112615|C01DA0201|Discotrine|forðapl|15|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|DKK|5458|6068|lyfalmen|||23|30|0|90|Vistor hf|Meda AB (V)|||3852||3852|6068 113394|A10BD0801|Eucreas|filmhtfl|0||60|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|10323|14849|lyfalmen|||00|60|0|0|Vistor hf|Novartis Europharm Ltd|||||10323|14849 113403|A10BD0801|Eucreas|filmhtfl|0||180|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|28416|37563|lyfalmen|||00|180|0|0|Vistor hf|Novartis Europharm Ltd|||||28416|37563 113412|A10BD0801|Eucreas|filmhtfl|0||60|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|10323|14849|lyfalmen|||00|60|0|0|Vistor hf|Novartis Europharm Ltd|||||10323|14849 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|stk|einnota dæla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|3265|5271|lyfalmen|||00|2|0|10|Vistor hf|Sanofi-aventis Norge AS|||3265||3265|5271 113421|A10BD0801|Eucreas|filmhtfl|0||180|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|28416|37563|lyfalmen|||00|180|0|0|Vistor hf|Novartis Europharm Ltd|||||28416|37563 113639|A02AD0105|Novaluzid|tuggutfl|500|mg|100|stk|1|þpakki||A02AD01|01.03.1983|31.01.2009|L|A|3|0|0|0|0|BIP|0|0|0|100|IKR|||lyflausa|||11|100|0|10|Vistor hf|BioPhausia AB|||||| 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|stk|einnota dæla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|5294|8025|lyfalmen|||00|4|0|20|Vistor hf|Sanofi-aventis Norge AS|||5294||5294|8025 113796|L01XC0602|Erbitux (Lyfjaver)|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.04.2008||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|34910|45330|lyfsjukr|||00|20|0|0|Lyfjaver ehf|Lyfjaver ehf|||34910||34910|45330 113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|þpakki||L01XE08|01.06.2008||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|788011|982941|lyfsjukr|||00|112|0|0|Vistor hf|Novartis Europharm Ltd|||788011||788011|982941 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|629|1694|lyfalmen|||00|20|0|10|Vistor hf|Recip AB|||629||629|1694 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|919|2088|lyfalmen|||00|30|0|15|Vistor hf|Recip AB|||919||919|2088 113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1220|2496|lyfalmen|||00|40|0|20|Vistor hf|Recip AB|||1220||1220|2496 114033|R03AC0210|Ventolin Diskus|innúðadu|200|mcg/sk|60|skammtar|1|stk|Diskus tæki|R03AC02|01.03.1999||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|764|1877|lyfalmen|||23|60|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||764||764|1877 114395|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|100|stk|1|þpakki||N06AB05|01.11.2008||R|A|3|0|0|B|0|RAN|0|1|0|30|IKR|2160|3506|lyfalmen|V0919|3506|00|100|0|100|Gróco ehf|Ranbaxy (UK) Ltd|||1964||1964|3506 114406|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|60|stk|1|þpakki||N06AB05|01.11.2008||R|A|3|0|0|B|0|RAN|0|1|0|30|IKR|1390|2556|lyfalmen|V0918|2556|00|60|0|60|Gróco ehf|Ranbaxy (UK) Ltd|||1264||1264|2556 114417|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|20|stk|1|þpakki||N06AB05|01.11.2008||R|A|3|0|0|B|0|RAN|0|1|0|30|IKR|526|1489|lyfalmen|V0917|1489|00|20|0|20|Gróco ehf|Ranbaxy (UK) Ltd|||478||478|1489 114447|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíð 20 mg|S01ED51|01.03.1999||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|2787|4622|lyfalmen|V0989|4546|06|5|0|0|Icepharma hf|M.S.D.|||2787||2787|4622 115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|2|0|0|E|0|BII|0|0|0|100|DKK|4441|6867|lyfalmen|||0|750|0|0|Vistor hf|Boehringer Ingelheim International|||4441||4441|6867 115285|J01CA0410|Amoxicillin Merck NM|töflur|750|mg|20|stk|1|þpakki||J01CA04|01.10.1998||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|1775|3249|lyfalmen|||00|20|0|15|Actavis Group PTC ehf|Merck NM AB|||1775||1775|3249 115318|B01AE0701|Pradaxa|hylki|75|mg|30|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|2|0|0|E|0|BII|0|0|0|100|DKK|13313|18760|lyfalmen|||0|2250|0|0|Vistor hf|Boehringer Ingelheim International|||13313||13313|18760 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|2|0|0|E|0|BII|0|0|0|100|DKK|26625|35333|lyfalmen|||0|4500|0|0|Vistor hf|Boehringer Ingelheim International|||26625||26625|35333 115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|2|0|0|E|0|BII|0|0|0|100|DKK|4441|6867|lyfalmen|||0|1100|0|0|Vistor hf|Boehringer Ingelheim International|||4441||4441|6867 115353|B01AE0701|Pradaxa|hylki|110|mg|30|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|2|0|0|E|0|BII|0|0|0|100|DKK|13313|18760|lyfalmen|||0|3300|0|0|Vistor hf|Boehringer Ingelheim International|||13313||13313|18760 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|2|0|0|E|0|BII|0|0|0|100|DKK|26625|35333|lyfalmen|||0|6600|0|0|Vistor hf|Boehringer Ingelheim International|||26625||26625|35333 115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|2055|3629|lyfalmen|V1090|3572|06|5|0|17|Icepharma hf|M.S.D.|||2055||2055|3629 115808|R06AX0201|Periactin|töflur|4|mg|100|stk|1|þpakki||R06AX02|01.10.2005||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|1300|2605|lyfalmen|||00|100|0|33|Icepharma hf|M.S.D.|||1300||1300|2605 115931|R03AC1202|Serevent Diskus|innúðadu|50|mcg/sk|60|sk|1|pakki||R03AC12|01.01.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|3526|5625|lyfalmen|||23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3526||3526|5625 115980|P03AX0301|Prioderm|húðlausn|5|mg/ml|55|ml|1|glas||P03AX03|01.12.1983||L|A|3|0|0|0|0|NOP|0|0|0|100|IKR|||lyfalmen|||23|55|0|0|Icepharma hf|Norpharma ||||||0 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|3783|5416|lyfsjukr|||03|5|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3783||3783|5416 116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|1978|2832|lyfsjukr|||03|5|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1978||1978|2832 116137|D07AC1301|Elocon|krem|1|mg/g|20|g|1|túpa|feitt|D07AC13|01.04.1994||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|954|2135|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|||954||954|2135 116160|D07AC1301|Elocon|krem|1|mg/g|50|g|1|túpa|feitt|D07AC13|01.04.1994||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|2109|3702|lyfalmen|||20|50|0|50|Vistor hf|Schering-Plough|||2109||2109|3702 116244|D11AF01|Verucid|áburður|0| |10|ml|1|glas||D11AF|01.11.1981||L|K|2|0|0|0|0|GAN|0|0|0|100|IKR|||lyfalmen|||23|10|0|10|Icepharma hf|Galderma Nordic AB||||||0 116368|D07AC1301|Elocon|smyrsli|1|mg/g|20|g|1|túpa||D07AC13|01.04.1994||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|954|2135|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|||954||954|2135 116400|D07AC1301|Elocon|smyrsli|1|mg/g|50|g|1|túpa||D07AC13|01.04.1994||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|2098|3687|lyfalmen|||20|50|0|50|Vistor hf|Schering-Plough|||2098||2098|3687 116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|þpakki||M01AE01|01.12.2008||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|20|0|3|Actavis Group hf|Actavis hf|||||| 116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|þpakki||M01AE01|01.05.2008||L|A|2|0|0|E|0|ACA|0|0|1|100|IKR|||lyfalmen|V0670|1284|00|30|0|10|Actavis Group hf|Actavis hf||||||1284 116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|þpakki||M01AE01|01.08.2008||R|A|5|0|0|E|0|ACA|0|0|1|100|XEU|847|1990|lyfalmen|||00|100|0|33|Actavis Group hf|Actavis hf|||847||847|1990 116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|þpakki||M01AE01|01.07.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|474|1484|lyfalmen|||00|30|0|15|Actavis Group hf|Actavis hf|||474||474|1484 116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|þpakki||M01AE01|01.05.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|1146|2396|lyfalmen|||00|100|0|50|Actavis Group hf|Actavis hf|||1146||1146|2396 116694|G04BD1101|Toviaz|forðatfl|4|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|19495|26456|lyfalmen|||00|84|0|0|Vistor hf|Pfizer Limited|||||19495|26456 116705|G04BD1101|Toviaz|forðatfl|4|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|6899|10203|lyfalmen|||00|28|0|0|Vistor hf|Pfizer Limited|||||6899|10203 116716|G04BD1101|Toviaz|forðatfl|8|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|7329|10786|lyfalmen|||00|28|0|0|Vistor hf|Pfizer Limited|||||7329|10786 116727|G04BD1101|Toviaz|forðatfl|8|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|22082|29677|lyfalmen|||00|84|0|0|Vistor hf|Pfizer Limited|||||22082|29677 116997|N05AX1203|Abilify (Lyfjaver)|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|LVR|0|1|0|100|DKK|39518|51385|lyfalmen|V1702|51385|00|56|0|37|Lyfjaver ehf|Lyfjaver ehf|||39518||39518|51385 117008|N05AX1203|Abilify (Lyfjaver)|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|LVR|0|1|0|100|DKK|39518|51385|lyfalmen|V1703|51385|00|56|0|56|Lyfjaver ehf|Lyfjaver ehf|||39518||39518|51385 117408|QA12AX0001|Calcimag vet. Kela|irl|0| |500|ml|12|plastf||QA12AX00|01.04.2004||R|A|2|0|0|0|0|KEL|1|0|0|100|NOK|9079|17465|vetalmen|||00|6000|0|0|Icepharma hf|Kela Laboratoria NV|||9079||9079|17465 117515|M01AE0303|Orudis|forðahlk|200|mg|100|stk|1|hylki||M01AE03|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|7753|11362|lyfalmen|||10|100|0|133|Vistor hf|Sanofi-aventis Norge AS|||7753||7753|11362 117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|6246|9317|lyfalmen|||00|100|0|33|Icepharma hf|Roche|||6246||6246|9317 117550|N05AH0405|Seroquel Prolong|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|12971|18334|lyfalmen|||00|100|0|12|Vistor hf|AstraZeneca UK Ltd|||||12971|18334 117561|N05AH0405|Seroquel Prolong|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|22924|30725|lyfalmen|||00|100|0|50|Vistor hf|AstraZeneca UK Ltd|||||22924|30725 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|2575|4335|lyfalmen|||10|100|0|8|Icepharma hf|Roche|||2575||2575|4335 117573|N05AH0405|Seroquel Prolong|forðatfl|300|mg|10|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|3964|6220|lyfalmen|||00|10|0|8|Vistor hf|AstraZeneca UK Ltd|||||3964|6220 117584|N05AH0405|Seroquel Prolong|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|39639|51536|lyfalmen|||00|100|0|75|Vistor hf|AstraZeneca UK Ltd|||||39639|51536 117595|N05AH0405|Seroquel Prolong|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|45848|59266|lyfalmen|||00|100|0|100|Vistor hf|AstraZeneca UK Ltd|||||45848|59266 117721|D11AF01|Verucid|hlaup|0| |5|g|1|túpa||D11AF|01.08.1984||L|A|3|0|0|0|0|GAN|0|0|0|100|DKK|||lyflausa|||23|5|0|5|Icepharma hf|Galderma Nordic AB|||||| 117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|10403|18003|vetorma|||00|250|0|0|Vistor hf|Bayer Animal Health GmbH|||10403||10403|18003 117788|C08CA0502|Adalat Oros|forðatfl|30|mg|28|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|2762|4589|lyfalmen|||61|28|0|28|Vistor hf|Bayer HealthCare AG|||2762||2762|4589 117796|C08CA0502|Adalat Oros|forðatfl|30|mg|98|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|4860|7436|lyfalmen|||61|98|0|98|Vistor hf|Bayer HealthCare AG|||4860||4860|7436 117820|C08CA0502|Adalat Oros|forðatfl|60|mg|98|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|11651|16651|lyfalmen|||61|98|0|196|Vistor hf|Bayer HealthCare AG|||11651||11651|16651 117929|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|6342|12252|vetalmen|||00|1200|0|0|Icepharma hf|Kela Laboratoria NV|||6342||6342|12252 117937|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|11123|21359|vetalmen|||00|6000|0|0|Icepharma hf|Kela Laboratoria NV|||11123||11123|21359 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.05.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|4279|4761|lyfalmen|V0809|4761|00|28|0|7|Actavis Group hf|Actavis Group PTC ehf|||2889||2889|4761 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|6082|6412|lyfalmen|V0810|6412|00|28|0|14|Actavis Group hf|Actavis Group PTC ehf|||4106||4106|6412 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|23586|22007|lyfalmen|V0812|22007|00|56|0|56|Actavis Group hf|Actavis Group PTC ehf|||15921||15921|22007 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|18018|17328|lyfalmen|V0815|17328|00|28|0|42|Actavis Group hf|Actavis Group PTC ehf|||12163||12163|17328 118158|J01DC0203|Zinnat|mixt.kyr|25|mg/ml|100|ml|1|glas||J01DC02|01.10.1990||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|1703|3151|lyfalmen|||65|100|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1703||1703|3151 118165|N06AX2103|Cymbalta (Lyfjaver)|sþ-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.05.2008|31.01.2009|R|A|3|0|0|B|0|LVR|0|1|0|100|NOK|||lyfalmen|||00|28|0|14|Lyfjaver ehf|Lyfjaver ehf|||3841||| 118176|N06AX2103|Cymbalta (Lyfjaver)|sþ-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.05.2008|31.01.2009|R|A|3|0|0|B|0|LVR|0|1|0|100|NOK|||lyfalmen|||00|98|0|98|Lyfjaver ehf|Lyfjaver ehf|||18395||| 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|A|3|0|0|0|1|AGA|0|0|0|100|IKR|9512|13619|lyfsjukr|||00|4|0|0|Ísaga ehf|AGA AB|||9512||9512|13619 118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|þpakki||A02BA02|01.04.1994||L|A|3|0|0|E|0|ACA|0|0|0|30|IKR|||lyfalmen|||00|30|0|15|Actavis Group hf|Actavis hf||||||2172 118315|M01AB0505|Voltaren|eþ-stil|100|mg|5|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|762|1874|lyfalmen|||04|5|0|5|Vistor hf|Novartis Healthcare A/S-|||762||762|1874 118323|M01AB0505|Voltaren|eþ-stil|100|mg|50|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|7632|11197|lyfalmen|||04|50|0|50|Vistor hf|Novartis Healthcare A/S-|||7632||7632|11197 118349|D07AC1301|Elocon|áburður|1|mg/g|20|ml|1|glas||D07AC13|01.04.1994||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|954|2135|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|||954||954|2135 118406|A02BA0201|Asyran|töflur|300|mg|30|stk|1|þpakki||A02BA02|01.04.1994||R|A|3|0|0|E|0|ACA|0|0|0|30|IKR|1062|2282|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|||1062||1062|2282 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|18542|17767|lyfalmen|V0811|17767|00|56|0|42|Actavis Group hf|Actavis Group PTC ehf|||12516||12516|17767 118570|A07EC0203|Pentasa Sachets|forðakyr|1|g|50|stk|1|pakki||A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|9838|14191|lyfalmen|||00|50|0|33|Vistor hf|Ferring|||9838||9838|14191 118612|A07EC0203|Pentasa Sachets|forðakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|28937|38212|lyfalmen|||00|150|0|100|Vistor hf|Ferring|||28937||28937|38212 118674|N05AH0204|Leponex (Lyfjaver)|töflur|25|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|DKK|3806|6005|lyfalmen|V1401|6005|00|100|0|8|Lyfjaver ehf|Lyfjaver ehf|||||3806|6005 118685|N05AH0204|Leponex (Lyfjaver)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|DKK|11213|16057|lyfalmen|V1400|16057|00|100|0|33|Lyfjaver ehf|Lyfjaver ehf|||||11213|16057 119031|L01XC0801|Vectibix|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.06.2008||R|K|3|0|1|0|1|AEU|0|0|0|100|DKK|89942|113845|lyfsjukr|||00|5|0|0|Vistor hf|Amgen Europe B.V.|||89942||89942|113845 119305|B05BA0109|Vamin Glukos|irl|0| |1000|ml|6|fl||B05BA01|01.09.1998|31.12.2008|R|A|1.5|0|0|0|1|FRP|0|0|0|100|DKK|21823|29037|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|||21823||21823|29037 119719|C09BA0801|Inhibace Comp.|töflur|17,5|mg|98|stk|1|pakki|þp ( 5+ 12,5 mg)|C09BA08|01.12.1997||R|A|3|0|0|B|0|ROC|0|0|0|100|DKK|13589|19103|lyfalmen|||00|98|0|98|Icepharma hf|Roche|||13589||13589|19103 119962|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.03.2008||L|A|3|0|0|E|0|POF|0|0|1|100|IKR|||lyfalmen|V0670|1284|00|30|0|10|PortFarma ehf|PortFarma ||||||1284 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|A|2|0|1|0|0|GGL|0|0|0|100|GBP|468667|585675|lyfalmen|||00|30|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||||468667|585675 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|A|2|0|1|0|0|GGL|0|0|0|100|GBP|468667|585675|lyfalmen|||00|30|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||||468667|585675 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|A|2|0|0|E|0|ALC|0|0|0|100|USD|1001|2199|lyfalmen|||06|10|0|0|K.Pétursson hf|Alcon|||1001||1001|2199 120062|L01BA0401|Alimta|irþ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|A|2|0|1|0|1|LIL|0|0|0|100|XEU|50372|64581|lyfsjukr|||00|1|0|0|Icepharma hf|Lilly ICOS Limited|||||50372|64581 120341|N06DA0402|Reminyl (Lyfjaver)|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.05.2008||R|A|2|0|0|E|0|LVR|0|0|0|100|SEK|12849|17137|lyfalmen|V1370|17137|00|28|0|14|Lyfjaver ehf|Lyfjaver ehf|||12010||12010|17137 120353|N06DA0402|Reminyl (Lyfjaver)|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.05.2008||R|A|2|0|0|E|0|LVR|0|0|0|100|SEK|39541|48230|lyfalmen|V1371|48230|00|84|0|84|Lyfjaver ehf|Lyfjaver ehf|||36984||36984|48230 120950|N06AB1003|Cipralex (Lyfjaver)|filmhtfl|10|mg|28|stk|1|þpakki||N06AB10|01.05.2008||R|A|3|0|0|B|0|LVR|0|1|0|30|DKK|3438|5506|lyfalmen|V0939|5416|00|28|0|28|Lyfjaver ehf|Lyfjaver ehf|||3438||3438|5506 120961|N06AB1003|Cipralex (Lyfjaver)|filmhtfl|10|mg|200|stk|1|plglas||N06AB10|01.05.2008||R|A|3|0|0|B|0|LVR|0|1|0|30|NOK|20347|27517|lyfalmen|||00|200|0|200|Lyfjaver ehf|Lyfjaver ehf|||20347||20347|27517 120973|N03AX1402|Keppra (Lyfjaver)|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.05.2008||R|A|3|0|1|E|0|LVR|0|0|0|100|DKK|20788|28066|lyfalmen|V1710|28066|00|100|0|25|Lyfjaver ehf|Lyfjaver ehf|||||20788|28066 121269|N05CD0505|Triazolam NM Pharma|töflur|0,25|mg|100|stk|1|glas||N05CD05|01.07.1991||R|A|4|0|0|0|0|MNA|0|0|0|100|SEK|756|1866|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|||756||756|1866 121327|R03AC0204|Ventolin|innúðal|0,1|mg/sk|200|sk|1|stauk||R03AC02|01.12.1972||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|347|1311|lyfalmen|||24|200|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||347||347|1311 121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|þpakki||B03BB01|01.01.2008||R|A|2|0|0|E|0|AUK|0|0|1|100|GBP|393|1374|lyfalmen|||00|28|0|28|Actavis Group hf|Actavis UK Ltd.|||393||393|1374 121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|þpakki||N06AA04|01.03.1977||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|2144|3750|lyfalmen|V0908|1667|00|100|0|25|Vistor hf|Novartis Healthcare A/S-|||2144||2144|3750 121863|A07EC0204|Asacol|eþ-stil|500|mg|30|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|SCH|0|0|0|100|SEK|3278|5289|lyfalmen|||98|30|0|10|Icepharma hf|Schering Oy|||3278||3278|5289 123166|M01AE5101|Ibukod|töflur|0| |100|stk|1|glas|10+200 mg|M01AE51|01.10.1998||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|1507|2885|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|||1507||1507|2885 123216|N05BA0105|Stesolid|eþ-stil|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|590|1641|lyfalmen|||04|10|0|5|Actavis Group hf|Actavis Group hf|||590||590|1641 123224|N05BA0105|Stesolid|eþ-stil|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|920|2089|lyfalmen|||04|10|0|10|Actavis Group hf|Actavis Group hf|||920||920|2089 123273|N05BA0603|Temesta|töflur|1|mg|100|stk|1|þpakki||N05BA06|01.11.2005||R|A|3|0|0|0|0|LDR|0|0|1|100|IKR|1755|3222|lyfalmen|||00|100|1|40|Parlogis hf|Parlogis - óskráð lyf|||1755||1755|3222 123275|A07AA0904|Vancomycin Alpharma|hylki|250|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.04.1996||R|A|2|0|0|E|0|ALP|0|0|1|100|DKK|25939|34479|lyfalmen|||00|28|0|4|Actavis Group hf|Alpharma ApS|||||25939|34479 123319|M05BA0704|Optinate Septimum (Lyfjaver)|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|NOK|12839|18170|lyfalmen|V1080|17628|00|12|0|84|Lyfjaver ehf|Lyfjaver ehf|||12839||12839|18170 123414|C01AA0504|Lanoxin mite|töflur|62,5|mcg|100|stk|1|glas||C01AA05|01.03.1978||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|313|1265|lyfalmen|||00|100|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||313||313|1265 123596|N02AA5904|Ibukod sterkar|töflur|0| |100|stk|1|glas|30+200 mg|N02AA59|01.10.1998||R|A|2|1|0|0|0|ACA|0|0|1|100|IKR|2116|3712|lyfalmen|||00|100|0|33|Actavis Group hf|Actavis hf|||2116||2116|3712 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|þpakki||N07XX02|01.05.1998||R|A|3|0|0|E|0|AVS|0|0|0|100|NOK|39370|51201|lyfalmen|||00|56|0|28|Vistor hf|Aventis Pharma SA|||39370||39370|51201 124248|R06AD0301|Torecan|töflur|6,5|mg|20|stk|1|þpakki||R06AD03|01.10.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|623|1686|lyfalmen|||00|20|1|10|Parlogis hf|Parlogis - óskráð lyf|||623||623|1686 124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|þpakki||G02AB01|01.03.1980||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|1070|2292|lyfalmen|||00|30|0|19|Vistor hf|Novartis Healthcare A/S-|||1070||1070|2292 124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|glas||C09AA02|01.01.1994||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|612|1671|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|||612||612|1671 125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|glas||C09AA02|01.01.1994||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1153|2405|lyfalmen|V0168|2405|00|100|0|100|Actavis Group hf|Actavis hf|||1153||1153|2405 125163|C01BD0104|Cordarone (Lyfjaver)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.01.2009||R|A|5|0|0|B|0|LVR|0|0|0|100|NOK|2307|3971|lyfalmen|V0144|3911|0|30|0|15|Lyfjaver ehf|Lyfjaver ehf|||2307||2307|3971 126163|N05AX1202|Abilify (D.A.C)|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|DAC|0|1|0|100|DKK|23141|26415|lyfalmen|V1701|26415|00|28|0|6|D.A.C. ehf|D.A.C. ehf|||19462||19462|26415 126231|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|NOK|17899|24469|lyfalmen|V1732|20104|00|100|0|11|Lyfjaver ehf|Lyfjaver ehf|||17899||17899|24469 126242|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|NOK|15882|21958|lyfalmen|V1730|19915|00|100|0|22|Lyfjaver ehf|Lyfjaver ehf|||15882||15882|21958 126253|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|21674|29169|lyfalmen|V1731|29169|00|100|0|33|Lyfjaver ehf|Lyfjaver ehf|||21674||21674|29169 126326|A07DA0301|Imodium|töflur|2|mg|16|stk|1|þpakki||A07DA03|01.10.1991||L|A|5|0|0|0|0|JAS|0|0|0|100|SEK|||lyfalmen|||10|16|0|3|Vistor hf|Janssen-Cilag AB||||||0 126374|L01XX1702|Hycamtin|hylki|1|mg|10|stk|1|þpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|GSK|0|0|0|100|GBP|109294|137939|lyfsjukr|||00|10|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||109294|137939 126385|L01XX1702|Hycamtin|hylki|0,25|mg|10|stk|1|þpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|GSK|0|0|0|100|GBP|28049|36789|lyfsjukr|||00|10|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||28049|36789 126540|J01GB0303|Gentacoll|vsvamp|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|27155|35675|lyfsjukr|||00|1|0|1|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|||27155||27155|35675 126561|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|15|mg|28|stk|1|þpakki||A02BC03|01.09.2008||R|A|1,5|0|0|E|0|RAN|0|0|0|30|IKR|1607|3021|lyfalmen|||00|28|0|14|Gróco ehf|Ranbaxy (UK) Ltd|||1607||1607|3021 126572|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|15|mg|56|stk|1|þpakki||A02BC03|01.09.2008||R|A|1,5|0|0|E|0|RAN|0|0|0|30|IKR|3045|4973|lyfalmen|||00|56|0|28|Gróco ehf|Ranbaxy (UK) Ltd|||3045||3045|4973 126583|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|30|mg|28|stk|1|þpakki||A02BC03|01.09.2008||R|A|1,5|0|0|E|0|RAN|0|0|0|30|IKR|1607|3021|lyfalmen|||00|28|0|28|Gróco ehf|Ranbaxy (UK) Ltd|||1607||1607|3021 126594|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|30|mg|56|stk|1|þpakki||A02BC03|01.09.2008||R|A|1,5|0|0|E|0|RAN|0|0|0|30|IKR|3045|4973|lyfalmen|||00|56|0|56|Gróco ehf|Ranbaxy (UK) Ltd|||3045||3045|4973 126649|J01GB0303|Gentacoll|vsvamp|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|9051|12959|lyfsjukr|||00|1|0|0|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|||9051||9051|12959 126953|A07DA0301|Imodium|töflur|2|mg|100|stk|1|þpakki||A07DA03|01.10.1991||R|A|5|0|0|E|0|JAS|0|0|0|100|SEK|1728|3185|lyfalmen|||10|100|0|20|Vistor hf|Janssen-Cilag AB|||1728||1728|3185 127383|R02AA0302|Strepsils med honning og citron|sogtfl|0||36|stk|1|þpakki||R02AA03|01.01.2009||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyfalmen|||09|36|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|||||| 127647|V07AB10|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997|31.01.2009|L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|200|0|0|Actavis Group hf|Braun|||||| 127696|V07AB10|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997|31.01.2009|L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|400|0|0|Actavis Group hf|Braun|||||| 128058|N05AH0301|Zyprexa|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|10322|7031|lyfalmen|V0810|6412|00|28|0|14|Icepharma hf|Eli Lilly Nederland -|||4562||4562|7031 128173|C08DA0107|Verapamil Merck NM|töflur|40|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|447|1447|lyfalmen|||00|100|0|17|Actavis Group PTC ehf|Merck NM AB|||447||447|1447 128280|V07AB10|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.12.1997|31.01.2009|L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|1000|0|0|Actavis Group hf|Braun|||||| 128306|V07AB10|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|100|ml|20|hgl|leysir f.stungulyf|V07AB|01.12.1997|31.01.2009|L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|2000|0|0|Actavis Group hf|Braun|||||| 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|0| |100|stk|1|glas||C03AB01|01.05.1999||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1319|2630|lyfalmen|||10|100|0|50|Vistor hf|LEO Pharma A/S|||1319||1319|2630 128769|V07AB09|Sterilt Vatten Braun|leysir|0| |10|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997|31.01.2009|L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||00|200|0|0|Actavis Group hf|Braun||||||0 128819|V07AB09|Sterilt Vatten Braun|leysir|0| |20|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997|31.01.2009|L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||00|400|0|0|Actavis Group hf|Braun||||||0 128864|N07BA0136|Nicorette Spicemint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|30|0|2|Vistor hf|McNeil Denmark ApS|||||| 128875|N07BA0136|Nicorette Spicemint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|30|0|4|Vistor hf|McNeil Denmark ApS|||||| 128886|N07BA0136|Nicorette Spicemint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|210|0|14|Vistor hf|McNeil Denmark ApS|||||| 128897|N07BA0136|Nicorette Spicemint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|210|0|28|Vistor hf|McNeil Denmark ApS|||||| 128926|V07AB09|Sterilt Vatten Braun|leysir|0| |50|ml|20|hgl|leysir f.stungulyf|V07AB|01.12.1997|31.01.2009|L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||00|1000|0|0|Actavis Group hf|Braun||||||0 128934|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|4200|6013|lyfsjukr|||02|100|0|0|Icepharma hf|Baxter Medical AB|||4200||4200|6013 129098|N05AH0301|Zyprexa|húðuðtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|31524|19498|lyfalmen|V0811|17767|00|56|0|42|Icepharma hf|Eli Lilly Nederland -|||13906||13906|19498 129106|N05AH0301|Zyprexa|húðuðtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|40081|24209|lyfalmen|V0812|22007|00|56|0|56|Icepharma hf|Eli Lilly Nederland -|||17690||17690|24209 129254|V07AB09|Sterilt Vatten Braun|leysir|0| |100|ml|20|hgl|leysir f.stungulyf|V07AB|01.12.1997|31.01.2009|L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||00|2000|0|0|Actavis Group hf|Braun||||||0 129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH00|01.08.2005||L|A|5|0|0|0|0|REP|0|0|0|100|SEK|||lyfalmen|||00|100|0|0|Vistor hf|Recip AB||||||2780 129817|R03BB0101|Atrovent|innúðal|0,25|mg/ml|2|ml|60|plastl|í vél|R03BB01|01.04.1989||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|5316|8054|lyfalmen|||00|120|0|100|Vistor hf|Boehringer Ingelheim|||5316||5316|8054 130013|N05AH0401|Seroquel|töflur|100|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|16226|19814|lyfalmen|V0726|17623|00|100|0|25|Vistor hf|AstraZeneca UK Ltd|||14160||14160|19814 130021|N05AH0401|Seroquel|töflur|200|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|25685|30092|lyfalmen|V0727|27166|00|100|0|50|Vistor hf|AstraZeneca UK Ltd|||22415||22415|30092 130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|4278|6646|lyfalmen|||02|125|0|31|Gróco ehf|Nycomed Danmark A/S|||4278||4278|6646 130596|N07BA0301|Champix|filmhtfl|0||53|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|12172|17339|lyfalmen|||0|53|0|21|Vistor hf|Pfizer Limited|||||12172|17339 131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|412|1399|lyfalmen|||00|100|0|33|Vistor hf|Recip AB|||412||412|1399 131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|791|1914|lyfalmen|||00|100|0|15|Vistor hf|Recip AB|||791||791|1914 131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|865|2014|lyfalmen|||00|100|0|50|Vistor hf|Recip AB|||865||865|2014 131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|958|2140|lyfalmen|||00|100|0|100|Vistor hf|Recip AB|||958||958|2140 131565|G03CA0306|Evorel|forðapl|100|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|5776|8679|lyfalmen|||23|26|0|182|Vistor hf|Janssen-Cilag AB|||5776||5776|8679 131729|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|20|stk|1|þpakki||N07BA01|01.10.2008||L|A|2.5|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|20|0|1|Vistor hf|McNeil Denmark ApS|||||| 131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|90|0|6|Vistor hf|McNeil Denmark ApS|||||| 131987|J01AA0203|Doxytab|töflur|100|mg|10|stk|1|glas||J01AA02|01.12.2008|31.12.2008|R|A|4|0|0|0|0|AGP|0|0|1|100|IKR|||lyfalmen|||00|10|0|10|Actavis Group hf|Actavis Group PTC ehf|||||| 131995|J01AA0203|Doxytab|töflur|100|mg|30|stk|1|glas||J01AA02|01.04.1987||R|A|4|0|0|0|0|ACA|0|0|1|100|IKR|1192|2458|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|||1192||1192|2458 132229|N06AA0905|Amitriptyline|töflur|10|mg|28|stk|1|þpakki||N06AA09|01.04.2008||R|A|3|0|0|B|0|AUK|0|1|0|100|GBP|245|1173|lyfalmen|||00|28|0|4|Actavis Group hf|Actavis UK Ltd.|||245||245|1173 132240|N06AA0905|Amitriptyline|töflur|25|mg|28|stk|1|þpakki||N06AA09|01.04.2008||R|A|3|0|0|B|0|AUK|0|1|0|100|GBP|323|1279|lyfalmen|||00|28|0|9|Actavis Group hf|Actavis UK Ltd.|||323||323|1279 132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|XEU|13206|18626|lyfalmen|V0192|18626|00|98|0|196|Actavis Group hf|Actavis Group PTC ehf|||13206||13206|18626 132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|XEU|9139|13242|lyfalmen|V0191|13242|00|98|0|98|Actavis Group hf|Actavis Group PTC ehf|||9139||9139|13242 132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|A|5|1|0|E|0|REP|0|0|1|100|SEK|1521|2904|lyfalmen|||00|100|0|25|Vistor hf|Recip AB|||1521||1521|2904 132663|N06BA0402|Concerta|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|7802|11428|lyfalmen|||0|30|0|27|Vistor hf|Janssen-Cilag AB|||||7802|11428 132761|D08AG0201|Betadine|áburður|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|A|3|0|0|0|0|NAP|0|0|0|100|IKR|||lyfalmen|||23|8|0|8|Icepharma hf|Napp||||||0 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|K|2|0|0|0|0|ALC|0|0|0|100|USD|1142|2390|lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon|||1142||1142|2390 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|A|3|0|0|0|0|ABI|0|0|0|100|IKR|||lyfalmen|||00|100|0|3|Vistor hf|Abigo Medical AB||||||0 132902|G03AB0402|Trinovum 28|töflur|0| |84|stk|1|þpakki||G03AB04|01.01.1993||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|864|2013|lyfalmen|||23|84|0|84|Vistor hf|Janssen-Cilag AB|||864||864|2013 133074|L03AA1001|Granocyte|sts|33,6|millj ae|1|stk|5|hgl|+ leysir|L03AA10|01.07.1994||R|A|2|0|1|0|1|CSA|0|0|0|100|NOK|79974|101435|lyfsjukr|||02|5|0|4|Vistor hf|Chugai sanofi-aventis|||79974||79974|101435 133097|M03AX0101|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|34532|44860|lyfsjukr|||0|1|0|0|Vistor hf|Eisai Ltd|||||34532|44860 133109|M03AX0101|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|38580|49900|lyfsjukr|||0|1|0|0|Vistor hf|Eisai Ltd|||||38580|49900 133120|M03AX0101|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|42867|55237|lyfsjukr|||0|1|0|0|Vistor hf|Eisai Ltd|||||42867|55237 133736|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|SEK|9258|13404|lyfalmen|||10|100|0|25|Icepharma hf|Sandoz GmbH|||9258||9258|13404 134274|J02AC0302|Vfend (D.A.C.)|filmhtfl|200|mg|14|stk|1|þpakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|118204|149031|lyfsjukr|||00|14|0|7|D.A.C. ehf|D.A.C. ehf|||118204||118204|149031 134338|J01FA0901|Klacid|mixt.kyr|50|mg/ml|50|ml|1|glas|pl.fl. m/sk.sprautu|J01FA09|01.07.1998||R|A|2|0|0|0|0|ABS|0|0|1|100|DKK|2536|4282|lyfalmen|||00|50|0|5|Vistor hf|Abbott Scandinavia AB|||2536||2536|4282 134862|J05AR0601|Atripla|filmhtfl|0| |30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|A|2|0|1|0|1|GSI|0|0|0|100|DKK|176680|221735|lyfsjukr|||00|30|0|0|Lyfjaver ehf|Gilead Science International (L)|||176600||176600|221735 135095|M01AC0101|Felden|töflur|20|mg|60|stk|1|þpakki||M01AC01|01.01.1997||R|A|4|0|0|E|0|PFI|0|0|1|100|DKK|4569|7041|lyfalmen|||00|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4569||4569|7041 135111|H01AC0101|Genotropin|sts|0| |12|mg|1|rörlyk|tvíhólfa|H01AC01|01.04.1992||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|77058|97802|lyfsjukr|||00|12|0|18|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||77056||77056|97802 135319|C08DA0107|Verapamil Merck NM|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|818|1950|lyfalmen|||00|100|0|33|Actavis Group PTC ehf|Merck NM AB|||818||818|1950 135434|R03BA0502|Flixotide Diskus|innúðadu|100|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|2163|3776|lyfalmen|||23|60|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2163||2163|3776 136168|G03AB0401|Trinovum|töflur|0| |63|stk|1|þpakki||G03AB04|01.10.1988||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|864|2013|lyfalmen|||23|63|0|84|Vistor hf|Janssen-Cilag AB|||864||864|2013 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|6425|9559|lyfalmen|||00|100|0|100|Vistor hf|Recip AB|||6425||6425|9559 136564|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|10|hgl|röntgenskuggaefni|V08CA01|01.01.1993||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|105526|133247|lyfsjukr|||02|150|0|0|Icepharma hf|Bayer Schering Pharma AG|||105526||105526|133247 136572|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|10|hgl|röntgenskuggaefni|V08CA01|01.06.1997||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|78141|99153|lyfsjukr|||02|100|0|0|Icepharma hf|Bayer Schering Pharma AG|||78141||78141|99153 137141|N02BA5102|Treo|freyðit|0| |20|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||14|20|0|3|Vistor hf|McNeil Denmark ApS||||||0 137158|N02BA5102|Treo|freyðit|0| |60|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||14|60|0|10|Vistor hf|McNeil Denmark ApS||||||0 137364|N05AB0301|Trilafon|töflur|4|mg|100|stk|1|þpakki||N05AB03|01.01.1986||R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|1587|2994|lyfalmen|||00|100|0|13|Vistor hf|Schering-Plough|||1587||1587|2994 137455|N05AB0301|Trilafon|töflur|2|mg|100|stk|1|þpakki||N05AB03|01.01.1986||R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|1052|2268|lyfalmen|||00|100|0|7|Vistor hf|Schering-Plough|||1052||1052|2268 137513|S01XA2011|Oculac|augndr|0| |10|ml|1|glas|með rotvörn|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|10|0|0|Vistor hf|Novartis Healthcare A/S-||||||1355 137521|S01XA2011|Oculac|augndr|0| |0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|8|0|0|Vistor hf|Novartis Healthcare A/S-||||||1978 137641|S01LA0401|Lucentis|stl|10|mg/ml|0,23|ml|1|hgl|lausn|S01LA04|01.03.2007||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|167423|210309|lyfsjukr|||00|0|0|0|Vistor hf|Novartis Europharm Ltd|||167423||167423|210309 137679|A09AA0205|Creon|sh-hylki|0| |100|stk|1|glas|plastglas|A09AA02|01.04.1990||R|A|2|0|0|E|0|KAC|0|0|0|100|XEU|4660|7164|lyfalmen|||10|100|0|100|Medico ehf|Kali-Chemie|||4660||4660|7164 137992|J01XA0106|Vancomycin Hospira|irs|500|mg/hgl|500|mg|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|2292|3282|lyfsjukr|||00|500|0|0|Vistor hf|Hospira Enterprises B.V.|||2292||2292|3282 138073|J01XA0106|Vancomycin Hospira|irs|1|g/hgl|1|g|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|3116|4461|lyfsjukr|||00|1|0|0|Vistor hf|Hospira Enterprises B.V.|||3116||3116|4461 138560|S01ED0105|Optimol|augndr|2,5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2149|3757|lyfalmen|||00|15|0|60|Icepharma hf|Santen Oy|||2149||2149|3757 138594|S01ED0105|Optimol|augndr|5|mg/ml|0,5|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2281|3936|lyfalmen|||00|30|0|60|Icepharma hf|Santen Oy|||2281||2281|3936 139410|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|250|ml|1|fl||QP52AC13|01.07.1987||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|2901|5020|vetorma|||13|250|0|0|Icepharma hf|Intervet International B.V.|||2901||2901|5020 139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.08.1981||R|A|5|0|0|E|0|NHE|0|0|1|100|DKK|3190|5169|lyfalmen|||00|100|0|50|Artasan ehf|Novartis Healthcare A/S-A|||3190||3190|5169 140118|A10BA0202|Glucophage (Lyfjaver)|töflur|1000|mg|180|stk|1|glas||A10BA02|01.07.2008||R|A|3|0|0|*|0|LVR|0|0|0|100|NOK|2730|4545|lyfalmen|||00|180|0|90|Lyfjaver ehf|Lyfjaver ehf|||2730||2730|4545 140186|R03BB0101|Atrovent|innúðadu|40|mcg|100|stk|1|þpakki||R03BB01|01.10.1988||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|2683|4481|lyfalmen|||19|100|0|33|Vistor hf|Boehringer Ingelheim|||2683||2683|4481 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|1815|3303|lyfalmen|||00|30|0|1|Vistor hf|Boehringer Ingelheim International |||1815||1815|3303 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|A|2|0|0|0|1|LBK|0|1|0|100|DKK|15044|20597|lyfsjukr|||02|10|0|33|Lundbeck Export A/S|H. Lundbeck A/S|||15044||15044|20597 140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|K|5|0|0|0|1|NOH|0|0|0|100|DKK|678|971|lyfsjukr|||02|5|0|3|Vistor hf|Novartis Healthcare A/S-|||678||678|971 140954|N07BA0103|Nicorette|nefúði|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|A|2|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|10|0|3|Vistor hf|McNeil Denmark ApS||||||0 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|spr|einnotaspr|H02AB04|01.04.1994||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|1435|2788|lyfalmen|||03|2|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1435||1435|2788 141164|N01BB2005|Emla (D.A.C.)|krem|5|%|5|g|5|túpa|0|N01BB20|01.11.2008||R|A|3|0|0|0|0|DAC|0|0|1|100|SEK|3187|5165|lyfalmen|V2002|5165|00|25|0|5|D.A.C. ehf|D.A.C. ehf|||||3187|5165 141175|J01CA0409|Flemoxin (D.A.C.)|mixtúrud|50|mg/ml|100|ml|1|glas||J01CA04|01.10.2008||R|A|4|0|0|0|0|DAC|0|0|1|100|XEU|1448|2805|lyfalmen|V0451|2805|08|80|0|0|D.A.C. ehf|D.A.C. ehf|||1448||1448|2805 141197|N02BE0112|Perfalgan (D.A.C.)|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.05.2008||R|A|2|0|0|0|1|DAC|0|0|0|100|DKK|9468|13556|lyfsjukr|||00|1200|0|4|D.A.C. ehf|D.A.C. ehf|||9468||9468|13556 141208|B03AC0204|Venofer (D.A.C.)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.10.2008||R|A|3|0|0|E|0|DAC|0|0|1|100|CHF|15119|21008|lyfalmen|V0011|18085|00|25|0|5|D.A.C. ehf|D.A.C. ehf|||15119||15119|21008 141219|J02AC0302|Vfend (D.A.C.)|irs|200|mg|1|hgl|1|pakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|28698|37597|lyfsjukr|||00|1|0|0|D.A.C. ehf|D.A.C. ehf|||28698||28698|37597 141432|N04BC0502|Sifrol|töflur|0,18|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|A||0|0|E|0|BII|0|0|0|100|DKK|3509|5602|lyfalmen|||00|30|0|2|Vistor hf|Boehringer Ingelheim International |||3509||3509|5602 141684|G03AA1205|Yaz|filmhtfl|0||84|stk|1|þpakki|0,02mg/3mg|G03AA12|01.02.2009||R|A|5|0|0|0|0|BAB|0|0|0|100|SEK|4253|6612|lyfalmen|||0|84|0|0|Icepharma hf|Bayer AB|||||4253|6612 141751|J01EE0106|Co-trimoxazole|töflur|480|mg|28|stk|1|glas|80+400 mg|J01EE01|01.02.2008||R|A|5|0|0|0|0|AUK|0|0|1|100|GBP|650|1722|lyfalmen|||00|28|0|7|Actavis Group hf|Actavis UK Ltd.|||||650|1722 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|9698|14001|lyfalmen|||00|100|0|7|Vistor hf|Boehringer Ingelheim International|||9698||9698|14001 142059|C07AA0509|Propranolol Merck NM|töflur|10|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|460|1465|lyfalmen|||00|100|0|6|Actavis Group PTC ehf|Merck NM AB|||460||460|1465 142190|C07AA0509|Propranolol Merck NM|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|591|1642|lyfalmen|||00|100|0|25|Actavis Group PTC ehf|Merck NM AB|||591||591|1642 142299|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|10|lykjur||C01BD01|01.04.1987||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|7690|11010|lyfsjukr|||02|30|0|8|Vistor hf|Sanofi-aventis Norge AS|||7690||7690|11010 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.04.1987||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|963|2147|lyfalmen|V0143|2147|70|30|0|30|Vistor hf|Sanofi-aventis Norge AS|||963||963|2147 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|A|5|0|0|0|0|MEB|0|0|1|100|DKK|3652|4339|lyfalmen|||00|100|0|50|Vistor hf|Meda AB (V)|||2578||2578|4339 142596|C07AA0509|Propranolol Merck NM|töflur|80|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|818|1950|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|||818||818|1950 143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|2187|3808|lyfalmen|||03|1|0|6|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2187||2187|3808 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|4909|7028|lyfsjukr|||03|1|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4909||4909|7028 143412|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|778|1896|lyfalmen|||07|5|0|0|Vistor hf|Novartis Healthcare A/S-|||778||778|1896 143413|S01JX|Methocel 2%|lausn|20|mg/ml|30|ml|1|glas||S01|01.05.1998||R|A||0|0|0|0|PCO|0|0|1|100|IKR|1370|2700|lyfalmen|||00|30|1|0|Distica|Distica - óskráð lyf|||1370||1370|2700 143511|J07BC2002|Twinrix Peadriatric|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|3340|5373|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|||3340||3340|5373 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|A|3|0|0|0|0|ALC|0|0|0|100|USD|943|2120|lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon|||943||943|2120 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|þpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1859|3363|lyfalmen|||00|2|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1859||1859|3363 143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|þpakki||N02CX02|01.04.1974||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2375|4063|lyfalmen|||00|100|0|25|Vistor hf|Boehringer Ingelheim|||2375||2375|4063 143653|N06AB0403|Cipramil (D.A.C.)|töflur|20|mg|98|stk|1|glas||N06AB04|01.11.2008||R|A|3|0|0|B|0|DAC|0|1|0|30|DKK|11503|6431|lyfalmen|V0926|4223|00|98|0|98|D.A.C. ehf|D.A.C. ehf|||4120||4120|6431 143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|981|2172|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|||981||981|2172 143800|N05AN0101|Litarex|forðatfl|564|mg|100|stk|1|glas||N05AN01|01.04.1974||R|A|5|0|0|*|0|AGT|0|1|0|100|DKK|1281|2579|lyfalmen|||10|100|0|25|Actavis Group hf|Actavis Group hf|||1281||1281|2579 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|2971|4872|lyfalmen|V0429|4834|00|3|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2971||2971|4872 143917|L01DB0301|Farmorubicin|stl|2|mg/ml|5|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|4495|6436|lyfsjukr|||02|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4495||4495|6436 143933|L01DB0301|Farmorubicin|stl|2|mg/ml|10|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|8640|12370|lyfsjukr|||02|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||8640||8640|12370 144030|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|A|2|0|0|E|0|MSD|0|0|0|100|XEU|4021|6297|lyfalmen|||10|100|0|17|Icepharma hf|M.S.D.|||4021||4021|6297 144089|J07BC0203|Vaqta|bóluefni|50|ein|1|ml|1|spr|áfyllt spr. með nál|J07BC02|01.03.2001||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|5066|7715|lyfalmen|||51|1|0|0|Icepharma hf|Sanofi Pasteur MSD|||5066||5066|7715 144105|L01DB0301|Farmorubicin|stl|2|mg/ml|25|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|15800|21539|lyfsjukr|||02|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||15800||15800|21539 144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|102214|129124|lyfsjukr|||AC|2|0|22|Vistor hf|Novo-Nordisk|||102214||102214|129124 144330|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|glas||A02BC01|01.02.2009||L|A|3|0|0|0|0|AGT|0|0|0|30|IKR|||lyflausa|||0|28|0|28|Actavis Group hf|Actavis Group hf|||||| 144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|64178|81769|lyfsjukr|||AC|2|0|15|Vistor hf|Novo-Nordisk|||64178||64178|81769 144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|41728|53819|lyfsjukr|||AC|2|0|7|Vistor hf|Novo-Nordisk|||41728||41728|53819 144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|958|2140|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|||958||958|2140 144964|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|445|1444|lyfalmen|||00|24|0|8|Actavis Group hf|Actavis Group hf|||445||445|1444 144980|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|770|1885|lyfalmen|||00|24|0|20|Actavis Group hf|Actavis Group hf|||770||770|1885 145292|J07BC0203|Vaqta|bóluefni|25|ein|0,5|ml|1|spr|áfyllt spr. með nál|J07BC02|01.03.2001||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|3391|5442|lyfalmen|||51|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||3391||3391|5442 145508|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|5257|7974|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|||5257||5257|7974 145540|P02CX0101|Vanquin|mixtúra|10|mg/ml|30|ml|1|glas||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|DKK|||lyfalmen|||24|30|0|0|Vistor hf|Recip AB||||||0 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|þpakki||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|DKK|||lyfalmen|||23|8|0|0|Vistor hf|Recip AB||||||0 145631|P02CX0101|Vanquin|töflur|50|mg|32|stk|1|þpakki||P02CX01|01.01.1995||L|A|3|0|0|0|0|REP|0|0|0|100|DKK|||lyfalmen|||23|32|0|0|Vistor hf|Recip AB||||||0 145698|N05AH0301|Zyprexa|húðuðtfl|10|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|22310|29961|lyfalmen|||00|28|0|28|Icepharma hf|Eli Lilly Nederland -|||22310||22310|29961 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|þpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|753|1862|lyfalmen|||41|10|0|2|Vistor hf|Sanofi-aventis Norge AS|||753||753|1862 147512|G03DA0202|Perlutex|töflur|5|mg|50|stk|1|þpakki||G03DA02|01.03.1981||R|A|5|0|0|E|0|LEP|0|0|0|100|DKK|1355|2679|lyfalmen|||00|50|0|50|Vistor hf|LEO Pharma A/S|||1355||1355|2679 147702|B05AA0501|Macrodex 60 mg/ml med glukos|irl|0| |500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|12798|17801|lyfsjukr|||00|6000|0|6|Icepharma hf|Meda AB|||12798||12798|17801 147728|B05AA0508|Rheomacrodex med glukos|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|20459|27339|lyfsjukr|||00|6000|0|6|Icepharma hf|Meda AB|||20459||20459|27339 147926|J01GB0301|Garamycin|stl|40|mg/ml|2|ml|100|hgl||J01GB03|01.12.1975||R|A|5|0|0|0|1|SCP|0|0|0|100|DKK|43240|55701|lyfsjukr|||02|200|0|33|Vistor hf|Schering-Plough|||43240||43240|55701 148213|R05CB1301|Pulmozyme|innúðal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|K|2|0|0|0|0|ROA|0|0|1|100|DKK|130770|164994|lyfalmen|||00|750|0|30|Icepharma hf|Roche as|||130770||130770|164994 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|þpakki||N04AA02|01.11.2005||R|A|5|0|0|*|0|LFS|0|1|0|100|DKK|1130|2374|lyfalmen|||00|100|0|20|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|||1130||1130|2374 148650|G03AA0703|Neogynon|töflur|0| |63|stk|1|þpakki||G03AA07|01.12.1974|31.12.2008|R|A|5|0|0|0|0|SAG|0|0|0|100|SEK|1105|2340|lyfalmen|||23|63|0|84|Icepharma hf|Schering AG|||1105||1105|2340 148939|D05AX5202|Daivobet (D.A.C.)|smyrsli|0||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.11.2008||R|A|2|0|0|B|0|DAC|0|0|0|100|DKK|16687|20188|lyfalmen|V2001|20188|00|120|0|120|D.A.C. ehf|D.A.C. ehf|||14460||14460|20188 148972|C09DA0304|Diovan Comp 160/12,5 mg (D.A.C.)|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.11.2008||R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|16174|22322|lyfalmen|V0192|18626|00|98|0|196|D.A.C. ehf|D.A.C. ehf|||||16174|22322 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|A|3,25|0|0|0|0|BAN|1|0|0|100|DKK|3876|7554|vetalmen|||27|25|0|0|Vistor hf|Bayer Animal Health GmbH|||3876||3876|7554 149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|þpakki||N05AG02|01.03.2004||R|A|5|0|0|0|0|PCO|0|1|0|100|IKR|1719|3173|lyfalmen|||00|75|1|19|Distica|Distica - óskráð lyf|||1719||1719|3173 150243|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|SEK|14326|20021|lyfalmen|||10|100|0|50|Icepharma hf|Sandoz GmbH|||14326||14326|20021 150996|J07AH0401|Mencevax ACWY|stl|50|mcg|0,5|ml|1|hgl||J07AH04|01.11.2008||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3508|5601|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||3508|5601 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|7652|11225|lyfalmen|||02|10|0|50|Lundbeck Export A/S|H. Lundbeck A/S|||7652||7652|11225 151217|G01AF0102|Flagyl|sk-stil|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1015|2218|lyfalmen|||05|10|0|10|Vistor hf|Sanofi-aventis Norge AS|||1015||1015|2218 151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|17017|23371|lyfalmen|||00|28|0|28|Lundbeck Export A/S - útibú Íslandi|H. Lundbeck A/S|||||17017|23371 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|52544|67602|lyfalmen|||00|28|0|98|Lundbeck Export A/S - útibú Íslandi|H. Lundbeck A/S|||||52544|67602 151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.05.2006||R|A|3|0|0|E|0|MYL|0|0|0|100|SEK|6365|9478|lyfalmen|V0437|9478|00|90|0|90|Actavis Group PTC ehf|Mylan AB|||||6365|9478 151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|1715|3168|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1715||1715|3168 151944|N06AA1201|Sinquan|hylki|10|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|1183|2446|lyfalmen|||10|100|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1183||1183|2446 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|746|1068|lyfsjukr|||02|5|0|0|Vistor hf|Novartis Healthcare A/S-|||746||746|1068 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PFI|0|0|1|100|DKK|||lyfalmen|||23|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS||||||0 152397|R03BA0202|Pulmicort Turbuhaler|innúðadu|100|mcg/sk|200|sk|1|stauk||R03BA02|01.04.1991||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|3971|6229|lyfalmen|||23|200|0|25|Vistor hf|AstraZeneca A/S DK|||3971||3971|6229 152413|R03BA0202|Pulmicort Turbuhaler|innúðadu|200|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|6146|9181|lyfalmen|||23|200|0|50|Vistor hf|AstraZeneca A/S DK|||6146||6146|9181 152421|R03BA0202|Pulmicort Turbuhaler|innúðadu|400|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|ASZ|0|0|0|100|SEK|9922|14305|lyfalmen|||23|200|0|100|Vistor hf|AstraZeneca UK Ltd|||9922||9922|14305 152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|þpakki||J02AC02|01.01.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|1671|3108|lyfalmen|||10|4|0|2|Vistor hf|Janssen-Cilag AB|||1671||1671|3108 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|þpakki||R06AE07|01.01.1998||L|A|3|0|0|E|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|10|0|10|Actavis Group hf|Actavis hf||||||1185 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|1790|3269|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||1790||1790|3269 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|þpakki||R06AE07|01.01.1998||L|A|3|0|0|E|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf||||||1766 153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2024|3587|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|||2024||2024|3587 153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|1617|3035|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|||1617||1617|3035 153288|R06AE0704|Histasin|töflur|10|mg|100|stk|1|þpakki||R06AE07|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|2214|3845|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|||2214||2214|3845 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|A|3|0|0|0|1|GSC|0|0|0|100|DKK|395581|494366|lyfsjukr|||00|10|0|14|Swedish Orphan International AB|Gilead Science International (S) |||395581||395581|494366 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|þpakki||J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|5599|8438|lyfalmen|||10|15|0|8|Vistor hf|Janssen-Cilag AB|||5599||5599|8438 153593|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|5|lykjur||B03BA03|01.12.1972||R|A|2|0|0|E|0|HEX|0|0|1|100|DKK|7306|10755|lyfalmen|||02|5|0|250|Vistor hf|Hexal A/S|||7306||7306|10755 153734|L01CA0101|Velbe|sts|10|mg/hgl|1|sk|1|hgl||L01CA01|01.01.1998||R|K||0|1|0|1|LDR|0|0|0|100|IKR|2880|4123|lyfsjukr|||00|1|1|0|Parlogis hf|Parlogis - óskráð lyf|||2880||2880|4123 154484|G04CA0102|Xatral Uno|forðatfl|10|mg|30|stk|1|þpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|5507|8314|lyfalmen|||00|30|0|40|Vistor hf|Sanofi-aventis Norge AS|||5507||5507|8314 154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|pakki|þp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|1440|2795|lyfalmen|||10|20|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1440||1440|2795 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|pakki|þp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|5637|8490|lyfalmen|||10|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5637||5637|8490 154732|G04CA0102|Xatral Uno|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|11667|16673|lyfalmen|||00|90|0|120|Vistor hf|Sanofi-aventis Norge AS|||11667||11667|16673 155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|K|3|0|0|*|0|GSK|0|0|0|100|GBP|1235|2516|lyfalmen|||00|25|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1235||1235|2516 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|1798|3280|lyfalmen|||00|100|0|17|Lundbeck Export A/S|H. Lundbeck A/S|||1798||1798|3280 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|557|1596|lyfalmen|||00|100|0|5|Lundbeck Export A/S|H. Lundbeck A/S|||557||557|1596 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|þpakki||J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|10593|15216|lyfalmen|||00|28|0|14|Vistor hf|Janssen-Cilag AB|||10593||10593|15216 155903|J05AF0101|Retrovir|mixtúra|10|mg/ml|200|ml|1|glas||J05AF01|01.07.1995|31.12.2008|R|A|2|0|1|0|1|GSK|0|0|0|100|GBP|6472|9266|lyfsjukr|||63|200|0|3|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||6472||6472|9266 156505|A08AB0101|Xenical|hylki|120|mg|42|stk|1|þpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|6760|10014|lyfalmen|||00|42|0|14|Icepharma hf|Roche|||6760||6760|10014 156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|þpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|9890|14262|lyfalmen|||00|84|0|28|Icepharma hf|Roche|||||9890|14262 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|þpakki||P02CA01|01.12.1982||R|A|5|0|0|0|0|JAS|0|0|0|100|SEK|341|1303|lyfalmen|||00|6|0|3|Vistor hf|Janssen-Cilag AB|||341||341|1303 157206|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdæla|26|g|10|spr|.|QP52AF02|01.04.1992||R|A|1|0|0|0|0|PAL|0|0|0|100|DKK|7795|13490|vetorma|||16|260|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||7795||7795|13490 157598|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyfalmen|||00|96|0|13|D.A.C. ehf|D.A.C. ehf|||||| 157609|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyfalmen|||00|204|0|27|D.A.C. ehf|D.A.C. ehf|||||| 157642|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyfalmen|||00|204|0|14|D.A.C. ehf|D.A.C. ehf|||||| 157768|S01AA3001|Terramycin Polymyxin B|augnsm|0| |3,5|g|1|túpa||S01AA30|01.01.2000||R|S|5|0|0|E|0|PCO|0|0|1|100|IKR|554|1592|lyfalmen|||07|4|1|0|Distica|Distica - óskráð lyf|||554||554|1592 157909|D07XC0101|Diprosalic|áburður|0| |100|ml|1|glas||D07XC01|01.01.1987||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|3601|5727|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|||3601||3601|5727 158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|þpakki||N03AF01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|1076|2301|lyfalmen|||00|50|0|10|Vistor hf|Novartis Healthcare A/S-|||1076||1076|2301 158683|H01BB0201|Syntocinon|nefúði|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.07.1988||R|K|4|0|0|E|0|NOH|0|0|0|100|DKK|1197|2465|lyfalmen|||23|5|0|13|Vistor hf|Novartis Healthcare A/S-|||1197||1197|2465 158725|M01AB0515|Diklofenak Merck NM|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.12.2008||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|901|2063|lyfalmen|V0608|2063|10|100|0|50|Actavis Group PTC ehf|Mylan AB|||||901|2063 158729|C07AB0208|Selo-ZOC (D.A.C.)|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.11.2008||R|A|3|0|0|B|0|DAC|0|0|0|100|SEK|2125|3724|lyfalmen|V2003|3724|00|98|0|31|D.A.C. ehf|D.A.C. ehf|||||2125|3724 159107|N02AB0303|Fentanyl Actavis|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|3757|5939|lyfalmen|V1050|5939|00|5|0|21|Actavis Group hf|Actavis Group PTC ehf|||||3757|5939 159118|N02AB0303|Fentanyl Actavis|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|7235|10659|lyfalmen|V1051|10659|00|5|0|42|Actavis Group hf|Actavis Group PTC ehf|||||7235|10659 159130|N02AB0303|Fentanyl Actavis|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|10124|14579|lyfalmen|V1052|14579|00|5|0|62|Actavis Group hf|Actavis Group PTC ehf|||||10124|14579 159141|N02AB0303|Fentanyl Actavis|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|12171|17338|lyfalmen|V1053|17338|00|5|0|83|Actavis Group hf|Actavis Group PTC ehf|||||12171|17338 159517|N06AB0401|Cipramil|töflur|20|mg|56|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|30|DKK|6946|4751|lyfalmen|V0925|3253|00|56|0|56|Lundbeck Export A/S|H. Lundbeck A/S|||2882||2882|4751 159533|L02BG0601|Aromasin|töflur|25|mg|30|stk|1|þpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PFI|0|0|0|100|DKK|27502|36425|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||27502||27502|36425 159541|N06AB0401|Cipramil|töflur|40|mg|56|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|30|DKK|14218|12909|lyfalmen|V0929|7881|00|56|0|112|Lundbeck Export A/S|H. Lundbeck A/S|||8893||8893|12909 159558|N06AB0401|Cipramil|töflur|10|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|30|DKK|2010|2605|lyfalmen|V0921|1893|00|28|0|14|Lundbeck Export A/S|H. Lundbeck A/S|||1300||1300|2605 159632|N06AB0401|Cipramil|töflur|20|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|30|DKK|3481|3727|lyfalmen|V0923|2562|00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|||2127||2127|3727 159640|N06AB0401|Cipramil|töflur|40|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|30|DKK|7172|5016|lyfalmen|V0927|3332|00|28|0|56|Lundbeck Export A/S|H. Lundbeck A/S|||3077||3077|5016 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|A|3|0|0|0|1|ACA|0|0|0|100|DKK|181691|228073|lyfsjukr|||00|2|0|1|Actavis Group PTC ehf|Actavis Group PTC ehf|||181691||181691|228073 159806|QG51BE0001|Streptoc. m/sulfadim., vet.|legstil|0| |50|stk|50|stilar||QG51BE00|01.11.1979||R|A|2|0|0|0|0|BID|1|0|0|100|DKK|10833|20806|vetalmen|||00|2500|0|0|Vistor hf|Boehringer Ingelheim Danmark|||10833||10833|20806 160051|C07AA0701|Sotacor|töflur|160|mg|100|stk|1|þpakki||C07AA07|01.05.1983|31.12.2008|R|A|4|0|0|B|0|BRS|0|0|0|100|DKK|||lyfalmen|||00|100|0|100|Vistor hf|Bristol-Myers Squibb|||2395||| 160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|A|3|0|0|0|1|AGT|0|0|0|100|DKK|2431|3481|lyfsjukr|||02|50|0|25|Actavis Group hf|Actavis Group hf|||2431||2431|3481 160408|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|45479|58489|lyfsjukr|||00|100|0|0|Icepharma hf|GE Healthcare AS|||45479||45479|58489 160457|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|68218|86799|lyfsjukr|||00|150|0|0|Icepharma hf|GE Healthcare AS|||68218||68218|86799 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|þpakki||N05AB04|01.06.1981||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|859|2006|lyfalmen|||00|100|0|5|Vistor hf|Sanofi-aventis Norge AS|||859||859|2006 160531|C10AC0101|Questran|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1988||R|A|5|0|0|0|0|BRS|0|0|0|100|DKK|2532|4276|lyfalmen|||42|50|0|14|Vistor hf|Bristol-Myers Squibb|||2532||2532|4276 160622|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|90958|115110|lyfsjukr|||00|200|0|0|Icepharma hf|GE Healthcare AS|||90958||90958|115110 160739|M01AB0515|Diklofenak Merck NM|sþ-tfl|50|mg|30|stk|1|þpakki||M01AB05|01.12.2008||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|341|1303|lyfalmen|||10|30|0|15|Actavis Group PTC ehf|Mylan AB|||||341|1303 160945|N02AA5901|Panocod|freyðit|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|335|1295|lyfalmen|||14|20|0|7|Vistor hf|Sanofi-aventis Norge AS|||335||335|1295 161065|J05AG0401|Intelence|töflur|100|mg|120|stk|1|glas||J05AG04|01.02.2009||R|A|2|0|1|0|1|JCI|0|0|0|100|SEK|79526|100877|lyfsjukr|||0|120|0|30|Vistor hf|Janssen-Cilag International N.V.|||||79526|100877 161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|A|2|0|0|B|0|PFI|0|0|1|100|DKK|819|1952|lyfalmen|||03|1|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||819||819|1952 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|1917|2745|lyfsjukr|||03|1|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1917||1917|2745 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|3288|4708|lyfsjukr|||03|5|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3288||3288|4708 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|752|1861|lyfalmen|||03|1|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||752||752|1861 161133|G03CA0306|Evorel|forðapl|75|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|5141|7817|lyfalmen|||23|26|0|136|Vistor hf|Janssen-Cilag AB|||5141||5141|7817 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|þpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PFI|0|0|0|100|DKK|71918|91723|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||71918||71918|91723 161802|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|USD|2976|4261|lyfsjukr|||00|2|0|1|Icepharma hf|Wyeth AB|||2976||2976|4261 161901|D11AC0301|Selsun|hársápa|25|mg/ml|120|ml|1|glas||D11AC03|01.12.1972||L|A|3|0|0|0|0|CHT|0|0|0|100|DKK|||lyflausa|||01|120|0|120|Vitaflo Scandinavia AB|Chattem Clobal Consumer Products|||||| 162016|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|USD|6080|8705|lyfsjukr|||00|5|0|2|Icepharma hf|Wyeth AB|||6080||6080|8705 162305|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|USD|16258|22109|lyfsjukr|||00|18|0|6|Icepharma hf|Wyeth AB|||16258||16258|22109 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|0|100|DKK|2533|4278|lyfalmen|||00|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2533||2533|4278 162933|R03BA0501|Flixotide|innúðal|50|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|2163|3776|lyfalmen|||24|120|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2163||2163|3776 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.12.1972||R|A|2|1|0|0|0|NOH|0|0|0|100|DKK|1275|2571|lyfalmen|||00|30|0|10|Vistor hf|Novartis Healthcare A/S-|||||1275|2571 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|þpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|1656|3088|lyfalmen|||41|30|0|6|Vistor hf|Sanofi-aventis Norge AS|||1656||1656|3088 163274|C03AA0304|Dehydratin Neo|töflur|25|mg|20|stk|1|pakki||C03AA03|01.02.2009||R|A|3|0|0|E|0|AEA|0|0|0|100|XEU|217|1135|lyfalmen|||0|20|0|20|Actavis hf|Asctavis EAD|||||217|1135 163493|R03BA0501|Flixotide|innúðal|125|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|2882|4751|lyfalmen|||24|120|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2882||2882|4751 163709|V03AE0101|Resonium|duft|0| |454|g|1|stauk||V03AE01|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|6575|9763|lyfalmen|||00|454|1|0|Parlogis hf|Parlogis - óskráð lyf|||6575||6575|9763 164251|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.06.2001||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|2720|4532|lyfalmen|||00|25|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2720||2720|4532 164871|A07EC0204|Asacol|eþ-stil|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|SCH|0|0|0|100|SEK|6422|9555|lyfalmen|V0299|9555|98|60|0|20|Icepharma hf|Schering Oy|||6422||6422|9555 165001|C05AA0102|Proctosedyl|eþ-stil|0| |12|stk|1|pakki||C05AA01|01.12.1972||L|K|1,5|0|0|0|0|SNO|0|0|0|100|NOK|||lyfalmen|||04|12|0|0|Vistor hf|Sanofi-aventis Norge AS||||||0 165019|C05AA0102|Proctosedyl|eþ-smyr|0| |30|g|1|túpa||C05AA01|01.03.1981||L|A|3|0|0|0|0|SNO|0|0|0|100|IKR|||lyfalmen|||00|30|0|0|Vistor hf|Sanofi-aventis Norge AS||||||0 165431|C08CA0202|Plendil|forðatfl|2,5|mg|98|stk|1|þpakki||C08CA02|01.01.1992||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|5095|7755|lyfalmen|||43|98|0|49|Vistor hf|AstraZeneca A/S DK|||5095||5095|7755 165449|C08CA0202|Plendil|forðatfl|10|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|4448|6877|lyfalmen|V0324|3906|43|98|0|196|Vistor hf|AstraZeneca A/S DK|||4448||4448|6877 165548|C08CA0202|Plendil|forðatfl|5|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2871|4736|lyfalmen|V0316|2769|43|98|0|98|Vistor hf|AstraZeneca A/S DK|||2871||2871|4736 165589|QH02AB0602|Prednisolonacetat, vet."Intervet"|stl|10|mg/ml|50|ml|5|hgl||QH02AB06|01.12.1972||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|7371|14212|vetalmen|||58|250|0|0|Icepharma hf|Intervet International B.V.|||7371||7371|14212 165639|H01CA0201|Synarela|nefúði|200|mcg/sk|4|ml|1|stauk|30 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PFI|0|0|0|100|DKK|15454|21425|lyfalmen|||23|4|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||15454||15454|21425 165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|þpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCB|0|0|1|100|SEK|905|2069|lyfalmen|||00|100|0|50|Vistor hf|U.C.B|||905||905|2069 165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|þpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCB|0|0|1|100|SEK|321|1276|lyfalmen|||00|25|0|12|Vistor hf|U.C.B|||321||321|1276 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.12.1972||L|A|5|0|0|0|0|UCB|0|0|1|100|SEK|||lyfalmen|||00|10|0|5|Vistor hf|U.C.B||||||0 165894|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|227395|284974|lyfsjukr|||00|500|0|0|Icepharma hf|GE Healthcare AS|||227395||227395|284974 165928|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|fl|plastfl.|V08AB09|01.05.1999||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|13480|18650|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||13480||13480|18650 166033|R06AB0201|Polaramin|forðatfl|6|mg|100|stk|1|þpakki||R06AB02|01.06.1980||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|2653|4441|lyfalmen|||10|100|0|100|Vistor hf|Schering-Plough|||2653||2653|4441 166090|N05AA0401|Plegicil|töflur|10|mg|10|stk|1|glas||N05AA04|01.03.2007||R|A|5|0|0|0|0|PSW|0|0|0|100|SEK|939|2115|lyfalmen|||00|10|0|1|Vistor hf|Pharmaxim Sweden AB|||939||939|2115 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|þpakki||P01BA02|01.12.1972||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|2278|3932|lyfalmen|||00|100|0|39|Vistor hf|Sanofi-aventis Norge AS|||2278||2278|3932 166165|H01CA0201|Synarela|nefúði|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PFI|0|0|0|100|DKK|17495|23966|lyfalmen|||23|8|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||17495||17495|23966 166272|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|fl|plastfl.|V08AB09|01.05.1999||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|15297|20912|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||15297||15297|20912 166918|J02AA0102|Amphocil|irs|50|mg/hgl|1|hgl|1|pakki||J02AA01|01.04.1996||R|A|2|0|0|0|1|TRP|0|0|0|100|SEK|26529|34896|lyfsjukr|||00|1|0|1|Vitaflo Scandinavia AB|Three Rivers Pharmaceuticals Limited|||26529||26529|34896 167007|J02AA0102|Amphocil|irs|100|mg/hgl|1|hgl|1|pakki||J02AA01|01.04.1996||R|A|2|0|0|0|1|TRP|0|0|0|100|SEK|53058|67925|lyfsjukr|||00|1|0|3|Vitaflo Scandinavia AB|Three Rivers Pharmaceuticals Limited|||53058||53058|67925 168716|N03AF0105|Tegretol Retard|forðatfl|200|mg|50|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1228|2507|lyfalmen|||10|50|0|10|Vistor hf|Novartis Healthcare A/S-|||1228||1228|2507 168740|N03AF0105|Tegretol Retard|forðatfl|200|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3996|6263|lyfalmen|V0789|6235|10|200|0|40|Vistor hf|Novartis Healthcare A/S-|||3996||3996|6263 168815|N03AF0105|Tegretol Retard|forðatfl|400|mg|30|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1285|2584|lyfalmen|||10|30|0|12|Vistor hf|Novartis Healthcare A/S-|||1285||1285|2584 168971|N03AF0105|Tegretol Retard|forðatfl|400|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|7467|10973|lyfalmen|V0713|10675|10|200|0|80|Vistor hf|Novartis Healthcare A/S-|||7467||7467|10973 168997|L01CA0401|Navelbine|irþ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|47794|61371|lyfsjukr|||00|10|0|0|Vistor hf|Pierre Fabre Pharma|||47794||47794|61371 169433|L01CA0401|Navelbine|irþ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|217072|272122|lyfsjukr|||00|50|0|0|Vistor hf|Pierre Fabre Pharma|||217072||217072|272122 169524|J01AA0203|Doxytab|töflur|100|mg|14|stk|1|glas||J01AA02|01.07.1993|31.12.2008|R|A|4|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|14|0|14|Actavis Group hf|Actavis hf|||720||| 169540|P01BB0101|Paludrin|töflur|100|mg|100|stk|1|glas||P01BB01|01.01.1998||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1500|2876|lyfalmen|||00|100|1|50|Distica|Distica - óskráð lyf|||1500||1500|2876 169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|A|3|0|0|0|1|ROA|0|0|0|30|DKK|26010|34250|lyfsjukr|||00|5|0|5|Icepharma hf|Roche as|||26010||26010|34250 169664|J07BK0101|Varilrix|bóluefni|0| |0,5|ml|1|hgl|þurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|5386|8149|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||5386||5386|8149 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3188|5167|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|||3188||3188|5167 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3424|5487|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|||3424||3424|5487 170092|J07BC2001|Twinrix Adult|bóluefni|0| |1|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|4933|7535|lyfalmen|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|||4933||4933|7535 170225|R01AA0702|Otrivin|nefdr|1|mg/ml|10|ml|1|glas||R01AA07|01.12.1972||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||06|10|0|12|Artasan ehf|Novartis Healthcare A/S-A||||||0 170233|R01AA0702|Otrivin|nefdr|0,5|mg/ml|10|ml|1|glas||R01AA07|01.12.1972||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||06|10|0|6|Artasan ehf|Novartis Healthcare A/S-A||||||0 170514|C01BC0301|Rytmonorm|töflur|150|mg|100|stk|1|þpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|XEU|5240|7951|lyfalmen|||59|100|0|50|Vistor hf|Abbott Scandinavia AB|||5240||5240|7951 170548|C01BC0301|Rytmonorm|töflur|300|mg|100|stk|1|þpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|XEU|9625|13902|lyfalmen|||59|100|0|100|Vistor hf|Abbott Scandinavia AB|||9625||9625|13902 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|1461|2823|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||1461||1461|2823 170712|A07AA0901|Vancocin|hylki|125|mg|30|stk|1|þpakki|hart hylki|A07AA09|01.10.1988||R|A|2|0|0|E|0|NMA|0|0|1|100|IKR|10000|14411|lyfalmen|V0125|14411|10|30|0|2|Icepharma hf|NordMedica A/S|||10000||10000|14411 170845|A07AA0901|Vancocin|hylki|250|mg|30|stk|1|þpakki|hart hylki|A07AA09|01.10.1988|31.12.2008|R|A|2|0|0|E|0|NMA|0|0|1|100|IKR|||lyfalmen|||10|30|0|4|Icepharma hf|NordMedica A/S|||20000||| 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|3212|5199|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||3212||3212|5199 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|3461|5537|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||3461||3461|5537 171777|H03BB0101|Neo-Mercazole|töflur|5|mg|100|stk|1|glas||H03BB01|01.08.2005||R|A||0|0|B|0|LDR|0|0|0|100|IKR|732|1834|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||732||732|1834 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|3921|6161|lyfalmen|V0709|6161|00|60|0|5|Vistor hf|Janssen-Cilag AB|||3921||3921|6161 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|6454|9599|lyfalmen|V0710|9599|00|60|0|10|Vistor hf|Janssen-Cilag AB|||6454||6454|9599 171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|47965|61584|lyfsjukr|||02|75|0|0|Icepharma hf|Bayer Schering Pharma AG|||47965||47965|61584 172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|41204|53166|lyfsjukr|||02|50|0|0|Icepharma hf|Bayer Schering Pharma AG|||41204||41204|53166 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|11656|16658|lyfalmen|V0711|16342|00|60|0|20|Vistor hf|Janssen-Cilag AB|||11656||11656|16658 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|23906|31948|lyfalmen|||00|60|0|40|Vistor hf|Janssen-Cilag AB|||23906||23906|31948 172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|71612|91024|lyfsjukr|||02|100|0|0|Icepharma hf|Bayer Schering Pharma AG|||71612||71612|91024 172619|L01AB0101|Myleran|töflur|2|mg|100|stk|1|glas||L01AB01|01.06.2001||R|A|3|0|0|*|0|GSK|0|0|0|100|GBP|2748|4570|lyfalmen|||00|100|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2748||2748|4570 172627|C07FB0202|Logimax forte|forðatfl|105|mg|98|stk|1|pakki|þp 10 + 95 mg|C07FB02|01.07.1999||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|13053|18436|lyfalmen|||00|98|0|0|Vistor hf|AstraZeneca A/S DK|||13053||13053|18436 172684|N02AA0303|Palladon|forðahlk|4|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|7124|10508|lyfalmen|||10|56|0|11|Icepharma hf|Norpharma |||7124||7124|10508 172692|N02AA0303|Palladon|forðahlk|8|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|13596|19112|lyfalmen|||10|56|0|22|Icepharma hf|Norpharma |||13596||13596|19112 172759|N02AA0303|Palladon|forðahlk|16|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|22613|30338|lyfalmen|||10|56|0|45|Icepharma hf|Norpharma |||22613||22613|30338 172767|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|hgl||J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2458|4176|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|||2458||2458|4176 172775|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2458|4176|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|||2458||2458|4176 172825|J07CA0203|DiTeKiPol|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07CA02|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|3501|5591|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|||3501||3501|5591 172874|D01AC0801|Fungoral|krem|20|mg/g|30|g|1|túpa||D01AC08|01.10.1989||R|A|5|0|0|0|0|JAS|0|0|1|100|SEK|889|2047|lyfalmen|||00|30|0|30|Vistor hf|Janssen-Cilag AB|||889||889|2047 172916|N02AA0303|Palladon|forðahlk|24|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|25960|34505|lyfalmen|||10|56|0|67|Icepharma hf|Norpharma |||25960||25960|34505 173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.12.1972||R|A|5|0|0|0|0|VAL|0|0|1|100|DKK|840|1980|lyfalmen|V0901|1959|00|50|0|50|Icepharma hf|Valeant Pharmaceuticals B.V.|||840||840|1980 173310|N05BE0107|Buspiron Merck NM|töflur|5|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MEK|0|0|1|100|SEK|2529|4272|lyfalmen|||00|100|0|17|Actavis Group PTC ehf|Merck NM AB (A)|||2529||2529|4272 173344|A06AG1101|Microlax|innhl|0| |5|ml|12|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|60|0|12|Vistor hf|McNeil Denmark ApS||||||3601 173518|N05BE0107|Buspiron Merck NM|töflur|10|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MEK|0|0|1|100|SEK|5399|8167|lyfalmen|||00|100|0|33|Actavis Group PTC ehf|Merck NM AB (A)|||5399||5399|8167 173641|M01AC0202|Tilcotil|töflur|20|mg|10|stk|1|þpakki||M01AC02|01.04.1988||R|A|5|0|0|E|0|MAS|0|0|1|100|DKK|1410|2191|lyfalmen|||00|10|0|10|Vistor hf|Meda AS|||995||995|2191 173856|N05CF0104|Zopiklon Merck NM|töflur|5|mg|30|stk|1|þpakki||N05CF01|01.10.2001||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|310|1261|lyfalmen|||00|30|0|20|Actavis Group PTC ehf|Merck NM AB|||310||310|1261 173898|N07AA0201|Mestinon|töflur|10|mg|250|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2087|3673|lyfalmen|||00|250|1|14|Parlogis hf|Parlogis - óskráð lyf|||2087||2087|3673 173948|N07AA0201|Mestinon|töflur|60|mg|150|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|9140|13244|lyfalmen|||00|150|1|50|Parlogis hf|Parlogis - óskráð lyf|||9140||9140|13244 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|1476|2113|lyfsjukr|||02|20|0|10|Actavis Group hf|Actavis Group hf|||1476||1476|2113 174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|þpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|592|1644|lyfalmen|||00|14|0|6|Vistor hf|Recip AB|||592||592|1644 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|þpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|605|1661|lyfalmen|||00|14|0|7|Vistor hf|Recip AB|||605||605|1661 174615|N05CF0104|Zopiklon Merck NM|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.09.1999||R|A|2|0|0|0|0|MNA|0|0|0|100|SEK|229|1151|lyfalmen|V0886|1142|00|30|0|30|Actavis Group PTC ehf|Merck NM AB|||229||229|1151 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|30|GBP|2451|3685|lyfalmen|V0507|3685|00|10|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2096||2096|3685 176214|N05AH0301|Zyprexa|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.1999||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|7448|5195|lyfalmen|V0809|4761|00|28|0|7|Icepharma hf|Eli Lilly Nederland -|||3209||3209|5195 177022|J01MA0101|Tarivid|töflur|200|mg|20|stk|1|þpakki||J01MA01|01.10.1988||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|4038|6320|lyfalmen|||00|20|0|10|Vistor hf|Sanofi-aventis Norge AS|||4038||4038|6320 177253|N03AG0101|Depakine|sh-tfl|200|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|705|1797|lyfalmen|||43|40|0|5|Vistor hf|Sanofi-aventis Norge AS|||705||705|1797 177295|M02AA1501|Voltaren Emulgel|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.10.2004||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|50|0|0|Artasan ehf|Novartis Healthcare A/S-A||||||0 177311|QJ51RC2202|Nafpenzal vet.|spenalyf|0| |3|g|4|spr||QJ51RC22|01.04.1985||R|A|2|0|0|0|0|INI|0|0|0|100|XEU|679|1340|vetalmen|||16|12|0|0|Icepharma hf|Intervet International B.V.|||679||679|1340 177360|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|A|2|0|0|B|0|SPL|0|0|1|100|DKK|785|1906|lyfalmen|||03|1|0|5|Vistor hf|Schering-Plough Europe|||785||785|1906 177741|D07CB0102|Kenalog Comp med Mycostatin|smyrsli|0| |15|g|1|túpa||D07CB01|01.12.1972|31.12.2008|R|A|4|0|0|B|0|BRS|0|0|1|100|DKK|533|1564|lyfalmen|||00|15|0|15|Vistor hf|Bristol-Myers Squibb|||533||533|1564 178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|A|3|0|0|E|0|PCO|0|0|1|100|IKR|426|1418|lyfalmen|||03|1|1|5|Distica|Distica - óskráð lyf|||426||426|1418 179267|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|12|hgl||M03AC09|01.01.1997||R|K|3|0|0|0|1|ORG|0|0|0|100|DKK|11296|15931|lyfsjukr|||00|60|0|0|Vistor hf|N.V. Organon|||11296||11296|15931 179333|R02AA0304|Strepsils Menthol|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.12.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|||||| 180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|A|5|0|0|B|0|UCB|0|0|0|100|DKK|6172|9216|lyfalmen|||10|100|0|25|Vistor hf|U.C.B|||6172||6172|9216 180539|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||06|10|0|12|Artasan ehf|Novartis Healthcare A/S-A||||||0 180646|C10AA0302|Pravachol|töflur|20|mg|98|stk|1|þpakki||C10AA03|01.08.2008||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|16451|22666|lyfalmen|||00|98|0|98|Vistor hf|Bristol-Myers Squibb|||16451||16451|22666 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|0| |5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|933|2107|lyfalmen|||30|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||933||933|2107 181131|J01EE0103|Primazol|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.04.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|XEU|791|1914|lyfalmen|||01|100|0|2|Actavis Group hf|Actavis hf|||791||791|1914 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|A|3|0|0|0|0|BAS|0|0|0|100|DKK|||lyfalmen|||23|50|0|5|Vistor hf|Bayer A/S||||||0 181396|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|glas||M01AE01|01.01.1988|31.12.2008|R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|30|0|15|Actavis Group hf|Actavis hf|||345||| 181552|QJ51DA3201|Pathozone, vet.|spenalyf|250|mg/dælu|10|ml|10|dælur|dæla + rýja|QJ51DA32|01.10.1995||R|A|1,5|0|0|0|0|PFV|0|0|0|100|DKK|7991|15393|vetalmen|||16|100|0|0|Icepharma hf|Pfizer vet.|||7991||7991|15393 181750|L01BA0105|Methotrexate Wyeth Lederle|irþ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|32907|42837|lyfsjukr|||00|10|0|0|Icepharma hf|Wyeth AB|||32907||32907|42837 181990|L01BA0105|Methotrexate Wyeth Lederle|irþ|100|mg/ml|50|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|44851|57707|lyfsjukr|||00|50|0|0|Icepharma hf|Wyeth AB|||44851||44851|57707 182170|QM01AG9001|Finadyne, vet.|kyrni|25|mg/g|10|g|10|skammt||QM01AG90|01.01.1991||R|A|2|0|0|0|0|SPA|0|0|0|100|DKK|5234|10141|vetalmen|||16|100|0|0|Vistor hf|Schering-Plough A/S|||5234||5234|10141 183293|D08AG0201|Betadine|smyrsli|100|mg/g|40|g|1|túpa||D08AG02|01.07.1988|31.12.2008|L|A|3|0|0|0|0|NAP|0|0|0|100|CHF|||lyflausa|||00|40|0|40|Icepharma hf|Napp|||||| 183319|D08AG0201|Betadine|smyrsli|100|mg/g|80|g|1|túpa||D08AG02|01.07.1988|31.12.2008|L|A|3|0|0|0|0|NAP|0|0|0|100|IKR|||lyfalmen|||00|80|0|80|Icepharma hf|Napp||||||0 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|A|2|0|0|0|0|SPA|1|0|0|100|DKK|5785|11191|vetalmen|||27|50|0|0|Vistor hf|Schering-Plough A/S|||5785||5785|11191 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|K|2|0|0|B|0|BRS|0|0|0|100|DKK|1275|2571|lyfalmen|||00|100|0|100|Vistor hf|Bristol-Myers Squibb|||1275||1275|2571 183947|P01AB0102|Flagyl|töflur|200|mg|21|stk|1|þpakki||P01AB01|01.10.1995||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|826|1961|lyfalmen|||41|21|0|2|Vistor hf|Sanofi-aventis Norge AS|||826||826|1961 184143|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|2|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|1622|3042|lyfalmen|||00|2|0|2|Vistor hf|AstraZeneca UK Ltd|||1622||1622|3042 184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|437|1433|lyfalmen|||08|100|0|2|Actavis Group hf|LEK Pharmaceuticals d.d.|||437||437|1433 184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|795|1919|lyfalmen|||08|100|0|5|Actavis Group hf|LEK Pharmaceuticals d.d.|||795||795|1919 184200|J01CR0201|Amoksiklav|töflur|375|mg|15|stk|1|glas|250+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|555|1594|lyfalmen|||00|15|0|4|Actavis Group hf|LEK Pharmaceuticals d.d.|||555||555|1594 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|A|3|0|0|B|0|SCH|0|0|0|100|SEK|4455|6886|lyfalmen|||98|700|0|5|Icepharma hf|Schering Oy|||4455||4455|6886 184259|L02BG0401|Femar|töflur|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|25015|33329|lyfalmen|||00|30|0|30|Vistor hf|Novartis Healthcare A/S-|||25015||25015|33329 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|66076|84450|lyfalmen|||00|100|0|100|Vistor hf|Novartis Healthcare A/S-|||||66076|84450 184309|R03DA0404|Theo-Dur|forðatfl|200|mg|100|stk|1|glas||R03DA04|01.11.1981|31.01.2009|R|A|3|0|0|B|0|BIP|0|0|0|100|SEK|1527|2913|lyfalmen|||10|100|0|50|Vistor hf|BioPhausia AB|||1527||1527|2913 184341|J01CR0201|Amoksiklav|töflur|625|mg|16|stk|1|glas|500+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1104|2339|lyfalmen|||00|16|0|8|Actavis Group hf|LEK Pharmaceuticals d.d.|||1104||1104|2339 184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|4886|7471|lyfalmen|||00|6|0|6|Vistor hf|AstraZeneca UK Ltd|||4886||4886|7471 184671|N06AX0306|Mianserin Merck NM|filmhtfl|10|mg|90|stk|1|þpakki||N06AX03|01.06.2008||R|A||0|0|B|0|MNA|0|1|0|100|SEK|1049|2264|lyfalmen|V1140|2264|00|90|0|15|Actavis Group PTC ehf|Merck NM AB|||1049||1049|2264 186742|R03DA0404|Theo-Dur|forðatfl|300|mg|100|stk|1|glas||R03DA04|01.11.1981|31.01.2009|R|A|3|0|0|B|0|BIP|0|0|0|100|SEK|2166|3780|lyfalmen|||10|100|0|75|Vistor hf|BioPhausia AB|||2166||2166|3780 187203|B01AA0101|Dicumarol|töflur|20|mg|100|stk|1|glas||B01AA01|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|3601|5727|lyfalmen|||00|100|1|20|Distica|Distica - óskráð lyf|||3601||3601|5727 188532|R03BA0202|Pulmicort Turbuhaler|innúðadu|400|mcg/sk|50|sk|1|stauk||R03BA02|01.10.1993|31.12.2008|R|A|2|0|0|0|1|AZD|0|0|0|100|IKR|2824|4043|lyfsjukr|||23|50|0|25|Vistor hf|AstraZeneca A/S DK|||2824||2824|4043 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|3145|5108|lyfalmen|||00|250|0|10|Vistor hf|Desitin Artzneimittel|||3145||3145|5108 188987|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.12.1972||R|A|4|0|0|*|0|GPL|0|0|0|100|XEU|2184|3804|lyfalmen|||00|100|0|33|Icepharma hf|Goldshield Pharmaceuticals Ltd|||2184||2184|3804 189126|L02BB0301|Casodex|töflur|150|mg|30|stk|1|þpakki||L02BB03|01.05.2000||R|A|4|0|0|*|0|ASZ|0|0|0|100|SEK|51098|60714|lyfalmen|V0561|60714|00|30|0|90|Vistor hf|AstraZeneca UK Ltd|||47011||47011|60714 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|A|4|0|0|0|1|NOV|0|0|0|100|DKK|11169|15773|lyfsjukr|||00|10|0|0|Icepharma hf|Novartis Healthcare A/S|||11169||11169|15773 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|3259|5263|lyfalmen|||03|5|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3259||3259|5263 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|1394|2732|lyfalmen|||03|2|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1394||1394|2732 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|730|1831|lyfalmen|||03|1|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||730||730|1831 190702|M01AB0101|Confortid|eþ-stil|100|mg|10|stk|1|pakki||M01AB01|01.12.1972||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|866|2016|lyfalmen|||04|10|0|10|Actavis Group hf|Actavis Group hf|||866||866|2016 190728|M01AB0101|Confortid|eþ-stil|50|mg|10|stk|1|pakki||M01AB01|01.12.1972||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|469|1477|lyfalmen|||04|10|0|5|Actavis Group hf|Actavis Group hf|||469||469|1477 190751|M01AB0101|Confortid|hylki|25|mg|100|stk|1|glas||M01AB01|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|1902|3421|lyfalmen|||10|100|0|25|Actavis Group hf|Actavis Group hf|||1902||1902|3421 191064|B05XC03|Vitalipid Infant|irþ|0| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|4797|6868|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|||4797||4797|6868 191247|B05XC02|Vitalipid Adult|irþ|0| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|4892|7004|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|||4892||4892|7004 191254|B05XC01|Soluvit|irs|0| |10|ml|10|hgl||B05XC|01.10.1985||R|K||0|0|0|1|FRP|0|0|0|100|DKK|6317|9044|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|||6317||6317|9044 191403|R01AA0503|Nezeril|nefúði|0,25|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyfalmen|||23|8|0|5|Vistor hf|AstraZeneca A/S DK||||||0 191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|532|1562|lyfalmen|||07|4|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||532||532|1562 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |100|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1724|3180|lyfalmen|||10|100|0|100|Vistor hf|LEO Pharma A/S|||1724||1724|3180 192625|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |25|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|480|1492|lyfalmen|||10|25|0|25|Vistor hf|LEO Pharma A/S|||480||480|1492 193573|R06AB0201|Polaramin|forðatfl|6|mg|25|stk|1|þpakki||R06AB02|01.10.1991||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|723|1822|lyfalmen|||10|25|0|25|Vistor hf|Schering-Plough|||723||723|1822 193821|A12AA0601|Calcium-Sandoz|freyðit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|A|3|0|0|0|0|SAN|0|0|0|100|IKR|||lyfalmen|||14|20|0|22|Vistor hf|Sandoz A/S||||||1665 193862|A12AA0201|Calcium Sandoz|stl|100|mg/ml|10|ml|5|lykjur||A12AA02|01.12.1972||R|A|5|0|0|0|0|SAN|0|0|0|100|DKK|1208|2480|lyfalmen|||02|50|0|3|Vistor hf|Sandoz A/S|||1208||1208|2480 194076|N02CA5201|Cafergot|töflur|0| |20|stk|1|þpakki||N02CA52|01.03.1999||R|A|3|0|0|E|0|LDR|0|0|0|100|IKR|2645|4430|lyfalmen|||00|20|1|5|Parlogis hf|Parlogis - óskráð lyf|||2645||2645|4430 194209|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|2|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|1293|1851|lyfsjukr|||02|2|0|0|Icepharma hf|Wyeth AB|||1293||1293|1851 194258|A03BB0101|Buscopan|töflur|10|mg|100|stk|1|glas||A03BB01|01.12.1972||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2206|3834|lyfalmen|||00|100|0|17|Vistor hf|Boehringer Ingelheim|||2206||2206|3834 194266|A03BB0101|Buscopan|töflur|10|mg|20|stk|1|glas||A03BB01|01.12.1972||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|531|1561|lyfalmen|||00|20|0|3|Vistor hf|Boehringer Ingelheim|||531||531|1561 194720|N03AX0901|Lamictal|dreifit.|5|mg|28|stk|1|þpakki||N03AX09|01.01.1996||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|639|1708|lyfalmen|||00|28|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||639||639|1708 194795|M05BA0301|Aredia|irs|90|mg/hgl|1|hgl|1|pakki|+ 10 ml leysir|M05BA03|01.03.1998||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|46457|59706|lyfsjukr|||00|1|0|2|Vistor hf|Novartis Healthcare A/S-|||46457||46457|59706 194977|J01MA0202|Ciproxin|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1988||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|1868|3375|lyfalmen|V0514|1374|00|10|0|2|Vistor hf|Bayer HealthCare AG|||1868||1868|3375 194985|J01MA0202|Ciproxin|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1988||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|4053|6340|lyfalmen|V0518|1706|00|20|0|5|Vistor hf|Bayer HealthCare AG|||4053||4053|6340 195032|J01MA0202|Ciproxin|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.01.1991||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|3969|6227|lyfalmen|V0522|1718|00|10|0|5|Vistor hf|Bayer HealthCare AG|||3969||3969|6227 195065|J01MA0202|Ciproxin|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1991||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|7698|11287|lyfalmen|V0526|2425|00|20|0|10|Vistor hf|Bayer HealthCare AG|||7698||7698|11287 195149|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|5|lykjur||B03BA02|01.11.1981||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|3387|5437|lyfalmen|||03|5|0|250|Actavis Group hf|Actavis Group hf|||3387||3387|5437 195156|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|1|lykja||B03BA02|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|844|1986|lyfalmen|||03|1|0|50|Actavis Group hf|Actavis Group hf|||844||844|1986 195354|A07DA0301|Imodium|töflur|2|mg|40|stk|1|þpakki||A07DA03|01.10.1991||R|A|5|0|0|E|0|JAS|0|0|0|100|SEK|913|2079|lyfalmen|||10|40|0|8|Vistor hf|Janssen-Cilag AB|||913||913|2079 195610|G03AC0801|Implanon|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2001||R|A|5|0|0|0|0|ORG|0|0|0|100|DKK|23278|31166|lyfalmen|||00|1|0|1015|Vistor hf|N.V. Organon|||23278||23278|31166 195669|D01AC2002|Pevisone|krem|0| |15|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|705|1797|lyfalmen|||20|15|0|15|Vistor hf|Janssen-Cilag AB|||705||705|1797 195768|R01BA0101|Rinexin|forðatfl|50|mg|30|stk|1|þpakki||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|340|1302|lyfalmen|||10|30|0|15|Vistor hf|Recip AB|||340||340|1302 195776|R01BA0101|Rinexin|forðatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|804|1931|lyfalmen|||10|100|0|50|Vistor hf|Recip AB|||804||804|1931 196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|þp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1281|2579|lyfalmen|||23|63|0|84|Icepharma hf|Bayer Schering Pharma AG|||1281||1281|2579 197103|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|1|hgl||QH01CA90|01.07.1998||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|2743|5396|vetalmen|||27|10|0|0|Icepharma hf|Intervet International B.V.|||2743||2743|5396 197111|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|5|hgl||QH01CA90|01.07.1986||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|13059|25047|vetalmen|||27|50|0|0|Icepharma hf|Intervet International B.V.|||13059||13059|25047 197343|D11AX0101|Regaine|húðlausn|20|mg/ml|60|ml|1|glas||D11AX01|01.10.1988||L|A|4|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||00|60|0|60|Vistor hf|McNeil Denmark ApS||||||6258 197400|S01GA5101|Antistina-Privin|augndr|5,25|mg/ml|10|ml|1|glas|5+0,25 mg|S01GA51|01.03.1981||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|817|1949|lyfalmen|||06|10|0|0|Vistor hf|Novartis Healthcare A/S-|||817||817|1949 197533|N03AX0901|Lamictal|dreifit.|100|mg|56|stk|1|þpakki||N03AX09|01.01.1996||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|3690|5347|lyfalmen|V0705|5347|00|56|0|19|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3321||3321|5347 197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|þpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|913|2079|lyfalmen|||00|20|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||913||913|2079 197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|þpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|4327|6712|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4327||4327|6712 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|2504|4238|lyfalmen|||00|100|0|0|Vistor hf|AstraZeneca A/S DK|||2504||2504|4238 198432|N02BE5102|Parkodin|eþ-stil|510|mg|10|stk|1|pakki|10+500 mg|N02BE51|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|498|1516|lyfalmen|||04|10|0|2|Actavis Group hf|Actavis hf|||498||498|1516 198580|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2001||R|K|2|0|1|*|0|GSK|0|0|0|100|GBP|1660|3093|lyfalmen|||00|25|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1660||1660|3093 198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|10892|15428|lyfsjukr|||02|200|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||10892||10892|15428 198861|N04AA0201|Akineton|stl|5|mg/ml|1|ml|5|lykjur||N04AA02|01.12.1975||R|A|5|0|0|0|1|LFS|0|1|0|100|DKK|446|639|lyfsjukr|||02|5|0|2|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|||446||446|639 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|39757|51682|lyfalmen|||00|100|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||39757||39757|51682 199307|L01CB0101|Vepesid|stl|20|mg/ml|5|ml|10|hgl||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|17114|23174|lyfsjukr|||00|50|1|0|Distica|Distica - óskráð lyf|||17114||17114|23174 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.11.1981||R|A|4|0|0|0|0|PFI|0|0|1|100|DKK|945|2123|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||945||945|2123 199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|8220|11995|lyfalmen|||44|8|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||8220||8220|11995 199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|K|3|0|0|0|1|CET|0|0|0|100|XEU|60424|77095|lyfsjukr|||00|5|0|0|Icepharma hf|Centocor -|||60424||60424|77095 300373|A05AA0201|Destolit|töflur|150|mg|60|stk|1|glas||A05AA02|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|4982|7601|lyfalmen|||00|60|1|12|Distica|Distica - óskráð lyf|||4982||4982|7601 327817|A03AA0701|Dicykloverinklorid|mixtúra|1|mg/ml|100|ml|1|glas|sykursaft|A03AA07|01.01.2000||R|A||0|1|E|0|LDR|0|0|0|100|IKR|3959|6213|lyfalmen|||00|100|1|1|Parlogis hf|Parlogis - óskráð lyf|||3959||3959|6213 335968|A04AD0102|Skopolamin|stl|0,3|mg/ml|1|ml|10|lykjur||A04AD01|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|6034|9029|lyfalmen|||00|10|1|0|Parlogis hf|Parlogis - óskráð lyf|||6034||6034|9029 336792|A03AA0701|Dicykloverinklorid|mixtúra|1|mg/ml|100|ml|1|glas|sykurlaus|A03AA07|01.01.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2125|3724|lyfalmen|||00|100|1|1|Parlogis hf|Parlogis - óskráð lyf|||2125||2125|3724 338236|C01CA0301|Noradrenalin|stl|1|mg/ml|2|ml|10|lykjur||C01CA03|01.01.2000||R|A||0|0|0|1|LDR|0|0|0|100|IKR|3940|5641|lyfsjukr|||00|20|1|3|Parlogis hf|Parlogis - óskráð lyf|||3940||3940|5641 370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|612|876|lyfsjukr|||02|1|0|0|Icepharma hf|Roche|||612||612|876 370353|V08AB0501|Ultravist|stl/irl|300|mg J/ml|20|ml|10|hgl||V08AB05|01.04.1989||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|18534|24942|lyfsjukr|||02|200|0|0|Icepharma hf|Bayer Schering Pharma AG|||18534||18534|24942 370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|A|2|0|0|0|1|NOM|0|0|0|100|IKR|544|779|lyfsjukr|||03|1|0|0|Icepharma hf|NordMedica ApS|||544||544|779 371583|A06AG1001|Klyx|innhl|0| |240|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyfalmen|||23|240|0|1|Vistor hf|Ferring Lægemidler A/S||||||0 371609|A06AG1001|Klyx|innhl|0| |120|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyfalmen|||23|120|0|1|Vistor hf|Ferring Lægemidler A/S||||||0 371617|A06AG1001|Klyx|innhl|0| |120|ml|10|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|SEK|||lyfalmen|||23|1200|0|10|Vistor hf|Ferring Lægemidler A/S||||||7628 371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|þpakki||A02BA02|01.10.1995||L|A|3|0|0|E|0|ACA|0|0|0|30|IKR|||lyfalmen|||00|10|0|5|Actavis Group hf|Actavis hf||||||1300 372037|N05AL0501|Solian|töflur|50|mg|30|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|2766|4594|lyfalmen|||00|30|0|4|Vistor hf|Sanofi-aventis Norge AS|||2766||2766|4594 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|7755|11364|lyfalmen|||00|90|0|11|Vistor hf|Sanofi-aventis Norge AS|||7755||7755|11364 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|4412|6828|lyfalmen|||00|100|0|17|Icepharma hf|Roche|||4412||4412|6828 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|42|0|7|Vistor hf|McNeil Denmark ApS||||||0 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|18|0|3|Vistor hf|McNeil Denmark ApS||||||0 372615|M05BA0401|Fosamax|töflur|10|mg|98|stk|1|þpakki||M05BA04|01.01.1996||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|20039|27134|lyfalmen|||00|98|0|98|Icepharma hf|M.S.D.|||20039||20039|27134 372714|N05AL0501|Solian|töflur|200|mg|30|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|9247|13389|lyfalmen|||00|30|0|15|Vistor hf|Sanofi-aventis Norge AS|||9247||9247|13389 372722|B02BD0801|NovoSeven|sts|1,2|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|128288|161586|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|||128288||128288|161586 372730|B02BD0801|NovoSeven|sts|2,4|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|256161|320788|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|||256161||256161|320788 372748|B02BD0801|NovoSeven|sts|4,8|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|589276|735516|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|||589276||589276|735516 373001|G03AB0501|Gracial|töflur|0| |66|stk|1|pakki|þp 3 x (15+7 stk)|G03AB05|01.07.1998||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2675|4470|lyfalmen|||23|66|0|88|Vistor hf|N.V. Organon|||2675||2675|4470 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|24520|32712|lyfalmen|||00|90|0|45|Vistor hf|Sanofi-aventis Norge AS|||24520||24520|32712 373324|R03AK0602|Seretide Diskus|innúðadu|150|mcg/sk|60|sk|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|4207|6549|lyfalmen|||23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||4207||4207|6549 373340|R03AK0602|Seretide Diskus|innúðadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|6571|9758|lyfalmen|||23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||6571|9758 373365|R03AK0602|Seretide Diskus|innúðadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|8600|12511|lyfalmen|||23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||8600|12511 373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|3121|5076|lyfalmen|||44|2|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3121||3121|5076 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|þpakki||A10BA02|01.01.1987||R|A|5|0|0|*|0|MCK|0|0|0|100|XEU|838|1978|lyfalmen|||00|100|0|25|Icepharma hf|Merck Santé s.a.s.|||838||838|1978 374348|G04CA0201|Omnic|forðahlk|0,4|mg|30|stk|1|þpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|5297|8029|lyfalmen|||00|30|0|30|Vistor hf|Yamanouchi Europe|||5297||5297|8029 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|þpakki||J05AB11|01.01.2003||R|A|2|0|0|E|0|GSK|0|0|1|30|GBP|11050|15836|lyfalmen|||00|60|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||11050||11050|15836 374504|G01AF0502|Pevaryl Depot|krem/sti|0| |15|g|1|sett|kr.+1sk-stíll m.forðaverkun|G01AF05|01.01.1997||L|A|3|0|0|0|0|JAS|0|0|0|100|SEK|||lyfalmen|||00|15|0|2|Vistor hf|Janssen-Cilag AB||||||0 374520|L02BB0301|Casodex|töflur|50|mg|30|stk|1|þpakki||L02BB03|01.04.1997||R|A|5|0|0|*|0|ASZ|0|0|0|100|SEK|19749|26772|lyfalmen|V0560|22054|00|30|0|30|Vistor hf|AstraZeneca UK Ltd|||19749||19749|26772 374579|R01AC0101|Lomudal Nasal|nefúði|5,2|mg/sk|15|ml|1|glas||R01AC01|01.10.1992||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|2496|4228|lyfalmen|||23|15|0|15|Vistor hf|Sanofi-aventis Norge AS|||2496||2496|4228 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|7170|10570|lyfalmen|||00|6|0|30|Vistor hf|Sanofi-aventis Norge AS|||7170||7170|10570 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|7973|11660|lyfalmen|||00|8|0|40|Vistor hf|Sanofi-aventis Norge AS|||7973||7973|11660 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|10868|15589|lyfalmen|||00|10|0|50|Vistor hf|Sanofi-aventis Norge AS|||10868||10868|15589 377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|4792|7343|lyfalmen|||63|14|0|14|Vistor hf|Abbott Scandinavia AB|||4792||4792|7343 377259|J01FA0901|Klacid|töflur|500|mg|100|stk|1|glas||J01FA09|01.04.1992||R|A|2|0|0|0|0|ABS|0|0|1|100|DKK|39196|50984|lyfalmen|||63|100|0|100|Vistor hf|Abbott Scandinavia AB|||39196||39196|50984 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|30|GBP|10702|13248|lyfalmen|V0508|13248|00|42|0|7|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||9143||9143|13248 379669|H01CB0202|Sandostatin Lar|sts|5|mg/ml|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|168234|211319|lyfsjukr|||00|2|0|14|Vistor hf|Novartis Healthcare A/S-|||168234||168234|211319 379677|H01CB0202|Sandostatin Lar|sts|10|mg/ml|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|187778|235651|lyfsjukr|||00|2|0|29|Vistor hf|Novartis Healthcare A/S-|||187778||187778|235651 379685|H01CB0202|Sandostatin Lar|sts|15|mg/ml|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|235695|295308|lyfsjukr|||00|2|0|43|Vistor hf|Novartis Healthcare A/S-|||235695||235695|295308 379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|1610|3025|lyfalmen|||00|12|0|2|Actavis Group hf|Actavis Group hf|||1610||1610|3025 379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|1990|3541|lyfalmen|||00|12|0|5|Actavis Group hf|Actavis Group hf|||1990||1990|3541 379925|L01CD0201|Taxotere|irs|40|mg/ml|0,5|ml|1|hgl|+ leysir|L01CD02|01.10.1996||R|K|1,5|0|1|0|1|AVS|0|0|0|100|NOK|26122|34389|lyfsjukr|||00|0|0|0|Vistor hf|Aventis Pharma SA|||26122||26122|34389 379933|L01CD0201|Taxotere|irs|40|mg/ml|2|ml|1|hgl|+ leysir|L01CD02|01.10.1996||R|K|2|0|1|0|1|AVS|0|0|0|100|NOK|104886|132451|lyfsjukr|||00|2|0|0|Vistor hf|Aventis Pharma SA|||104886||104886|132451 380642|A10AD0402|Humalog Mix50 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.12.2001||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|6405|9532|lyfalmen|||17|15|0|38|Icepharma hf|Eli Lilly Nederland -|||6405||6405|9532 381194|A10AD0401|Humalog Mix25 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.09.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|6294|9382|lyfalmen|||00|15|0|38|Icepharma hf|Eli Lilly Nederland -|||6294||6294|9382 382531|C10AA0101|Zocor|töflur|40|mg|98|stk|1|þpakki||C10AA01|01.07.1995||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|16211|12534|lyfalmen|V0367|3035|00|98|0|261|Icepharma hf|M.S.D.|||8617||8617|12534 383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|6136|9167|lyfalmen|||00|100|0|50|Vistor hf|AstraZeneca A/S DK|||6136||6136|9167 383075|N02AA5904|Ibukod sterkar|töflur|0| |20|stk|1|glas|30+200 mg|N02AA59|01.02.1999||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|460|1465|lyfalmen|||00|20|0|7|Actavis Group hf|Actavis hf|||460||460|1465 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||L|A|5|0|0|0|0|BAN|0|0|0|100|DKK|||vetorma|||00|2|0|0|Vistor hf|Bayer Animal Health GmbH||||||1827 383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|8265|14303|vetorma|||00|20|0|0|Vistor hf|Bayer Animal Health GmbH|||8265||8265|14303 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||23|60|0|60|Actavis Group hf|Actavis hf||||||0 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|V0355|2143|23|120|0|120|Actavis Group hf|Actavis hf||||||2143 383737|R06AX1301|Clarityn|freyðit|10|mg|10|stk|1|þpakki||R06AX13|01.10.1995||L|A|2|0|0|E|0|SCP|0|0|1|100|DKK|||lyfalmen|||00|10|0|10|Vistor hf|Schering-Plough||||||1942 386953|L02BG0301|Arimidex|töflur|1|mg|98|stk|1|þpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|ASZ|0|0|0|100|SEK|53553|68858|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca UK Ltd|||53553||53553|68858 387662|QA12CC0202|Magnesiumsulfat Icepharma vet.|stl|200|mg/ml|100|ml|1|plhgl||QA12CC02|01.07.1996||R|A|3|0|0|0|0|ICE|0|0|0|100|XEU|781|1541|vetalmen|||00|100|0|0|Icepharma hf|Icepharma hf|||781||781|1541 387746|J02AA0101|Abelcet|irþ|5|mg/ml|20|ml|10|hgl|+ síunálar|J02AA01|01.04.1996||R|K|2|0|0|0|1|ZPL|0|0|0|100|DKK|239510|300057|lyfsjukr|||00|200|0|29|Zeneus Pharma Limited|Zeneus Pharma Limited|||239510||239510|300057 388256|N01BB2001|Emla|krem|0| |5|g|5|túpa|+12 umbúð.|N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3252|5254|lyfalmen|V2002|5165|00|25|0|5|Vistor hf|AstraZeneca A/S DK|||3252||3252|5254 388264|N01BB2001|Emla|krem|0| |30|g|1|túpa||N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3668|5818|lyfalmen|||00|30|0|30|Vistor hf|AstraZeneca A/S DK|||3668||3668|5818 388272|N01BB2001|Emla|plástur|0| |2|stk|1|pakki||N01BB20|01.04.1994||L|A|2|0|0|0|0|AZD|0|0|1|100|IKR|||lyfalmen|||23|2|0|0|Vistor hf|AstraZeneca A/S DK||||||0 388280|N01BB2001|Emla|plástur|0| |20|stk|1|pakki||N01BB20|01.04.1994||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|6845|10129|lyfalmen|||23|20|0|0|Vistor hf|AstraZeneca A/S DK|||6845||6845|10129 388660|C09BA0201|Darazið|töflur|22,5|mg|100|stk|1|glas|10+12.5 mg|C09BA02|01.04.1998||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|2966|4865|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|||2966||2966|4865 389106|G03FA0103|Femanor|töflur|0| |84|stk|1|pakki|þp 2+1 mg |G03FA01|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2539|4286|lyfalmen|V0388|4286|23|84|0|84|Vistor hf|BioPhausia AB|||2539||2539|4286 389122|G03FB0503|Femasekvens|töflur|0| |84|stk|1|pakki|þp samsett pk. |G03FB05|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2320|3989|lyfalmen|||23|84|0|84|Vistor hf|BioPhausia AB|||2320||2320|3989 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|958|2140|lyfalmen|V0408|2140|00|84|0|84|Vistor hf|BioPhausia AB|||958||958|2140 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|681|1765|lyfalmen|||00|84|0|42|Vistor hf|BioPhausia AB|||681||681|1765 389361|V08AB0501|Ultravist|stl/irl|300|mg J/ml|500|ml|8|fl||V08AB05|01.04.1989||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|324691|406108|lyfsjukr|||02|4000|0|0|Icepharma hf|Bayer Schering Pharma AG|||324691||324691|406108 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|1037|2248|lyfalmen|||00|3|0|0|Vistor hf|Novartis Healthcare A/S-|||1037||1037|2248 389577|A04AA0201|Kytril|töflur|2|mg|5|stk|1|þpakki||A04AA02|01.10.1994||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|12772|18086|lyfalmen|||00|5|0|5|Icepharma hf|Roche as|||12772||12772|18086 389783|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1985||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|2496|4228|lyfalmen|||00|30|0|8|Vistor hf|Recip AB|||2496||2496|4228 390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|K|1|0|0|E|0|BRS|0|0|1|100|DKK|3618|5750|lyfalmen|||01|100|0|7|Vistor hf|Bristol-Myers Squibb|||3618||3618|5750 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|8014|11716|lyfalmen|||00|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||8014||8014|11716 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|3214|5202|lyfalmen|||00|20|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3214||3214|5202 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|15105|20991|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||15105||15105|20991 391730|N01BB0203|Xylocain|úðalyf|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.1990||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2962|4860|lyfalmen|||00|50|0|0|Vistor hf|AstraZeneca A/S DK|||2962||2962|4860 393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dælu|1|stk|24|spr||QJ51CF02|01.09.1983||R|S|4|0|0|0|0|PAL|0|0|0|100|XEU|5371|10402|vetalmen|||16|24|0|0|Icepharma hf|Pfizer Oy Animal Health|||5371||5371|10402 393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A||||||0 393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A||||||0 393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A||||||0 394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A||||||0 395715|D10AD0301|Differin|hlaup|0,1|%|30|g|1|túpa||D10AD03|01.07.2001||R|A|3|0|0|0|0|GAN|0|0|0|100|SEK|982|2173|lyfalmen|||00|30|0|30|Icepharma hf|Galderma Nordic AB|||982||982|2173 395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|188129|236088|lyfsjukr|||02|300|0|0|Icepharma hf|Bayer Schering Pharma AG|||188129||188129|236088 397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|þpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|11498|16183|lyfsjukr|||00|60|0|0|Icepharma hf|Roche|||11498||11498|16183 397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|þpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|66657|84855|lyfsjukr|||00|120|0|0|Icepharma hf|Roche|||66657||66657|84855 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2049|3343|lyfalmen|V0703|3343|00|56|0|9|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1844||1844|3343 399527|N03AX0901|Lamictal|dreifit.|200|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|6434|8873|lyfalmen|V0706|8873|00|56|0|37|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||5919||5919|8873 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|11588|16566|lyfalmen|||02|3|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||11588||11588|16566 399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|A|3|0|0|0|0|NHE|0|0|1|100|DKK|||lyfalmen|||00|2|0|2|Artasan ehf|Novartis Healthcare A/S-A||||||0 400044|S03CA0102|Sofradex|aug.eydr|0| |8|ml|1|glas||S03CA01|01.03.1980||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1539|2929|lyfalmen|||06|8|0|0|Vistor hf|Sanofi-aventis Norge AS|||1539||1539|2929 400101|R05DB2002|Pektolin|mixtúra|0| |150|ml|1|glas||R05DB20|01.06.1981||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|150|0|0|Actavis Group hf|Actavis hf||||||0 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|þpakki||C10AB04|01.04.1988||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|5964|8934|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5964||5964|8934 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|388|1367|lyfalmen|||00|25|0|12|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||388||388|1367 400275|N05BA0402|Sobril|töflur|15|mg|250|stk|1|glas||N05BA04|01.01.1985|31.12.2008|R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|2577|4337|lyfalmen|||00|250|0|75|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2577||2577|4337 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|632|1698|lyfalmen|||00|100|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||632||632|1698 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|276|1215|lyfalmen|||00|25|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||276||276|1215 400804|N07BA0103|Nicorette|forðapl|15|mg/16kls|7|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|7|0|8|Vistor hf|McNeil Denmark ApS||||||0 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|812|1942|lyfalmen|||00|100|0|13|Lundbeck Export A/S|H. Lundbeck A/S|||812||812|1942 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|1300|2605|lyfalmen|||00|100|0|33|Lundbeck Export A/S|H. Lundbeck A/S|||1300||1300|2605 401877|C09AA0103|Katopril|töflur|25|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1246|2531|lyfalmen|||00|100|0|50|Actavis Group hf|Actavis hf|||1246||1246|2531 401901|C09AA0103|Katopril|töflur|50|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|2000|3554|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|||2000||2000|3554 402651|J07BB0205|Influvac|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOB|0|0|0|100|XEU|699|1789|lyfalmen|||51|0|0|0|Icepharma hf|Solvay Biologicals B.V.|||699||699|1789 402743|QJ01RA0102|Streptocillin, vet.|stl|0| |100|ml|1|hgl||QJ01RA01|01.11.1979||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1704|3363|vetalmen|||58|100|0|0|Vistor hf|Boehringer Ingelheim Danmark|||1704||1704|3363 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|A|2|0|0|0|0|SPA|1|0|0|100|DKK|5504|10655|vetalmen|||27|20|0|0|Vistor hf|Schering-Plough A/S|||5504||5504|10655 403550|C08CA0302|Lomir Retard|forðahlk|2,5|mg|100|stk|1|þpakki||C08CA03|01.10.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|7498|11016|lyfalmen|||10|100|0|50|Vistor hf|Novartis Healthcare A/S-|||7498||7498|11016 403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1230|2510|lyfalmen|||06|14|0|0|Vistor hf|Sanofi-aventis Norge AS|||1230||1230|2510 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|A|2,5|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|10|0|0|Icepharma hf|Santen Oy||||||1770 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|A|3|0|0|0|1|BOI|0|0|0|100|DKK|106054|133905|lyfsjukr|||02|1|0|0|Vistor hf|Boehringer Ingelheim|||106054||106054|133905 404640|A07AA0904|Vancomycin Alpharma|hylki|125|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.04.1996||R|A|2|0|0|E|0|ALP|0|0|1|100|DKK|12952|18310|lyfalmen|V0125|13450|00|28|0|2|Actavis Group hf|Alpharma ApS|||12952||12952|18310 404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|671|961|lyfsjukr|||02|5|0|2|Icepharma hf|Roche|||671||671|961 405589|J07BD5203|Priorix|bóluefni|0| |0,5|ml|1|hgl|+ einnota dæla|J07BD52|01.03.1999||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|1720|3175|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1720||1720|3175 405597|J07BD5203|Priorix|bóluefni|0| |0,5|ml|10|hgl||J07BD52|01.11.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|21227|28613|lyfalmen|||00|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||21227||21227|28613 405985|N05AE0301|Serdolect|filmhtfl|12|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|22085|29681|lyfalmen|||00|28|0|21|Lundbeck Export A/S|H. Lundbeck A/S|||22085||22085|29681 406025|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|20662|27592|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||20662||20662|27592 406033|N05AE0301|Serdolect|filmhtfl|16|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|22085|29681|lyfalmen|||00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|||22085||22085|29681 406165|N05AE0301|Serdolect|filmhtfl|20|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|22085|29681|lyfalmen|||00|28|0|35|Lundbeck Export A/S|H. Lundbeck A/S|||22085||22085|29681 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|22305|29955|lyfalmen|||00|100|0|25|Lundbeck Export A/S|H. Lundbeck A/S|||22305||22305|29955 406355|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|23122|30654|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|||23122||23122|30654 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|67245|85905|lyfalmen|||00|100|0|75|Lundbeck Export A/S|H. Lundbeck A/S|||67245||67245|85905 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|72935|92989|lyfalmen|||00|100|0|100|Lundbeck Export A/S|H. Lundbeck A/S|||72935||72935|92989 406397|N05AE0301|Serdolect|filmhtfl|20|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|78624|100072|lyfalmen|||00|100|0|125|Lundbeck Export A/S|H. Lundbeck A/S|||78624||78624|100072 406462|N05AE0301|Serdolect|filmhtfl|4|mg|30|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|7453|10954|lyfalmen|||00|30|0|8|Lundbeck Export A/S|H. Lundbeck A/S|||7453||7453|10954 406751|M01AB0101|Confortid|hylki|25|mg|30|stk|1|þpakki||M01AB01|01.05.1974||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|613|1672|lyfalmen|||10|30|0|8|Actavis Group hf|Actavis Group hf|||613||613|1672 407395|N02CA7201|Anervan|töflur|160,5|mg|100|stk|1|pakki|þp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|2001|3556|lyfalmen|||00|100|0|50|Vistor hf|Recip AB|||2001||2001|3556 407403|A01AB0402|Fungizone|sogtfl|10|mg|60|stk|1|þpakki||A01AB04|01.04.1993|31.12.2008|R|A|1,5|0|0|E|0|BRS|0|0|1|100|DKK|1214|2488|lyfalmen|||00|60|0|15|Vistor hf|Bristol-Myers Squibb|||1214||1214|2488 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PFI|0|0|1|100|DKK|261|1195|lyfalmen|||00|25|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||261||261|1195 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PFI|0|0|0|100|DKK|736|1839|lyfalmen|||00|100|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||736||736|1839 408724|D07AC0104|Diproderm|smyrsli|0,5|mg/g|20|g|1|túpa||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1137|2383|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|||1137||1137|2383 408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|5217|7920|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|||5217||5217|7920 408757|D07AC0104|Diproderm|áburður|0,5|mg/ml|20|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1137|2383|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|||1137||1137|2383 408773|D07AC0104|Diproderm|áburður|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3106|5055|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|||3106||3106|5055 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|5585|8419|lyfalmen|||08|35|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5585||5585|8419 409193|N02BE0101|Panodil|töflur|500|mg|20|stk|1|þpakki||N02BE01|01.07.1975|31.12.2008|L|A|5|0|0|0|0|GCH|0|0|1|100|DKK|||lyfalmen|||00|20|0|3|Icepharma hf|GlaxoSmithKline CH A/S||||||0 409417|C09CA0701|Micardis|töflur|80|mg|28|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|4125|6438|lyfalmen|||00|28|0|56|Vistor hf|Boehringer Ingelheim International |||4125||4125|6438 409425|R01AD0502|Rhinocort Turbuhaler|nefúðad|100|mcg/sk|200|sk|1|stauk||R01AD05|01.01.1992||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|3896|6127|lyfalmen|V0966|6023|23|200|0|100|Vistor hf|AstraZeneca A/S DK|||3896||3896|6127 409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|13325|18775|lyfalmen|||00|98|0|196|Vistor hf|Boehringer Ingelheim International |||13325||13325|18775 409516|C09CA0701|Micardis|töflur|40|mg|28|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|3250|5251|lyfalmen|||00|28|0|28|Vistor hf|Boehringer Ingelheim International |||3250||3250|5251 409532|QN05AA0402|Plegicil vet.|stl|10|mg/ml|20|ml|6|hgl||QN05AA04|01.11.2007||R|A|3|0|0|0|0|PSW|1|0|0|100|DKK|11339|21770|vetalmen|||27|120|0|0|Vistor hf|Pharmaxim Sweden AB|||11339||11339|21770 409631|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|glas||C07AB03|01.04.1987||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|575|1621|lyfalmen|V0290|1621|00|100|0|33|Actavis Group hf|Actavis hf|||575||575|1621 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|10797|15492|lyfalmen|||00|98|0|98|Vistor hf|Boehringer Ingelheim International |||10797||10797|15492 410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|þpakki||P01BA01|01.08.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|1163|2419|lyfalmen|||00|20|0|10|Vistor hf|Recip AB|||1163||1163|2419 410712|D10AD0102|Aberela|krem|0,05|%|30|g|1|túpa||D10AD01|01.10.2007||R|A|2|0|0|0|0|JAS|0|0|0|100|SEK|681|1765|lyfalmen|||23|30|0|30|Vistor hf|Janssen-Cilag AB|||681||681|1765 411033|M03BX0104|Baklofen Merck NM|töflur|10|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|A|3|0|0|E|0|MNA|0|0|1|100|SEK|596|1649|lyfalmen|||00|50|0|10|Actavis Group PTC ehf|Merck NM AB|||596||596|1649 411157|M03BX0104|Baklofen Merck NM|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.01.1990|31.01.2009|R|A|3|0|0|E|0|MNA|0|0|1|100|SEK|||lyfalmen|||00|50|0|25|Actavis Group PTC ehf|Merck NM AB|||1324||| 411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|7834|11216|lyfsjukr|||02|50|0|17|Icepharma hf|Roche|||7834||7834|11216 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|24374|32213|lyfsjukr|||00|60|0|30|GlaxoSmithKline ehf|Glaxo Group Limited|||24374||24374|32213 411868|M01AB0505|Voltaren|sh-tfl|25|mg|100|stk|1|þpakki||M01AB05|01.11.1981||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|1993|3545|lyfalmen|||67|100|0|25|Vistor hf|Novartis Healthcare A/S-|||1993||1993|3545 411918|N02CC0101|Imigran|nefúði|20|mg/sk|6|sk|1|pakki||N02CC01|01.07.2000||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|7625|11185|lyfalmen|||98|6|0|6|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||7623||7623|11185 412049|L02AE0301|Zoladex|vefjatfl|3,6|mg|1|stk|1|glas|+ dæla|L02AE03|01.01.1990||R|A|3|0|1|*|0|ASZ|0|0|0|100|SEK|22144|29754|lyfalmen|||00|1|0|28|Vistor hf|AstraZeneca UK Ltd|||22144||22144|29754 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|með rotv.|B01AB05|01.02.1999||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|3187|4563|lyfsjukr|||00|3|0|15|Vistor hf|Sanofi-aventis Norge AS|||3187||3187|4563 412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|A|3|0|0|0|0|MER|1|0|0|100|DKK|10721|20593|vetalmen|||02|100|0|0|Vistor hf|Merial|||10721||10721|20593 412825|L02BA0106|Tamoxifen NM Pharma|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|1974|3519|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|||1974||1974|3519 412833|L02BA0106|Tamoxifen NM Pharma|töflur|20|mg|30|stk|1|glas||L02BA01|01.01.1990||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|1261|2552|lyfalmen|||00|30|0|30|Actavis Group PTC ehf|Merck NM AB|||1261||1261|2552 413245|J06BA0205|Sandoglobulin|irs|12|g/fl|12|g|1|sett|leys+áhöld|J06BA02|01.04.1993||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|110913|139954|lyfsjukr|||00|12|0|0|Icepharma hf|CSL Denmark ApS|||110913||110913|139954 413369|S01AX1201|Noroxin|augndr|3|mg/ml|5|ml|1|glas||S01AX12|01.04.1992||R|A|3|0|0|E|0|LBO|0|0|1|100|XEU|693|1781|lyfalmen|||06|5|0|0|Laboratories THEA|Laboratories THEA|||693||693|1781 413856|M05BA0301|Aredia|irs|15|mg/hgl|4|hgl|1|pakki|+ 4 x 5 ml leysir|M05BA03|01.04.1998||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|35272|45781|lyfsjukr|||00|4|0|1|Vistor hf|Novartis Healthcare A/S-|||35272||35272|45781 413864|M05BA0301|Aredia|irs|30|mg/hgl|2|hgl|1|pakki|+ 2 x 10 ml leysir|M05BA03|01.04.1998||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|35272|45781|lyfsjukr|||00|2|0|1|Vistor hf|Novartis Healthcare A/S-|||35272||35272|45781 414458|V04CF0102|Tuberkulin|stl|2|TU/0,1ml|1,5|ml|1|hgl||V04CF01|01.01.1998||R|K||0|0|0|0|LDR|0|0|0|100|IKR|2026|3590|lyfalmen|||00|2|1|0|Parlogis hf|Parlogis - óskráð lyf|||2026||2026|3590 414680|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|90|stk|1|þpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|4863|7440|lyfalmen|||00|90|0|54|Icepharma hf|Servier|||4863||4863|7440 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1554|2949|lyfalmen|||00|300|0|6|Vistor hf|Novartis Healthcare A/S-|||1554||1554|2949 415679|G03CA0310|Vagifem|sk-tfl|25|mcg|15|stk|1|pakki|+stjaka|G03CA03|01.01.1995||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|2191|3814|lyfalmen|||05|15|0|15|Vistor hf|Novo-Nordisk|||2191||2191|3814 415687|V08BA0101|E-Z-HD|mixtduft|0| |12|0z|24|stk|plastdósir|V08BA01|01.01.1988||R|A|4|0|0|0|1|EZE|0|0|0|100|USD|17538|23702|lyfsjukr|||08|288|0|0|Icepharma hf|E-Z-Em|||17538||17538|23702 415711|V08BA0102|Polibar ACB|innhl|933|mg/g|16|0z|24|stk|plastpokar|V08BA01|01.01.1988||R|A|2|0|0|0|1|EZE|0|0|0|100|USD|49309|63257|lyfsjukr|||00|384|0|0|Icepharma hf|E-Z-Em|||49309||49309|63257 415737|V08BA0102|Polibar ACB|innhl|933|mg/g|20|0z|24|stk|plastpokar|V08BA01|01.01.1988||R|A|2|0|0|0|1|EZE|0|0|0|100|USD|61638|78607|lyfsjukr|||00|480|0|0|Icepharma hf|E-Z-Em|||61638||61638|78607 416222|C09DA0101|Cozaar Comp|töflur|62,5|mg|28|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|3835|6045|lyfalmen|||00|28|0|28|Icepharma hf|M.S.D.|||3835||3835|6045 416446|C09DA0101|Cozaar Comp|töflur|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|10231|9935|lyfalmen|V0198|9935|00|98|0|98|Icepharma hf|M.S.D.|||6702||6702|9935 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.07.2000||R|A||0|0|E|0|LDR|0|0|0|30|IKR|3849|6064|lyfalmen|||00|300|1|15|Parlogis hf|Parlogis - óskráð lyf|||3849||3849|6064 416859|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|3097|5043|lyfalmen|||23|10|0|0|Icepharma hf|Colgate Palmolive A/S|||3097||3097|5043 416867|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|30|ml|5|túpa||A01AA01|01.10.1988||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|26045|34611|lyfalmen|||23|150|0|0|Icepharma hf|Colgate Palmolive A/S|||26045||26045|34611 416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|A|5|0|0|0|0|IGB|0|0|0|100|SEK|1079|2305|lyfalmen|||00|30|0|30|Icepharma hf|Intendis GmbH Berlin|||1079||1079|2305 417030|A02AD0104|Balancid Novum|tuggutfl|0| |30|stk|1|þpakki||A02AD01|01.10.1992|31.01.2009|L|A|3|0|0|0|0|BIP|0|0|0|100|IKR|||lyflausa|||11|30|0|3|Vistor hf|BioPhausia AB|||||| 417238|QM01AE0301|Romefen, vet.|töflur|10|mg|10|stk|1|þpakki||QM01AE03|01.10.1995||R|A|3|0|0|0|0|MER|0|0|0|100|XEU|566|1117|vetalmen|||00|10|0|0|Vistor hf|Merial|||566||566|1117 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|þpakki||J05AF06|01.07.2005||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|39894|51536|lyfsjukr|||00|60|0|30|GlaxoSmithKline ehf|Glaxo Group Limited|||39894||39894|51536 418483|A07EC0201|Mesasal|sh-tfl|250|mg|100|stk|1|þpakki||A07EC02|01.10.1991||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|4181|6514|lyfalmen|||10|100|0|17|Vistor hf|Sanofi-aventis Norge AS|||4181||4181|6514 418665|D07XC0101|Diprosalic|smyrsli|0| |50|g|1|túpa||D07XC01|01.11.1979||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|1864|3370|lyfalmen|||20|50|0|50|Vistor hf|Schering-Plough|||1864||1864|3370 418731|A07EC0201|Mesasal|eþ-stil|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|A|4|0|0|B|0|SNO|0|0|0|100|NOK|8503|12379|lyfalmen|V0299|9555|00|60|0|20|Vistor hf|Sanofi-aventis Norge AS|||8503||8503|12379 418988|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|glas||QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|2086|4116|vetalmen|||13|200|0|0|Vistor hf|Boehringer Ingelheim Danmark|||2086||2086|4116 418996|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|sett|+ dæla|QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|2708|5330|vetalmen|||13|200|0|0|Vistor hf|Boehringer Ingelheim Danmark|||2708||2708|5330 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|4373|6775|lyfalmen|||10|100|0|25|Vistor hf|LEO Pharma A/S|||4373||4373|6775 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|10327|14855|lyfalmen|||10|100|0|100|Vistor hf|LEO Pharma A/S|||10327||10327|14855 419440|L01DB0103|Caelyx|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.05.1999||R|K|1,6|0|1|0|1|SCP|0|0|0|100|DKK|71538|90932|lyfsjukr|||00|10|0|0|Vistor hf|Schering-Plough|||71538||71538|90932 419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|A|3|0|1|0|1|MSD|0|0|0|100|XEU|59359|75769|lyfsjukr|||00|180|0|30|Icepharma hf|M.S.D.|||59359||59359|75769 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|A|2|0|1|0|1|ORP|0|0|0|100|DKK|50146|64299|lyfsjukr|||00|100|0|8|Swedish Orphan International AB|Orphan Europe (S)|||50146||50146|64299 419945|D07AD0101|Dermovat|áburður|0,5|mg/ml|25|ml|1|glas|í hársvörð|D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|806|1934|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||806||806|1934 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|12913|18262|lyfalmen|||02|10|0|40|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||12913||12913|18262 420356|B01AB0401|Fragmin|stl|2500|ae/ml|4|ml|10|hgl||B01AB04|01.04.1993||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|12936|17973|lyfsjukr|||00|40|0|40|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||12936||12936|17973 420471|B01AB0401|Fragmin|stl|12500|ae/ml|0,2|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|5625|8474|lyfalmen|||02|2|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5625||5625|8474 420497|B01AB0401|Fragmin|stl|25000|ae/ml|0,2|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|8167|11923|lyfalmen|||02|2|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||8167||8167|11923 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.07.1989||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|2309|3974|lyfalmen|V0144|3911|70|30|0|15|Vistor hf|Sanofi-aventis Norge AS|||2309||2309|3974 422246|C07AB0206|Seloken ZOC|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3271|5279|lyfalmen|||43|98|0|62|Vistor hf|AstraZeneca A/S DK|||3271||3271|5279 422337|C07AB0206|Seloken ZOC|forðatfl|190|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|6442|9582|lyfalmen|||43|98|0|124|Vistor hf|AstraZeneca A/S DK|||6442||6442|9582 422402|G03FB0505|Estracomb|forðapl|0| |8|stk|1|pakki|samsett pk|G03FB05|01.04.1993||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|2747|4568|lyfalmen|||23|8|0|28|Vistor hf|Novartis Healthcare A/S-|||2747||2747|4568 422659|G02CB0102|Parlodel|töflur|2,5|mg|100|stk|1|glas||G02CB01|01.11.1979||R|A|3|0|0|E|0|MAS|0|0|0|100|DKK|12169|12496|lyfalmen|||49|100|0|50|Vistor hf|Meda AS|||8589||8589|12496 424846|M04AA0103|Hexanurat|töflur|100|mg|100|stk|1|glas||M04AA01|01.02.2006||R|A||0|0|E|0|PCO|0|0|0|100|IKR|391|1371|lyfalmen|||00|100|1|25|Distica|Distica - óskráð lyf|||391||391|1371 424960|QP52AC1302|Panacur, vet.|pasta|187,5|mg/g|24|g|1|sk-dæl||QP52AC13|01.05.1999||L|A|3|0|0|0|0|INI|0|0|0|100|DKK|||vetorma|||16|24|0|0|Icepharma hf|Intervet International B.V.||||||2170 425181|N05CD0305|Flunitrazepam Merck NM|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|A|5|1|0|0|0|MNA|0|0|0|100|SEK|935|2109|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|||935||935|2109 425538|N04BC0102|Parlodel|hylki|10|mg|100|stk|1|þpakki||N04BC01|01.11.1979||R|A|4|0|0|E|0|MAS|0|0|0|100|DKK|42229|39291|lyfalmen|||52|100|0|25|Vistor hf|Meda AS|||29804||29804|39291 426122|R01AA0503|Nezeril|nefdr|0,1|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|2|0|0|0|0|AZD|0|0|1|100|IKR|||lyfalmen|||23|2|0|0|Vistor hf|AstraZeneca A/S DK||||||0 426312|J02AC0101|Diflucan|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.04.1993||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|3663|5811|lyfalmen|V0555|2796|10|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3663||3663|5811 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|592|1644|lyfalmen|||00|20|0|5|Vistor hf|Recip AB|||592||592|1644 426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|773|1889|lyfalmen|||00|30|0|8|Vistor hf|Recip AB|||773||773|1889 427351|N07BA0103|Nicorette|forðapl|5|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|14|0|5|Vistor hf|McNeil Denmark ApS||||||0 427369|N07BA0103|Nicorette|forðapl|10|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|14|0|10|Vistor hf|McNeil Denmark ApS||||||0 427377|N07BA0103|Nicorette|forðapl|15|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|14|0|15|Vistor hf|McNeil Denmark ApS||||||0 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|A|3|0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen|||00|30|0|45|Vistor hf|Boehringer Ingelheim International ||||||1824 428441|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1065|2286|lyfalmen|||20|30|0|30|Vistor hf|Schering-Plough|||1065||1065|2286 428524|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1057|2275|lyfalmen|||20|30|0|30|Vistor hf|Schering-Plough|||1057||1057|2275 428565|J01MA0202|Ciproxin|irl|2|mg/ml|100|ml|10|pokar||J01MA02|01.01.1990||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|30527|39874|lyfsjukr|||00|1000|0|4|Vistor hf|Bayer HealthCare AG|||30527||30527|39874 428656|J01MA0202|Ciproxin|irl|2|mg/ml|200|ml|10|pokar||J01MA02|01.01.1990||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|47807|61387|lyfsjukr|||00|2000|0|8|Vistor hf|Bayer HealthCare AG|||47807||47807|61387 428672|J01CA0406|Flemoxin Solutab|lausnart|125|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|538|1570|lyfalmen|||23|14|0|2|Vistor hf|Astellas Pharma A/S|||538||538|1570 428680|J01CA0406|Flemoxin Solutab|lausnart|250|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|886|2043|lyfalmen|||23|14|0|4|Vistor hf|Astellas Pharma A/S|||886||886|2043 428813|C07AB0309|Atenolol Actavis|töflur|25|mg|30|stk|1|glas||C07AB03|01.01.1992||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|180|1085|lyfalmen|||00|30|0|10|Actavis Group hf|Actavis hf|||180||180|1085 429167|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|1|hgl|+ dreifa í dælu|J07CA06|01.10.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|5952|8918|lyfalmen|||AC|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||5952||5952|8918 429225|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|10|hgl||J07CA06|01.12.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|44523|57616|lyfalmen|||AC|5|0|0|Icepharma hf|Sanofi Pasteur MSD|||44523||44523|57616 429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|þpakki||C03DA01|01.11.1981||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|6140|9173|lyfalmen|||00|100|0|133|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6140||6140|9173 430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|1730|2477|lyfsjukr|||02|50|0|0|Vistor hf|Janssen-Cilag AB|||1730||1730|2477 430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|2089|2991|lyfsjukr|||02|50|0|3|Icepharma hf|Roche|||2089||2089|2991 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|A|3|0|0|0|0|SPA|0|0|0|100|DKK|4099|7979|vetalmen|||27|100|0|0|Vistor hf|Schering-Plough A/S|||4099||4099|7979 430710|J07AP0301|Typhim Vi|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07AP03|01.07.1994||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2721|4533|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||2721||2721|4533 430967|N07BA0105|Nicorette Mint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.1993||L|A|2.5|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|2|Vistor hf|McNeil Denmark ApS||||||0 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|815|1946|lyfalmen|||20|15|0|15|Vistor hf|LEO Pharma A/S|||815||815|1946 431049|C01DA0801|Sorbangil|töflur|10|mg|100|stk|1|þpakki||C01DA08|01.07.1989||R|A|3|0|0|B|0|REP|0|0|0|100|DKK|1740|2507|lyfalmen|||00|100|0|17|Vistor hf|Recip AB|||1228||1228|2507 431106|N07BA0105|Nicorette Mint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.10.1995||L|A|2.5|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|210|0|14|Vistor hf|McNeil Denmark ApS||||||0 431122|N07BA0105|Nicorette Mint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.1993||L|A|2.5|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|4|Vistor hf|McNeil Denmark ApS||||||0 431171|N07BA0105|Nicorette Mint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.10.1995||L|A|2.5|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||00|210|0|28|Vistor hf|McNeil Denmark ApS||||||0 431205|C08DB0107|Korzem|töflur|30|mg|100|stk|1|þpakki||C08DB01|01.01.1989||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|785|1906|lyfalmen|||00|100|0|12|Actavis Group hf|Actavis hf|||785||785|1906 432336|J01GB0701|Netilyn|stl/irþ|10|mg/ml|1,5|ml|10|lykjur||J01GB07|01.01.1986|30.11.2008|R|A|5|0|0|0|1|SCP|0|0|0|100|DKK|2449|3506|lyfsjukr|||02|15|0|0|Vistor hf|Schering-Plough|||2449||2449|3506 432880|N02BE0107|Paratabs|töflur|500|mg|300|stk|1|glas|öryggislok|N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|952|2132|lyfalmen|||00|300|0|50|Actavis Group hf|Actavis hf|||952||952|2132 432971|J01DC0201|Cefuroxim Scand Pharm|sts|750|mg/hgl|750|mg|1|hgl||J01DC02|01.01.1996|31.12.2008|R|A|3|0|0|0|1|GEN|0|0|0|100|IKR|230|329|lyfsjukr|||00|750|0|0|NM Pharma ehf|Generics|||230||230|329 432989|J01DC0201|Cefuroxim Scand Pharm|sts/irs|1,5|g/hgl|1,5|g|1|hgl||J01DC02|01.01.1996|31.12.2008|R|A|3|0|0|0|1|GEN|0|0|0|100|IKR|459|657|lyfsjukr|||00|2|0|0|NM Pharma ehf|Generics|||459||459|657 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|13243|18673|lyfalmen|||00|100|0|20|Vistor hf|Orion Corporation|||13243||13243|18673 433292|N02AA0106|Contalgin Uno|forðahlk|30|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|2656|4445|lyfalmen|||00|28|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2656||2656|4445 433300|N02AA0106|Contalgin Uno|forðahlk|60|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|4872|7452|lyfalmen|||00|28|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4872||4872|7452 433318|N02AA0106|Contalgin Uno|forðahlk|90|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|6515|9682|lyfalmen|||00|28|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6515||6515|9682 433326|N02AA0106|Contalgin Uno|forðahlk|120|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|8157|11910|lyfalmen|||00|28|0|34|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||8157||8157|11910 433342|N02AA0106|Contalgin Uno|forðahlk|150|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|9398|13594|lyfalmen|||00|28|0|42|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||9398||9398|13594 433359|N02AA0106|Contalgin Uno|forðahlk|200|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|12688|17982|lyfalmen|||00|28|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||12688||12688|17982 433722|J01EE0104|Primazol sterkar|töflur|960|mg|10|stk|1|glas|160+800 mg|J01EE01|01.07.1989||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|486|1500|lyfalmen|||00|10|0|5|Actavis Group hf|Actavis hf|||486||486|1500 433730|J01EE0104|Primazol sterkar|töflur|960|mg|20|stk|1|glas|160+800 mg|J01EE01|01.07.1989||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|929|2101|lyfalmen|||00|20|0|10|Actavis Group hf|Actavis hf|||929||929|2101 434639|QP52AC1302|Panacur, vet.|töflur|250|mg|10|stk|1|þpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|||vetorma|||99|10|0|0|Icepharma hf|Intervet International B.V.||||||1381 434670|D01AC2001|Daktacort|krem|0| |50|g|1|túpa||D01AC20|01.10.1988||R|K|3|0|0|0|0|JAS|0|0|1|100|SEK|1452|2811|lyfalmen|||20|50|0|50|Vistor hf|Janssen-Cilag AB|||1452||1452|2811 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,7|0|0|B|0|ALK|0|0|1|100|DKK|7746|11352|lyfalmen|||00|1|0|1|Vistor hf|ALK-Abello A/S|||7746||7746|11352 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,75|0|0|B|0|ALK|0|0|1|100|DKK|7746|11352|lyfalmen|||00|1|0|0|Vistor hf|ALK-Abello A/S|||7746||7746|11352 434852|N06AB0302|Fontex|lausnart|20|mg|100|stk|1|pakki|þp (10x10 stk)|N06AB03|01.06.1998||R|A|2|0|0|B|0|ELI|0|1|0|30|XEU|11546|16509|lyfalmen|||00|100|0|100|Icepharma hf|Eli Lilly Danmark A/S|||11546||11546|16509 435537|N02CC0301|Zomig|töflur|5|mg|6|stk|1|þpakki||N02CC03|01.06.1999||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|5889|8832|lyfalmen|||00|6|0|12|Vistor hf|AstraZeneca UK Ltd|||5889||5889|8832 435578|N02CC0301|Zomig|töflur|2,5|mg|3|stk|1|þpakki||N02CC03|01.11.1998||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|2518|4257|lyfalmen|||00|3|0|3|Vistor hf|AstraZeneca UK Ltd|||2518||2518|4257 435594|N02CC0301|Zomig|töflur|2,5|mg|6|stk|1|þpakki||N02CC03|01.11.1998||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|4918|7514|lyfalmen|||00|6|0|6|Vistor hf|AstraZeneca UK Ltd|||4918||4918|7514 435651|N05AH0401|Seroquel|töflur|25|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|7267|9444|lyfalmen|V0725|8209|00|100|0|6|Vistor hf|AstraZeneca UK Ltd|||6340||6340|9444 435974|C01DA0801|Sorbangil|töflur|10|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|DKK|4050|4719|lyfalmen|||00|250|0|42|Vistor hf|Recip AB|||2858||2858|4719 436022|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|3986|6250|lyfalmen|||00|28|0|28|Vistor hf|Novartis Healthcare A/S-|||3986||3986|6250 436030|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|98|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|11423|16342|lyfalmen|V0191|13242|00|98|0|98|Vistor hf|Novartis Healthcare A/S-|||11423||11423|16342 436071|N04BC0401|Requip|töflur|0,25|mg|210|stk|1|þpakki||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|5841|8767|lyfalmen|||00|210|0|9|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||5841||5841|8767 436139|N04BC0401|Requip|töflur|0,5|mg|21|stk|1|þpakki||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|983|2174|lyfalmen|||00|21|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||983||983|2174 436147|M01AE0216|Naproxen-E Merck NM|sh-tfl|250|mg|20|stk|1|þpakki||M01AE02|01.07.1993||L|A|5|0|0|E|0|MNA|0|0|1|100|SEK|||lyfalmen|||10|20|0|10|Actavis Group PTC ehf|Merck NM AB||||||1535 436238|N04BC0401|Requip|töflur|1|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|6428|9563|lyfalmen|||00|84|0|14|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||6428||6428|9563 436279|N04BC0401|Requip|töflur|2|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|11655|16657|lyfalmen|V0728|16323|00|84|0|28|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||11655||11655|16657 436295|N04BC0401|Requip|töflur|5|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|24775|33030|lyfalmen|||00|84|0|70|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||24775||24775|33030 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|793|1917|lyfalmen|||20|15|0|15|Vistor hf|LEO Pharma A/S|||793||793|1917 436527|M01AE0216|Naproxen-E Merck NM|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|1948|3484|lyfalmen|||10|100|0|50|Actavis Group PTC ehf|Merck NM AB|||1948||1948|3484 436550|M01AE0211|Naproxen-E NM Pharma|sh-tfl|375|mg|20|stk|1|þpakki||M01AE02|01.01.1995||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|781|1900|lyfalmen|||10|20|0|15|Actavis Group PTC ehf|Merck NM AB|||781||781|1900 436626|M01AE0216|Naproxen-E Merck NM|sh-tfl|375|mg|100|stk|1|glas||M01AE02|01.01.1995||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|3225|5217|lyfalmen|||10|100|0|75|Actavis Group PTC ehf|Merck NM AB|||3225||3225|5217 436808|M01AE0216|Naproxen-E Merck NM|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|3688|5845|lyfalmen|||10|100|0|100|Actavis Group PTC ehf|Merck NM AB|||3688||3688|5845 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|908|2073|lyfalmen|||00|100|0|12|Vistor hf|Janssen-Cilag AB|||908||908|2073 436931|N05AD0101|Haldol|töflur|4|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|3182|5159|lyfalmen|||00|100|0|50|Vistor hf|Janssen-Cilag AB|||3182||3182|5159 438218|N06AX1602|Efexor Depot|forðahlk|75|mg|100|stk|1|glas||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|19488|26448|lyfalmen|V0955|19006|00|100|0|75|Icepharma hf|Wyeth AB|||19488||19488|26448 438333|N06AX1602|Efexor Depot|forðahlk|150|mg|28|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|9914|14294|lyfalmen|||00|28|0|42|Icepharma hf|Wyeth AB|||||9914|14294 438374|N07BC0201|Metadon|töflur|5|mg|20|stk|1|glas||N07BC02|01.01.1998||R|A||1|0|0|0|LDR|0|0|0|100|IKR|498|1516|lyfalmen|||00|20|1|4|Parlogis hf|Parlogis - óskráð lyf|||498||498|1516 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|0| |10|ml|1|túpa|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|A|2|0|0|E|0|ALC|0|0|1|100|USD|1262|2553|lyfalmen|||00|10|0|0|K.Pétursson hf|Alcon|||1262||1262|2553 438424|N06AX1602|Efexor Depot|forðahlk|75|mg|28|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|5227|7934|lyfalmen|||00|28|0|21|Icepharma hf|Wyeth AB|||5227||5227|7934 438432|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|18006|24602|lyfalmen|V0955|18626|00|98|0|74|Icepharma hf|Wyeth AB|||18006||18006|24602 438457|N06AX1602|Efexor Depot|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|34027|44549|lyfalmen|V0956|33512|00|98|0|147|Icepharma hf|Wyeth AB|||34027||34027|44549 438465|N06AX1602|Efexor Depot|forðahlk|150|mg|100|stk|1|glas||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|36793|47992|lyfalmen|V0956|34196|00|100|0|150|Icepharma hf|Wyeth AB|||36793||36793|47992 438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.07.1989||L|A|4|0|0|E|0|SCP|0|0|1|100|DKK|||lyfalmen|||00|10|0|10|Vistor hf|Schering-Plough||||||1801 438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|2101|3692|lyfalmen|V0982|1895|00|30|0|30|Vistor hf|Schering-Plough|||2101||2101|3692 438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|6342|9447|lyfalmen|V0984|3662|00|100|0|100|Vistor hf|Schering-Plough|||6342||6342|9447 439208|J01DC0203|Zinnat|töflur|250|mg|14|stk|1|þpakki||J01DC02|01.10.1990||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|2215|3846|lyfalmen|||66|14|0|7|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2215||2215|3846 439489|C07FB0201|Logimax|forðatfl|55|mg|98|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|10187|14665|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca A/S DK|||10187||10187|14665 439794|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyfalmen|||06|10|0|12|Artasan ehf|Novartis Healthcare A/S-A||||||0 440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1066|2287|lyfalmen|||00|70|0|6|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1066||1066|2287 440123|S01BA0401|Ultracortenol|augndr|5|mg/ml|5|ml|1|glas||S01BA04|01.12.1972|31.01.2009|R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|774|1891|lyfalmen|||29|5|0|0|Vistor hf|Novartis Healthcare A/S-|||774||774|1891 440677|J01CE0105|Penicillin Alpharma|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|1585|2269|lyfsjukr|||00|10|0|2|Actavis Group hf|Actavis Group hf|||1585||1585|2269 440693|J01CE0105|Penicillin Alpharma|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|2503|3584|lyfsjukr|||00|10|0|3|Actavis Group hf|Actavis Group hf|||2503||2503|3584 440933|M01AB0507|Vostar|eþ-stil|50|mg|10|stk|1|pakki||M01AB05|01.01.1990||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|548|1584|lyfalmen|||04|10|0|5|Actavis Group hf|Actavis hf|||548||548|1584 441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|þpakki||C03DA01|01.12.1972||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|1549|2942|lyfalmen|V0221|2932|00|100|0|33|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1549||1549|2942 441279|D01AC2002|Pevisone|krem|0| |30|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|1347|2668|lyfalmen|||20|30|0|30|Vistor hf|Janssen-Cilag AB|||1347||1347|2668 441634|P03AC0401|Nix|hársápa|10|mg/ml|59|ml|1|pakki||P03AC04|01.01.1996||L|A|2|0|0|0|0|ACH|0|0|0|100|GBP|||lyflausa|||00|59|0|0|Aco Hud Nordic AB|ACO Hud AB|||||| 441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|glas||G03DC02|01.12.1972||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|875|2028|lyfalmen|||00|30|0|30|Icepharma hf|Bayer Schering Pharma AG|||875||875|2028 442152|J05AF0101|Retrovir|hylki|250|mg|40|stk|1|þpakki||J05AF01|01.07.1995||R|A|5|0|1|0|1|GSK|0|0|0|100|GBP|29328|38381|lyfsjukr|||61|40|0|17|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||29328||29328|38381 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dæla|H04AA01|01.01.1989||R|K|3|0|0|*|0|NON|0|0|1|100|DKK|3926|6168|lyfalmen|||02|1|0|1|Vistor hf|Novo-Nordisk|||3926||3926|6168 443358|N02AA0101|Contalgin|forðatfl|200|mg|90|stk|1|þpakki||N02AA01|01.04.1993||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|33962|44468|lyfalmen|||10|90|0|180|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||33962||33962|44468 444240|J05AF0401|Zerit|hylki|30|mg|56|stk|1|þpakki||J05AF04|01.11.1998||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|48324|62031|lyfsjukr|||00|56|0|21|Vistor hf|Bristol-Myers Squibb|||48324||48324|62031 444299|J05AF0401|Zerit|hylki|40|mg|56|stk|1|þpakki||J05AF04|01.11.1998||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|49015|62891|lyfsjukr|||00|56|0|28|Vistor hf|Bristol-Myers Squibb|||49015||49015|62891 444315|N06AB0302|Fontex|lausnart|20|mg|30|stk|1|pakki|þp (2 x 15 stk)|N06AB03|01.06.1998||R|A|2|0|0|B|0|ELI|0|1|0|30|XEU|3469|5548|lyfalmen|V0914|2128|00|30|0|30|Icepharma hf|Eli Lilly Danmark A/S|||3469||3469|5548 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3056|4988|lyfalmen|||00|100|0|8|Icepharma hf|Roche|||3056||3056|4988 444927|M05BA0601|Bondronat|irþ|1|mg/ml|2|ml|1|hgl||M05BA06|01.04.2006||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|19440|26070|lyfsjukr|||00|2|0|0|Icepharma hf|Roche|||19440||19440|26070 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|A|3|0|0|B|0|LEO|0|0|1|100|DKK|1929|3458|lyfalmen|||00|30|0|30|Vistor hf|LEO A/S|||1929||1929|3458 445759|G04CB0101|Proscar|töflur|5|mg|98|stk|1|þpakki||G04CB01|01.04.1993||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|13123|6038|lyfalmen|V0411|6038|10|98|0|98|Icepharma hf|M.S.D.|||3830||3830|6038 445965|H01AC0104|Saizen|sts|0| |1,33|mg|1|hgl|+ leysir|H01AC01|01.07.1992|31.12.2008|R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|5733|8208|lyfsjukr|||02|1|0|2|Gróco ehf|Serono Nordic|||5733||5733|8208 446187|QA12CX9001|Tonophosphan, vet.|stl|200|mg/ml|50|ml|1|hgl||QA12CX90|01.12.1972||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|1548|3055|vetalmen|||27|50|0|0|Icepharma hf|Intervet International B.V.|||1548||1548|3055 446807|J02AC0101|Diflucan|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|4328|6714|lyfalmen|V0551|3202|10|7|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4328||4328|6714 446930|J02AC0101|Diflucan|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|1844|3343|lyfalmen|V0554|1864|10|1|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1844||1844|3343 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|12064|17205|lyfalmen|||00|4|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||12064||12064|17205 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|6882|10180|lyfalmen|||00|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6882||6882|10180 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|8430|12280|lyfalmen|||00|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||8430||8430|12280 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|10122|14576|lyfalmen|||00|3|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||10122||10122|14576 447912|C08DB0107|Korzem|töflur|60|mg|100|stk|1|þpakki||C08DB01|01.01.1989||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|706|1798|lyfalmen|V0352|1798|00|100|0|25|Actavis Group hf|Actavis hf|||706||706|1798 448217|C05AA0801|Doloproct|eþ-stil|0| |10|stk|1|pakki||C05AA08|01.01.1991||R|A|4|0|0|E|0|IGB|0|0|0|100|SEK|554|1592|lyfalmen|||04|10|0|0|Icepharma hf|Intendis GmbH Berlin|||554||554|1592 448233|C05AA0801|Doloproct|eþ-krem|0| |30|g|1|túpa||C05AA08|01.01.1991||R|A|3|0|0|E|0|IGB|0|0|0|100|SEK|1083|2310|lyfalmen|||00|30|0|0|Icepharma hf|Intendis GmbH Berlin|||1083||1083|2310 448498|R03DA0503|Aminophylline|stl|30|mg/ml|10|ml|10|lykjur||R03DA05|01.07.2000||R|A||0|0|E|0|LDR|0|0|0|100|IKR|6496|9656|lyfalmen|||02|100|1|5|Parlogis hf|Parlogis - óskráð lyf|||6496||6496|9656 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2524|4266|lyfalmen|V0712|2613|00|50|0|25|Vistor hf|Novartis Healthcare A/S-|||2524||2524|4266 449595|C07AB0310|Atenolol Merck NM|töflur|50|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|833|1971|lyfalmen|||00|98|0|65|Actavis Group PTC ehf|Merck NM AB|||||833|1971 449611|C07AB0310|Atenolol Merck NM|töflur|100|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|1224|2501|lyfalmen|V0306|1907|00|98|0|131|Actavis Group PTC ehf|Merck NM AB|||1224||1224|2501 449819|J01CE0105|Penicillin Alpharma|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|5936|8499|lyfsjukr|||00|10|0|8|Actavis Group hf|Actavis Group hf|||5936||5936|8499 450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|pakki|þp 875+125 mg|J01CR02|01.01.1997||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1115|2233|lyfalmen|V0466|2233|00|12|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1026||1026|2233 450734|N05CF0201|Stilnoct|töflur|10|mg|20|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|1074|1690|lyfalmen|V0902|1600|00|20|0|20|Vistor hf|Sanofi-aventis Norge AS|||626||626|1690 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|3386|4757|lyfalmen|V0903|4408|00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|||2886||2886|4757 451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|45479|58806|lyfalmen|||00|100|0|0|Icepharma hf|GE Healthcare AS|||45479||45479|58806 451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|68218|87116|lyfalmen|||00|150|0|0|Icepharma hf|GE Healthcare AS|||68218||68218|87116 451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|90958|115428|lyfalmen|||00|200|0|0|Icepharma hf|GE Healthcare AS|||90958||90958|115428 451989|N06AB0401|Cipramil|töflur|30|mg|28|stk|1|þpakki||N06AB04|01.11.1999||R|A|3|0|0|B|0|LBK|0|1|0|30|DKK|6129|8325|lyfalmen|||00|28|0|42|Lundbeck Export A/S|H. Lundbeck A/S|||5515||5515|8325 451997|N06AB0401|Cipramil|töflur|30|mg|100|stk|1|glas||N06AB04|01.11.1999||R|A|3|0|0|B|0|LBK|0|1|0|30|DKK|20331|26601|lyfalmen|||00|100|0|150|Lundbeck Export A/S|H. Lundbeck A/S|||19611||19611|26601 452268|J02AC0101|Diflucan|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|17764|24301|lyfalmen|V0552|10534|10|30|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||17764||17764|24301 452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|A|3|0|0|E|0|ROA|0|0|1|100|DKK|1244|2529|lyfalmen|||00|5|0|5|Icepharma hf|Roche as|||1244||1244|2529 452300|J02AC0101|Diflucan|hylki|50|mg|100|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|59492|76253|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||59492||59492|76253 452482|V07AB09|Sterilt Vatten Braun|leysir|0||100|ml|10|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|1000|0|0|Actavis Group hf|Braun|||||| 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|A|2|0|0|0|0|LAB|0|0|1|100|DKK|19715|19508|lyfalmen|||00|3000|0|3|Vistor hf|Laboratories 3M Santé|||13914||13914|19508 452896|A06AD1701|Phosphoral|mixtúra|0| |45|ml|2|fl||A06AD17|01.03.1999||L|A|3|0|0|0|0|LCF|0|0|0|100|IKR|||lyfalmen|||00|90|0|0|Vistor hf|Laboratorios Casen-Fleet S.L.U.||||||0 452904|N02AA0501|Oxycontin|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2737|4555|lyfalmen|||10|28|0|4|Icepharma hf|Norpharma |||2737||2737|4555 452920|N02AA0501|Oxycontin|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|9007|13063|lyfalmen|||10|98|0|13|Icepharma hf|Norpharma |||9007||9007|13063 452953|L04AX0102|Imurel|töflur|50|mg|100|stk|1|þpakki||L04AX01|01.10.1995||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|2537|4283|lyfalmen|||10|100|0|33|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2537||2537|4283 452995|N02AA0501|Oxycontin|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|5169|7855|lyfalmen|||10|28|0|7|Icepharma hf|Norpharma |||5169||5169|7855 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dæl||QP54AA01|01.01.1991||L|A|3|0|0|0|0|MEF|0|0|0|100|XEU|||vetorma|||16|6|0|0|Vistor hf|Merial (MSD)||||||2734 453175|N02AA0501|Oxycontin|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|16364|22558|lyfalmen|||10|98|0|26|Icepharma hf|Norpharma |||16364||16364|22558 453498|N02AA0501|Oxycontin|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|10412|14970|lyfalmen|||10|28|0|15|Icepharma hf|Norpharma |||10412||10412|14970 453571|N02AA0501|Oxycontin|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|28095|37163|lyfalmen|||10|98|0|52|Icepharma hf|Norpharma|||28095||28095|37163 453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|A|3|0|0|0|1|PFI|0|1|0|100|DKK|3866|5535|lyfsjukr|||02|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3866||3866|5535 453795|J07AL0102|Pneumo 23|bóluefni|0| |0,5|ml|1|dæla||J07AL01|01.09.2003||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2463|4183|lyfalmen|||00|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||2463||2463|4183 454199|C10AA0101|Zocor|töflur|20|mg|98|stk|1|þpakki||C10AA01|01.01.1991||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|10886|8635|lyfalmen|V0365|2265|00|98|0|131|Icepharma hf|M.S.D.|||5744||5744|8635 454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|16461|22679|lyfalmen|||00|28|0|19|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||16461||16461|22679 454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|50892|65546|lyfalmen|V0375|65546|00|98|0|65|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||50892||50892|65546 454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|18572|25307|lyfalmen|||00|28|0|37|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||18572||18572|25307 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|55065|70741|lyfalmen|V0376|70740|00|98|0|131|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||55065||55065|70741 454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|A|3|0|1|0|1|GSK|0|0|0|100|GBP|51403|65864|lyfsjukr|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||51403||51403|65864 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1171|2311|vetalmen|||16|100|0|0|Vistor hf|Boehringer Ingelheim Danmark|||1171||1171|2311 455329|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|þpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BHC|0|0|0|100|SEK|893|2052|lyfalmen|||00|30|0|5|Vistor hf|Bayer HealthCare AG|||893||893|2052 455337|A10BF0101|Glucobay|töflur|50|mg|120|stk|1|þpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BHC|0|0|0|100|SEK|3208|5194|lyfalmen|||00|120|0|20|Vistor hf|Bayer HealthCare AG|||3208||3208|5194 455428|B03XA0103|NeoRecormon|sts|10000|ae/rörly|1|ml|3|rörlyk|+leysir|B03XA01|01.02.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|68501|87151|lyfsjukr|||00|3|0|30|Icepharma hf|Roche|||68501||68501|87151 455527|B03XA0103|NeoRecormon|sts|20000|ae/rörly|1|ml|3|rörlyk|+leysir|B03XA01|01.02.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|136200|171437|lyfsjukr|||00|3|0|60|Icepharma hf|Roche|||136200||136200|171437 455576|B03XA0103|NeoRecormon|sts|100000|ae/hgl|5|ml|1|hgl|+leysir|B03XA01|01.02.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|222852|279318|lyfsjukr|||00|5|0|10|Icepharma hf|Roche|||222852||222852|279318 455584|J05AB0901|Famvir|töflur|500|mg|21|stk|1|þpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|30|DKK|23487|31426|lyfalmen|||00|21|0|14|Vistor hf|Novartis Healthcare A/S-|||23487||23487|31426 455717|C05AD0102|Sulgan|eþ-smyr|0| |30|g|1|túpa||C05AD01|01.12.1972||L|A|5|0|0|0|0|DOE|0|0|0|100|CHF|||lyfalmen|||00|30|0|0|Icepharma hf|Doetsch Grether||||||0 455725|C05AD0102|Sulgan|eþ-stil|0| |10|stk|1|pakki||C05AD01|01.12.1972||L|A|5|0|0|0|0|DOE|0|0|0|100|CHF|||lyfalmen|||00|10|0|0|Icepharma hf|Doetsch Grether||||||0 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|þpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|ACA|0|0|1|100|XEU|1069|2291|lyfalmen|||00|10|0|10|Actavis Group hf|Actavis hf|||1069||1069|2291 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|þpakki||J01AA02|01.01.2009||R|A|4|0|0|0|0|ACA|0|0|1|100|XEU|1166|2423|lyfalmen|||0|15|0|15|Actavis Group hf|Actavis hf|||1166||1166|2423 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|þpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|ACA|0|0|1|100|XEU|2554|4306|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|||2554||2554|4306 456079|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|6000|ml|2|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4291|6144|lyfsjukr|||00|12000|0|12|Icepharma hf|Baxter|||4291||4291|6144 456202|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|6000|ml|2|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4291|6144|lyfsjukr|||00|12000|0|12|Icepharma hf|Baxter|||4291||4291|6144 456277|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|5000|ml|2|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4684|6706|lyfsjukr|||00|10000|0|0|Icepharma hf|Baxter|||4684||4684|6706 456392|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|5000|ml|2|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4684|6706|lyfsjukr|||00|10000|0|0|Icepharma hf|Baxter|||4684||4684|6706 457002|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7014|10042|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||7014||7014|10042 457036|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7014|10042|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||7014||7014|10042 457069|B05DB0001|Dianeal PD1 Glucose|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7014|10042|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||7014||7014|10042 457119|B05DA0002|Dianeal PD1 Glucose Duo|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|8779|12569|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||8779||8779|12569 457127|N05BA1202|Paxal|töflur|0,25|mg|20|stk|1|glas||N05BA12|01.04.1990||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|117|999|lyfalmen|V0844|999|00|20|0|5|Actavis Group hf|Actavis hf|||117||117|999 457135|N05BA1202|Paxal|töflur|0,25|mg|50|stk|1|glas||N05BA12|01.04.1990|31.01.2009|R|A|5|0|0|0|0|ACA|0|0|0|100|IKR|||lyfalmen|||00|50|0|12|Actavis Group hf|Actavis hf|||246||| 457143|N05BA1202|Paxal|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.04.1990|31.12.2008|R|A|5|0|0|0|0|ACA|0|0|0|100|IKR|||lyfalmen|||00|100|0|25|Actavis Group hf|Actavis hf|||461||| 457150|N05BA1202|Paxal|töflur|0,5|mg|20|stk|1|glas||N05BA12|01.04.1990||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|199|1110|lyfalmen|V0856|1110|00|20|0|10|Actavis Group hf|Actavis hf|||199||199|1110 457192|N05BA1202|Paxal|töflur|0,5|mg|50|stk|1|glas||N05BA12|01.04.1990||R|A|5|0|0|0|0|ACA|0|0|0|100|IKR|440|1437|lyfalmen|V0860|1437|00|50|0|25|Actavis Group hf|Actavis hf|||440||440|1437 457242|B05DB0002|Dianeal PD1 Glucose Duo|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|8558|12253|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||8558||8558|12253 457291|B05DB0002|Dianeal PD1 Glucose Duo|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|11378|16033|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||11378||11378|16033 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|A|2|0|0|0|0|ARA|0|0|1|100|SEK|1030|2238|lyfalmen|||00|25|0|5|Vistor hf|Astra|||1030||1030|2238 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|þpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|1715|3168|lyfalmen|||43|20|0|7|Vistor hf|LEO Pharma A/S|||1715||1715|3168 458356|J01CA0801|Selexid|töflur|200|mg|30|stk|1|þpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|2571|4329|lyfalmen|||43|30|0|10|Vistor hf|LEO Pharma A/S|||2571||2571|4329 458422|J01CA0801|Selexid|töflur|200|mg|100|stk|1|þpakki||J01CA08|01.12.2007||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|9357|13538|lyfalmen|V0456|13538|00|100|0|33|Vistor hf|LEO Pharma A/S|||9357||9357|13538 458737|B05DA0003|Dianeal PD4 Glucose Duo|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|11468|16145|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||11468||11468|16145 458778|B05DB0003|Dianeal PD4 Glucose Duo|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|11468|16145|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||11468||11468|16145 458794|B05DB0003|Dianeal PD4 Glucose Duo|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|11468|16145|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||11468||11468|16145 459214|B05DB0004|Nutrineal PD4 1,1% Amino Acids Clear|kvið.sk|0| |2000|ml|5|pokar||B05DB00|01.06.2004||R|S|2|0|0|0|1|BAM|0|0|0|100|SEK|13644|18854|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|||13644||13644|18854 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|1523|2181|lyfsjukr|||02|2|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1523||1523|2181 459412|M05BA0601|Bondronat|irþ|1|mg/ml|2|ml|5|lykjur||M05BA06|01.02.2002||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|91483|115764|lyfsjukr|||00|10|0|2|Icepharma hf|Roche|||91483||91483|115764 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|1868|2675|lyfsjukr|||02|4|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1868||1868|2675 459727|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2165|3778|lyfalmen|||06|15|0|75|Icepharma hf|Santen Oy|||2165||2165|3778 459743|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2374|4062|lyfalmen|||06|15|0|75|Icepharma hf|Santen Oy|||2374||2374|4062 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|þpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|DKK|3403|4100|lyfalmen|||00|30|0|8|Vistor hf|Meda AS|||2402||2402|4100 459867|B02AA0201|Cyklokapron|töflur|500|mg|60|stk|1|þpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|DKK|6922|7470|lyfalmen|||00|60|0|15|Vistor hf|Meda AS|||4885||4885|7470 460071|J01CA0406|Flemoxin Solutab|lausnart|250|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1078|2303|lyfalmen|||23|20|0|5|Vistor hf|Astellas Pharma A/S|||1078||1078|2303 460170|J07BC0202|Avaxim|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07BC02|01.04.1998||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|4549|7014|lyfalmen|||51|0|0|0|Icepharma hf|Aventis Pasteur MSD A/S|||4549||4549|7014 460196|J01CA0406|Flemoxin Solutab|lausnart|500|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1613|3029|lyfalmen|||23|20|0|10|Vistor hf|Astellas Pharma A/S|||1613||1613|3029 460303|J01CA0406|Flemoxin Solutab|lausnart|750|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|2933|4821|lyfalmen|||23|20|0|15|Vistor hf|Astellas Pharma A/S|||2933||2933|4821 460618|L01AX0301|Temodal|hylki|5|mg|20|stk|1|glas| |L01AX03|01.05.2001||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|19395|26014|lyfsjukr|||00|20|0|0|Vistor hf|Schering-Plough|||19395||19395|26014 460782|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.10.1992||L|A|3|0|0|0|0|JAS|0|0|1|100|SEK|||lyfalmen|V0355|2143|23|120|0|120|Vistor hf|Janssen-Cilag AB||||||3249 460972|J07BB0205|Influvac|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOB|0|0|0|100|XEU|6507|9671|lyfalmen|||51|5|0|0|Icepharma hf|Solvay Biologicals B.V.|||6507||6507|9671 461178|L01AX0301|Temodal|hylki|20|mg|20|stk|1|glas| |L01AX03|01.05.2001||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|77576|98450|lyfsjukr|||00|20|0|0|Vistor hf|Schering-Plough|||77576||77576|98450 461335|L01AX0301|Temodal|hylki|100|mg|5|stk|1|glas| |L01AX03|01.05.2001||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|94840|119943|lyfsjukr|||00|5|0|0|Vistor hf|Schering-Plough|||94840||94840|119943 461467|L01AX0301|Temodal|hylki|250|mg|5|stk|1|glas| |L01AX03|01.05.2001||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|204703|256723|lyfsjukr|||00|5|0|0|Vistor hf|Schering-Plough|||204703||204703|256723 461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|193|1102|lyfalmen|||00|10|0|2|Actavis Group hf|Actavis hf|||193||193|1102 462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|644|1714|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||644||644|1714 462036|D07AD0101|Dermovat|krem|0,5|mg/g|100|g|1|túpa||D07AD01|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2534|4279|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2534||2534|4279 462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|644|1714|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||644||644|1714 462051|D07AD0101|Dermovat|smyrsli|0,5|mg/g|100|g|1|túpa||D07AD01|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2534|4279|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2534||2534|4279 462143|B05AA0703|Hemohes 10%|irl|100|mg/ml|500|ml|10|fl||B05AA07|01.11.1999||R|A|3|0|0|0|1|BRA|0|0|0|100|XEU|22985|30484|lyfsjukr|||00|5000|0|5|Actavis Group hf|Braun|||22985||22985|30484 462226|B05AA0702|Hemohes 6%|irl|60|mg/ml|500|ml|10|fl||B05AA07|01.11.1999||R|A|3|0|0|0|1|BRA|0|0|0|100|XEU|17315|23425|lyfsjukr|||00|5000|0|5|Actavis Group hf|Braun|||17315||17315|23425 462358|A07EA0601|Entocort|innhl|20|mcg/ml|7|stk|1|pakki|samsett pk|A07EA06|01.04.1993||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|7534|11064|lyfalmen|V0297|10399|56|7|0|7|Vistor hf|AstraZeneca A/S DK|||7534||7534|11064 462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|K|3|0|0|0|0|PAL|1|0|0|100|DKK|7182|13852|vetalmen|||02|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||7182||7182|13852 463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|5729|11084|vetalmen|||00|100|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||5729||5729|11084 463778|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|glas||M01AE01|01.01.1989|31.12.2008|L|A|5|0|0|E|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|20|0|3|Actavis Group hf|Actavis hf||||||0 464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.04.1992||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyfalmen|||00|30|0|5|Icepharma hf|GlaxoSmithKline CH A/S||||||0 464370|N05AD0301|Buronil|töflur|25|mg|100|stk|1|glas||N05AD03|01.12.1972||R|A|5|0|0|*|0|OVA|0|1|0|100|DKK|1896|3413|lyfalmen|||00|100|0|8|Swedish Orphan International AB|Ovation Healthcare International Ltd.|||1896||1896|3413 465203|QJ01RA0103|Depomycine, vet.|stl|0| |100|ml|1|hgl||QJ01RA01|01.12.1982||R|S|3|0|0|0|0|INI|0|0|0|100|DKK|1272|2510|vetalmen|||58|100|0|0|Icepharma hf|Intervet International B.V.|||1272||1272|2510 465237|QJ01CR5001|Duplocillin L.A., vet.|stl|0| |100|ml|1|hgl||QJ01CR50|01.05.1983||R|S|3|0|0|0|0|INI|1|0|0|100|DKK|1202|2372|vetalmen|||58|100|0|0|Icepharma hf|Intervet International B.V.|||1202||1202|2372 465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|A|3|0|0|0|0|INI|0|0|0|100|DKK|1288|2542|vetalmen|||27|100|0|0|Icepharma hf|Intervet International B.V.|||1288||1288|2542 465278|QJ51RC2301|Nafpenzal DC, vet.|spenalyf|0| |3|g|4|spr||QJ51RC23|01.04.1985||R|A|3|0|0|0|0|INI|0|0|0|100|XEU|679|1340|vetalmen|||16|12|0|0|Icepharma hf|Intervet International B.V.|||679||679|1340 466086|N02AA0101|Contalgin|forðatfl|10|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|804|1931|lyfalmen|||10|25|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||804||804|1931 466094|N02AA0101|Contalgin|forðatfl|10|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|2820|4667|lyfalmen|||10|100|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2820||2820|4667 466169|N02AA0101|Contalgin|forðatfl|30|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|1710|3161|lyfalmen|||10|25|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1710||1710|3161 466219|N02AA0101|Contalgin|forðatfl|30|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|6863|10154|lyfalmen|||10|100|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6863||6863|10154 466466|N02AA0101|Contalgin|forðatfl|60|mg|25|stk|1|þpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|3288|5302|lyfalmen|||10|25|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3288||3288|5302 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|9174|13290|lyfalmen|||10|50|0|5|Vistor hf|Novartis Healthcare A/S-|||9174||9174|13290 466680|N02AA0101|Contalgin|forðatfl|100|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|5263|7983|lyfalmen|||10|25|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5263||5263|7983 466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|þpakki||N06AG02|01.10.1990||R|A|5|0|0|B|0|MAS|0|1|0|100|DKK|7591|8111|lyfalmen|||64|100|0|50|Vistor hf|Meda AS|||5358||5358|8111 467191|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2|0|1|0|1|AEU|0|0|0|100|DKK|16996|23028|lyfsjukr|||00|0|0|1|Vistor hf|Amgen Europe B.V.|||16996||16996|23028 467258|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2|0|1|0|1|AEU|0|0|0|100|DKK|26638|35032|lyfsjukr|||00|0|0|1|Vistor hf|Amgen Europe B.V.|||26638||26638|35032 467480|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|28842|37773|lyfsjukr|||00|1|0|9|Vistor hf|Schering-Plough|||28840||28840|37773 467498|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|46979|60356|lyfsjukr|||00|1|0|15|Vistor hf|Schering-Plough|||46979||46979|60356 467514|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.04.2004||R|A|2|0|1|*|0|WTE|0|0|0|100|USD|41097|53351|lyfalmen|||00|60|0|20|Icepharma hf|Wyeth Europe|||41097||41097|53351 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|17785|24327|lyfalmen|||10|50|0|10|Vistor hf|Novartis Healthcare A/S-|||17785||17785|24327 467621|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|96166|121594|lyfsjukr|||00|1|0|30|Vistor hf|Schering-Plough|||96166||96166|121594 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|33662|44094|lyfalmen|||10|50|0|20|Vistor hf|Novartis Healthcare A/S-|||33662||33662|44094 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|A|5|0|0|0|1|JAS|0|1|0|100|SEK|733|1049|lyfsjukr|||00|5|0|3|Vistor hf|Janssen-Cilag AB|||733||733|1049 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|30|DKK|6865|6878|lyfalmen|V0922|4508|00|100|0|50|Lundbeck Export A/S|H. Lundbeck A/S|||4449||4449|6878 468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|427|611|lyfsjukr|||02|10|0|0|Vistor hf|Janssen-Cilag AB|||427||427|611 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|30|DKK|11978|6547|lyfalmen|V0926|4309|00|100|0|100|Lundbeck Export A/S|H. Lundbeck A/S|||4205||4205|6547 468165|N06AB0401|Cipramil|töflur|40|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|30|DKK|25256|13378|lyfalmen|V0930|8459|00|100|0|200|Lundbeck Export A/S|H. Lundbeck A/S|||9239||9239|13378 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|þpakki||C10AB04|01.07.1991||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|10888|15616|lyfalmen|||00|98|0|49|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||10888||10888|15616 469742|N02AX0206|Nobligan Retard|forðatfl|200|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|3109|5059|lyfalmen|||00|20|0|13|Icepharma hf|Grunenthal|||3109||3109|5059 469817|N02AX0206|Nobligan Retard|forðatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|12672|17962|lyfalmen|V0738|14262|00|100|0|67|Icepharma hf|Grunenthal|||12672||12672|17962 469866|N02AX0206|Nobligan Retard|forðatfl|150|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|2431|4139|lyfalmen|||00|20|0|10|Icepharma hf|Grunenthal|||2431||2431|4139 469874|N02AX0206|Nobligan Retard|forðatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|9623|13899|lyfalmen|V0736|11033|00|100|0|50|Icepharma hf|Grunenthal|||9623||9623|13899 469890|N02AX0206|Nobligan Retard|forðatfl|100|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1652|3082|lyfalmen|V0733|2537|00|20|0|7|Icepharma hf|Grunenthal|||1652||1652|3082 469932|N02AX0206|Nobligan Retard|forðatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|6573|9760|lyfalmen|V0734|7482|00|100|0|33|Icepharma hf|Grunenthal|||6573||6573|9760 470385|R03BA0501|Flixotide|innúðal|250|mcg/sk|120|sk|1|stauk||R03BA05|01.04.1995||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|5200|7897|lyfalmen|||24|120|0|50|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||5200||5200|7897 470989|V08AB0201|Omnipaque|stl|180|mg J/ml|15|ml|10|plastf||V08AB02|01.01.2005||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|6223|8910|lyfsjukr|||02|150|0|0|Icepharma hf|GE Healthcare AS|||6223||6223|8910 471144|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|7625|10917|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|||7625||7625|10917 471151|V08AB0201|Omnipaque|stl|300|mg J/ml|10|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|6396|9157|lyfsjukr|||02|100|0|0|Icepharma hf|GE Healthcare AS|||6396||6396|9157 471169|V08AB0201|Omnipaque|stl|300|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|9018|12912|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|||9018||9018|12912 471177|V08AB0201|Omnipaque|stl|350|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|9600|13745|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|||9600||9600|13745 471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|þpakki||A10BB07|01.07.1990||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|2132|3734|lyfalmen|||68|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2132||2132|3734 471821|QP52AC1302|Panacur, vet.|töflur|250|mg|20|stk|1|þpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|||vetorma|||99|20|0|0|Icepharma hf|Intervet International B.V.||||||2504 471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.01.1988||R|A|3|0|0|*|0|BAM|0|0|0|100|SEK|2253|3898|lyfalmen|||00|100|0|0|Icepharma hf|Baxter Medical AB|||2253||2253|3898 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|A|3|0|0|0|0|ORC|1|0|0|100|DKK|5100|9886|vetalmen|||27|10|0|0|Vistor hf|Orion Corporation|||5100||5100|9886 472092|C07AB0206|Seloken ZOC|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2168|3782|lyfalmen|V2003|3724|43|98|0|31|Vistor hf|AstraZeneca A/S DK|||2168||2168|3782 472332|J07BC0201|Havrix|bóluefni|1440|ein/ml|0,5|ml|1|dæla|einnota dæla|J07BC02|01.10.1995||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2408|4108|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2408||2408|4108 473348|A03AA0402|Spasmerin|töflur|135|mg|50|stk|1|glas||A03AA04|01.07.1990||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|957|2139|lyfalmen|||00|50|0|22|Actavis Group hf|Actavis hf|||957||957|2139 473371|A03AA0402|Spasmerin|töflur|135|mg|100|stk|1|glas||A03AA04|01.07.1990||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|1680|3120|lyfalmen|||00|100|0|45|Actavis Group hf|Actavis hf|||1680||1680|3120 474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|13600|18800|lyfsjukr|||00|400|0|0|Icepharma hf|Meda AB|||13600||13600|18800 474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|GBP|||lyflausa|||00|50|0|0|Icepharma hf|Mentholatum Company Ltd.|||||| 474114|N02CA7201|Anervan|töflur|160,5|mg|30|stk|1|pakki|þp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|975|2163|lyfalmen|||00|30|0|15|Vistor hf|Recip AB|||975||975|2163 474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|GBP|||lyflausa|||00|15|0|0|Icepharma hf|Mentholatum Company Ltd.|||||| 474395|J05AG0101|Viramune|töflur|200|mg|60|stk|1|þpakki||J05AG01|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|44632|57434|lyfsjukr|||00|60|0|30|Vistor hf|Boehringer Ingelheim International |||44632||44632|57434 474551|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.05.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|2066|3644|lyfalmen|||00|140|0|35|Vistor hf|Schering-Plough|||2066||2066|3644 475327|N02BE0113|Pinex Junior|eþ-stil|250|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||04|10|0|1|Actavis Group hf|Actavis Group hf||||||0 475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|720|1817|lyfalmen|||00|100|0|27|Actavis Group hf|Actavis hf|||720||720|1817 475467|G03CA0306|Evorel|forðapl|50|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|3969|6227|lyfalmen|||23|26|0|91|Vistor hf|Janssen-Cilag AB|||3969||3969|6227 475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|206|1120|lyfalmen|V0775|1120|00|20|0|7|Actavis Group hf|Actavis hf|||206||206|1120 475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|285|1227|lyfalmen|||00|30|0|10|Actavis Group hf|Actavis hf|||285||285|1227 475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|1|0|0|0|ACA|0|0|1|100|NOK|799|1925|lyfalmen|V0780|1925|00|100|0|33|Actavis Group hf|Actavis hf|||799||799|1925 475756|C09AA0801|Inhibace|töflur|2,5|mg|98|stk|1|þpakki||C09AA08|01.07.1991||R|A|3|0|0|B|0|ROC|0|0|0|100|DKK|6681|9907|lyfalmen|||00|98|0|98|Icepharma hf|Roche|||6681||6681|9907 475798|R03AC1302|Oxis Turbuhaler|innúðadu|4,5|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|3245|5244|lyfalmen|||00|60|0|11|Vistor hf|AstraZeneca A/S DK|||3245||3245|5244 475822|R03AC1302|Oxis Turbuhaler|innúðadu|9|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|4340|6730|lyfalmen|||00|60|0|22|Vistor hf|AstraZeneca A/S DK|||4340||4340|6730 475889|C09AA0801|Inhibace|töflur|5|mg|98|stk|1|þpakki||C09AA08|01.07.1991||R|A|3|0|0|B|0|ROC|0|0|0|100|DKK|12812|18136|lyfalmen|||00|98|0|196|Icepharma hf|Roche|||12812||12812|18136 475921|A10AB0404|Humalog Pen|stl|100|ae/ml|3|ml|5|pennar|einnota pennar|A10AB04|01.11.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|6296|9384|lyfalmen|||00|15|0|38|Icepharma hf|Eli Lilly Nederland -|||6296||6296|9384 476093|A10AC0106|Humulin NPH Pen|stl|100|ae/ml|3|ml|5|pennar|Einnota pennar|A10AC01|01.06.1999||R|K|2|0|0|*|0|ELI|0|0|0|100|XEU|5075|7727|lyfalmen|||51|15|0|38|Icepharma hf|Eli Lilly Danmark A/S|||5075||5075|7727 476580|R03AC0206|Ventoline|lausn|2|mg/ml|2,5|ml|20|lykjur|f. vél|R03AC02|01.04.1992||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1111|2348|lyfalmen|||00|50|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1111||1111|2348 476648|N05AH0401|Seroquel|töflur|100|mg|30|stk|1|þpakki|stakskammtar|N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|6619|9820|lyfalmen|||00|30|0|8|Vistor hf|AstraZeneca UK Ltd|||6617||6617|9820 476655|N05AH0401|Seroquel|töflur|200|mg|30|stk|1|þpakki|stakskammtar|N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|10058|14490|lyfalmen|||00|30|0|15|Vistor hf|AstraZeneca UK Ltd|||10058||10058|14490 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|glas|250 + 100 mg|P01BB51|01.02.2006||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|4362|6760|lyfalmen|||00|12|0|3|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||4362||4362|6760 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |20|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||00|200|0|0|Icepharma hf|Fresenius Kabi||||||0 477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |50|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||00|500|0|0|Icepharma hf|Fresenius Kabi||||||0 477752|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||02|200|0|0|Icepharma hf|Fresenius Kabi||||||0 477760|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||02|500|0|0|Icepharma hf|Fresenius Kabi||||||0 477786|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||02|1000|0|0|Icepharma hf|Fresenius Kabi||||||0 479691|C09AA0701|Cibacen|töflur|10|mg|98|stk|1|þpakki||C09AA07|01.07.1991||R|A|3|0|0|B|0|MAS|0|0|0|100|DKK|14119|14363|lyfalmen|||00|98|0|131|Vistor hf|Meda AS|||9965||9965|14363 479717|C09AA0701|Cibacen|töflur|20|mg|98|stk|1|þpakki||C09AA07|01.07.1991||R|A|3|0|0|B|0|MAS|0|0|0|100|DKK|30289|28799|lyfalmen|||00|98|0|261|Vistor hf|Meda AS|||21377||21377|28799 480863|G03XC0101|Evista|töflur|60|mg|28|stk|1|þpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|ELD|0|0|0|100|IKR|3183|5160|lyfalmen|||00|28|0|28|Icepharma hf|Eli Lilly Nederland -|||3183||3183|5160 480897|G03XC0101|Evista|töflur|60|mg|84|stk|1|þpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|ELD|0|0|0|100|IKR|9486|13713|lyfalmen|||00|84|0|84|Icepharma hf|Eli Lilly Nederland -|||||9486|13713 481168|N06AX1201|Zyban|forðatfl|150|mg|60|stk|1|þpakki||N06AX12|01.09.2000||R|A|2|0|0|0|0|GSK|0|1|1|100|GBP|7305|10754|lyfalmen|||00|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||7305|10754 481176|N06AX1201|Zyban|forðatfl|150|mg|100|stk|1|þpakki||N06AX12|01.09.2000||R|A|2|0|0|0|0|GSK|0|1|1|100|GBP|11273|16138|lyfalmen|||00|100|0|50|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||11273||11273|16138 481598|M03AX0102|Dysport|sts|500|ein|1|hgl|1|pakki||M03AX01|01.05.2003||R|K|2|0|1|0|1|INP|0|0|0|100|XEU|42458|54728|lyfsjukr|||02|1|0|0|Icepharma hf|Institut Produits Synthése (IPSEN) AB|||42458||42458|54728 483552|J02AC0101|Diflucan|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.08.2000||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|66493|84969|lyfalmen|V0557|33109|10|28|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||66493||66493|84969 483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|3855|5519|lyfsjukr|||00|50|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3855||3855|5519 483636|N07BA0103|Nicorette|tungur.t|2|mg|30|stk|1|þpakki||N07BA01|01.02.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|30|0|2|Vistor hf|McNeil Denmark ApS||||||0 483644|N07BA0103|Nicorette|tungur.t|2|mg|105|stk|1|þpakki||N07BA01|01.02.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|DKK|||lyfalmen|||23|105|0|7|Vistor hf|McNeil Denmark ApS||||||0 483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|5842|8364|lyfsjukr|||00|100|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5842||5842|8364 484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|88153|111618|lyfsjukr|||00|3|0|84|Vistor hf|Ferring|||88153||88153|111618 484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|þpakki||D11AX10|01.08.1999||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|7167|10566|lyfalmen|||00|28|0|28|Icepharma hf|M.S.D.|||7167||7167|10566 484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|A|3|0|0|E|0|MEB|0|0|1|100|DKK|1863|2625|lyfalmen|||00|300|0|0|Vistor hf|Meda AB (V)|||1315||1315|2625 484832|B05BB0118|Natrium Bicarbonat|irl|50|mg/ml|100|ml|1|fl||B05BB01|01.05.2004||R|A||0|0|0|1|LDR|0|0|0|100|IKR|543|777|lyfsjukr|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|||543||543|777 486779|M01AE0215|Naproxen Merck NM|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.04.1995||L|A|4|0|0|E|0|MNA|0|0|1|100|SEK|||lyfalmen|||00|20|0|10|Actavis Group PTC ehf|Merck NM AB||||||1155 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|A|3|0|0|E|0|ALC|0|0|1|100|USD|699|1789|lyfalmen|||29|5|0|0|K.Pétursson hf|Alcon|||699||699|1789 486886|S01CA0101|Maxitrol|augndr|0| |5|ml|1|glas||S01CA01|01.07.1990||R|A|2|0|0|E|0|ALC|0|0|1|100|USD|688|1774|lyfalmen|||29|5|0|0|K.Pétursson hf|Alcon|||688||688|1774 487264|C09AA0401|Coversyl|töflur|2|mg|30|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|2666|4458|lyfalmen|||00|30|0|15|Icepharma hf|Servier|||2666||2666|4458 487280|C09AA0401|Coversyl|töflur|4|mg|30|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|3891|6121|lyfalmen|||00|30|0|30|Icepharma hf|Servier|||3891||3891|6121 487900|J01XE0101|Furadantin|töflur|50|mg|25|stk|1|þpakki||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|777|1895|lyfalmen|||00|25|0|6|Vistor hf|Recip AB|||777||777|1895 487959|N02BE0113|Pinex Junior|eþ-stil|125|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||04|10|0|0|Actavis Group hf|Actavis Group hf||||||0 488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|835|1974|lyfalmen|||00|20|0|10|Icepharma hf|Meda AB|||835||835|1974 488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|2488|4217|lyfalmen|||00|60|0|30|Icepharma hf|Meda AB|||2488||2488|4217 488114|N02BE0114|Pinex|eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||04|10|0|2|Actavis Group hf|Actavis Group hf||||||0 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|ACA|0|0|0|100|DKK|10429|14993|lyfalmen|||67|50|0|14|Actavis Group PTC ehf|Actavis Group PTC ehf|||10429||10429|14993 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|ACA|0|0|0|100|DKK|18825|25622|lyfalmen|||67|50|0|36|Actavis Group PTC ehf|Actavis Group PTC ehf|||18825||18825|25622 489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|338|1101|lyfalmen|||67|10|0|5|Vistor hf|Novartis Healthcare A/S-|||192||192|1101 489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|960|1474|lyfalmen|V0609|1444|67|30|0|15|Vistor hf|Novartis Healthcare A/S-|||467||467|1474 490417|G03FB0504|Evorel Sequi|forðapl|0| |8|stk|1|pakki||G03FB05|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2338|4013|lyfalmen|||23|8|0|28|Vistor hf|Janssen-Cilag AB|||2338||2338|4013 490425|G03FA0104|Evorel Conti|forðapl|0| |8|stk|1|pakki||G03FA01|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2740|4559|lyfalmen|||23|8|0|28|Vistor hf|Janssen-Cilag AB|||2740||2740|4559 490557|A04AA0201|Kytril|stl|1|mg/ml|1|ml|5|lykjur||A04AA02|01.10.1999||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|9188|13309|lyfalmen|||00|5|0|2|Icepharma hf|Roche as|||9188||9188|13309 490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|5055|7700|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5055||5055|7700 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|11596|11044|lyfalmen|V0337|6756|00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||7519||7519|11044 490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|7845|11486|lyfalmen|||00|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||7845||7845|11486 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|16457|15043|lyfalmen|V0338|9234|00|100|0|200|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||10466||10466|15043 490839|C10AA0501|Zarator|töflur|40|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|12178|17347|lyfalmen|||00|30|0|120|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||12178||12178|17347 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|20930|18623|lyfalmen|V0339|11516|00|100|0|400|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||13203||13203|18623 491639|N06DA0301|Exelon|mixtúra|2|mg/ml|120|ml|1|fl||N06DA03|01.05.2003||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|23611|31581|lyfalmen|||00|120|0|27|Vistor hf|Novartis Europharm Ltd|||23611||23611|31581 491753|C10AC0102|Questran Loc|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1992|31.12.2008|R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|2922|4806|lyfalmen|||00|50|0|14|Vistor hf|Bristol-Myers Squibb|||2922||2922|4806 491860|L03AX0301|Oncotice|duft|500|millj ae|3|hgl|1|pakki|Fyrir ídreypivökva.|L03AX03|01.03.1999||R|K|1|0|1|0|1|ORG|0|0|0|100|DKK|51847|66417|lyfsjukr|||00|3|0|21|Vistor hf|N.V. Organon|||51847||51847|66417 492405|N04BA0202|Madopar Depot|forðahlk|125|mg|100|stk|1|hylki|100+25 mg|N04BA02|01.01.1991||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3636|5775|lyfalmen|||10|100|0|17|Icepharma hf|Roche|||3636||3636|5775 492520|A02BC0105|Losec MUPS|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|A|3|0|0|E|0|AZD|0|0|0|30|SEK|7880|11534|lyfalmen|V1800|9735|00|100|0|50|Vistor hf|AstraZeneca A/S DK|||7880||7880|11534 492587|N06AX0303|Mianserin NM Pharma|töflur|10|mg|100|stk|1|glas||N06AX03|01.01.1994||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|1375|2706|lyfalmen|V1140|2516|00|100|0|17|Actavis Group PTC ehf|Merck NM AB|||1375||1375|2706 493148|C10AA0302|Pravachol|töflur|20|mg|28|stk|1|þpakki||C10AA03|01.07.1989||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|4588|7067|lyfalmen|||00|28|0|28|Vistor hf|Bristol-Myers Squibb|||4588||4588|7067 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|A|5|0|0|B|0|SNO|0|1|0|100|NOK|1463|2826|lyfalmen|||00|100|0|17|Vistor hf|Sanofi-aventis Norge AS|||1463||1463|2826 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|þpakki||N02CX01|01.04.1974||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|4207|6549|lyfalmen|||00|100|0|33|Vistor hf|Novartis Healthcare A/S-|||4207||4207|6549 494237|L01XC0201|MabThera|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|93585|118381|lyfsjukr|||00|20|0|0|Icepharma hf|Roche Registration Limited|||93585||93585|118381 494286|L01XC0201|MabThera|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|233965|293154|lyfsjukr|||00|50|0|0|Icepharma hf|Roche Registration Limited|||233965||233965|293154 494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburður, fleyti|D10AF01|01.10.1995||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|2429|4137|lyfalmen|||00|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2429||2429|4137 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|2771|4601|lyfalmen|V0408|2140|23|84|0|84|Vistor hf|Novo-Nordisk|||2771||2771|4601 494724|G03FA0102|Kliogest|töflur|0| |84|stk|1|skífup||G03FA01|01.10.1986||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|3516|5612|lyfalmen|V0388|4286|23|84|0|84|Vistor hf|Novo-Nordisk|||3516||3516|5612 494831|B01AC0702|Persantin retard|forðahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|3386|5435|lyfalmen|||00|60|0|30|Vistor hf|Boehringer Ingelheim International |||3386||3386|5435 495259|A02BA0205|Zantac|freyðit|150|mg|15|stk|2|stauk|2 x 15 stk.|A02BA02|01.04.1990||L|A|2|0|0|E|0|GSK|0|0|0|30|GBP|||lyfalmen|||14|30|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf||||||5011 495267|A04AA0101|Zofran|töflur|4|mg|100|stk|1|glas||A04AA01|01.01.1991|31.12.2008|R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|95283|120812|lyfalmen|||00|100|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||95283||95283|120812 495275|A04AA0101|Zofran|töflur|8|mg|100|stk|1|glas||A04AA01|01.01.1991|31.12.2008|R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|134227|169298|lyfalmen|||00|100|0|50|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||134227||134227|169298 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|þpakki||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|17901|24472|lyfalmen|||00|15|0|8|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||17901||17901|24472 495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|6962|10288|lyfalmen|V1088|7729|02|10|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||6962||6962|10288 495390|A04AA0101|Zofran|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|9947|14339|lyfalmen|V1089|12111|02|20|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||9947||9947|14339 495572|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.04.2002||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|18383|25072|lyfalmen|||00|100|0|33|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||18383||18383|25072 495580|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.04.2002||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|30987|40764|lyfalmen|||00|100|0|44|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||30987||30987|40764 495820|J05AH0101|Relenza|innúðadu|5|mg/úðask|20|sk|1|stauk|+diskhaler|J05AH01|01.02.2000||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|2731|4546|lyfalmen|||00|20|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2731||2731|4546 496547|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|3945|6194|lyfalmen|||02|100|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3945||3945|6194 496554|C07AG0101|Trandate|töflur|100|mg|50|stk|1|glas||C07AG01|01.02.1982||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|996|2192|lyfalmen|||00|50|0|8|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||996||996|2192 496752|C07AG0101|Trandate|töflur|200|mg|100|stk|1|glas||C07AG01|01.01.1986||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|3126|5083|lyfalmen|||00|100|0|33|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3126||3126|5083 496935|N02AG0201|Ketogan|eþ-stil|0| |10|stk|1|pakki||N02AG02|01.07.1994||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|597|1651|lyfalmen|||04|10|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||597||597|1651 496950|N02AG0201|Ketogan|töflur|0| |20|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PFI|0|0|0|100|DKK|907|2071|lyfalmen|||00|20|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||907||907|2071 497099|N02AG0201|Ketogan|töflur|0| |100|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PFI|0|0|0|100|DKK|3457|5532|lyfalmen|||00|100|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3457||3457|5532 497263|N06BA0103|Amfetamin Actavis|töflur|5|mg|30|stk|1|glas||N06BA01|01.07.1991||R|A|3|1|0|0|0|ACA|0|0|0|100|IKR|1036|2246|lyfalmen|||00|30|0|10|Actavis Group hf|Actavis hf|||1036||1036|2246 497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|419|1409|lyfalmen|||00|30|0|15|Actavis Group hf|Actavis hf|||419||419|1409 497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|802|1929|lyfalmen|V0167|1929|00|100|0|50|Actavis Group hf|Actavis hf|||802||802|1929 497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2725|4538|lyfalmen|V0169|4538|00|100|0|200|Actavis Group hf|Actavis hf|||2725||2725|4538 497511|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.12.1983||L|A|3|0|0|0|0|BIG|0|0|0|100|SEK|||lyflausa|||00|250|0|250|Icepharma hf|Bioglan AB|||||| 497818|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3|0|0|B|0|BIG|0|0|1|100|SEK|773|1889|lyfalmen|||20|30|0|30|Icepharma hf|Bioglan AB|||773||773|1889 498048|H02AB0103|Diprospan|stl|7|mg/ml|2|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1457|2818|lyfalmen|||03|2|0|35|Vistor hf|Schering-Plough|||1457||1457|2818 498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|19612|26602|lyfalmen|||00|56|0|14|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||19612||19612|26602 498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|21142|28507|lyfalmen|||00|56|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||21142||21142|28507 499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|28608|37802|lyfalmen|||00|56|0|42|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||28608||28608|37802 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|32876|43116|lyfalmen|||00|56|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||32876||32876|43116 500314|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3,5|0|0|B|0|BIG|0|0|1|100|SEK|773|1889|lyfalmen|||20|30|0|30|Icepharma hf|Bioglan AB|||773||773|1889 500751|M01AB0101|Confortid|hylki|50|mg|30|stk|1|plglas||M01AB01|01.01.1977|31.12.2008|R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|1068|2290|lyfalmen|||10|30|0|15|Actavis Group hf|Actavis Group hf|||1068||1068|2290 500769|M01AB0101|Confortid|hylki|50|mg|100|stk|1|glas||M01AB01|01.01.1977|31.12.2008|R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|||lyfalmen|||10|100|0|50|Actavis Group hf|Actavis Group hf||2323|2323|2323|| 501734|M01AB0508|Vostar-R|forðatfl|75|mg|100|stk|1|glas||M01AB05|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|3199|5182|lyfalmen|||67|100|0|75|Actavis Group hf|Actavis hf|||3199||3199|5182 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3794|5989|lyfalmen|||10|100|0|17|Icepharma hf|Roche|||3794||3794|5989 502187|D07AB0201|Locoid|lausn|1|mg/ml|100|ml|1|glas||D07AB02|01.03.1977||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|2257|3903|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|||2257||2257|3903 502633|N06AA2101|Ludiomil|töflur|25|mg|100|stk|1|þpakki||N06AA21|01.06.1977||R|A|5|0|0|B|0|AMD|0|1|0|100|DKK|3196|5178|lyfalmen|||00|100|0|25|Vistor hf|Amdipharm Ltd|||3196||3196|5178 502930|N05AB0301|Trilafon|töflur|16|mg|100|stk|1|þpakki||N05AB03|01.01.1986||R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|4656|7159|lyfalmen|||00|100|0|53|Vistor hf|Schering-Plough|||4656||4656|7159 503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|33073|43043|lyfsjukr|||00|1|0|28|Vistor hf|Ferring|||33073||33073|43043 503722|A01AC0102|Kenalog|munnh.pa|1|mg/g|10|g|1|túpa||A01AC01|01.05.1998|31.12.2008|R|A|5|0|0|E|0|BRS|0|0|1|100|DKK|1267|2558|lyfalmen|||20|10|0|0|Vistor hf|Bristol-Myers Squibb|||1267||1266|2558 503961|D07AC0301|Ibaril|krem|2,5|mg/g|50|g|1|túpa||D07AC03|01.10.1976||R|A|5|0|0|B|0|SNO|0|0|1|100|NOK|2039|3607|lyfalmen|||20|50|0|50|Vistor hf|Sanofi-aventis Norge AS|||2039||2039|3607 504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.01.1988||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|2379|4069|lyfalmen|||00|90|0|45|Vistor hf|N.V. Organon|||2379||2379|4069 504746|R06AB0201|Polaramin|forðatfl|6|mg|50|stk|1|þpakki||R06AB02|01.01.1977||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|1386|2721|lyfalmen|||10|50|0|50|Vistor hf|Schering-Plough|||1386||1386|2721 504753|R06AB0201|Polaramin|töflur|2|mg|50|stk|1|pakki|þp|R06AB02|01.06.2007||R|A|5|0|0|E|0|SCP|0|0|0|100|DKK|646|1717|lyfalmen|||00|50|0|0|Vistor hf|Schering-Plough|||646||646|1717 504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|glas||N05BA08|01.01.1987||R|A|5|0|0|0|0|ROC|0|0|1|100|DKK|1368|2697|lyfalmen|||00|100|0|30|Icepharma hf|Roche|||1368||1368|2697 505644|A01AA0104|Fluorette|tyggigúm|0,25|mg|90|stk|1|stk||A01AA01|01.01.1996|31.12.2008|L|A|1,5|0|0|0|0|FET|0|0|1|100|DKK|||lyfalmen|||00|90|0|20|Icepharma hf|Fertin A/S||||||0 505743|N06AA2101|Ludiomil|töflur|75|mg|100|stk|1|þpakki||N06AA21|01.05.1978||R|A|5|0|0|B|0|AMD|0|1|0|100|DKK|8792|12772|lyfalmen|||00|100|0|75|Vistor hf|Amdipharm Ltd|||8792||8792|12772 505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|3539|5067|lyfsjukr|||02|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3539||3539|5067 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|6889|9863|lyfsjukr|||02|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6889||6889|9863 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|12224|17086|lyfsjukr|||02|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||12224||12224|17086 506774|J01GB0301|Garamycin|stl|10|mg/ml|2|ml|10|lykjur||J01GB03|01.11.1977||R|A|5|0|0|0|1|SCP|0|0|0|100|DKK|3346|4791|lyfsjukr|||02|20|0|1|Vistor hf|Schering-Plough|||3346||3346|4791 506949|N01AB0601|Forene|innönd.l|0| |250|ml|1|stauk||N01AB06|01.10.1993||R|A|5|0|0|0|1|ABS|0|0|0|100|DKK|31019|40486|lyfsjukr|||00|250|0|0|Vistor hf|Abbott Scandinavia AB|||31019||31019|40486 506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|2623|4400|lyfalmen|||10|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2623||2623|4400 506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|þpakki||A06AB02|01.12.1975||L|A|3|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||10|25|0|12|Vistor hf|Orion Pharma||||||0 507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|þpakki||A06AB02|01.12.1975||R|A|3|0|0|0|0|ERC|0|0|0|100|DKK|428|1421|lyfalmen|||10|100|0|50|Vistor hf|Orion Pharma|||428||428|1421 507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|24|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||1220 507111|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|5|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|120|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||5190 507343|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|1000|ml|1|fl||QP52AC13|01.12.1978||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|9734|16845|vetorma|||13|1000|0|0|Icepharma hf|Intervet International B.V.|||9734||9734|16845 507582|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|50|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.06.1999||R|A|3|0|0|0|0|SPA|0|0|0|100|DKK|2692|5299|vetalmen|||27|50|0|0|Vistor hf|Schering-Plough A/S|||2692||2692|5299 508622|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|5718|8600|lyfalmen|||10|98|0|98|Vistor hf|Abbott Scandinavia AB|||5718||5718|8600 508689|QJ01M0001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|4388|8530|vetalmen|||0|50|0|0|Vistor hf|Bayer Animal Health GmbH|||4388||4388|8530 508705|QJ01M0001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|13577|26033|vetalmen|||0|100|0|0|Vistor hf|Bayer Animal Health GmbH|||13577||13577|26033 508952|G03FB0902|Nuvelle|töflur|0| |84|stk|1|þpakki||G03FB09|01.08.1997||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|3198|5180|lyfalmen|||00|84|0|84|Icepharma hf|Bayer Schering Pharma AG|||3198||3198|5180 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|A|3|0|0|*|0|LBK|0|1|0|100|DKK|10687|15343|lyfalmen|||02|10|0|133|Lundbeck Export A/S|H. Lundbeck A/S|||10687||10687|15343 509091|J01CF0101|Diclocil|hylki|500|mg|100|stk|1|þpakki||J01CF01|01.09.1977|31.12.2008|R|A|1,5|0|0|0|0|BRS|0|0|1|100|DKK|10473|15051|lyfalmen|||10|100|0|25|Vistor hf|Bristol-Myers Squibb|||10473||10472|15051 509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||00|15|0|75|Vistor hf|N.V. Organon||||||2796 509448|D10AE0102|Panoxyl|hlaup|50|mg/g|40|g|1|túpa||D10AE01|01.12.1982||R|A|5|0|0|0|0|STI|0|0|0|100|XEU|440|1437|lyfalmen|||23|40|0|40|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|||440||440|1437 509455|D10AE0102|Panoxyl|hlaup|100|mg/g|40|g|1|túpa||D10AE01|01.12.1982||R|A|5|0|0|0|0|STI|0|0|0|100|XEU|496|1513|lyfalmen|||23|40|0|40|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|||496||496|1513 509463|D10AE0102|Panoxyl|áburður|50|mg/ml|30|ml|1|fl||D10AE01|01.12.1982||R|A|3|0|0|0|0|STI|0|0|0|100|XEU|363|1333|lyfalmen|||23|30|0|30|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|||363||363|1333 509471|D10AE0102|Panoxyl|krem|50|mg/g|40|g|1|túpa||D10AE01|01.12.1982||R|A|5|0|0|0|0|STI|0|0|0|100|XEU|440|1437|lyfalmen|||23|40|0|40|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|||440||440|1437 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|þpakki|150+300 mg|J05AR01|01.05.2004||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|46299|59510|lyfsjukr|||00|60|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||46299||46299|59510 510248|B03XA0103|NeoRecormon|stl|1000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|14072|19387|lyfsjukr|||00|2|0|6|Icepharma hf|Roche|||14072||14072|19387 510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|28145|36908|lyfsjukr|||00|2|0|12|Icepharma hf|Roche|||28145||28145|36908 510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|41087|53021|lyfsjukr|||00|2|0|18|Icepharma hf|Roche|||41087||41087|53021 510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|69400|88271|lyfsjukr|||00|2|0|30|Icepharma hf|Roche|||69400||69400|88271 510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|115163|145245|lyfsjukr|||00|4|0|60|Icepharma hf|Roche|||115163||115163|145245 510321|B03XA0103|NeoRecormon|stl|20000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|263188|329537|lyfsjukr|||00|4|0|120|Icepharma hf|Roche|||263188||263188|329537 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|4464|6898|lyfalmen|V0411|6038|00|98|0|98|Actavis Group hf|Actavis hf|||4464||4464|6898 511071|C09CA0701|Micardis|töflur|20|mg|28|stk|1|þpakki||C09CA07|01.03.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|3053|4983|lyfalmen|||00|28|0|14|Vistor hf|Boehringer Ingelheim International |||3053||3053|4983 511303|G03FB0501|Trisekvens|töflur|0| |84|stk|1|skífup||G03FB05|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|2882|4751|lyfalmen|V0385|4656|23|84|0|84|Vistor hf|Novo-Nordisk|||2882||2882|4751 511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|20459|27339|lyfsjukr|||00|6000|0|6|Icepharma hf|Meda AB|||20459||20459|27339 511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|0| |500|ml|12|pokar||B05AA05|01.07.1991||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|12798|17801|lyfsjukr|||00|6000|0|6|Icepharma hf|Meda AB|||12798||12798|17801 512608|B05XA3101|Peditrace|irþ|0| |10|ml|10|hgl||B05XA31|01.07.1993||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|10182|14544|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|||10182||10182|14544 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|A|5|0|0|0|0|AZD|0|0|1|100|SEK|||lyfalmen|||00|35|0|0|Vistor hf|AstraZeneca A/S DK||||||1618 514265|R03AC0302|Bricanyl Turbuhaler|innúðadu|0,25|mg/sk|200|sk|1|stauk||R03AC03|01.07.1993||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|1921|3447|lyfalmen|||23|200|0|25|Vistor hf|AstraZeneca A/S DK|||1921||1921|3447 515031|N06AX1801|Edronax|töflur|4|mg|20|stk|1|þpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|2248|3891|lyfalmen|||00|20|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2248||2248|3891 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|þpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|5392|8158|lyfalmen|||00|60|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5392||5392|8158 516476|A02BC0105|Losec MUPS|sh-tfl|10|mg|14|stk|1|glas||A02BC01|01.01.1999||R|A|2|0|0|E|0|AZD|0|0|0|30|SEK|1532|2919|lyfalmen|||00|14|0|7|Vistor hf|AstraZeneca A/S DK|||1532||1532|2919 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|4221|6568|lyfalmen|||00|90|0|11|Vistor hf|Novo-Nordisk|||4221||4221|6568 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|4954|7563|lyfalmen|||00|90|0|22|Vistor hf|Novo-Nordisk|||4954||4954|7563 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|6094|9110|lyfalmen|||00|90|0|45|Vistor hf|Novo-Nordisk|||6094||6094|9110 518241|M01AB0509|Modifenac|forðahlk|75|mg|20|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|982|2173|lyfalmen|||00|20|0|15|Actavis Group hf|Actavis Group hf|||982||982|2173 518258|M01AB0509|Modifenac|forðahlk|75|mg|100|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|4671|7179|lyfalmen|||00|100|0|75|Actavis Group hf|Actavis Group hf|||4671||4671|7179 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2001||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2232|3869|lyfalmen|||23|84|0|84|Vistor hf|N.V. Organon|||2232||2232|3869 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|969|2155|lyfalmen|||08|125|0|3|Vistor hf|Recip AB|||969||969|2155 519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|8859|12862|lyfalmen|||02|2|0|6|Gróco ehf|Nycomed Danmark A/S|||8859||8859|12862 520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|5154|7835|lyfalmen|||00|4|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5154||5154|7835 520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|5820|8738|lyfalmen|||00|4|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5820||5820|8738 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|17650|24159|lyfalmen|||00|12|0|12|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||17650||17650|24159 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|6246|9317|lyfalmen|V1300|8927|00|4|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6246||6246|9317 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|18688|25452|lyfalmen|||00|12|0|24|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||18688||18688|25452 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1623|3043|lyfalmen|V0308|3043|00|100|0|100|Actavis Group hf|Actavis hf|||1623||1623|3043 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2644|4428|lyfalmen|V0310|4428|00|100|0|200|Actavis Group hf|Actavis hf|||2644||2644|4428 520759|M03BC5101|Norgesic|töflur|0| |30|stk|1|þpakki||M03BC51|01.03.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|DKK|568|1385|lyfalmen|||00|30|0|9|Vistor hf|Meda AB (V)|||401||401|1385 521203|N04BC0502|Sifrol|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|36169|47215|lyfalmen|||00|100|0|28|Vistor hf|Boehringer Ingelheim International|||36169||36169|47215 521757|L01XX0501|Hydrea|hylki|500|mg|100|stk|1|glas||L01XX05|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|8676|12422|lyfsjukr|||00|100|1|0|Distica|Distica - óskráð lyf|||8676||8676|12422 522003|QJ51RC2302|Streptocillin, vet.|spenalyf|0| |8|g|40|spr||QJ51RC23|01.12.1982||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|8554|16465|vetalmen|||16|320|0|0|Vistor hf|Boehringer Ingelheim Danmark|||8554||8554|16465 522599|J07CA0202|Tetravac|bóluefni|0| |0,5|ml|1|spr|einnota dæla|J07CA02|01.10.1999||R|K|3,5|0|0|0|0|SPM|0|0|0|100|XEU|3560|5671|lyfalmen|||AC|0|0|0|Icepharma hf|Sanofi Pasteur MSD|||3560||3560|5671 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|K|1,5|0|1|0|1|NOE|0|0|0|100|DKK|284428|355980|lyfsjukr|||00|1|0|0|Vistor hf|Novartis Europharm Ltd|||284428||284428|355980 522730|N02AX0204|Tradolan|töflur|50|mg|20|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|SEK|427|1420|lyfalmen|||00|20|0|3|Vistor hf|Lannacher Heimittel Gmbh|||427||427|1420 522771|N02AX0204|Tradolan|töflur|50|mg|100|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|SEK|1765|3236|lyfalmen|||00|100|0|17|Vistor hf|Lannacher Heimittel Gmbh|||1765||1765|3236 522797|N02AX0204|Tradolan|töflur|50|mg|250|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|DKK|10425|14988|lyfalmen|||00|250|0|208|Vistor hf|Lannacher Heimittel Gmbh|||10425||10425|14988 522813|N02AX0204|Tradolan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|DKK|922|2092|lyfalmen|V0732|2092|02|10|0|2|Vistor hf|Lannacher Heimittel Gmbh|||922||922|2092 522839|D05AX0201|Daivonex|lausn|50|mcg/ml|120|ml|1|glas|í hársvörð|D05AX02|01.12.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|9516|13754|lyfalmen|||00|120|0|0|Vistor hf|LEO Pharma A/S|||9516||9516|13754 523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|þp 30+500 mg|N02AA59|01.11.1998||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|365|1336|lyfalmen|||00|40|0|13|Actavis Group hf|Actavis hf|||365||365|1336 523274|S01XA2008|Artelac|augndr|0| |10|ml|1|glas|plastglas|S01XA20|01.05.1998||L|A|3|0|0|E|0|GEM|0|0|0|100|IKR|||lyfalmen|||00|10|0|0|Actavis Group hf|Gerhard Mann||||||1199 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|þpakki||R06AD02|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|1114|2352|lyfalmen|||00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|||1114||1114|2352 523886|L02BB0101|Eulexin|töflur|250|mg|84|stk|1|þpakki||L02BB01|01.01.1993||R|A|5|0|0|*|0|SCP|0|0|0|100|DKK|25550|33995|lyfalmen|||00|84|0|28|Vistor hf|Schering-Plough|||25550||25550|33995 524215|C01DA1401|Imdur|forðatfl|30|mg|28|stk|1|þpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|983|2174|lyfalmen|||43|28|0|21|Vistor hf|AstraZeneca A/S DK|||983||983|2174 524223|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2464|4184|lyfalmen|||43|98|0|74|Vistor hf|AstraZeneca A/S DK|||2464||2464|4184 524694|C01DA0204|Nitromex|tungur.t|0,25|mg|30|stk|1|glas||C01DA02|01.12.1983||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|30|0|3|Actavis Group hf|Actavis Group hf||||||1146 524710|C01DA0204|Nitromex|tungur.t|0,5|mg|30|stk|1|glas||C01DA02|01.11.1981||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|30|0|6|Actavis Group hf|Actavis Group hf||||||1125 525014|M03BC5101|Norgesic|töflur|0| |100|stk|1|þpakki||M03BC51|01.06.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|DKK|1559|2333|lyfalmen|||00|100|0|29|Vistor hf|Meda AB (V)|||1100||1100|2333 525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|1082|2309|lyfalmen|||00|15|0|0|Vistor hf|Novartis Healthcare A/S-|||1082||1082|2309 525147|M01AB0504|Klofen-L|forðahlk|100|mg|30|stk|1|hylki||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|1532|2919|lyfalmen|||10|30|0|30|Actavis Group hf|Actavis hf|||1532||1532|2919 525170|M01AB0504|Klofen-L|forðahlk|100|mg|100|stk|1|hylki||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|5105|7768|lyfalmen|||10|100|0|100|Actavis Group hf|Actavis hf|||5105||5105|7768 525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.03.2002||R|A|5|0|0|0|0|ORG|0|0|0|100|DKK|11792|16843|lyfalmen|||00|30|0|10|Vistor hf|N.V. Organon|||11792||11792|16843 525998|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|1000|0|0|Actavis Group hf|Braun|||||| 526004|V07AB09|Sterilt Vatten Braun|leysir|0||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|1000|0|0|Actavis Group hf|Braun|||||| 526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|7808|11436|lyfalmen|||00|100|0|33|Icepharma hf|Roche|||7808||7808|11436 526376|N03AG0103|Orfiril Retard|forðatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|4925|7524|lyfalmen|||10|100|0|20|Vistor hf|Desitin Artzneimittel|||4925||4925|7524 526384|QJ01EW1001|Tribrissen, vet.|pasta|400|mg/g|37,5|g|5|spr|til inntöku|QJ01EW10|01.03.2007||R|A|5|0|0|0|0|SPA|0|0|0|100|DKK|7134|13760|vetalmen|||16|188|0|0|Vistor hf|Schering-Plough A/S|||7134||7134|13760 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|4368|6768|lyfalmen|||10|100|0|40|Vistor hf|Desitin Artzneimittel|||4368||4368|6768 527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|A|3|0|0|0|1|SNO|0|0|0|100|NOK|13375|18519|lyfsjukr|||00|2000|0|7|Vistor hf|Sanofi-aventis Norge AS|||13375||13375|18519 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|A|2,5|0|0|E|0|ALC|0|0|0|100|USD|1274|2569|lyfalmen|||00|5|0|0|K.Pétursson hf|Alcon|||1274||1274|2569 529263|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|þpakki||N07BC01|01.11.1999||R|A|1|1|0|0|1|SCP|0|0|0|100|DKK|2053|2939|lyfsjukr|||00|7|0|2|Vistor hf|Schering-Plough|||2053||2053|2939 529289|R02AA0301|Strepsils|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|||||| 529438|QJ51RC2002|Ampiclox vet.|spenalyf|0| |3|g|24|spr|spenadælur|QJ51RC20|01.06.1998||R|A|1.5|0|0|0|0|PAL|0|0|0|100|DKK|4578|8892|vetalmen|||16|72|0|0|Icepharma hf|Pfizer Oy Animal Health|||4578||4578|8892 529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|3943|7682|vetalmen|||16|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||3943||3943|7682 529586|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|þpakki||N07BC01|01.11.1999||R|A|1|1|0|0|1|SCP|0|0|0|100|DKK|5250|7517|lyfsjukr|||00|7|0|7|Vistor hf|Schering-Plough|||5250||5250|7517 529735|N03AB0501|Pro-Epanutin|irþ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|K|2|0|0|0|1|PFI|0|0|0|100|DKK|85558|108387|lyfsjukr|||00|100|0|11|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||85558||85558|108387 530030|J06BA0205|Sandoglobulin|irs|1|g/fl|1|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|10226|14599|lyfsjukr|||00|1|0|0|Icepharma hf|CSL Denmark ApS|||10226||10226|14599 530048|J06BA0205|Sandoglobulin|irs|3|g/fl|3|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|27728|36389|lyfsjukr|||00|3|0|0|Icepharma hf|CSL Denmark ApS|||27728||27728|36389 530055|J06BA0205|Sandoglobulin|irs|6|g/fl|6|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|55457|70911|lyfsjukr|||00|6|0|0|Icepharma hf|CSL Denmark ApS|||55457||55457|70911 530741|G03FA0105|Activelle|töflur|0| |84|stk|1|pakki|þp 1+0,5 mg|G03FA01|01.03.2000||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|3695|5855|lyfalmen|||23|84|0|84|Vistor hf|Novo-Nordisk|||3695||3695|5855 531459|R03CC0303|Bricanyl Retard|forðatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2615|4389|lyfalmen|||43|100|0|50|Vistor hf|AstraZeneca A/S DK|||2615||2615|4389 531913|J05AG0101|Viramune|mixtúra|10|mg/ml|240|ml|1|fl||J05AG01|01.03.2007||R|A|0,5|0|1|0|1|BII|0|0|0|100|DKK|9698|13885|lyfsjukr|||00|240|0|6|Vistor hf|Boehringer Ingelheim International |||9698||9698|13885 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|A|5|0|0|0|0|JAS|0|0|0|100|SEK|332|1291|lyfalmen|||01|30|0|3|Vistor hf|Janssen-Cilag AB|||332||332|1291 532739|V07AB10|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|5|ml|20|plastl|leysir f.stungulyf|V07AB|01.12.1997|31.01.2009|L|A|3,5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|100|0|0|Actavis Group hf|Braun|||||| 533737|R03CC0303|Bricanyl Retard|forðatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1766|3237|lyfalmen|||43|100|0|33|Vistor hf|AstraZeneca A/S DK|||1766||1766|3237 534537|J01EE0103|Primazol|töflur|480|mg|20|stk|1|glas|80+400 mg|J01EE01|01.10.1995||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|476|1486|lyfalmen|||00|20|0|5|Actavis Group hf|Actavis hf|||476||476|1486 534552|J01EE0103|Primazol|töflur|480|mg|100|stk|1|glas|80+400 mg|J01EE01|01.10.1995|31.12.2008|R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|100|0|25|Actavis Group hf|Actavis hf||2062|2062|2062|| 535773|P03AA5401|Tenutex|áburður|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|K|3|0|0|0|0|BPA|0|0|0|100|IKR|||lyfalmen|||00|100|0|0|Icepharma hf|Bioglan Pharma AB||||||0 535898|G04BD0401|Ditropan|töflur|5|mg|84|stk|1|þpakki||G04BD04|01.06.1998||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|5633|8485|lyfalmen|||00|84|0|28|Vistor hf|Sanofi-aventis Norge AS|||5633||5633|8485 536029|S01EB0105|Isopto Carpine|augndr|10|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|ALC|0|0|0|100|USD|370|1342|lyfalmen|||06|10|0|25|K.Pétursson hf|Alcon|||370||370|1342 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|ALC|0|0|0|100|USD|449|1450|lyfalmen|||06|10|0|25|K.Pétursson hf|Alcon|||449||449|1450 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|ALC|0|0|0|100|USD|572|1617|lyfalmen|||06|10|0|25|K.Pétursson hf|Alcon|||572||572|1617 536938|N04BC0102|Parlodel|hylki|5|mg|100|stk|1|þpakki||N04BC01|01.05.1983||R|A|4|0|0|E|0|MAS|0|0|0|100|DKK|21899|21428|lyfalmen|||52|100|0|12|Vistor hf|Meda AS|||15456||15456|21428 537373|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|2|g|1|spr||QP52AF02|01.07.1995||L|A|3|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|2|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||671 537720|L01CB0101|Vepesid|hylki|100|mg|10|stk|1|glas||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|13691|18913|lyfsjukr|||00|10|1|0|Distica|Distica - óskráð lyf|||13691||13691|18913 537811|G03CA0401|Ovestin|sk-stil|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||05|15|0|38|Vistor hf|N.V. Organon||||||2360 538181|A02AD0106|Rennie|sog/tugg|0| |24|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyfalmen|||00|24|0|2|Icepharma hf|Bayer AB||||||0 538199|A02AD0106|Rennie|sog/tugg|0| |48|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyfalmen|||00|48|0|5|Icepharma hf|Bayer AB||||||0 538207|A02AD0106|Rennie|sog/tugg|0| |96|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyfalmen|||00|96|0|10|Icepharma hf|Bayer AB||||||0 538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|131804|165963|lyfsjukr|||00|6|0|61|Gróco ehf|Serono Nordic|||131804||131804|165963 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|þpakki||N03AG04|01.10.1992||R|A|5|0|1|E|0|SNO|0|0|0|100|NOK|10153|14619|lyfalmen|||00|100|0|25|Vistor hf|Sanofi-aventis Norge AS|||10153||10153|14619 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|188|1096|lyfalmen|||00|25|0|5|Actavis Group hf|Actavis Group hf|||188||188|1096 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|0|100|DKK|408|1394|lyfalmen|||00|100|0|20|Actavis Group hf|Actavis Group hf|||408||408|1394 539783|D01AC2001|Daktacort|krem|0| |15|g|1|túpa||D01AC20|01.04.1986||L|K|3|0|0|0|0|JAS|0|0|1|100|SEK|||lyfalmen|||20|15|0|15|Vistor hf|Janssen-Cilag AB||||||0 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|2722|4534|lyfalmen|||23|40|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2722||2722|4534 540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|2983|4888|lyfalmen|||00|250|0|250|Icepharma hf|Smith & Nephew|||2983||2983|4888 540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.07.2000||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|8362|12188|lyfalmen|||06|15|0|0|Icepharma hf|M.S.D.|||8362||8362|12188 541060|R03AC0302|Bricanyl Turbuhaler|innúðadu|0,5|mg/sk|200|sk|1|stauk||R03AC03|01.01.1989||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|1806|3291|lyfalmen|V0987|3279|23|200|0|50|Vistor hf|AstraZeneca A/S DK|||1806||1806|3291 541128|M01CC0101|Atamir|hylki|150|mg|200|stk|1|glas||M01CC01|01.09.1983||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|10177|14651|lyfalmen|||10|200|0|60|Swedish Orphan International AB|Sandoz GmbH (S)|||10177||10177|14651 541136|M01CC0101|Atamir|hylki|250|mg|200|stk|1|plglas||M01CC01|12.10.2004||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|16484|22708|lyfalmen|||10|200|0|100|Swedish Orphan International AB|Sandoz GmbH (S)|||16484||16484|22708 541169|R02AA0302|Strepsils med honning og citron|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|||||| 542803|C08DA0103|Isoptin retard|forðatfl|240|mg|28|stk|1|þpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|1601|3013|lyfalmen|||10|28|0|28|Vistor hf|Abbott Scandinavia AB|||1601||1601|3013 542977|J04BA0201|Dapson|töflur|50|mg|100|stk|1|glas||J04BA02|01.05.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|1638|3063|lyfalmen|||00|100|1|100|Parlogis hf|Parlogis - óskráð lyf|||1638||1638|3063 543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|þpakki||C07AA03|01.12.1983||R|A|5|0|0|B|0|NOH|0|0|0|100|DKK|4710|7232|lyfalmen|||00|98|0|65|Vistor hf|Novartis Healthcare A/S-|||4710||4710|7232 543413|R06AA5201|Koffinatin|töflur|0| |10|stk|1|þpakki||R06AA52|01.12.1982||L|A|4|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|10|0|2|Actavis Group hf|Actavis hf||||||0 543686|B02BD0203|ReFacto|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2003||R|K|2|0|0|0|1|WTE|0|0|0|100|USD|26825|35265|lyfsjukr|||00|1|0|0|Icepharma hf|Wyeth Europe|||26825||26825|35265 543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyfalmen|||42|250|0|22|Vistor hf|Recip AB||||||0 543744|R01AA0503|Nezeril|nefúði|0,5|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyfalmen|||23|8|0|9|Vistor hf|AstraZeneca A/S DK||||||0 543827|B02BD0203|ReFacto|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2003||R|K|2|0|0|0|1|WTE|0|0|0|100|USD|53158|68049|lyfsjukr|||00|1|0|1|Icepharma hf|Wyeth Europe|||53158||53158|68049 543835|B02BD0203|ReFacto|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2003||R|K|2|0|0|0|1|WTE|0|0|0|100|USD|105598|133337|lyfsjukr|||00|1|0|2|Icepharma hf|Wyeth Europe|||105598||105598|133337 543850|B02BD0203|ReFacto|sts|2000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.04.2004||R|K|2|0|0|0|1|WTE|0|0|0|100|USD|191996|240903|lyfsjukr|||00|1|0|4|Icepharma hf|Wyeth Europe|||191996||191996|240903 543926|D11AC0302|Selsun Blue|hársápa|10|mg/ml|120|ml|1|glas||D11AC03|01.08.1984||L|A|3|0|0|0|0|CHT|0|0|0|100|DKK|||lyflausa|||01|120|0|120|Vitaflo Scandinavia AB|Chattem Clobal Consumer Products|||||| 544049|C01DA1402|Monit-L|forðahlk|60|mg|100|stk|1|glas||C01DA14|01.10.1992|31.12.2008|R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|2489|4218|lyfalmen|||10|100|0|150|Actavis Group hf|Actavis hf|||2489||2489|4218 544502|G03GA0501|Gonal-F|sts|37,5|ae/lykju|10|lyk|1|pakki|+ leysir 1 ml|G03GA05|01.02.2002||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|24390|32551|lyfalmen|||00|10|0|5|Gróco ehf|Serono Nordic|||24390||24390|32551 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|708|1801|lyfalmen|||00|15|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||708||708|1801 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1274|2567|lyfalmen|||00|100|0|7|Lundbeck Export A/S|H. Lundbeck A/S|||1272||1272|2567 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|3386|5435|lyfalmen|||00|100|0|33|Lundbeck Export A/S|H. Lundbeck A/S|||3386||3386|5435 545996|V01AA0507|Alutard SQ, birkifrjo|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|32346|42456|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|||32346||32346|42456 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|26079|34653|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||26079||26079|34653 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|32537|42694|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|||32537||32537|42694 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|27642|36599|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|||27642||27642|36599 546143|N02BE0108|Paratabs Retard|forðatfl|500|mg|30|stk|1|þpakki||N02BE01|01.10.1993||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||10|30|0|5|Actavis Group hf|Actavis hf||||||0 546168|N02BE0108|Paratabs Retard|forðatfl|500|mg|100|stk|1|þpakki||N02BE01|01.10.1993||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|521|1547|lyfalmen|||10|100|0|17|Actavis Group hf|Actavis hf|||521||521|1547 546531|N06AF0101|Marplan|töflur|10|mg|56|stk|1|glas||N06AF01|01.10.2001||R|A||0|0|E|0|LDR|0|0|0|100|IKR|6004|8988|lyfalmen|||00|56|1|37|Parlogis hf|Parlogis - óskráð lyf|||6004||6004|8988 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|þpakki||A02BX02|01.01.1986||L|A|5|0|0|0|0|ORC|0|0|0|30|DKK|||lyfalmen|||23|60|0|15|Vistor hf|Orion Corporation||||||4472 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|9887|14156|lyfsjukr|||00|100|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||9887||9887|14156 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|3258|4665|lyfsjukr|||00|10|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||3258||3258|4665 547729|G03GA0601|Puregon|stl|100|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|9174|13290|lyfalmen|||63|0|0|1|Vistor hf|N.V. Organon|||9174||9174|13290 547869|G03GA0601|Puregon|stl|150|ae/hgl|0,5|ml|5|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|57036|73195|lyfalmen|||63|2|0|5|Vistor hf|N.V. Organon|||57036||57036|73195 547893|G03GA0601|Puregon|stl|50|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|4712|7235|lyfalmen|||63|0|0|0|Vistor hf|N.V. Organon|||4712||4712|7235 547901|G03GA0601|Puregon|stl|50|ae/hgl|0,5|ml|5|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|22934|30738|lyfalmen|||63|2|0|2|Vistor hf|N.V. Organon|||22934||22934|30738 548297|A08AA1001|Reductil|hylki|10|mg|98|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|18398|25090|lyfalmen|||00|98|0|98|Vistor hf|Abbott Laboratories A/S|||18398||18398|25090 548347|A08AA1001|Reductil|hylki|15|mg|98|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|18398|25090|lyfalmen|||00|98|0|147|Vistor hf|Abbott Laboratories A/S|||18398||18398|25090 548511|J01CF0101|Diclocil|sts/irs|500|mg|1|stk|10|hgl||J01CF01|01.04.1987||R|A|3|0|0|0|1|BRS|0|0|0|100|DKK|2246|3216|lyfsjukr|||03|10|0|2|Vistor hf|Bristol-Myers Squibb|||2246||2246|3216 548776|M05BA0701|Optinate|filmhtfl|5|mg|28|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|5271|7993|lyfalmen|||00|28|0|28|Vistor hf|Sanofi-aventis Norge AS|||5271||5271|7993 548784|M05BA0701|Optinate|filmhtfl|5|mg|84|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|14389|20099|lyfalmen|||00|84|0|84|Vistor hf|Sanofi-aventis Norge AS|||14389||14389|20099 548792|M05BA0701|Optinate|filmhtfl|30|mg|28|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|36883|48104|lyfalmen|||00|28|0|168|Vistor hf|Sanofi-aventis Norge AS|||36883||36883|48104 549113|J06BB1601|Synagis|sts|50|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|111021|140089|lyfsjukr|||17|1|0|0|Vistor hf|Abbott Laboratories Ltd|||111021||111021|140089 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|8321|12132|lyfalmen|||02|5|0|152|Vistor hf|Janssen-Cilag AB|||8321||8321|12132 549170|J06BB1601|Synagis|sts|100|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|159182|200049|lyfsjukr|||17|1|0|0|Vistor hf|Abbott Laboratories Ltd|||159182||159182|200049 550020|J07AP0302|Typherix|bóluefni|50|mcg/ml|0,5|ml|1|spr|einnota sprauta|J07AP03|01.10.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|2064|3641|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2064||2064|3641 550061|N02BE0102|Panodil Brus|freyðit|500|mg|24|stk|1|þpakki||N02BE01|01.04.1992||L|A|4|0|0|0|0|GCH|0|0|1|100|DKK|||lyfalmen|||00|24|0|4|Icepharma hf|GlaxoSmithKline CH A/S||||||0 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|A|3|0|0|0|0|GCH|0|0|1|100|DKK|||lyfalmen|||00|60|0|0|Icepharma hf|GlaxoSmithKline CH A/S||||||0 550731|N02BE0103|Panodil Junior|eþ-stil|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|A|5|0|0|0|0|GCH|0|0|1|100|DKK|||lyfalmen|||00|10|0|0|Icepharma hf|GlaxoSmithKline CH A/S||||||0 551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|9624|13901|lyfalmen|||00|12|0|12|Vistor hf|AstraZeneca UK Ltd|||9624||9624|13901 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|1604|3017|lyfalmen|||03|1|0|3|Icepharma hf|Meda AB|||1604||1604|3017 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|3657|5803|lyfalmen|||00|100|0|50|Icepharma hf|Meda AB|||3657||3657|5803 551739|N02AA0102|Morfin|töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|S||1|0|E|0|LDR|0|0|0|100|IKR|905|2069|lyfalmen|||00|20|1|2|Parlogis hf|Parlogis - óskráð lyf|||905||905|2069 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|30|SEK|2695|4498|lyfalmen|||00|28|0|14|Vistor hf|Eisai Ltd|||2695||2695|4498 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|30|SEK|4382|6787|lyfalmen|||00|56|0|28|Vistor hf|Eisai Ltd|||4382||4382|6787 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.11.2001||R|A|2|0|0|E|0|EIS|0|0|0|30|SEK|2385|4077|lyfalmen|||00|14|0|14|Vistor hf|Eisai Ltd|||2385||2385|4077 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|30|SEK|4170|6499|lyfalmen|||00|28|0|28|Vistor hf|Eisai Ltd|||4170||4170|6499 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|30|SEK|8345|12165|lyfalmen|||00|56|0|56|Vistor hf|Eisai Ltd|||8345||8345|12165 552224|C08CA0501|Adalat|töflur|20|mg|100|stk|1|þpakki||C08CA05|01.04.1985||R|A|5|0|0|B|0|BHC|0|0|0|100|SEK|3770|5956|lyfalmen|||63|100|0|67|Vistor hf|Bayer HealthCare AG|||3770||3770|5956 552703|M01AB0509|Modifenac|forðahlk|75|mg|10|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|642|1712|lyfalmen|||00|10|0|8|Actavis Group hf|Actavis Group hf|||642||642|1712 552877|N05CF0104|Zopiklon Merck NM|filmhtfl|7,5|mg|500|stk|1|plglas||N05CF01|01.07.2007||R|A|2|0|0|0|0|MNA|0|0|0|100|SEK|4413|6829|lyfalmen|||00|500|0|500|Actavis Group PTC ehf|Merck NM AB|||4413||4413|6829 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|þpakki||N03AF02|01.10.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3739|5914|lyfalmen|||00|100|0|15|Vistor hf|Novartis Healthcare A/S-|||3739||3739|5914 552919|N03AF0201|Trileptal|filmhtfl|300|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3712|5878|lyfalmen|||00|50|0|15|Vistor hf|Novartis Healthcare A/S-|||3712||3712|5878 553313|N02CC0601|Relpax|töflur|40|mg|3|stk|1|þpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2549|4299|lyfalmen|||00|3|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2549||2549|4299 553339|N02CC0601|Relpax|töflur|40|mg|6|stk|1|þpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|4927|7527|lyfalmen|||00|6|0|6|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4927||4927|7527 554154|QA12CE9902|Selevitan, vet.|stl|0| |100|ml|5|hgl||QA12CE99|01.05.1983||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|7754|14941|vetalmen|||27|500|0|0|Vistor hf|Boehringer Ingelheim Danmark|||7754||7754|14941 555607|N06AB0601|Zoloft|mixtúra|20|mg/ml|60|ml|1|fl||N06AB06|01.03.2001||R|A|3|0|0|B|0|PFI|0|1|0|30|DKK|5225|7931|lyfalmen|||00|60|0|24|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5225||5225|7931 556589|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3379|4838|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|||3379||3379|4838 556654|B05BA0313|Glucos 500 mg/ml Fresenius Kabi|irl|500|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.05.2004||R|A|1|0|0|0|1|FRP|0|0|0|100|DKK|6501|9308|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|||6501||6501|9308 556662|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|5512|7892|lyfsjukr|||00|6000|0|0|Icepharma hf|Fresenius Kabi|||5512||5512|7892 556738|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|4061|5814|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|||4061||4061|5814 556753|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3775|5405|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|||3775||3775|5405 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|5881|8821|lyfalmen|||00|100|0|30|Vistor hf|Novartis Healthcare A/S-|||5881||5881|8821 556944|N03AF0201|Trileptal|filmhtfl|600|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|7199|10610|lyfalmen|||00|50|0|30|Vistor hf|Novartis Healthcare A/S-|||7199||7199|10610 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|12814|18138|lyfalmen|||00|100|0|60|Vistor hf|Novartis Healthcare A/S-|||12814||12814|18138 557546|D10AF0202|Zineryt|áburður|0| |30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|A|2|0|0|0|0|ASP|0|0|0|100|XEU|1709|3160|lyfalmen|||38|30|0|30|Vistor hf|Astellas Pharma A/S|||1709||1709|3160 558585|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|10|hgl|röntgenskuggaefni|V08CA01|01.07.1992||R|A|5|0|0|0|1|SAG|0|0|0|100|SEK|159943|200997|lyfsjukr|||02|200|0|0|Icepharma hf|Schering AG|||159943||159943|200997 559013|C08DA0103|Isoptin retard|forðatfl|120|mg|28|stk|1|þpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|1047|2261|lyfalmen|||10|28|0|14|Vistor hf|Abbott Scandinavia AB|||1047||1047|2261 559021|C08DA0103|Isoptin retard|forðatfl|120|mg|98|stk|1|þpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|2348|4027|lyfalmen|||10|98|0|49|Vistor hf|Abbott Scandinavia AB|||2348||2348|4027 559062|N02AX0201|Nobligan|hylki|50|mg|100|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1119|2359|lyfalmen|V0731|1524|10|100|0|17|Icepharma hf|Grunenthal|||1119||1119|2359 559070|N02AX0201|Nobligan|hylki|50|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|628|1693|lyfalmen|V0730|1238|10|20|0|3|Icepharma hf|Grunenthal|||628||628|1693 559104|N02AX0201|Nobligan|eþ-stil|100|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1751|3217|lyfalmen|||04|20|0|7|Icepharma hf|Grunenthal|||1751||1751|3217 559120|N02AX0201|Nobligan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1007|2207|lyfalmen|V0732|2092|02|10|0|2|Icepharma hf|Grunenthal|||1007||1007|2207 559146|J06BA0201|Gammagard S/D|irs|0,5|g/fl|1|fl|1|pakki|+ leysir 10 ml|J06BA02|01.10.1991|31.10.2008|R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|||lyfsjukr|||00|1|0|0|Icepharma hf|Baxter|||||| 559153|J06BA0201|Gammagard S/D|irs|2,5|g/fl|1|fl|1|pakki|+ leysir 50 ml|J06BA02|01.10.1991|31.10.2008|R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|||lyfsjukr|||00|1|0|0|Icepharma hf|Baxter|||||| 559161|J06BA0201|Gammagard S/D|irs|5|g/fl|1|fl|1|pakki|+ leysir 96 ml|J06BA02|01.10.1991|31.10.2008|R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|||lyfsjukr|||00|1|0|0|Icepharma hf|Baxter|||||| 559187|J06BA0201|Gammagard S/D|irs|10|g/fl|1|fl|1|pakki|+ leysir 192 ml|J06BA02|01.10.1991|31.10.2008|R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|||lyfsjukr|||00|1|0|0|Icepharma hf|Baxter|||||| 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|XEU|||lyfalmen|||00|100|0|100|Icepharma hf|STADA Arzneimittel AG||||||0 559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|2596|4363|lyfalmen|||06|5|0|0|Icepharma hf|Santen Oy|||2596||2596|4363 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|XEU|||lyfalmen|||00|100|0|0|Icepharma hf|STADA Arzneimittel AG||||||0 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|7590|11140|lyfalmen|||23|1|0|90|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||7590||7590|11140 559963|C01DA0201|Discotrine|forðapl|5|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|DKK|4033|4703|lyfalmen|||23|30|0|30|Vistor hf|Meda AB (V)|||2846||2846|4703 559971|C01DA0201|Discotrine|forðapl|10|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|DKK|4454|5107|lyfalmen|||23|30|0|60|Vistor hf|Meda AB (V)|||3144||3144|5107 559989|N01AB0701|Suprane|innönd.l|0| |240|ml|1|fl||N01AB07|01.01.1995||R|A|3|0|0|0|1|BAX|0|0|0|100|DKK|10620|15089|lyfsjukr|||00|240|0|0|Icepharma hf|Baxter|||10620||10620|15089 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|A|3|0|0|E|0|GEM|0|0|0|100|XEU|||lyfalmen|||07|10|0|0|Actavis Group hf|Gerhard Mann||||||1311 560193|C09AA0101|Capoten|töflur|12,5|mg|100|stk|1|þpakki||C09AA01|01.07.1990|31.12.2008|R|A|4|0|0|B|0|BRS|0|0|0|100|DKK|2182|3800|lyfalmen|||00|100|0|25|Vistor hf|Bristol-Myers Squibb|||2182||2181|3800 560235|C09AA0101|Capoten|töflur|25|mg|100|stk|1|þpakki||C09AA01|01.04.1995|31.12.2008|R|A|4|0|0|B|0|BRS|0|0|0|100|DKK|||lyfalmen|||00|100|0|50|Vistor hf|Bristol-Myers Squibb|||3166||| 560250|C09AA0101|Capoten|töflur|50|mg|100|stk|1|þpakki||C09AA01|01.04.1995|31.12.2008|R|A|4|0|0|B|0|BRS|0|0|0|100|DKK|||lyfalmen|||00|100|0|100|Vistor hf|Bristol-Myers Squibb|||5286||| 560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.07.1989||R|A|5|0|0|E|0|GSK|0|0|1|30|GBP|2945|4837|lyfalmen|||00|25|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2945||2945|4837 560334|J05AB0102|Zovir|töflur|200|mg|100|stk|1|þpakki||J05AB01|01.07.1994||R|A|5|0|0|E|0|GSK|0|0|1|30|GBP|11597|16578|lyfalmen|||00|100|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||11597||11597|16578 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyfalmen|||20|2|0|2|Icepharma hf|GlaxoSmithKline CH A/S||||||0 560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|1680|3120|lyfalmen|||07|4|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1680||1680|3120 560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|30|GBP|5614|8459|lyfalmen|||00|125|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||5614||5614|8459 560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|30|GBP|6087|9101|lyfalmen|||00|100|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||6087||6087|9101 560490|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|K|3|0|1|0|1|ABS|0|0|0|100|DKK|115850|146101|lyfsjukr|||00|5|0|1|Vistor hf|Abbott Scandinavia AB|||115850||115850|146101 560557|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|K|3|0|1|0|1|ABS|0|0|0|100|DKK|610610|573438|lyfsjukr|||00|20|0|5|Vistor hf|Abbott Scandinavia AB|||459093||459093|573438 561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|2601|4370|lyfalmen|||06|5|0|0|Icepharma hf|Santen Oy|||2601||2601|4370 561571|N06AX1101|Remeron|töflur|30|mg|250|stk|1|glas|til notkunar vélskömmtun lyfja|N06AX11|01.11.2002||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|35643|46561|lyfalmen|||00|250|0|250|Vistor hf|N.V. Organon|||35643||35643|46561 563346|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|3|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|26636|35347|lyfalmen|||02|6|0|17|Gróco ehf|Nycomed Danmark A/S|||26636||26636|35347 563361|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|5|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|41004|53235|lyfalmen|||02|10|0|29|Gróco ehf|Nycomed Danmark A/S|||41004||41004|53235 563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|655|1729|lyfalmen|||20|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||655||655|1729 563387|D07AC1701|Cutivat|krem|0,5|mg/g|100|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2033|3599|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2033||2033|3599 563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|655|1729|lyfalmen|||20|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||655||655|1729 563403|D07AC1701|Cutivat|smyrsli|50|mcg/g|100|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2033|3599|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||2033||2033|3599 563494|N02AA0101|Contalgin|forðatfl|5|mg|25|stk|1|þpakki||N02AA01|01.10.1993|31.12.2008|R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|613|1672|lyfalmen|||10|25|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||613||613|1672 563502|N02AA0101|Contalgin|forðatfl|5|mg|100|stk|1|þpakki||N02AA01|01.10.1993||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|1734|3193|lyfalmen|||10|100|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1734||1734|3193 563528|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|30|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|220272|276424|lyfalmen|||02|60|0|172|Gróco ehf|Nycomed Danmark A/S|||220272||220272|276424 563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|5080|7734|lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy|||5080||5080|7734 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|5351|8102|lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy|||5351||5351|8102 563684|C10AA0401|Lescol|hylki|20|mg|98|stk|1|þpakki||C10AA04|01.10.1997||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|9450|13664|lyfalmen|||00|98|0|49|Vistor hf|Novartis Healthcare A/S-|||9450||9450|13664 563700|C10AA0401|Lescol|hylki|40|mg|98|stk|1|þpakki||C10AA04|01.10.1997||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|11964|17076|lyfalmen|||00|98|0|98|Vistor hf|Novartis Healthcare A/S-|||11964||11964|17076 564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|þpakki|hart|J05AB04|01.02.2002||R|A|2|0|1|0|1|SCP|0|0|0|30|DKK|162440|204105|lyfsjukr|||00|168|0|34|Vistor hf|Schering-Plough|||162440||162440|204105 565275|C07AG0202|Dimitone|töflur|12,5|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|6003|8987|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||6003||6003|8987 565325|C07AG0202|Dimitone|töflur|25|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|9009|13066|lyfalmen|||00|100|1|67|Parlogis hf|Parlogis - óskráð lyf|||9009||9009|13066 565374|C07AG0202|Dimitone|töflur|6,25|mg|28|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|1593|3002|lyfalmen|||00|28|1|5|Parlogis hf|Parlogis - óskráð lyf|||1593||1593|3002 565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|A|4|0|0|B|0|UCB|0|0|0|100|DKK|12359|17572|lyfalmen|||00|100|0|50|Vistor hf|U.C.B|||12359||12359|17572 566018|D01BA0201|Lamisil|töflur|125|mg|14|stk|1|þpakki||D01BA02|01.07.1995||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|3141|2835|lyfalmen|||00|14|0|7|Vistor hf|Novartis Healthcare A/S-|||1470||1470|2835 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|1422|2770|lyfalmen|||06|5|0|25|K.Pétursson hf|Alcon|||1422||1422|2770 566661|L04AB0101|Enbrel|sts|0| |25|mg|4|hgl|+ leysir|L04AB01|01.11.2000||R|K|3|0|1|0|1|WTE|0|0|0|100|USD|112803|142307|lyfsjukr|||00|100|0|14|Icepharma hf|Wyeth Europe|||112803||112803|142307 566984|A10BG0201|Avandia|töflur|4|mg|28|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.12.2000|31.12.2008|R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|5178|7866|lyfalmen|||00|28|0|19|GlaxoSmithKline ehf|SmithKline Beecham PLC|||5178||5177|7866 566992|J02AC0101|Diflucan|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.10.1993||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|6186|9235|lyfalmen|V0556|4233|10|4|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6186||6186|9235 567016|R06AD0201|Phenergan|mixtúra|1|mg/ml|100|ml|1|glas||R06AD02|01.10.1995||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1453|2812|lyfalmen|||00|100|0|4|Vistor hf|Sanofi-aventis Norge AS|||1453||1453|2812 567073|A10BG0201|Avandia|töflur|4|mg|56|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.12.2000||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|7693|11280|lyfalmen|||00|56|0|37|GlaxoSmithKline ehf|SmithKline Beecham PLC|||||7693|11280 567149|A10BG0201|Avandia|töflur|8|mg|28|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.12.2000||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|6091|9106|lyfalmen|||00|28|0|37|GlaxoSmithKline ehf|SmithKline Beecham PLC|||6091||6091|9106 567503|N05AX0801|Risperdal|töflur|1|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|5971|8943|lyfalmen|V0791|4040|00|60|0|12|Vistor hf|Janssen-Cilag AB|||5971||5971|8943 567511|N05AX0801|Risperdal|töflur|2|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|13145|18551|lyfalmen|V0793|8270|00|60|0|24|Vistor hf|Janssen-Cilag AB|||13145||13145|18551 567529|N05AX0801|Risperdal|töflur|3|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|21849|29387|lyfalmen|V0794|11709|00|60|0|36|Vistor hf|Janssen-Cilag AB|||21849||21849|29387 567537|N05AX0801|Risperdal|töflur|4|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|28950|38228|lyfalmen|V0795|18331|00|60|0|48|Vistor hf|Janssen-Cilag AB|||28950||28950|38228 567545|R01AC0201|Livostin|nefúði|0,5|mg/úðask|15|ml|1|glas||R01AC02|01.06.1998||L|A|3|0|0|0|0|JAS|0|0|1|100|SEK|||lyfalmen|||24|15|0|12|Vistor hf|Janssen-Cilag AB||||||0 567719|C10AA0302|Pravachol|töflur|40|mg|98|stk|1|þpakki||C10AA03|01.06.1998||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|22166|29782|lyfalmen|||00|98|0|196|Vistor hf|Bristol-Myers Squibb|||22166||22166|29782 567990|V08AB0901|Visipaque|stl|150|mg J/ml|200|ml|6|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|14023|19326|lyfsjukr|||02|1200|0|0|Icepharma hf|GE Healthcare AS|||14023||14023|19326 568022|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|27452|36045|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|||27452||27452|36045 568030|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|5568|7972|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|||5568||5568|7972 568055|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|28937|37894|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|||28937||28937|37894 568238|A02BC0401|Pariet|sh-tfl|20|mg|120|stk|1|þpakki||A02BC04|01.05.2002||R|A|2|0|0|E|0|EIS|0|0|0|30|SEK|17044|23405|lyfalmen|||00|120|0|120|Vistor hf|Eisai Ltd|||17044||17044|23405 568519|N05AB0301|Trilafon|töflur|8|mg|100|stk|1|þpakki||N05AB03|01.01.1986||R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|2155|3765|lyfalmen|||00|100|0|27|Vistor hf|Schering-Plough|||2155||2155|3765 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|1053|2269|lyfalmen|||00|3|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||1053||1053|2269 568790|N02AA5902|Parkodin forte|eþ-stil|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.07.1993||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|489|1504|lyfalmen|||04|10|0|3|Actavis Group hf|Actavis hf|||489||489|1504 568840|C08CA0201|Feldil|forðatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|1463|2826|lyfalmen|V0316|2826|10|100|0|100|Actavis Group hf|Actavis hf|||1463||1463|2826 568865|C08CA0201|Feldil|forðatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|2318|3986|lyfalmen|V0324|3986|10|100|0|200|Actavis Group hf|Actavis hf|||2318||2318|3986 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|19030|25560|lyfsjukr|||02|5|0|18|Vistor hf|Novartis Healthcare A/S-|||19030||19030|25560 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|5|0|0|0|1|NOH|0|0|0|100|DKK|19030|25560|lyfsjukr|||02|20|0|18|Vistor hf|Novartis Healthcare A/S-|||19030||19030|25560 569897|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|spr|án nálar|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2458|4176|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|||2458||2458|4176 569913|J07CA0203|DiTeKiPol|bóluefni|0| |0,5|ml|1|spr|án nálar|J07CA02|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|3501|5591|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|||3501||3501|5591 572768|B02BC1001|Tisseel Duo Quick|vefjalím|0| |0,5|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|130602|164467|lyfsjukr|||00|5|0|0|Icepharma hf|Baxter|||130602||130602|164467 572776|B02BC1001|Tisseel Duo Quick|vefjalím|0| |1|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|170950|214700|lyfsjukr|||00|10|0|0|Icepharma hf|Baxter|||170950||170950|214700 572784|B02BC1001|Tisseel Duo Quick|vefjalím|0| |2|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|321599|402258|lyfsjukr|||00|20|0|0|Icepharma hf|Baxter|||321599||321599|402258 573287|G03CA0306|Evorel|forðapl|25|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|3552|5661|lyfalmen|||23|26|0|46|Vistor hf|Janssen-Cilag AB|||3552||3552|5661 573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|109303|137950|lyfsjukr|||00|1|0|0|Icepharma hf|Roche|||109303||109303|137950 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|ASZ|0|0|0|100|SEK|27682|36332|lyfsjukr|||00|5000|0|2|Vistor hf|AstraZeneca UK Ltd|||27682||27682|36332 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|ASZ|0|0|0|100|SEK|54179|69320|lyfsjukr|||00|10|0|5|Vistor hf|AstraZeneca UK Ltd|||54179||54179|69320 573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|2756|2507|lyfalmen|V0610|2451|67|100|0|50|Vistor hf|Novartis Healthcare A/S-|||1228||1228|2507 575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PFI|0|1|0|30|DKK|3848|3578|lyfalmen|V0931|2428|00|28|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2017||2017|3578 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PFI|0|1|0|30|DKK|12729|9782|lyfalmen|V0933|6361|00|98|0|98|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6589||6589|9782 575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PFI|0|1|0|30|DKK|6600|5434|lyfalmen|V0935|3559|00|28|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3385||3385|5434 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PFI|0|1|0|30|DKK|20764|15955|lyfalmen|V0937|10351|00|98|0|196|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||11138||11138|15955 575472|P03AX0301|Prioderm|hársápa|10|mg/ml|40|g|1|túpa||P03AX03|01.04.1994||L|K|2|0|0|0|0|NOP|0|0|0|100|IKR|||lyfalmen|||23|40|0|0|Icepharma hf|Norpharma ||||||0 575506|C01EB1001|Adenocor|stl|3|mg/ml|2|ml|6|hgl||C01EB10|01.11.2007||R|A|3|0|0|0|1|SAA|0|0|0|100|NOK|5622|8049|lyfsjukr|||00|12|0|0|Vistor hf|Sanofi - Aventis|||5622||5622|8049 575787|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.12.2000||R|K|3|0|1|0|1|CEO|0|0|0|100|DKK|101424|128140|lyfsjukr|||00|1|0|27|Vistor hf|Centocor B.V.|||101424||101424|128140 577494|M05BA0101|Didronate|töflur|200|mg|28|stk|1|þpakki||M05BA01|01.04.1996||R|A|4|0|0|E|0|PGA|0|0|0|100|DKK|6827|10105|lyfalmen|||00|28|0|14|Sofus Consulting AB|Procter & Gamble-|||6827||6827|10105 577668|C07FB0201|Logimax|forðatfl|55|mg|28|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2951|4845|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca A/S DK|||2951||2951|4845 579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|1149|2400|lyfalmen|||02|10|0|0|Vistor hf|AstraZeneca A/S DK|||1149||1149|2400 579854|L04AX0301|Methotrexate Wyeth Lederle|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|A|3|0|0|*|0|WAB|0|0|0|100|USD|906|2070|lyfalmen|||00|30|0|30|Icepharma hf|Wyeth AB|||906||906|2070 582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|32859|42777|lyfsjukr|||02|1|0|9|Icepharma hf|Eli Lilly Danmark A/S|||32859||32859|42777 582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|65423|83319|lyfsjukr|||02|1|0|18|Icepharma hf|Eli Lilly Danmark A/S|||65423||65423|83319 582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|131137|165133|lyfsjukr|||02|1|0|36|Icepharma hf|Eli Lilly Danmark A/S|||131137||131137|165133 582213|R01AA0503|Nezeril|nefúði|0,1|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyfalmen|||23|8|0|2|Vistor hf|AstraZeneca A/S DK||||||0 582247|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|5315|9198|vetorma|||16|50|0|0|Icepharma hf|Pfizer Oy Animal Health|||5315||5315|9198 582262|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|20027|34658|vetorma|||16|200|0|0|Icepharma hf|Pfizer Oy Animal Health|||20027||20027|34658 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|39554|51112|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|||39554||39554|51112 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|70812|90028|lyfsjukr|||02|3000|0|0|Icepharma hf|GE Healthcare AS|||70812||70812|90028 582775|C07AB0205|Seloken|töflur|50|mg|28|stk|1|þpakki||C07AB02|01.12.2001||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|518|1543|lyfalmen|||00|28|0|9|Vistor hf|AstraZeneca A/S DK|||518||518|1543 582783|C07AB0205|Seloken|töflur|100|mg|28|stk|1|þpakki||C07AB02|01.12.2001||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|716|1812|lyfalmen|||00|28|0|19|Vistor hf|AstraZeneca A/S DK|||716||716|1812 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|27452|36045|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|||27452||27452|36045 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|53298|68224|lyfsjukr|||02|2000|0|0|Icepharma hf|GE Healthcare AS|||53298||53298|68224 583443|C07AA0704|Sotalol Merck NM|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|1042|2254|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|||1042||1042|2254 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|82356|104401|lyfsjukr|||02|3000|0|0|Icepharma hf|GE Healthcare AS|||82356||82356|104401 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|28937|37894|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|||28937||28937|37894 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|61388|78296|lyfsjukr|||02|2000|0|0|Icepharma hf|GE Healthcare AS|||61388||61388|78296 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|92841|117455|lyfsjukr|||02|3000|0|0|Icepharma hf|GE Healthcare AS|||92841||92841|117455 583849|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4069|5826|lyfsjukr|||00|5000|0|5|Icepharma hf|Fresenius Kabi|||4069||4069|5826 583856|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2119|3034|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|||2119||2119|3034 583914|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|50|ml|30|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|7824|11202|lyfsjukr|||00|1500|0|0|Icepharma hf|Fresenius Kabi|||7824||7824|11202 583922|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|20|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6418|9189|lyfsjukr|||00|5000|0|5|Icepharma hf|Fresenius Kabi|||6418||6418|9189 583930|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3118|4464|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|||3118||3118|4464 584011|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|30|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|8911|12758|lyfsjukr|||00|3000|0|3|Icepharma hf|Fresenius Kabi|||8911||8911|12758 584029|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3526|5048|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|||3526||3526|5048 584102|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|4203|6018|lyfsjukr|||00|9000|0|0|Icepharma hf|Fresenius Kabi|||4203||4203|6018 584276|B05BB0115|Ringer-acetat Fresenius Kabi|irl|0| |1000|ml|9|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2376|3402|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|||2376||2376|3402 584284|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |100|ml|30|pokar|excel umbúðir|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||00|3000|0|0|Icepharma hf|Fresenius Kabi||||||0 584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|þpakki||N06AG02|01.07.1995||R|A|5|0|0|B|0|MAS|0|1|0|100|DKK|5213|5833|lyfalmen|||64|30|0|30|Vistor hf|Meda AS|||3679||3679|5833 585646|B01AB0101|Heparin Leo|stl|25000|ae/ml|2|ml|10|hgl||B01AB01|01.11.1981||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|10638|15112|lyfsjukr|||02|20|0|50|Vistor hf|LEO Pharma A/S|||10638||10638|15112 585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|3875|5548|lyfsjukr|||02|25|0|12|Vistor hf|LEO Pharma A/S|||3875||3875|5548 585844|J01DH5101|Tienam|irs|500|mg|12|hgl|1|pakki|monovial|J01DH51|01.04.1988||R|A|2|0|0|0|1|MSD|0|0|0|100|XEU|38094|49295|lyfsjukr|||00|12|0|3|Icepharma hf|M.S.D.|||38094||38094|49295 585869|J07BC0201|Havrix|bóluefni|1440|ein/ml|1|ml|1|dæla|einnota dæla|J07BC02|01.07.1994||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3495|5583|lyfalmen|||02|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||3495||3495|5583 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|36896|48120|lyfalmen|||00|50|0|20|Vistor hf|Novartis Healthcare A/S-|||36896||36896|48120 586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|2808|4651|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|||2808||2808|4651 587667|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|0| |1000|ml|9|plpok|Excel umbúðir|B05BB02|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3302|4728|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|||3302||3302|4728 588152|S01GX0401|Tilavist|augndr|20|mg/ml|5|ml|1|glas||S01GX04|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1352|2675|lyfalmen|||06|5|0|0|Vistor hf|Sanofi-aventis Norge AS|||1352||1352|2675 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.10.1995||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|2340|4016|lyfalmen|V0426|3951|43|20|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2340||2340|4016 588590|B01AC0501|Ticlid|töflur|250|mg|30|stk|1|þpakki||B01AC05|01.04.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|3786|5978|lyfalmen|||00|30|0|15|Vistor hf|Sanofi-aventis Norge AS|||3786||3786|5978 588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|þpakki||B01AC05|01.04.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|11929|17029|lyfalmen|||00|100|0|50|Vistor hf|Sanofi-aventis Norge AS|||11929||11929|17029 588723|B03AA0702|Ferlen-R|forðatfl|100|mg|60|stk|1|glas||B03AA07|01.01.1994||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||10|60|0|30|Actavis Group hf|Actavis hf|||||| 588772|H05BA0103|Miacalcic Nasal|nefúði|200|ae/sk|2|ml|1|úðagl|14 skammt|H05BA01|01.03.2002||R|K|3|0|0|E|0|NOH|0|0|0|100|DKK|9364|13548|lyfalmen|||23|2|0|14|Vistor hf|Novartis Healthcare A/S-|||9364||9364|13548 589358|QP54AA0501|Stronghold vet.|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|6497|11243|vetorma|||16|3|0|0|Icepharma hf|Pfizer Animal Health|||6497||6497|11243 589366|QP54AA0501|Stronghold vet.|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|2518|4358|vetorma|||16|1|0|0|Icepharma hf|Pfizer Animal Health|||2518||2518|4358 589374|QP54AA0501|Stronghold vet.|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|6268|10847|vetorma|||16|6|0|0|Icepharma hf|Pfizer Animal Health|||6268||6268|10847 589382|QP54AA0501|Stronghold vet.|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3386|5860|vetorma|||16|1|0|0|Icepharma hf|Pfizer Animal Health|||3386||3386|5860 589390|QP54AA0501|Stronghold vet.|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3517|6086|vetorma|||16|2|0|0|Icepharma hf|Pfizer Animal Health|||3517||3517|6086 589408|QP54AA0501|Stronghold vet.|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|2724|4714|vetorma|||16|2|0|0|Icepharma hf|Pfizer Animal Health|||2724||2724|4714 589497|D11AF0102|Canthacur|lausn|0,7|%|7,5|ml|1|glas||D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2566|4323|lyfalmen|||00|8|1|8|Parlogis hf|Parlogis - óskráð lyf|||2566||2566|4323 589500|D11AF0103|Canthacur-PS|lausn|36|%|7,5|ml|1|glas|1%+30%+5%|D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|5480|8277|lyfalmen|||00|8|1|8|Parlogis hf|Parlogis - óskráð lyf|||5480||5480|8277 589911|L01BB0501|Fludara|sts|50|mg/hgl|50|mg|5|hgl||L01BB05|01.01.1996||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|144223|181425|lyfsjukr|||00|250|0|0|Icepharma hf|Bayer Schering Pharma AG|||144223||144223|181425 590315|J05AE0301|Norvir|hylki|100|mg|84|stk|4|glös|mjúk hylki|J05AE03|01.08.2003||R|K|2|0|1|0|1|ABL|0|0|0|100|DKK|91561|115861|lyfsjukr|||00|336|0|28|Vistor hf|Abbott Laboratories A/S|||91561||91561|115861 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|A|3|0|0|0|0|BAS|0|0|1|100|DKK|||lyfalmen|||00|20|0|20|Vistor hf|Bayer A/S||||||0 590539|A01AD1101|Bonjela|hlaup|0| |15|g|1|túpa|hlaup í munn|A01AD11|01.01.1996||L|A|3|0|0|0|0|REB|0|0|1|100|IKR|||lyfalmen|||00|15|0|0|Icepharma hf|Reckitt Benckiser Healthcare Ltd.||||||0 590562|C01DA1403|Ismo|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.10.1999||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1404|2746|lyfalmen|V0139|2746|10|98|0|147|Actavis Group hf|Actavis hf|||1404||1404|2746 590752|N05AF0102|Fluanxol Depot|stl|100|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1979||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|28276|37389|lyfalmen|||02|10|0|250|Lundbeck Export A/S|H. Lundbeck A/S|||28276||28276|37389 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|A|2|0|0|0|1|BOI|0|0|0|100|DKK|208525|261481|lyfsjukr|||00|1|0|1|Vistor hf|Boehringer Ingelheim|||208525||208525|261481 591131|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|6|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|31979|41681|lyfsjukr|||00|1200|0|0|Icepharma hf|GE Healthcare AS|||31979||31979|41681 591149|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|6|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|36833|47725|lyfsjukr|||00|1200|0|0|Icepharma hf|GE Healthcare AS|||36833||36833|47725 592097|N01AF0301|Pentothal Natrium|sts|500|mg|1|stk|12|hgl||N01AF03|01.07.1990||R|A|4|0|0|0|1|HOS|0|0|0|100|DKK|3470|4968|lyfsjukr|||02|12|0|0|Vistor hf|Hospira Enterprises B.V.|||3470||3470|4968 592147|D05AX0301|Silkis|smyrsli|3|mcg/g|100|g|1|túpa||D05AX03|01.06.2001||R|A|3|0|0|B|0|GAN|0|0|0|100|XEU|6692|9922|lyfalmen|||00|100|0|0|Icepharma hf|Galderma Nordic AB|||6692||6692|9922 592378|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|500|ml|1|glas||D08AC02|01.10.1976||L|A|3|0|0|0|0|REM|0|0|0|100|SEK|||lyflausa|||00|500|0|500|Vistor hf|Regent Medical Overseas Limited|||||| 592469|N02BE0107|Paratabs|lausnart|160|mg|30|stk|1|þpakki||N02BE01|01.01.1995||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||09|30|0|2|Actavis Group hf|Actavis hf||||||0 593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|691|1778|lyfalmen|||00|50|0|3|Icepharma hf|Roche|||691||691|1778 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|1079|2305|lyfalmen|||00|150|0|9|Icepharma hf|Roche|||1079||1079|2305 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|1834|3329|lyfalmen|||00|100|0|25|Icepharma hf|Roche|||1834||1834|3329 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|18798|25588|lyfalmen|||03|12|0|32|Icepharma hf|Meda AB|||18798||18798|25588 594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||625 594721|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|10|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|100|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||5190 594903|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|0| |1000|ml|9|plpok|Exel umbúðir|B05BB02|01.04.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3044|4358|lyfsjukr|||02|9000|0|0|Icepharma hf|Fresenius Kabi|||3044||3044|4358 594945|QA12CE9903|Selenevit, vet.|stl|26|mg/ml|100|ml|1|hgl|1+25 mg/ml|QA12CE99|01.09.1982||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|1092|2155|vetalmen|||27|100|0|0|Icepharma hf|Intervet International B.V.|||1092||1092|2155 595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|K|5|0|0|0|1|NOH|0|0|0|100|DKK|9291|13302|lyfsjukr|||02|5|0|5|Vistor hf|Novartis Healthcare A/S-|||9291||9291|13302 595991|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|596|1649|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||596||596|1649 596023|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|250|ml|1|glas||D08AC02|01.06.1982||L|A|3|0|0|0|0|REM|0|0|0|100|SEK|||lyflausa|||00|250|0|250|Vistor hf|Regent Medical Overseas Limited|||||| 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|þpakki||J01FF01|01.06.1979||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|4145|6465|lyfalmen|||43|24|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4145||4145|6465 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|A|2|0|0|0|0|JAS|0|0|1|100|SEK|||lyfalmen|||00|30|0|30|Vistor hf|Janssen-Cilag AB||||||0 597575|D01AC0301|Pevaryl|húðduft|10|mg/g|30|g|1|stauk||D01AC03|01.07.1991||L|A|5|0|0|0|0|JAS|0|0|1|100|SEK|||lyfalmen|||00|30|0|30|Vistor hf|Janssen-Cilag AB||||||0 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|900|2062|lyfalmen|||00|150|0|25|Vistor hf|Sanofi-aventis Norge AS|||900||900|2062 801120|A11HA0503|Biotin Bayer|töflur|5|mg|20|stk|1|glas||A11HA05|01.12.2005||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1218|2493|lyfalmen|||00|20|1|0|Distica|Distica - óskráð lyf|||1218||1218|2493 907024|A04AD0501|Vogalene|eþ-stil|5|mg|10|stk|1|pakki||A04AD05|01.01.1998||R|A||0|0|E|0|PCO|0|0|1|100|IKR|1597|3008|lyfalmen|||00|10|1|3|Distica|Distica - óskráð lyf|||1597||1597|3008 908048|J07AM5201|Immunoglob. mot tetanus|bóluefni|250|ae|1,2|ml|1|hgl||J07AM52|01.01.1998||R|K||0|0|0|0|LDR|0|0|1|100|IKR|9865|14228|lyfalmen|||00|1|1|0|Parlogis hf|Parlogis - óskráð lyf|||9865||9865|14228 912792|N07CA0301|Sibelium|hylki|5|mg|50|stk|1|glas||N07CA03|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|4276|6643|lyfalmen|||00|50|1|25|Distica|Distica - óskráð lyf|||4276||4276|6643 916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|glas||A03FA03|01.05.1998||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2314|3981|lyfalmen|||00|100|1|33|Distica|Distica - óskráð lyf|||2314||2314|3981 922866|N05BA0602|Ativan|stl|4|mg/ml|1|ml|4|lykjur||N05BA06|01.11.2005||R|A||0|0|0|1|LDR|0|0|0|100|IKR|3294|4716|lyfsjukr|||00|4|1|0|Parlogis hf|Parlogis - óskráð lyf|||3294||3294|4716 923351|S01XA2006|Lacri - Lube|augnsm|0| |3,5|g|1|túpa||S01XA20|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|480|1492|lyfalmen|||00|4|1|0|Distica|Distica - óskráð lyf|||480||480|1492 923608|C03BA0801|Metenix|töflur|5|mg|100|stk|1|þpakki||C03BA08|01.05.1998||R|A||0|0|0|0|PCO|0|0|0|100|IKR|4460|6893|lyfalmen|||00|100|1|100|Distica|Distica - óskráð lyf|||4460||4460|6893 924698|G03DA0402|Gestone|stl|50|mg/ml|2|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|IKR|8792|12772|lyfalmen|||00|20|1|200|Distica|Distica - óskráð lyf|||8792||8792|12772 927361|A12AA1201|Phos-Ex|töflur|167|mg|180|stk|1|glas||A12AA12|01.01.1998||R|A||0|1|0|0|LDR|0|0|0|100|IKR|1768|3240|lyfalmen|||00|180|1|15|Parlogis hf|Parlogis - óskráð lyf|||1768||1768|3240 937980|C01CA2403|Adrenalin|stl|0,1|mg/ml|10|ml|1|spr||C01CA24|01.05.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|1461|2092|lyfsjukr|||02|10|1|2|Parlogis hf|Parlogis - óskráð lyf|||1461||1461|2092 938376|N07BC0201|Metadon|hylki|40|mg|100|stk|1|glas||N07BC02|01.07.2000||R|A||1|0|0|0|LDR|0|0|0|100|IKR|8233|12013|lyfalmen|||00|100|1|160|Parlogis hf|Parlogis - óskráð lyf|||8233||8233|12013 938417|N07BC0201|Metadon|stl|10|mg/ml|1,1|ml|10|lykjur||N07BC02|01.07.2000||R|A||1|0|0|0|LDR|0|0|0|100|IKR|1770|3242|lyfalmen|||00|11|1|4|Parlogis hf|Parlogis - óskráð lyf|||1770||1770|3242 938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|2510|4247|lyfalmen|||00|100|1|50|Parlogis hf|Parlogis - óskráð lyf|||2510||2510|4247 938524|G04BE0201|Papaverin|stl|40|mg/ml|1|ml|10|lykjur||G04BE02|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|3002|4914|lyfalmen|||00|10|1|4|Parlogis hf|Parlogis - óskráð lyf|||3002||3002|4914 938649|C05BA0401|Elmiron|hylki|100|mg|100|stk|1|glas||C05BA04|01.05.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|35415|46277|lyfalmen|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|||35415||35415|46277 938665|A12CX0001|K-Phos Neutral|töflur|0| |100|stk|1|glas||A12CX00|01.03.2001||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2993|4902|lyfalmen|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|||2993||2993|4902 938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|A||0|0|E|0|LDR|0|0|0|100|IKR|7401|10884|lyfalmen|||00|100|1|2|Parlogis hf|Parlogis - óskráð lyf|||7401||7401|10884 939366|G03DA0402|Gestone|stl|50|mg/ml|1|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|IKR|8792|12772|lyfalmen|||00|10|1|100|Distica|Distica - óskráð lyf|||8792||8792|12772 940256|G03CA0313|Oestradiol|vefjatfl|25|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|2245|3887|lyfalmen|||00|1|1|83|Parlogis hf|Parlogis - óskráð lyf|||2245||2245|3887 940264|G03CA0313|Oestradiol|vefjatfl|50|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|4490|6934|lyfalmen|||00|1|1|167|Parlogis hf|Parlogis - óskráð lyf|||4490||4490|6934 940272|G03CA0313|Oestradiol|vefjatfl|100|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|8395|12233|lyfalmen|||00|1|1|333|Parlogis hf|Parlogis - óskráð lyf|||8395||8395|12233 940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|1837|3333|lyfalmen|||00|1|1|1|Distica|Distica - óskráð lyf|||1837||1837|3333 942468|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|glas||A04AD05|01.01.1998||R|A||0|0|E|0|PCO|0|0|1|100|IKR|3163|5133|lyfalmen|||00|20|1|20|Distica|Distica - óskráð lyf|||3163||3163|5133 944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|A||0|0|E|0|PCO|0|0|1|100|IKR|4544|7007|lyfalmen|||00|100|1|13|Distica|Distica - óskráð lyf|||4544||4544|7007 944745|G03BA0302|Testosteron|vefjatfl|25|mg|1|stk|1|pakki||G03BA03|01.01.2002||R|A||0|0|E|0|PCO|0|0|0|100|IKR|1061|2280|lyfalmen|||00|1|1|8|Distica|Distica - óskráð lyf|||1061||1061|2280 944852|A06AX0102|Glycerol infant|eþ-stil|0| |12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|1304|lyfalmen|||00|12|1|0|Parlogis hf|Parlogis - óskráð lyf|||342||342|1304 944886|H02AB0601|Prednisolon|töflur|1|mg|28|stk|1|pakki||H02AB06|01.10.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|122|1006|lyfalmen|||00|28|1|3|Parlogis hf|Parlogis - óskráð lyf|||122||122|1006 944985|A06AX0103|Glycerol adult|eþ-stil|0| |12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|1304|lyfalmen|||00|12|1|0|Parlogis hf|Parlogis - óskráð lyf|||342||342|1304 944993|V03AB1702|Methylen Blue|stl|10|mg/ml|10|ml|10|lykjur||V03AB17|01.11.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|10030|14355|lyfsjukr|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|||10030||10030|14355 945602|A11EA08|Vitamin B-komplex|stl|0| |2|ml|10|lykjur||A11EA|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|1202|2472|lyfalmen|||00|20|1|0|Parlogis hf|Parlogis - óskráð lyf|||1202||1202|2472 945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2293|3952|lyfalmen|||00|10|1|10|Distica|Distica - óskráð lyf|||2293||2293|3952 947236|N06BC0101|Koffein|töflur|200|mg|50|stk|1|glas||N06BC01|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|1558|2955|lyfalmen|||00|50|1|25|Parlogis hf|Parlogis - óskráð lyf|||1558||1558|2955 947690|C01CA2403|Adrenalin|stl|1|mg/ml|1|ml|10|lykjur||C01CA24|01.07.2000||R|A||0|0|0|0|LDR|0|0|1|100|IKR|1301|2606|lyfalmen|||00|10|1|20|Parlogis hf|Parlogis - óskráð lyf|||1301||1301|2606 947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|3266|5273|lyfalmen|||00|100|1|67|Parlogis hf|Parlogis - óskráð lyf|||3266||3266|5273 947822|H02AB0203|Dexamethason|töflur|4|mg|50|stk|1|glas||H02AB02|01.11.2001||R|A||0|0|E|0|LDR|0|0|1|100|IKR|8756|12723|lyfalmen|||00|50|1|133|Parlogis hf|Parlogis - óskráð lyf|||8756||8756|12723 947913|A11HA0203|Vitamin B6 Heve|stl|12,5|mg/ml|2|ml|10|lykjur||A11HA02|01.06.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|582|1630|lyfalmen|||00|20|1|2|Parlogis hf|Parlogis - óskráð lyf|||582||582|1630 948242|H02AB0203|Dexamethason|töflur|0,5|mg|100|stk|1|pakki||H02AB02|01.04.2005||R|A||0|0|E|0|LDR|0|0|1|100|IKR|2071|3651|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||2071||2071|3651 949620|G03DA0401|Utrogestan|hylki|100|mg|30|stk|1|pakki||G03DA04|01.01.1999||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2001|3556|lyfalmen|||00|30|1|10|Parlogis hf|Parlogis - óskráð lyf|||2001||2001|3556 950742|H02AB0204|Dexa-Ratiopharm|stl|4|mg/ml|1|ml|10|hgl||H02AB02|01.01.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|1307|1871|lyfsjukr|||55|10|1|0|Parlogis hf|Parlogis - óskráð lyf|||1307||1307|1871 951005|G03CA0102|Etinylestradiol|töflur|25|mcg|21|stk|1|pakki||G03CA01|01.09.2002||R|A||0|0|E|0|LDR|0|0|0|100|IKR|755|1865|lyfalmen|||00|21|1|21|Parlogis hf|Parlogis - óskráð lyf|||755||755|1865 951287|J01CA0101|Ampicillin|sts|0| |1|g|10|hgl||J01CA01|01.07.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|4952|7090|lyfsjukr|||00|10|1|5|Parlogis hf|Parlogis - óskráð lyf|||4952||4952|7090 952251|J01CA0101|Ampicillin|sts|0| |500|mg|10|hgl||J01CA01|01.07.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|4403|6304|lyfsjukr|||00|5000|1|2|Parlogis hf|Parlogis - óskráð lyf|||4403||4403|6304 952798|A03BA0101|Atropin|stl|1|mg/ml|1|ml|10|lykjur||A03BA01|01.07.2004||R|A||0|0|0|0|LDR|0|0|1|100|IKR|1315|2625|lyfalmen|||00|10|1|7|Parlogis hf|Parlogis - óskráð lyf|||1315||1315|2625 952855|N02AA0102|Morfin|eþ-stil|10|mg|12|stk|1|pakki||N02AA01|01.10.2004||R|S||1|0|E|0|LDR|0|0|0|100|IKR|3127|5084|lyfalmen|||00|12|1|4|Parlogis hf|Parlogis - óskráð lyf|||3127||3127|5084 953374|N05AB0602|Stelazine|töflur|1|mg|112|stk|1|glas||N05AB06|01.06.2007||R|A||0|0|*|0|LDR|0|0|0|100|IKR|1890|3405|lyfalmen|||00|112|1|6|Parlogis hf|Parlogis - óskráð lyf|||1890||1890|3405 953621|R03DA0504|Theofyllamin EDA Ratiopharm|stl|120|mg/ml|1|ml|5|lykja||R03DA05|01.09.2004||R|A||0|0|0|0|LDR|0|0|0|100|IKR|289|1233|lyfalmen|||00|5|1|1|Parlogis hf|Parlogis - óskráð lyf|||289||289|1233 955239|A11GA0108|Vitamin C 500|stl|100|mg/ml|5|ml|5|lykjur||A11GA01|01.01.2006||R|A||0|0|0|0|LDR|0|0|0|100|IKR|551|1588|lyfalmen|||00|25|1|12|Parlogis hf|Parlogis - óskráð lyf|||551||551|1588 956302|N07AA0101|Neostigmin|stl|0,5|mg/ml|1|ml|10|lykjur||N07AA01|01.01.2006||R|A||0|0|0|0|LDR|0|0|0|100|IKR|647|1718|lyfalmen|||00|10|1|2|Parlogis hf|Parlogis - óskráð lyf|||647||647|1718 958613|V03AB1503|Naloxon|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.01.2009||R|A||0|0|0|1|LDR|0|0|0|100|IKR|12107|16941|lyfsjukr|||00|10|1|0|Parlogis hf|Parlogis - óskráð lyf|||12107||12107|16941 958829|A06AD0002|Miralax|lausnduf|0| |238|g|1|stauk||A06AD00|01.05.2007||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2093|3681|lyfalmen|||00|238|1|0|Parlogis hf|Parlogis - óskráð lyf|||2093||2093|3681 960999|L02AB0101|Megace|töflur|160|mg|30|stk|1|glas||L02AB01|01.01.2009||R|A||0|1|0|1|PCO|0|0|0|100|IKR|9780|14003|lyfsjukr|||00|30|1|112|Distica|Distica - óskráð lyf|||9780||9780|14003 961286|H02AB0905|Hydrocortisone|töflur|20|mg|30|stk|1|glas|0|H02AB09|01.10.2008|31.12.2008|R|A|0|0|0|E|0|LDR|0|0|1|100|IKR|4836|7403|lyfalmen|||00|30|1|20|Parlogis hf|Parlogis - óskráð lyf|||4836||4836|7403 961393|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|glas||A04AD05|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|2108|3701|lyfalmen|||00|20|1|20|Parlogis hf|Parlogis - óskráð lyf|||||2108|3701 961658|H02AB0905|Hydrocortisone|töflur|20|mg|25|stk|1|glas||H02AB09|01.01.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|4400|6811|lyfalmen|||00|25|1|17|Parlogis hf|Parlogis - óskráð lyf|||4400||4400|6811